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Abstract 
 
Microscale devices for quantitative characterizations of human biology 
 
by 
 
Shaheen Jeeawoody 
 
Joint Doctor of Philosophy 
With University of California, San Francisco in Bioengineering 
University of California, Berkeley 
 
Professor Amy E. Herr, Chair 
 
 
To understand the function and dysfunction of cells in biological organisms, it is 
important to characterize one of the key functional actors of the cell, proteins. With 
indications of poor correlation between mRNA expression and proteomic expression at 
the single cell level, in vitro assays directly quantifying protein expression, in both the 
spatial and temporal context, are needed. To span the extensive cellular heterogeneity 
in gene and protein expression and activity observed in cells and tissues, proteomic 
assays should interrogate single- and low-cell resolution with sufficiently high 
throughput to identify cellular sub-populations. These proteomic assays would also 
require sufficiently high selectivity and analytical sensitivity with which to interrogate 
protein isoforms and post-translational modifications. To address this measurement 
gap, we introduce and further develop proteomic assays towards these specifications. 
 
We enhanced the analytical sensitivity of the ultrathin isoelectric focusing assay (IEF) 
with subsequent immunoblot, by developing a highly-porous hydrogel matrix as a new 
substrate for the assay. We characterized the effect of this 10-fold increase in gel 
porosity on the IEF separation performance, paired with a reagent modification that 
directly impacts separation performance. Additionally, we assessed the benefits of the 
increased porosity on the in-gel immunoblot.  
 
Furthermore, we investigated the compartmentalization of protein lysate from single 
cells within the microwells embedded in the hydrogel substrate in our proteomic assays. 
We characterized the height of the fluid film between multi-material interfaces. We used 
numerical modeling and experimental validation to assess the contribution of the fluid 
film to the diffusive losses that reduce analytical sensitivity in our assays. 
 
We then re-imagined the ultrathin IEF assay for a 100-fold increase in throughput by 
developing 3D projection electrophoresis. We interrogated the IEF separation 
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performance of this proof-of-concept high-throughput IEF assay with several 
optimizations. We conclude this section of this dissertation with an in-depth discussion 
of the potential further developments for this platform, towards a high-sensitivity, high-
throughput proteomic assay with multiplexing capabilities. 
 
 
In a parallel line of inquiry in this dissertation, to further understand and characterize 
cellular functions at a larger scale, in vitro biological models mimicking human 
physiology are needed. Due to inter-species differences in ion channels, biological 
pathways, and pharmacokinetic properties, animal models do not faithfully predict 
human cardiotoxicity. Human in vitro tissue models, with similar three-dimensional 
microenvironments to those found in in vitro human organs, that are predictive of human 
drug responses would be a significant advancement for understanding, studying, and 
developing new drugs and strategies for treating diseases. To assess the measurement 
needs in this space, we surveyed the breadth of in vitro cardiac devices mimicking 
human cardiac physiology. 
 
The lipid storage and processing within adipose tissue strongly affects drug 
concentrations in vivo, and adipose tissue interacts with other organs via paracrine 
signals and fatty acid release, affecting the safety profiles of a large number of drug-like 
molecules. To address this measurement gap, we developed a microfluidic device with 
adipose tissue. We used numerical modeling and an analytical model to characterize 
the convective and diffusive transport within the device. We confirmed the maintenance 
of adipose cell viability and growth, extracellular matrix deposition, and adipose tissue 
functionality over two weeks. 
 
We anticipate that the developments of analytical proteomic assays and in vitro 
biological models discussed in this dissertation will support quantitative 
characterizations of human biology, leading towards future development of targeted 
clinical therapies for improved length and quality of life. 
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Chapter 1: Introduction 
Measurement gap: high-selectivity, high-throughput low-cell and single-cell 
proteomic assays 
Understanding the function and dysfunction of cells in biological organisms, it is 
important to characterize one of the key functional actors of the cell, proteins. With 
indications of poor correlation between mRNA expression and proteomic expression at 
the single cell level,1,2 in vitro assays directly quantifying proteoform expression are an 
important area of ongoing development. Interrogations of protein expression, isoforms, 
post-translational modifications, localization and trafficking, activity, and degradation, in 
both the spatial and temporal context, would provide an expanded view of proteomic 
activity within the cell.3–7 However, to span the extensive cellular heterogeneity in gene 
and protein expression and activity observed in cells and tissues,4,8,9 proteomic assays 
should interrogate single- and low-cell resolution with sufficiently high throughput to 
identify cellular sub-populations. These proteomic assays would also require sufficiently 
high selectivity and analytical sensitivity with which to interrogate protein isoforms and 
post-translational modifications. 
 
Selectivity in protein identification is often conferred by antibody affinity; however, the 
development and application of site-specific antibodies for every protein isoform and 
post-translational modification serves as a major limiting factor. Liquid chromatography-
mass spectrometry10,11 specifically identifies phosphorylation site(s) and enables 
quantitative ratiometric analysis of protein activation, but has not yet been demonstrated 
at single cell resolution.12 While powerful de facto tools to interrogate protein expression 
in single cells at high throughput with either surface marker information or spatial 
information, flow cytometry and immunocytochemistry both rely on site-specific 
antibodies and introduce fixation artifacts. Multiple methods leverage physicochemical 
properties of protein isoforms in addition to immunoaffinity of a pan-antibody, rather 
than relying on site-specific antibodies. Single-cell Western blotting leverages both size 
separation and immunoaffinity at single cell resolution, and currently is limited at 4 kDa 
molecular weight differences.3 Capillary isoelectric focusing,13 mini-gel isoelectric 
focusing,14 and surface isoelectric focusing15 use charge-based proteomic separations, 
in addition to immunoaffinity, but again have not been demonstrated at single cell 
resolution. Specifically, isoelectric focusing (IEF) uses a pH gradient, canonically 
generated by a solution of carrier ampholyte species, to separate proteins by isoelectric 
point (pI), or the pH at which the protein is net neutrally charged.16 The cutting-edge 
single-cell mass spectrometry assay17,18 interrogates high-expression protein isoforms, 
serving as an assay for both discovery and targeted studies. 
 
As a complementary proteomic assay for targeted studies, the Herr lab introduced the 
single cell isoelectric focusing (scIEF) technique using an ultrathin hydrogel substrate19–
21 to leverage minute differences in protein net charge, in addition to immunoaffinity. 
Further advancement of this assay towards the ultimate goal of a high-selectivity, high-
throughput proteomic assay at single cell resolution is critical for adoption in 
interrogations of cellular function and dysfunction. 
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Measurement gap: in vitro biological tissue models mimicking human physiology 
Much of the promise in the stem cell field revolves around personalized medicine, 
especially with the discovery of human induced pluripotent stem cells (hiPSCs)22,23. One 
approach with great potential for generating personalized treatments to use hiPSCs to 
develop minimally-functional tissues integrated in microfluidic chips. Due to inter-
species differences in ion channels, biological pathways, and pharmacokinetic 
properties, animal models do not faithfully predict human cardiotoxicity. Human in vitro 
tissue models that are predictive of human drug responses would be a significant 
advancement for understanding, studying, and developing new drugs and strategies for 
treating diseases. Traditional 2D in vitro systems, although informative,24,25 cannot 
accurately mimic the complex 3D conditions of the in vivo microenvironment.26 In 
contrast, 3D models are characterized by establishment of adhesion complexes and 
tissue polarity and by changes in cytoskeletal structure and cell volume, that are 
significantly different from those found in cells cultured as monolayers. As a result, the 
translational results in 2D conditions are fundamentally different from those in 3D.27 
 
Complementing the myriad organ-on-a-chip platforms developed using mouse and 
human iPSCs,28–31 the Healy lab, in collaboration with the Lee, Willenbring, Conklin, and 
Stahl labs, have developed cardiac and liver microfluidic chips with cells derived from 
wild-type and patient-specific hiPSCs32 (and unpublished data). To effectively 
recapitulate human physiology using these microphysiological systems, inclusion of 
adipose tissue is essential. The lipid storage and processing within adipose tissue 
strongly affects drug concentrations in vivo, and adipose tissue interacts with other 
organs via paracrine signals and fatty acid release, affecting the safety profiles of a 
large number of drug-like molecules. 
Dissertation overview 
In this dissertation, we sought to address both the need for high-selectivity, high-
throughput proteomic assays at single- to low-cell resolution, and the need for in vitro 
assays better mimicking human physiology. This dissertation spans research efforts in 
both directions. 
 
In the first part of this dissertation, we address the need for additional developments in 
the single-cell proteomic assays, specifically within the electrophoretic cytometry space. 
In Chapter 2, we characterize the performance of the ultrathin IEF assay with a 
replacement of the ampholyte solution, a critical reagent that directly impacts separation 
performance. Furthermore, we leverage separation science theory to regain lost 
performance metrics from this reagent substitution in this ultrathin IEF assay. 
 
In Chapter 3, we enhance the analytical sensitivity of the ultrathin isoelectric focusing 
assay with subsequent immunoblot. We develop a highly-porous hydrogel matrix as a 
new substrate for the assay. We characterize the effect of this 10-fold increase in gel 
porosity on the IEF separation performance. Additionally, we assess the benefits of the 
increased porosity on the in-gel immunoblot. 
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Chapter 4 details the development of a parallel investigation of highly-porous hydrogel 
matrices via photo-polymerization. We characterize the performance of the ultrathin IEF 
assay with these novel matrices, and report the incompatibility of this polymerization 
chemistry with IEF. 
 
In Chapter 5, we investigate the compartmentalization of protein lysate from single cells 
within the microwells embedded in the hydrogel substrate for our electrophoretic 
cytometry assays. We characterize the height of the fluid film between multi-material 
interfaces. Furthermore, we use numerical modeling and experimental validation to 
assess the contribution of this fluid film to the diffusive losses that reduce analytical 
sensitivity in our assays. 
 
In Chapter 6, we enhance the ultrathin IEF assay for a 100-fold increase in throughput 
by developing 3D projection electrophoresis. In order to characterize this assay 
reproducibly, we design a fluorescently-labeled IEF protein ladder for future inclusion 
with single cells or other biological samples. We demonstrate a proof-of-concept IEF 
separation in this new assay, termed “high throughput IEF” (HTP IEF). In addition, we 
interrogate the IEF separation performance of this assay with several optimizations. We 
conclude this chapter with an in-depth discussion of the potential further developments 
for this platform. 
 
In the latter part of this dissertation, we address the need for in vitro tissue models with 
characteristics similar to those found in human physiology, specifically within the organ-
on-a-chip space. In Chapter 7, we design and develop the first microfluidic organ-on-a-
chip device with adipose tissue, named “WAT-on-a-chip.” We use numerical modeling 
and an analytical model to characterize the convective and diffusive transport within the 
device. We characterize the viability of the adipose tissue for over two weeks. 
Furthermore, we confirm the maintenance of adipose functionality by staining the 
extracellular matrix within the tissue and by visually assessing adipocyte cell growth and 
lipid droplet formation. 
 
In Chapter 8, we survey the breadth of in vitro cardiac devices mimicking human cardiac 
physiology. We discuss the essential developments in cardiomyocyte generation, 
biomaterial substrates, and microdevices in this research space. We compare the 
mechanical, electrophysiological, and biological outcomes of these in vitro models, and 
discuss the ideal in vitro cardiac tissue model for biological studies, disease modeling, 
drug screening, and design of tailored therapeutic responses in line with precision 
medicine efforts. 
 
Finally, in Chapter 9, we summarize the work in this dissertation and discuss potential 
future research directions. The appendix includes multiple protocols and analysis scripts 
used in this work, as well as shorter research inquiries. 
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Chapter 2: Ultrathin Isoelectric Focusing Performance Using Different 
Ampholyte Solutions 
2.1 Introduction 
Isoelectric focusing (IEF) is a preparatory and analytical technique for separating 
proteins, among other macromolecules, by isoelectric point (pI), or the pH at which the 
protein is net neutrally charged. This separation necessitates a pH gradient, increasing 
from anode to cathode, across which the proteins electrophorese under an applied 
electric field and focus to their pI. Over the last 60+ years, multiple methods have been 
developed and characterized for creating the pH gradient required for IEF.16,33 Of 
particular interest and adoption are ampholytes (abbreviated “CA”), applied in slab 
IEF,34 surface IEF,15 capillary IEF with and without subsequent immunoblot,13,35 
microfluidic IEF,36 ultrathin IEF with subsequent immunoblot,19–21 and many other 
platforms. An effective ampholyte solution for IEF is defined as a heterogenous solution 
of species, typically zwitterionic, that span a specific range of pI’s. Each ampholyte 
species should have both high buffering capacity and high conductivity at its pI, among 
other characteristics.16 According to the law of pH monotony, upon application of an 
electric field, the CA stack in order of pI across the separation axis, building from the 
anode and cathode inwards, to create an ideally-linear pH gradient.16  
 
Commercially-available CA solutions provide incomplete information on the particular 
IEF performance enabled by each CA mixture, making non-experimental comparisons 
difficult. For example, the Polybuffer® CA are reported by the manufacturer to generate 
a linear pH gradient for resolving pI differences of 0.4 with a buffering capacity of 0.070-
0.080 mmol/mL.37 A solution of polyamino-polycarboxylic acids, the SinuLyte® CA are 
reported by the manufacturer to resolve pI differences of 0.1, with “up to 1.5 to 2.5 
higher” buffering capacity “compared to established ampholytes,” but with no 
information on the linearity of the generated pH gradient.38 In contrast, the Zoom® CA 
are mixtures of ampholytes with “sulfonate and carboxylic acid groups at one end, and 
free primary and secondary amino groups at the other,” resulting in molecules with 
molecular weights ranging from 400 to 700 Daltons. The manufacturer specifies the 
conductivity and pH gradient ranges for a 2% solution, but provides no information on 
the linearity of the generated pH gradient in IEF.39 Recent work by Righetti et al. used 
mass spectrometry to experimentally characterize the buffering capacity and 
composition of four established and commercially-available CA most commonly used in 
IEF platforms: Ampholine (polyamino-polycarboxylic acids),40 Pharmalyte, Bio-Lyte, and 
Servalyt (polyamino-polysulfonic-polycarboxylic acids). This work highlighted a need for 
the identification of additional alkaline ampholytes.41,42 Comparative experimental 
studies have characterized the utility of the Polybuffer CA as a less expensive 
replacement for established ampholyte solutions.43 Without this missing information on 
the precise composition, buffering capacity, and IEF performance of CA solutions, 
integration with IEF modeling software such as Simul544 for non-experimental 
optimization of IEF separations is hampered. 
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Recently the Herr lab has developed an IEF assay19 (abbreviated “ultrathin IEF” or 
“ultrathin scIEF” with single cells) using an ultrathin hydrogel substrate, designed to 
separate proteins from arrays of single cells. This technique used Polybuffer® CA to 
form a pH 4-7 gradient, which spans 50-70% of the pI’s of the human proteome.45,46 
Given both our interest in refining the ultrathin IEF assay to interrogate protein isoforms 
and post-translational modifications, as well as commercial discontinuation of the 
Polybuffer® CA’s in 2015, we experimentally compare the performance of the ultrathin 
IEF assay using Polybuffer® versus SinuLyte® CA. Then, we use our knowledge of IEF 
theory to modify assay parameters for high-resolution separations of proteins with the 
SinuLyte® CA. We complete this short study with a discussion of alternative methods 
for generating pH gradients in IEF platforms. 
2.2 Materials and Methods 
Reagents 
Silicon wafers (University Wafer 1156), SU8 3050 photoresist (MicroChem), a custom 
in-house-designed mask (CAD/ART Services), GelSlick® (Lonza 50640), standard 
glass slides (VWR), dichlorodimethyl silane (Sigma 440272), 3-(trimethoxysilyl)propyl 
methacrylate (Sigma 440159), methanol (Sigma 179337), glacial acetic acid (Sigma 
8817-46), 30%T 29:1 acrylamide/bis-acrylamide solution (Sigma A3574), 40%T 29:1 
acrylamide/bis-acrylamide solution (Sigma A7802), 1.5 M pH 8.8 TrisHCl (TekNova 
T1588), N-[3-[(3- benzoylphenyl)formamido]propyl] methacrylamide (BPMA, custom 
synthesized by PharmAgra Labs), ammonium persulfate (APS, Sigma A3678), 
N,N,N',N'-tetramethylethylenediamine (TEMED, Sigma T9281), UV photoinitiator 2,2'-
Azobis[2-methyl-N-(2-hydroxyethyl)propionamide] (VA086, Wako Chemicals 61551), 
borosilicate glass sheets (McMaster-Carr 8476K62), and permanent lab markers (VWR 
52877-310) were used to fabricate materials in this study. 
 
IEF was conducted using the immobilines pKa 3.6 and pKa 9.3 acrylamido buffers 
(Sigma 01716, 01738), Polybuffer ampholytes (Sigma P9652, lot SLBD5427V), 
SinuLyte® pH 4-7 ampholytes (Sigma 05087, lot BCBJ7449V), an ABS electrophoresis 
device designed and printed in-house, graphite electrodes (Bio-Rad 1702980), 0.5 mm 
gel spacers (CBS Scientific MVS0510-R), and TritonX-100 detergent (Sigma X100). 
Tris-buffered saline with Tween-20 (TBS-T, CST 9997S) was used for gel incubation 
and wash steps. 
 
The proteins and molecules used in this study were fluorescent pI markers 4.5, 5.5, 6.6, 
and 6.8 (Sigma 89149, 77866, 73376, 89508), henceforth termed “pI markers,” and 
BSA (Sigma A7030). 
Wafer and Separation Gel Fabrication 
SU8 fabrication on a silicon wafer was conducted following a standard protocol.3 Briefly, 
a custom mask with rails spaced 22 mm apart was used to fabricate features of 40 µm 
in height (confirmed by optical profilometry) in SU8 on a silicon wafer. After wafer 
treatment with dichlorodimethyl silane, polyacrylamide (abbreviated “PA”) precursor 
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solutions were created containing 1% of each of the pI markers 4.5, 5.5, 6.6, and 6.8 
(from 1-3 mg/mL stock solutions from manufacturer). The mixed and degassed 
precursor solutions were combined with APS/TEMED and introduced to the silanized 
wafer. Gel polymerization onto silanized half-glass slides occurred for 20 minutes at 
room temperature, protected from light. After fabrication, these PA gels were used 
immediately for the IEF assay. For this study, we use the canonical notation of %T as 
the total acrylamide monomer concentration (w/v) in solution, and %C as the ratio of 
bis-acrylamide crosslinker concentration to the total acrylamide monomer 
concentration.47 We use a 6%T 3.3%C PA gel polymerized with APS/TEMED.19 
IEF 
Ultrathin IEF was conducted as previously described19 with minor modifications to 
accommodate purified protein solutions. During the 20-minute polymerization time of the 
PA gels described above, the 3-component IEF lid was fabricated using either a 1:100 
dilution of the stock 40% SinuLyte® ampholytes for a final concentration of 0.4%, or a 
1:10 dilution of the stock Polybuffer® ampholytes. Table 2-1 lists the components of two 
types of lid gels used in this study, which was polymerized for 4 minutes per component 
(in the order of anolyte, catholyte, and focusing region) at 20 mW/cm2 light intensity 
using a 390 nm UV long-pass filter (Edmund Optics) on an OAI Model 30 Collimated UV 
light source. 
 
The PA gel and lid gel were assembled in the IEF device previously described,19 and 
set on an Olympus IX-71 inverted microscope with an Olympus UPlanFi 4× (NA 0.13) 
objective and a EMCCD Camera iXon2 (Andor), with imaging settings loaded into 
MetaMorph software (7.10.1.161, Molecular Devices). After a 30 s delay for the soluble 
reagents in the focusing lid gel to diffuse into the PA gel, IEF was conducted by 
applying 690 V for 12-25 minutes using the Power-Pac high-voltage power supply 
device (HVPS, Bio-Rad 1645056). During this focusing period, pI markers were imaged 
using a UV-longpass filter cube (XF100-1, Omega Optical) at 2.5 minute intervals. The 
lab markers used to denote the gel edges along the separation axis is fluorescent in the 
UV-longpass channel and visible in brightfield imaging. 
 
Micrographs were analyzed using an in-house MATLAB (R2015b, MathWorks) 
script6,48,49 adapted to this microwell-free variant of the IEF (code in Appendix 11). 
Briefly, the micrographs were segmented into regions of interest (ROIs), converted into 
line plots averaged across the width of the ROI (maintaining the separation axis), and 
background-subtracted using the average background intensity across the ROI. 
Gaussian curve fitting to the line plots led to the extraction of the peak height, peak 
location, peak width, area under the curve, SNR, and other assay-specific parameters 
from each ROI. Validation of the Gaussian curve fits is conducted analytically (R2 ≥ 0.7 
and signal-to-noise ratio SNR ≥ 3) and confirmed manually. For the images taken on the 
Olympus microscope setup, 1 pixel corresponds to 4 μm. 
Statistical Analysis 
Linear regression fit was performed using an in-house MATLAB script. 
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Table 2-1. Composition of IEF lid gels for the ampholyte study. 
Components of the 3-part lid gel used for lysis and electrophoresis in this study, for both the Polybuffer® 
and SinuLyte® CA solutions. 
Polybuffer® 
Lid gel components 
pH 4 anolyte Focusing region pH 10 catholyte 
Polyacrylamide gel 15% T 
3.3% C 
0.2% VA-086 
15% T 
3.3% C 
0.2% VA-086 
15% T 
3.3% C 
0.2% VA-086 
IEF reagents and 
detergents 
 
1:10 dilution of stock 
Polybuffer® ampholytes 
 
1% TritonX-100 
 
Boundary conditions 13.5 mM pKa 3.6 
immobiline 
 
6.4 mM pKa 9.3 
immobiline 
 
5.6 mM pKa 3.6 
immobiline 
 
14.4 mM pKa 9.3 
immobiline 
 
SinuLyte® 
Lid gel components 
pH 4 anolyte Focusing region pH 10 catholyte 
Polyacrylamide gel 15% T 
3.3% C 
0.2% VA-086 
15% T 
3.3% C 
0.2% VA-086 
15% T 
3.3% C 
0.2% VA-086 
IEF reagents and 
detergents 
 
1:100 dilution of stock 
solution (0.4% final) 
SinuLyte® ampholytes 
 
1% TritonX-100 
 
Boundary conditions 13.5 mM pKa 3.6 
immobiline 
 
6.4 mM pKa 9.3 
immobiline 
 
5.6 mM pKa 3.6 
immobiline 
 
14.4 mM pKa 9.3 
immobiline 
 
2.3 Results and Discussion 
To interrogate IEF performance in the ultrathin IEF assay, we slightly modified the 
previously-developed ultrathin scIEF assay19 to accommodate purified protein solutions. 
Figure 2-1A and B depict the difference in separation gel between the scIEF and non-
single-cell IEF variants of this assay, namely the removal of the microwells. After the 
requisite solutions are diffusively introduced to the microwell-free IEF variant of the 
ultrathin separation gel, the lid gel is stacked on the separation gel (Figure 2-1C, D) for 
subsequent IEF (Figure 2-1E). 
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A 
 
B 
 
C 
 
D 
 
E 
 
Figure 2-1. Schematic of the ultrathin IEF assay. 
(A) Orthogonal view of the ultrathin PA separation gel, patterned with microwells in the ultrathin scIEF 
assay. (B) Orthogonal view of the ultrathin PA separation gel in the ultrathin IEF assay. (C) Orthogonal 
view of the assembly of gels within the ultrathin IEF chamber. (D) Side view of the assembly of gels in the 
ultrathin IEF assay. (E) The workflow of the ultrathin IEF assay, from gel incubation with protein solution 
through protein electrophoretic separation, immobilization, and imaging. 
 
 
Figure 2-2. Orthogonal view of the ultrathin IEF assay assembly on a widefield epifluorescence 
microscope. 
IEF device is black with purple edging, adhered to the microscope stage. Gel is oriented with anolyte 
boundary towards the top of the image with the red connector.  
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IEF Performance with Different Ampholyte Solutions 
We investigated the formation and stability of the pH gradients formed with either the 
Polybuffer® or SinuLyte® CA. To monitor and then characterize the pH gradient formed, 
we generated pH gradients that included four fluorescently-labeled pI markers (pI 4.5, 
5.5, 6.6, and 6.8). To characterize the pH gradient at equilibrium, we assessed IEF with 
each CA solution by considering the slope of each pH gradient, dpH/dx. To determine 
dpH/dx, each of the focused pI marker concentration distributions were fit to a Gaussian 
curve. Using the peak locations and knowledge of the ampholyte composition, we then 
used a linear regression fit of the pI markers to estimate the pH gradient properties. The 
dpH/dx was quantified as 0.61±0.06 mm-1 with Polybuffer® CA and 0.84±0.19 mm-1 with 
SinuLyte® CA over time (Figure 2-3A, mean ± standard deviation for time course of 
n=1 gel). For the same separation axis in ultrathin IEF, the dpH/dx was measured at 
0.40 mm-1 for the Polybuffer® ampholytes over a pH 4-9 gradient.19 
 
A 
 
B 
 
C 
 
 
Figure 2-3. The SinuLyte® ampholytes demonstrated increased dpH/dx compared to the 
Polybuffer® ampholytes in the ultrathin IEF assay. 
(A) dpH/dx, (B) R2 statistic for the linear fit , and (C) ΔpImin is reported over time for n=1 gel with the 
SinuLyte® CA (black) and Polybuffer® CA (blue) for the pI markers. 
 
To assess the linearity of the pH gradient, we measured the mean R2 statistic for the 
linear fits. We quantified R2 = 0.96±0.02 with Polybuffer® CA and 0.997±0.003  with 
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SinuLyte® CA (Figure 2-3B, mean ± standard deviation over time for n=1 gel). 
Discussion. The Polybuffer® CA used previously in a similar ultrathin IEF platform 
demonstrated 1.00±0.00 linearity.19,20 
 
We evaluated the minimum difference in pI for which two neighboring proteins are fully 
resolved (ΔpImin), a unitless metric determined by Equation 2-1.16 Using the pI markers 
(Figure 2-3C), we measured the ΔpImin as 0.38±0.13 with Polybuffer® CA and 
0.32±0.09  with SinuLyte® CA (mean ± standard deviation over time for n=1 gel). The 
smallest measured ΔpImin in this timeframe was 0.28 with Polybuffer® CA and 0.22 with 
SinuLyte® CA. However, the Polybuffer® CA used previously in a similar ultrathin IEF 
platform demonstrated ΔpImin of 0.13±0.02 over a pH 4-7 gradient.19 Researcher 
handling aside, this analysis indicated that the SinuLyte® CA may have negatively 
affected the separation performance of this ultrathin IEF assay.  
 
∆𝑝𝐼$%& = 3 ∗ 𝑑𝑝𝐻𝑑𝑥 ∗ 𝜎./012%& = 3 ∗ 3 𝐷 ∗ 𝑑𝑝𝐻𝑑𝑥𝐸 ∗ − 𝑑𝑢𝑑𝑝𝐻 
Equation 2-1. ΔpImin quantified for proteins focused in an IEF assay.16 
 
IEF Optimization with SinuLyte® Ampholytes 
We next modified the parameters of this IEF assay using the SinuLyte® CA to regain 
the IEF performance previously observed with the Polybuffer® CA. Specifically, 
Equation 2-1 describes ΔpImin as a function of the protein-specific parameters (the 
diffusivity of the protein in-gel or D, and the electrophoretic mobility shift across the pH 
gradient or du/dpH) and the assay-specific parameters (the strength of the applied 
electric field or E, and dpH/dx). Electric field strength is dependent on the applied 
voltage V and the separation length L (E = V / L).16 In order to investigate the design 
space of the ultrathin IEF assay with SinuLyte® CA, we started with the experimental 
conditions used in Figure 2-3: L = 9 mm, CA content = 0.4%, and V = 600 V, and  
systematically modified L, CA content, and V both analytically and experimentally. 
 
It is important to note that these experiments were designed with small sample size to 
rapidly assess the design space of the ultrathin IEF assay. Further research into the IEF 
separation performance and reproducibility at each of these conditions is required.  
 
From a theoretical perspective, increasing the separation length in this IEF assay would 
result in a decrease in the slope of the pH gradient dpH/dx and a decrease in the 
electric field strength. Experimentally modifying the separation length did not result in a 
large change in the ΔpImin (Figure 2-4A). Further research is required in this, due to the 
small sample size. 
 
In addition, assessing the optimal concentration of ampholytes for a robust IEF 
separation was essential, since insufficient ampholytes at any one pI would reduce the 
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buffering capacity at that pI, negatively impacting separation resolution. We anticipated 
that, above the threshold for sufficient buffering capacity, an increase in CA 
concentration would not change the separation performance of the assay. We observed 
no large change in the ΔpImin (Figure 2-4B). To preserve reagents, we maintained the 
0.4% CA content. 
 
Finally, increasing the applied voltage would theoretically increase the electric field 
strength, thereby sharpening IEF focusing and resulting in a smaller ΔpImin. From this 
set of experiments, we identified that the increase in the applied voltage was sufficient 
to achieve a ΔpImin near 0.1 (Figure 2-4C). Subsequent characterization of the IEF 
separation performance under these conditions (L = 9 mm, CA content = 0.4%, V = 
690V) yielded ΔpImin = 0.16±0.02 (mean ± standard deviation for n=3 gels, measured at 
12 minutes of IEF, averaged over 3 pI markers, Figure 3-7D). 
 
A 
 
B 
 
C 
 
 
Figure 2-4. Experimental assessment of the design space of the ultrathin IEF assay with 
SinuLyte® CA. 
ΔpImin averaged over time for the 3 pI markers, in the ultrathin IEF assay with modifications to (A) the 
separation axis with 600 V applied voltage, (B) the concentration of SinuLyte® CA with 600V applied 
voltage over a 9 mm separation axis and (B) the applied voltage with a 9 mm separation axis, for n=1-3 
gels. 
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2.4 Conclusions and Future Directions 
In this work, we modified the ultrathin IEF assay to accommodate a replacement 
ampholyte solution, and investigated how this modification affected IEF separation 
performance. We leveraged IEF separation theory to optimize assay parameters in 
order to regain IEF separation performance, reaching a ΔpImin = 0.16±0.02. More 
recently, the ΔpImin for Zoom® CA was characterized as 0.11 for a similar ultrathin IEF 
assay across a pH 4-7 gradient,21 indicating that alternate CA solutions might confer 
higher IEF performance in the same assay format.  
 
Given the limited information on the composition and chemical properties of 
commercially-available ampholyte solutions,16,41 as well as the risk for discontinuation of 
products, there is a clear need to design less-variable pH gradients that are not reliant 
on ampholytes. Out of the range of alternate methods for generating pH gradients,16,33,50 
including the “natural” pH gradient generated by splitting water molecules into H+ and 
OH- ions upon application of an electric field,51 and the thermally-generated pH 
gradient,52 we find that the creation of an immobilized pH gradient (IPG)50,53,54 would be 
a significant development in this particular ultrathin IEF assay. Notably, a pre-formed 
and immobilized pH gradient in the PA gel would allow researchers to specifically 
design a pH range for the target proteins of interest, and would ideally remove any 
technical variation in the location of specific pI’s along the separation axis. 
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Chapter 3: Laterally Aggregated Polyacrylamide Gels for 
Immunoprobed Isoelectric Focusing 
This work was performed in collaboration with Dr. Kevin A. Yamauchi and Alison Su. 
3.1 Introduction 
Polyacrylamide gels (abbreviated “PA”) are widely used for electrophoretic analysis and 
characterization of proteins.55–57 Used in important protein electrophoresis 
modalities16,58, PA gels offer exceptional separation resolution because (1) the pore size 
of the gel approximates the average diameter of globular proteins, making the gel a 
high-performance sieving matrix and (2) the porous gel retards molecular diffusion, as 
compared to electrophoresis in free solution (i.e., capillary zone electrophoresis, CZE; 
capillary isoelectric focusing, cIEF). 
 
In addition to acting as a separation medium for electrophoresis, PA gels offer auxiliary 
functions. For example, after slab-gel 2DE, the gel matrix is used to transfer specific 
focused proteins to mass spectrometry (MALDI) for definitive target identification, with 
the gel physically cut out of the slab, and transferred to the mass spectrometer.59 
Another example is Western blotting,60–62 where proteins are separated by size and 
then probed with immunoreagents, thus facilitating target identification using an 
immunoassay. Western blotting confers high selectivity, but may not afford detection 
resolution suitable for post-translational modifications and/or splice variants. Such 
proteoforms may not have detectable molecular mass differences. 
 
Appending an immunoassay to isoelectric focusing (IEF) can provide the resolving 
power necessary to measure a broader swath of proteoforms. IEF separates protein 
targets based on differences in isoelectric point (pI), not size.16 During IEF, species 
electromigrate through a pH gradient, stopping at the position in the gradient where the 
local pH and the pI of the target are equal. Protein targets then ‘focus’ at this position, 
with a sustained applied electric field and stable pH gradient. Unlike the PA gel of 
western blotting (protein sizing), the PA gel of IEF need not function as a molecular 
sieving matrix. When developed in a miniaturized format, IEF can operate with 
enhanced heat dissipation (i.e., Joule heating), reduced reagent and sample 
consumption, and improved separation performance (rapid separation times). 
 
While immunoblotting formats often rely on physical transfer of separated protein 
targets from the separation lane to a large-pore-size blotting membrane14,63,64, 
immunoprobed IEF formats have, instead, covalently immobilized separated proteins to 
the functionalized walls of the IEF separation capillary13,65 or, in our case, covalently 
immobilized protein peaks into a PA gel separation matrix.66–69 but only as an anti-
convective media (during IEF) and an immobilization scaffold for the subsequent 
immunoprobing (immunoassay). 
 
Consequently, we sought to assess the role of PA gel porosity and microarchitecture in 
immunoprobed IEF with in-gel target detection. We considered both PA gel formulations 
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similar to slab-gel and published formats (i.e., 6%T 3.3%C PA gel; mean pore radius = 
5-92 nm and fiber radius ~0.5 nm,70,71 depicted schematically in Figure 3-1A), as well 
as PA gels designed to offer larger mean pore radius characteristics by inducing lateral 
aggregation by including a preformed hydrophilic polymer (i.e., PEG) during PA gel 
polymerization. 72 Incorporation of PEG creates a bi-modal pore size distribution in the 
resultant hydrogel, with open fluidic spaces formerly occupied by the porogen and small 
pores created between bundles of polyacrylamide70,73,74 For these “highly porous” PA 
gel formulations, the mean pore radius can be ~250 nm (i.e., 5%T, 4%C PA gel 
incorporating 2% PEG with PA bundle radius at 150 nm, depicted schematically in 
Figure 3-1C), a 100-fold increase.70 After PA gel polymerization, the unfunctionalized 
PEG freely diffuses out of the PA hydrogel matrix. However, a small fraction of the PEG 
is thought to remain in the PA gel as a semi-interpenetrating network, which may inhibit 
in-gel diffusion of soluble species.72 
 
Specifically, for immunoprobed IEF, we address questions regarding the anti-convective 
characteristics of highly porous PA gels during IEF and, during immunoprobing, target 
immobilization to the PA gel matrix, introduction of antibody probe into the PA gels, and 
removal of unbound antibody probe (background) which impact detection performance. 
 
 
Figure 3-1. Generation of highly porous PA gels.  
(A) Depiction of random organization of porous microarchitecture in the negative control gels. (B) 
Depiction of bimodal distribution of pores in 0% PEG gels, with the voids formed from aggregation of the 
bis-acrylamide crosslinker at high concentration. (C) Depiction of bimodal distribution of pores in 2% PEG 
gels, with the voids formerly filled with hydrophilic 10 kDa PEG. Protein and fluorescently-labeled IgG* 
antibody depicted relative to the pores. Schematics not to scale. 
3.2 Materials and Methods 
Reagents 
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Borofloat wafers (University Wafer 516), SU8 3050 photoresist (MicroChem), titanium 
diisopropoxide bis(acetylacetonate) (Sigma 325252), anhydrous isopropanol (Sigma 
278475), a custom in-house-designed mask (CAD/ART Services), GelSlick® (Lonza 
50640), standard glass slides (VWR), dichlorodimethyl silane (Sigma 440272), 3-
(trimethoxysilyl)propyl methacrylate (Sigma 440159), methanol (Sigma 179337), glacial 
acetic acid (Sigma 8817-46), 30%T 29:1 acrylamide/bis-acrylamide solution (Sigma 
A3574), 40%T 29:1 acrylamide/bis-acrylamide solution (Sigma A7802), bis-acrylamide 
powder (Sigma 146072), 1.5 M pH 8.8 TrisHCl (TekNova T1588), N-[3-[(3- 
benzoylphenyl)formamido]propyl] methacrylamide (BPMA, custom synthesized by 
PharmAgra Labs), ammonium persulfate (APS, Sigma A3678), N,N,N',N'-
tetramethylethylenediamine (TEMED, Sigma T9281), UV photoinitiator VA086 (Wako 
Chemicals 61551), 10 kDa poly(ethylene glycol) (PEG, Sigma 92897), borosilicate glass 
sheets (McMaster-Carr 8476K62), #1.5H glass coverslips (Ibidi 0107999097), µ-Slide 4 
well glass-bottom chambered coverslips (Ibidi 80427), Array-It Hybridization Cassettes 
(AHC1x16, Array-It), and permanent lab markers (VWR 52877-310) were used to 
fabricate materials in this study. 
 
IEF was conducted using the immobilines pKa 3.6 and pKa 9.3 acrylamido buffers 
(Sigma 01716, 01738), SinuLyte® pH 4-7 ampholytes (Sigma 05087), an ABS 
electrophoresis device designed and printed in-house, graphite electrodes (Bio-Rad 
1702980), 0.5 mm gel spacers (CBS Scientific MVS0510-R), and TritonX-100 detergent 
(Sigma X100). Tris-buffered saline with Tween-20 (TBS-T, CST 9997S) was used for 
gel incubation and wash steps. 
 
The proteins and molecules used in this study were fluorescent pI markers 4.5, 5.5, and 
6.6 (Sigma 89149, 77866, 73376), henceforth termed “pI markers,” BSA (Sigma 
A7030), purified recombinant turboGFP (Evrogen FP522, lot 55201240718) termed 
“tGFP” (a variant of the GFP with increased fluorescence, MW 27 kDa), primary rabbit-
anti-turboGFP antibody (Pierce PA5-22688, lots UA2694351 and UA2718271), 
secondary polyclonal antibody AlexaFluor-647-labeled donkey-anti-rabbit (Invitrogen A-
31573) termed “IgG*.” The IgG* degree of labeling is reported by the manufacturer as 5 
fluorophores per molecule for lot 1964354 (Invitrogen). 
Wafer and Gel Fabrication 
SU8 fabrication on a glass wafer was conducted following a standard protocol.3 Briefly, 
a custom mask with rails spaced 22 mm apart was used to fabricate features of 40 µm 
in height (confirmed by optical profilometry) in SU8 on a borofloat wafer. After wafer 
treatment with GelSlick®, polyacrylamide (abbreviated “PA”) gels were fabricated on the 
wafer and polymerized onto silanized half glass slides. Table 3-1 lists the critical 
components of each gel condition, using 10 kDa PEG as the preformed hydrophilic 
polymer and leveraging porogen gel fabrication conditions developed by Righetti and 
colleagues (further details in Appendix 1).70 After fabrication, gels were incubated for 
16-24 hours in 1× TBS-T to allow for diffusion of soluble PEG porogen out of the PA gel 
network, thus forming the voids depicted in Figure 3-1B and C, then rinsed in DI water 
for 30 minutes before use. 
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For this study, we use the canonical notation of %T as the total acrylamide monomer 
concentration (w/v) in solution, and %C as the ratio of bis-acrylamide crosslinker 
concentration to the total acrylamide monomer concentration.47 To distinguish the six 
PA gel conditions, as outlined in Table 3-1, we define the 6%T 3.3%C APS/TEMED 
gels as “benchmarking gels,” the 6%T 8%C APS/TEMED + 0% PEG gels as 
“negative control gels,” the 6%T 8%C APS/TEMED + 0.5% PEG gels as “0.5% PEG 
highly porous PA gels,” the 6%T 8%C APS/TEMED + 1% PEG gels as “1% PEG 
highly porous PA gels,” the 6%T 8%C APS/TEMED + 1.5% PEG gels as “1.5% PEG 
highly porous PA gels,” and the 6%T 8%C APS/TEMED + 2% PEG gels as “2% PEG 
highly porous PA gels.” The PA gel matrix is formed from incorporation of acrylamide 
monomers and bis-acrylamide crosslinkers into a randomly organized hydrogel network, 
inducing heterogeneity in pore size.75–77 
 
Table 3-1. Composition of PA porogen gels. 
Primary components of all gel conditions used in this work, following standard gel fabrication techniques 
in 48. Highlighting indicates modifications from the 6%T 3.3%C APS/TEMED negative control gel 
condition, for ease of comparison between PA gel conditions. Concentrations reported as % are %w/v. 
Gel nomenclature Bench-
marking 
Negative 
control 
0.5% PEG 
 
Highly 
porous 
gel 
1% PEG 
 
Highly 
porous 
gel 
1.5% PEG 
 
Highly 
porous 
gel 
2% PEG 
 
Highly 
porous 
gel 
Acrylamide content 6% T 6% T 6% T 6% T 6% T 6% T 
Bisacrylamide : 
acrylamide ratio 
3.3% C 8% C 8% C 8% C 8% C 8% C 
10 kDa PEG 0.0% 0.0% 0.5% 1.0% 1.5% 2.0% 
Polymerization 
chemistry 
APS / 
TEMED 
APS / 
TEMED 
APS / 
TEMED 
APS / 
TEMED 
APS / 
TEMED 
APS / 
TEMED 
BPMA photo-
immobilization moiety 
5 mM 5 mM 5 mM 5 mM 5 mM 5 mM 
Thermodynamic Partitioning 
We used confocal imaging to measure the thermodynamic partitioning coefficient of 
IgG* into the PA gels68. After silanization of the µ-Slide chambered coverslips, gels were 
fabricated using wafer molds with 40 µm feature heights within these containers and 
incubated in TBS-T for 24 hours. Gels were then exposed to 1:20 dilution of IgG* 
solution (from 2 mg/mL stock solution from manufacturer, spun down to remove 
aggregates) in 2% BSA / TBS-T for > 2 hours to equilibrium. Confocal imaging 
experiments were conducted on an inverted Zeiss LSM 710 AxioObserver at the CRL 
Molecular Imaging Center. Images were acquired at room temperature using a 40× 
water immersion objective (LD C-Apochromat 40×/ 1.1 NA W Corr M27, Zeiss) with the 
correction collar manually assessed to optimal calibration at 0.150 mm. IgG* within the 
chambered coverslips was imaged using a HeNe633 laser at 17% power, using the 
MBS488/561/633 beam splitter and the Zen 2010 software (Zeiss). Z-stack images 
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were acquired with a step size of z=0.70 µm and a field of view of x=y=212.55 µm, and 
analyzed using an in-house Fiji (1.52i, NIH) script. 
Equilibrium Swelling Ratio 
The equilibrium swelling ratio was conducted using Flory-Rehner theory.47,78–80 After 
fabrication of PA gels on glass slides with 500 µm spacers to define gel height, gels 
were weighed immediately on an Ohaus Adventurer Pro weigh station to determine the 
“fabrication” weight, then incubated in 1× TBS-T for 24 hours for PEG diffusion out of 
the gel. After 12 hours of DI water incubation, the equilibrated gel was weighed again 
for the “hydration” weight, dehydrated fully with a nitrogen gas stream, and weighed a 
third time for the “dehydration” weight. 
IEF and Photocapture Efficiency 
The thin-film IEF was conducted as previously described19 with minor modifications to 
accommodate purified protein solutions (further details in Appendix 3). First, gels with a 
height of 40 µm were rinsed in DI water and then the fluid layer was  wicked off the top 
of the gel. Next, the gel was incubated in 40 µL of a solution of 1% each of the pI 
markers 4.5, 5.5, and 6.6 (from 1-3 mg/mL stock solutions from manufacturer), and 10% 
v/v tGFP (from 37 µM stock from manufacturer) for 30 minutes at room temperature, 
protected from light. The 3-component IEF lid was fabricated using a 1:100 dilution of 
the stock 40% Sinulyte ampholytes for a final concentration of 0.4%. Table 3-2 lists the 
components of the lid gel, which was polymerized for 4 minutes each at 20 mW/cm2 
light intensity using a 390 nm UV long-pass filter (Edmund Optics) on an OAI Model 30 
Collimated UV light source. 
 
The PA gel and lid gel were assembled in the IEF device previously described,19 and 
set on an Olympus IX-71 inverted microscope with an Olympus UPlanFi 4× (NA 0.13) 
objective and a EMCCD Camera iXon2 (Andor), with imaging settings loaded into 
MetaMorph software (7.10.1.161, Molecular Devices). After a 30 s delay for the soluble 
reagents in the focusing lid gel to diffuse into the PA gel, IEF was conducted by 
applying 690 V for 12 minutes using the Power-Pac high-voltage power supply device 
(HVPS, BioRad 1645056). During this focusing period, pI markers were imaged using a 
UV-longpass filter cube (XF100-1, Omega Optical) at 2.5-min intervals, and tGFP was 
imaged using a GFP filter cube (XF100-3, Omega Optical) 1 minute subsequently. After 
12 minutes of focusing, protein photo-immobilization was induced by application of UV 
at 100% intensity for 45 s with the Hamamatsu LC8 (Hamamatsu Photonics K.K.), 
sweeping across the gel assembly at 1.6 cm above the gels. After protein photo-
immobilization, gels were rinsed in TBS-T for 30 minutes to remove uncaptured species, 
and imaged with the same settings. The lab markers used to denote the gel edges 
along the separation axis is fluorescent in the UV-LP channel and visible in brightfield 
imaging. 
 
Micrographs were analyzed using an in-house MATLAB (R2015b, MathWorks) script6,48 
adapted to this microwell-free variant of the IEF (code in Appendix 11). Briefly, the 
micrographs were segmented into regions of interest (ROIs), converted into line plots 
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averaged across the width of the ROI (maintaining the separation axis), and 
background-subtracted using the average background intensity across the ROI. 
Gaussian curve fitting to the line plots enables extraction of the peak height, peak 
location, peak width, area under the curve, signal-to-noise ratio (SNR), and other assay-
specific parameters from each ROI. Validation of the Gaussian curve fits is conducted 
analytically (R2≥0.7 and signal-to-noise ratio SNR≥3) and confirmed manually. For the 
images taken on the Olympus microscope, 1 pixel is 4 μm × 4 μm. 
 
Table 3-2. Composition of IEF lid gel. 
Components of the 3-part lid gel used for lysis and electrophoresis in the ultrathin IEF assay. 
Lid gel components pH 4 anolyte Focusing region pH 10 catholyte 
Polyacrylamide gel 15% T 
3.3% C 
0.2% VA-086 
15% T 
3.3% C 
0.2% VA-086 
15% T 
3.3% C 
0.2% VA-086 
IEF reagents and 
detergents 
 
0.4% final SinuLyte® 
ampholytes 
 
1% TritonX-100 
 
Boundary conditions 13.5 mM pKa 3.6 
immobiline 
 
6.4 mM pKa 9.3 
immobiline 
 
5.6 mM pKa 3.6 
immobiline 
 
14.4 mM pKa 9.3 
immobiline 
Immunoprobing Efficiency 
Assessment of immunoprobing efficiency in hydrated gels was conducted as previously 
described.81,82 Briefly, gels on full glass slides were rinsed in DI water, dried with a 
nitrogen stream, and assembled into a 16-well Array-It Hybridization Cassette (2 
columns of 8 wells each). The gel region in each well was rehydrated in 100 µL 2% BSA 
/ TBS-T for 30 min. Each well in the left column was exposed to 50 µL of 200 nM tGFP 
protein diluted in 2% BSA / TBS-T for 30 min, while each well in the right column was 
exposed to 50 µL of 2% BSA / TBS-T as blanks. Proteins were immobilized to the 
photoactive gel by application of 18 mW/cm2 UV for 300 s using the OAI Model 30 
Collimated UV light source. 
 
After gels were rinsed in TBS-T for 30 min to remove uncaptured molecules, the gels 
were immunoprobed for tGFP using a standard immunoprobing protocol.48 Briefly, gels 
were exposed to 80 µL of 1:10 dilution of primary rabbit-anti-tGFP antibody in 2% BSA / 
TBS-T (667 nM and 1:10 dilution of secondary donkey-anti-rabbit-647 antibody in 2% 
BSA/TBS-T (1333 nM in solution).  
 
Gels were imaged on the GenePix 4300A microarray scanner (Molecular Devices) for 
native GFP fluorescence in the 488 channel and immunoprobed fluorescence signal in 
the 647 channel. Images were analyzed using an in-house Fiji script. Briefly, each well 
was segmented into a region of interest (ROIs) avoiding edge effects, and background-
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subtracted using the average “background” intensity in an adjacent blank ROI, for which 
the “background” was the gel autofluorescence in the absence of protein. This analysis 
yielded average fluorescence intensity and immunoprobing efficiency from each ROI. 
The SNR for each ROI was calculated by defining the “signal” as average fluorescence 
intensity in the protein-containing ROI, and the “noise” as the standard deviation of the 
“background” defined above. For the images acquired by the GenePix scanner, 1 pixel 
is 5 μm × 5 μm. 
Statistical Analysis 
To compare the means of the 3+ gel conditions in this study, we first assessed for 
normality using a Q-Q test. After identification that the distributions of means did not 
follow a normal distribution, we assessed statistical significance using a one-way 
ANOVA’s with Kruskal-Wallis test. To compare pairs of gel conditions, we applied a 
post-hoc Dunn’s multiple comparison test with p<0.05 (*), using GraphPad Prism 
version 8.1.1. The number of experimental replicates (n = 3 gels) was determined a 
priori. Linear regression fit was performed using an in-house MATLAB script. 
3.3 Results and Discussion 
We assessed three key functions of the laterally aggregated, photoactive PA gels in 
immunoprobed IEF: (i) acting as an anti-convective medium during IEF, (ii) acting as a 
scaffold for UV-induced immobilization of IEF bands, and (iii) facilitating heterogeneous 
immunoassays of the immobilized protein targets. The following sections investigate 
each aspect, starting with a physical characterization of the gel formulations. 
Physical Characterization of Highly Porous PA Gels 
For this study, we designed and fabricated a panel of PA gel formulations comprised of 
highly porous PA gels polymerized in the presence of hydrophilic polymer (0.5% - 
2.0% 10 kDa PEG, 6%T, 8%C), negative control gels (0% PEG, 6%T, 8%C), and 
benchmarking gels (0% PEG, 6%T, 3.3%C). Three notes on rationale: first, 
benchmarking gels were included to facilitate comparison of this study to other 
immunoprobed IEF studies19. Second, as compared to the benchmarking gel 
formulations, the highly porous PA gel formulations contain an increased bis-acrylamide 
crosslinker concentration for mechanical robustness, with APS/TEMED polymerization 
conditions consistent among all gel formulations (Table 3-1). Third, PA gel porosity 
increases both via incorporation of PEG at increasing molecular weights and increasing 
concentration.70 For this study, we chose to selectively vary the concentration of 10 kDa 
PEG with the PA gel precursor solution, because lower molecular weight PEG requires 
higher PEG concentrations to induce lateral aggregation (e.g., 25% for 1 kDa PEG).70 
 
After gel fabrication, we sought to characterize the dependence of matrix porosity on 
PEG concentration. Using the equilibrium swelling ratio assay, we first sought to 
validate the relevance of the assay to the gel formulations under study (Figure 3-1). To 
address this question, we observed a slight gel swelling as PEG diffuses out of the PA 
gels during equilibration of a newly-fabricated gel with a surrounding solution (Figure 
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3-2). The slight swelling suggests extensive water retention. As compared to the dry 
dehydrated state, the swelling confirms that the equilibrium swelling ratio assay is 
applicable to scrutinize the highly porous PA gels.80 
 
Next, using the equilibrium swelling ratio assay, we can determine the equilibrium 
swelling ratio (Q) defined in Equation 3-1, where mass hydrated gel and mass 
dehydrated gel are the mass of each gel when measured in the hydrated and 
dehydrated states, respectively47,77,78.  
 𝑄 = 𝑚𝑎𝑠𝑠	=>?/@12?	A2B𝑚𝑎𝑠𝑠	?2=>?/@12?	A2B 
Equation 3-1. Equilibrium swelling ratio in PA gels.  
 
In first comparing benchmarking gels to negative control gels, we observed a decrease 
in Q with the increase in bis-acrylamide crosslinker concentration (Figure 3-3). 
Comparison of Q values in the PA gel formulations studied here fall into the range of 
previously reported values for PA gels with 0% PEG (Q = 17.63±0.83; PA gel 10%T, 
3%C gel formulation; different chemical polymerization83). In comparison to the 
benchmarking gel formulation (3.3%C), we observed slightly increased opacity in the 
negative control gel formulation and highly porous PA gel formulations, all of which 
contained 8%C bis-acrylamide. 
 
In next comparing the negative control gels (0% PEG) to the highly porous PA gels, we 
observed a statistically significant increase in Q for the 2% PEG highly porous gel 
formulation (p < 0.05, Figure 3-3). Similarly, comparison to the benchmarking gel 
showed a significant increase in Q for the 2% PEG gel (p < 0.05, one-way ANOVA 
performed with Kruskal-Wallis test and post-test Dunn’s multiple comparison test). 
Swelling behavior in the highly porous PA gel formulations is corroborated by similar 
behavior in highly porous PA matrices observed by other groups.74 
 
 
Figure 3-2. Gel weights measured in the equilibrium swelling ratio experiment. 
The weight of the gels was measured immediately after fabrication, after incubation in solution to 
equilibrium, and after drying. Mean and standard deviation depicted for n=3 gels. 
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Figure 3-3. Characterization of highly porous PA gels. 
Equilibrium swelling ratio reports larger average pore size in 2% PEG-containing PA gel formulations. 
Swelling ratio (Q) for benchmark gel formulation (0% PEG, 6%T, 3.3%C) is 16.7±1.89, for negative 
control gel formulation (0% PEG, 6%T, 8%C) is 14.8±1.19 and for highly porous PA gels (0.5% to 2.0% 
PEG, 6%T, 8%C) is maximum at 19.7±3.54 for the 2% PEG formulation. Mean and standard deviation; 
n=4-9 gels; significance determined by one-way ANOVA with Kruskal-Wallis test and post-test Dunn’s 
multiple comparison test with p<0.05 (*). 
 
Taken together, the inclusion of 2% PEG in the PA gel formulation significantly 
increases Q, indicating an increase in gel porosity as desired. Consequently, our study 
focuses on this gel (2% PEG, 6%T, 8%C) as the matrix through which to understand the 
three key functions of the gel in immunoprobed IEF: as an anti-convective medium, a 
scaffold for protein immobilization, and an immunoassay substrate. 
IEF in Highly Porous PA Gels 
Next, to understand the PA gel formulations as anti-convective media for IEF, we 
investigated IEF behavior during the focusing and equilibrium stages, for an ampholyte 
system. During IEF focusing, proteins electrophorese along a pH gradient to the point in 
the gradient that matches the isoelectric point (pI) of that respective species (i.e., the pH 
at which a protein molecule is net neutrally-charged). Once at the pI position, IEF 
balances diffusive band broadening with a restorative electrophoretic force, thus forming 
a pseudo-equilibrium electrophoretic separation.16,84–86 The pH gradient follows the law 
of pH monotony.16 Performing IEF in a matrix reduces convection-associated dispersion 
along the separation axis, yielding sharply-focused protein bands.87 In addition to 
affecting convection, the PA gel porosity should affect the electrophoretic mobility and 
diffusivity of target species (and ampholytes), under certain conditions. 
 
We first characterized the formation and stability of IEF pH gradients formed in the 
benchmarking, negative control, and 2% PEG PA gel formulations. To monitor IEF, we 
included three fluorescently labeled pI markers (pI = 4.5, 5.5, and 6.6) as indicators of 
pH gradient formation (Figure 3-4). As a proxy for the duration required to establish a 
stable pH gradient, we monitored until the stable formation of a Gaussian concentration 
distribution for each pI marker. In the negative control and 2% PEG PA gel formulation 
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(8%C), the focusing time was ~5 min. In the benchmarking gel formulation (3.3%C), the 
focusing time was ~7.5 min. In all cases, the electrical current decreased during the 
same periods of time, as expected as ampholytes form a pH gradient (Figure 3-5).35,84 
 
PA gels are known to support cathodic drift during and after IEF pH gradient focusing. 
The drift of the stable pH gradient is generated by electroosmotic flow arising from 
applying an electric field to a fluid in a PA gel matrix, which includes slightly negatively 
charged polyacrylamide chains.88 To estimate the cathodic drift velocity, we measured 
the velocity of the 6.6 pI marker (from the 7.5 min to 10 min timepoint of elapsed IEF 
time) in IEF performed in the benchmarking, negative control, and 2% PEG PA gel 
formulations. We observed a statistically significant difference in the drift velocity of the 
pI marker between the benchmarking (6%T, 3.3%C) and negative control (6%T, 8%C) 
gel formulations (benchmarking gel: 0.06±0.02 mm/min; negative control: 0.17±0.01 
mm/min; mean ± standard deviation; n=3 gels; one-way ANOVA with Kruskal-Wallis test 
and post-test Dunn’s multiple comparison test, Figure 3-6). Reported values of cathodic 
drift during IEF in PA gels are similar (i.e., 0.021±0.003 mm/min in thin-film IEF,20 ~0.07 
mm/min in microchannel IEF,36 and ~0.1 mm/min in slab IEF88). Finally, in considering 
the 2% PEG gels, we observed a cathodic drift velocity of the pI marker (0.08±0.02 
mm/min) that was not statistically different from the benchmarking or negative control 
gel formulations, thus indicating that the 2% PEG PA gel formulation reduces 
convection during IEF, as desired. We hypothesize that the negative control gels, with 
increased bis-acrylamide content compared to the benchmarking gels, might exhibit 
increased negative charge per unit volume, yielding increased electroosmotic flow 
through the PA gel and increased drift velocity. 
 
Time Benchmarking gel Negative control gel 2% PEG 
Highly porous gel 
 
Figure 3-4. Characteristic focusing of pI markers in PA gels over time. 
Representative inverted micrographs of fluorescent pI markers focusing in IEF pH gradient over the 12 
minute timeframe. “A |” denotes the edge of the pH 4 boundary condition on the left. pH gradient spans 
pH 4-7 from left to right. “| B” denotes the edge of the pH 10 boundary condition. “4.5,” “5.5,” and “6.6” 
denote the pI markers that focus as pH 4.5, 5.5, and 6.6, respectively. 
Time 6%T 3.3%C
APS/TEMED
Negative control
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Figure 3-5. Electrical current during IEF. 
Each line indicates the electrical current for a single experimental run. Gray lines indicate the 
benchmarking gels, red the negative control gels, and blue the 2% PEG highly porous gels. 
 
 
Figure 3-6. Cathodic drift during IEF in highly-porous PA gels. 
Cathodic drift is significantly different between the negative control and the 0% PEG gels. Mean and 
standard deviation marked by vertical lines for n=3 gels per condition. One-way ANOVA with Kruskal-
Wallis test and post-test Dunn’s multiple comparison test was conducted with p<0.05 (*). 
 
We next characterized both the linearity and slope (dpH/dx) of the IEF pH gradient at 
equilibrium (10 min of elapsed IEF separation time, Figure 3-7). The three fluorescently 
labeled pI markers were here, again, used as indicators of pH gradient (Figure 3-7A, 
Figure 3-4). To assess the linearity of each pH gradient, we compared the mean R2 
statistic for linear fits of pI marker value versus location along the gradient. We 
hypothesized no notable impact on either parameter among the three gel formulations, 
as ampholyte focusing is dependent on the separation axis length, anolyte and 
catholyte conditions, and the ampholyte composition, not the hydrogel network.16 We 
observed no significant difference in the slope or the linearity of the pH gradients, 
among the three gel formulations (Figure 3-7B-C; one-way ANOVA performed with 
Kruskal-Wallis test and post-test Dunn’s multiple comparison test). The linearity and pH 
gradient slope are similar to previously reported values in anti-convective media.19,20 
 
To conservatively estimate the minimum pI difference for which two neighboring protein 
peaks are fully resolved16 (ΔpImin), we assessed the triad of fluorescently labeled pI 
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markers through the relationship in Equation 3-2, where dpH/dx is the slope of the pH 
gradient and sprotein is a measure of the peak quarter-width (i.e., standard deviation of 
the Gaussian fit to the fluorescence intensity profile when focused). The estimated 
ΔpImin is considered conservative, as the diffusivity of the pI markers is expected to be 
substantially larger than a moderate-sized protein. The pI markers studied have 
molecular masses that are 2 orders of magnitude smaller than a moderate-sized protein 
(e.g., tGFP at 27,000 Da vs 285 Da for a pI marker). Nevertheless, estimates of ΔpImin 
using the pI markers give an indication of the expected suitability of IEF resolution in the 
2% PEG highly porous PA gels. 
 ∆𝑝𝐼$%& = 3 ∗ 𝑑𝑝𝐻𝑑𝑥 ∗ 𝜎./012%&  
Equation 3-2. ΔpImin quantified for proteins focused in an IEF assay. 
 
For the 2% PEG highly porous PA gel formulation, we observed a ΔpImin that was 
statistically larger than that of the negative control gel formulation (Figure 3-7D). The 
ΔpImin values estimated for the 2% PEG PA gel and negative control PA gel were 
0.20±0.03 and 0.12±0.01 (mean ± standard deviation; n=3 gels), respectively. While 
differences in the ΔpImin between the negative control and benchmarking gels were not 
statistically significant (one-way ANOVA performed with Kruskal-Wallis test and post-
test Dunn’s multiple comparison test). The benchmarking PA gel formulation had ΔpImin 
= 0.16±0.02. 
 
Next, to estimate a less conservative ΔpImin, IEF analysis was performed on the well-
characterized, fluorescent model protein tGFP, which focuses into 2-3 isoform peaks67 
depending on IEF performance and design. In tGFP analysis via IEF, the 2% PEG 
highly porous PA gel supported a ΔpImin = 0.07±0.02 (mean ± standard deviation; n=3 
gels, Figure 3-9B). The benchmarking PA gel formulation had a ΔpImin = 0.11±0.03, 
with a similar ΔpImin measured for the negative control (ΔpImin = 0.12±0.02). The tGFP 
protein focused into two isoform peaks67 for all replicate IEF analyses in the 2% PEG 
PA gels, and in one of three replicated in the negative control gels (Figure 3-8, Figure 
3-9A).  
 
Comparison to other published IEF performance suggests that the 2% PEG highly 
porous PA gels offer ΔpImin performance on par with or exceeding that of commonly 
used formats, including capillary IEF89 and others (benchmarking gels, ΔpImin=0.13±0.02 
using Polybuffer® ampholytes over a pH 4-7 gradient19; IEF in free solution, ΔpImin=0.11 
for adherent-cell IEF platforms using Zoom® ampholytes over a pH 4-7 gradient21). 
Analysis of the 2% PEG highly porous PA gel formulation suggests the matrix is suitable 
as an anti-convective media for high performance IEF, which is important to resolving 
protein isoforms and post-translational modifications. 
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Figure 3-7. Highly porous PA gels are suitable for IEF. 
(A) Representative inverted micrographs and intensity plots of IEF-focused pI markers (4.5, 5.5, and 6.6 
markers, black arrows) at 10 min elapsed separation time. Y-axis indicates fluorescence intensity. (B) 
Slope of pH gradient is not significantly different between the gel conditions. (C) R2 statistic for linear 
regression fit of the 3 pI markers is not significantly different between pH gradient linearity between the 
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gel conditions. (D) The minimum resolvable pI difference (DpImin) is significantly different between highly 
porous PA gel formulations with 0% PEG (negative control) and 2% PEG. For all graphs, mean and 
standard deviation marked by horizontal lines for n=3 gels per condition. One-way ANOVA with Kruskal-
Wallis test and post-test Dunn’s multiple comparison test was conducted with p<0.05 (*). 
Immunoprobing Efficiency in Highly Porous PA Gels 
After IEF analysis, focused proteins are immobilized and probed using an immunoassay 
to complete the immunoprobed IEF assay. The PA gel formulations studied here have 
been designed to support in-situ immunoprobing, a transfer-free immunoblotting design. 
Transfer-free blotting reduces losses during re-solubilization of IEF-focused protein 
targets, which is advantageous to the analytical sensitivity of the IEF assay. In-situ 
immunoprobing uses the PA gel matrix as a scaffold for protein target immobilization, 
followed by an in-gel immunoassay on each immobilized protein target. Light-based 
blotting (immobilization) toggles the IEF matrix from an anti-convective media to the 
immobilization scaffold. One common approach to light-based blotting uses 
photoactivation (UV) of a light-sensitive monomer polymerized into each PA gel (i.e., 
benzophenone N-[3-[(3-benzoylphenyl)formamido]propyl] methacrylamide, BPMA). 
Upon UV activation, BPMA abstracts hydrogen from neighboring C—H bonds, thus 
irreversibly crosslinking protein targets to the gel matrix.3,90  
 
For the transfer-free immunoblotting design, we first assessed each PA gel formulation 
as an immobilization scaffold. We define photocapture efficiency, η, in Equation 3-3, 
where tGFP pre-immobilization and tGFP post-immobilization are the areas-under-the-curve (AUCs) 
of focused protein (tGFP) before exposure of the protein peak to UV light and after 
exposure to UV light, respectively (Figure 3-9A).  
 
Time Benchmarking gel Negative control gel 2% PEG 
Highly porous gel 
 
Figure 3-8. Characteristic tGFP protein focusing in PA gels over time. 
Representative inverted micrographs of purified recombinant tGFP protein focusing in IEF pH gradient 
over the 12 minute timeframe. “A |” denotes the edge of the pH 4 boundary condition on the left. pH 
gradient spans pH 4-7 from left to right. “| B” denotes the edge of the pH 10 boundary condition. 
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Figure 3-9. Characterization of photocapture efficiency in highly porous PA gels.(A) Representative 
inverted micrographs and intensity plots of IEF-focused tGFP (arrows) at 11 min of IEF (left) and after 
tGFP immobilization and wash (right). Y-axis indicates fluorescence intensity. (B) Estimated minimum 
resolvable pI difference, using the most abundant isoforms, shows no significant difference between gel 
formulations. (C) tGFP photocapture efficiency (η) over all tGFP isoforms indicates no significant 
difference. For all graphs, mean and standard deviation marked by vertical lines for n=3 gels per 
condition. One-way ANOVA with Kruskal-Wallis test and post-test Dunn’s multiple comparison test was 
conducted with p<0.05 (*). 
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Figure 3-10. Measurement of fluorescent intensity area-under-the-curve in photocapture efficiency 
measurements in PA gels. 
tGFP AUC indicates high technical variation from the pre-immobilization measurement. Mean and 
standard deviation reported for n=3 gels per condition. One-way ANOVA with Kruskal-Wallis test and 
post-test Dunn’s multiple comparison test was conducted with p<0.05 (*).  
 
We expect the increased pore size in the highly porous PA matrices to reduce η not due 
to the dimensions of the pores, but rather due to the sequestration of benzophenone 
immobilization moieties within the PA bundles. To assess the impact of the pore 
dimensions on photocapture efficiency, we first use the predicted molar volume of the 
benzophenone immobilization moiety91 to estimate that an individual benzophenone 
group occupies 0.279 nm3 of volume. Using the PA pore sizes from SEM 
characterization70 of 2.5 nm radius for 5%T 4%C PA gels and 250 nm radius for 5%T 
4%C + 2% PEG PA gels, we estimate that benzophenone groups occupy 0.084% of the 
volume of a single pore in a negative control PA gel, and similarly 0.084% of the volume 
of a single pore in the highly porous 2% PEG PA gels. This estimate assumes that the 
incorporation rate of hydrophobic BPMA into the hydrophilic PA chains during gel 
polymerization is not disrupted by the presence of hydrophilic PEG and the resultant 
lateral chain aggregation of PA in the highly porous 2% PEG gels. Thus, the same 
benzophenone occupancy would occur in these PA gels regardless of pore dimensions. 
Given a diffusivity of tGFP in a 6%T 3.3%C gel as D = 31.3 µm2/s 67, we estimate the 
time for tGFP diffusing across a single pore to be 4 orders of magnitude smaller than 
the 45 s of UV-induced immobilization. The limiting factor affecting photocapture 
efficiency therefore is not the dimension of the pore, but rather the number of active 
BPMA sites on the surface of the large PA pores for protein immobilization. 
 
Competitive occupation of the active BPMA sites for protein immobilization is of concern 
in the ultrathin IEF platform. During IEF and protein photocapture, the PA gels contain 
not only the 3.7 µM tGFP protein used as a model protein in this study, but also the 
ampholytes solution and TritonX-100. During the IEF stage, the 4 mM total solution of 
ampholytes stacks into individual bands of each ampholyte to form the pH gradient. 
During subsequent UV activation of BPMA, these ampholytes would likely compete with 
tGFP, and over any protein species of interest, for those active BPMA sites. However, 
this assessment is limited by a lack of information on the concentration distribution of 
commercially available ampholytes, as well as the relative binding affinity of each 
ampholyte species to BPMA. 
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We experimentally quantified η in these gels. Across all three gel formulations, no 
difference was measured in the η values (benchmarking gels, η = 27±15%; negative 
control gels, η = 25±10%; 2% PEG gels, η = 19±11%; mean ± standard deviation; n=3 
gels, Figure 3-9C). Using the benchmarking gel formulation, immunoprobed IEF on 
tGFP from single mammalian cell lysate (a more complex sample matrix) was 
performed with η = 17±1.5%.19 Note that the protein loading was not designed to control 
the total volume (and concomitantly, mass) of sample introduced to the gel (Figure 
3-10). The CV (calculated as the standard deviation divided by the mean) of the pre-
immobilization tGFP AUC was quantified as 87% for the negative control gels, 44% for 
the 0% PEG gels, and 36% for the 2% PEG gels. The CV of the post-immobilization 
tGFP AUC was 42% for the negative control gels, 56% for the 0% PEG gels, and 52% 
for the 2% PEG gels. Analyses of η for the 2% PEG highly porous PA gel formulation 
suggests that this material is a suitable scaffold for UV-induced protein immobilization. 
 𝜂 = 𝐴𝑈𝐶	𝑡𝐺𝐹𝑃	𝑝𝑜𝑠𝑡 − 𝑖𝑚𝑚𝑜𝑏𝑖𝑙𝑖𝑧𝑎𝑡𝑖𝑜𝑛𝐴𝑈𝐶	𝑡𝐺𝐹𝑃	𝑝𝑟𝑒 − 𝑖𝑚𝑚𝑜𝑏𝑖𝑙𝑖𝑧𝑎𝑡𝑖𝑜𝑛  
Equation 3-3. η for proteins immobilized in the PA gels using the benzophenone moiety. 
 
For the transfer-free immunoblotting design, we next assessed the performance of the 
in-situ immunoassay (immunoprobing) step. Performing an immunoassay on target 
immobilized in a hydrogel brings makes consideration the thermodynamic partitioning 
(K) characteristics of the hydrogel important. Gel microarchitecture affects the size-
exclusion phenomena observed with small-pore gels and large-molecular-weight 
soluble species.69,92,93 Typically dominated by size-exclusion mechanisms, the 
thermodynamic partitioning reduces the concentration of immunoprobe in the gel, as 
compared to in free solution, and impacts binding kinetics of the immunoassay. In turn, 
the concentration of immunoprobe in the gel impacts the analytical sensitivity of the 
immunoprobed IEF assay, as well as reagent consumption. 
 
First, given the relationship between PEG concentration and resultant porosity of each 
PA gel formulation, we sought to measure the partition coefficient (K) of a canonical 
immunoprobe (IgG*, a fluorescently labeled primary antibody), using the following 
relationship69,77,92 in Equation 3-4. Here, IgG* fluorescence gel is the fluorescent signal 
from the labeled immunoprobe in the gel, IgG* fluorescence solution is the fluorescence 
signal of the labeled immunoprobe in the gel, autofluorescence gel, blank is the 
background autofluorescence in the gel without IgG*, and autofluorescence solution, blank is 
the autofluorescence in the solution without IgG*. 
 𝐾 = 𝐼𝑔𝐺∗	𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒	A2B 	−	𝑎𝑢𝑡𝑜𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒	A2B,XB@&Y𝐼𝑔𝐺∗	𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒Z0B[1%0& 	− 	𝑎𝑢𝑡𝑜𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒	Z0B[1%0&,XB@&Y  
Equation 3-4. Partition coefficient K for IgG* in PA gels. 
 
As PEG concentration increases, we anticipate K will also increase. Increased K directly 
increases the concentration of immunoreagent available for the downstream 
immunoassay, impacting assay sensitivity.69 The value of K ranges from 0 (no entry of 
the soluble species into the gel at equilibrium) to 1.0 (near-equivalent concentrations of 
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the soluble species between free solution and the gel at equilibrium) for species with no 
specific interactions with the gel network.  
 
As reported in Figure 3-11, we observed a partition coefficient for the 2% PEG highly 
porous PA gels that was significantly larger than both the benchmarking gels and 
negative control gels (benchmarking gels, K = 0.11±0.01; negative control gels, K = 
0.20±0.01; 2% PEG highly porous PA gels, K = 0.35±0.02; mean ± standard deviation; 
n = 3-6 gels). The observed K values are corroborated by wide-field epifluorescence 
microscopy of PA gel formulations similar to our benchmarking gel formulations.3 
Characterization of PA gels created under lateral chain aggregation conditions by 
scanning electron microscopy (SEM) reports similar porosity.70 
 
The two-fold increase in K between the benchmarking gels and negative control gel is 
hypothesized to arise from bis-acrylamide aggregating into bundles in the higher %C 
formulation, as has been previously observed (20%C and 60%C PA gels)94, and 
corroborated by freeze-etched transmission electron microscopy (TEM) of similar PA 
gel formulations95 and an observed decrease in elastic modulus96 (10%C PA gels 
versus lower %C PA gels). 
 
 
Figure 3-11. Partition coefficient, K, is sensitive to PA gel formulation. 
Partitioning of AlexaFluor-647-labeled donkey-anti-rabbit antibody (IgG*) into the hydrogel network 
indicates a statistically significant increase in K due to the gel formulation and incorporation of the PEG. 
Mean and standard deviation marked for n=3-6 gels per condition. 
 
Lastly, we sought to compare the dependence of background signal on the gel 
formulation, after in-gel immunoassay completion. Background signal can be attributed 
to immunoprobe retained in the PA gel after each round of washing. High background 
signal can degrade detection sensitivity and is an acute challenge in PA gel 
immunoassay formats. Here, we considered an immunoassay probed by an unlabeled 
primary polyclonal antibody to the target, followed by detection using a fluorescently 
labeled secondary polyclonal antibody. We sought a well-characterized protein target, 
and so opted to employ the naturally fluorescent tGFP protein. 
 
The post-immunoassay background signal in the 2% PEG highly porous PA gels was 2x 
and 3x lower than background signal measured in the benchmarking gels and negative 
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control gels, respectively (benchmarking gels, 1850±1060 AFU; negative control gels, 
1290±380 AFU; 2% PEG highly porous PA gels, 606±72 AFU). We attribute the lower 
background measured in the highly porous PA gels to reduced entropic trapping of 
antibody probes in these larger pore size matrices. Freely diffusing molecules are 
known to become trapped in regions of hydrogel pore-size inhomogeneity.93 In these 
larger pore size regions, molecules can be trapped in a free energy minimum.  
Entropic trapping is particularly relevant for macromolecules of intermediate size.93 
Immunoreagents such as antibodies (5-8 nm hydrodynamic radius97,98) would be 
expected to be entropically trapped in the negative control PA gels (5-92 nm mean pore 
radius70,71). In the 2% PEG highly porous PA gels, however, the estimated mean pore 
radius is substantially larger (~250 nm; Figure 3-1C).70  
 
The observed decrease in background signal during immunoprobing in the 2% PEG 
highly porous PA gels is attributed to reduced entropic trapping of antibody probes in 
hydrogel. Reduced entropic trapping would facilitate more effective washout of both the 
primary and secondary antibodies during the immunoprobing steps. Overcoming the 
high post-immunoprobing background signal makes the 2% PEG highly porous PA gels 
an attractive material in which to perform immunoprobed IEF. 
3.4 Conclusions 
We sought to design a PA gel to enhance performance of the immunoassay stage of 
immunoprobed IEF, while maintaining the separations performance of IEF stage. Here, 
we utilized lateral aggregation during PA gel polymerization to increase the mean pore 
size of PA gels. To do this, we devised PA gel formulations that included the hydrophilic 
polymer PEG. We validated that we created significantly larger porous PA gels and 
observed a significant increase in antibody partitioning into the gel matrix. Comparing 
the highly porous polyacrylamide gel to benchmarking gels (utilized in previous 
immunoprobed IEF assays), we observed no significant impact on the formation or 
stability of the IEF pH gradient, and an improvement in separation resolution. 
Consequently, the highly porous PA gels are suitable for IEF analysis of protein targets. 
In the subsequent immunoassay stage, the large pore size gels allow for more effective 
washout (removal) of unbound immunoreagent at immunoassay completion. The highly 
porous PA matrices therefore serve to support high performance IEF separations while 
providing an immobilization scaffold that is well-suited for heterogeneous 
immunoassays needed for selective target readout. 
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Chapter 4: Isoelectric Focusing Performance in Highly-Porous 
Polyacrylamide Gels Polymerized with Different Initiators 
This work was performed in collaboration with Dr. Kevin A. Yamauchi. 
4.1 Introduction 
Since the development of isoelectric focusing (IEF) in the 1960’s by Svensson and 
Vesterberg, extensive research has gone into the design of an ideal substrate 
specifically for IEF as an analytical assay. Polyacrylamide (PA) gels serve as an anti-
convective substrate for IEF-based separations of proteins.16 As a precursor to 
investigating the performance of the IEF immunoblot in highly porous PA gels (Chapter 
3), we considered the mechanism by which these highly porous PA gels were created. 
In Righetti et al,70 the pre-formed polymer poly(ethylene glycol) (PEG) was incorporated 
into the gel precursor solution as a porogen. During polymerization, acrylamide 
monomers form chains that are interconnected and stabilized by bis-acrylamide 
crosslinkers, resulting in a randomly-organized three-dimensional hydrogel network of 
heterogeneous pore size on the order of 2.5 nm. The hydrophilic PEG induces lateral 
aggregation of the PA chains into bundles at an estimated 150 nm radius. After 
polymerization, the PEG freely diffuses out of the PA gel matrix, creating large water-
filled voids of an estimated mean pore radius of 250 nm, and much smaller pores within 
the PA bundles.70 
 
The mechanism for inducing PA gel polymerization in Righetti et al70 is one of the 
canonical initiator/catalyst pairs for free radical polymerization of hydrogels, ammonium 
persulfate (APS) and N,N,N',N'-tetramethylethylenediamine (TEMED). The timeframe of 
PA polymerization by APS/TEMED is reported to be ~15-20 min for initial gel stability 
and ~ 2 hours for reaction completion.75 During this extended timeframe, the diffusion of 
PEG out of the gel matrix into the free solution sink may result in the partial collapse of 
the laterally aggregated PA chains in the gravitational field. Thus, we investigated if use 
of a photoinitator to rapidly initialize gel polymerization would result in larger pores in the 
PA gel matrix. Specifically, we considered two photoinitiators: 2,2'-azobis[2-methyl-N-(2-
hydroxyethyl)propionamide] (VA-086)99,100 or lithium phenyl-2,4,6-
trimethylbenzoylphosphinate (LAP).101 LAP exhibits increased absorbance within visible 
light and near-UV ranges, resulting in more rapid activation of the initiators in the PA 
precursor solution and subsequently more rapid PA gel polymerization, compared to 
VA-086. 
 
In this study, we interrogated how different gel chemistries, from bis-acrylamide content 
and polymerization initiators to the incorporation of PEG as a porogen, change gel 
microstructure. To characterize use of these gels for the recently-developed IEF 
immunoblot assay,19 we investigated both antibody partitioning into the gels and the 
performance of IEF within these modified PA gels. 
4.2 Materials and Methods 
Reagents 
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Borofloat wafers (University Wafer 516), SU8 3050 photoresist (MicroChem), titanium 
diisopropoxide bis(acetylacetonate) (Sigma 325252), anhydrous isopropanol (Sigma 
278475), a custom in-house-designed mask (CAD/ART Services), GelSlick® (Lonza 
50640), standard glass slides (VWR), dichlorodimethyl silane (Sigma 440272), 3-
(trimethoxysilyl)propyl methacrylate (Sigma 440159), methanol (Sigma 179337), glacial 
acetic acid (Sigma 8817-46), 30%T 29:1 acrylamide/bis-acrylamide solution (Sigma 
A3574), 40%T 29:1 acrylamide/bis-acrylamide solution (Sigma A7802), bis-acrylamide 
powder (Sigma 146072), 1.5 M pH 8.8 TrisHCl (TekNova T1588), N-[3-[(3- 
benzoylphenyl)formamido]propyl] methacrylamide (BPMA, custom synthesized by 
PharmAgra Labs), ammonium persulfate (APS, Sigma A3678), N,N,N',N'-
tetramethylethylenediamine (TEMED, Sigma T9281), UV photoinitiator 2,2'-Azobis[2-
methyl-N-(2-hydroxyethyl)propionamide] (VA086, Wako Chemicals 61551), UV 
photoinitiator LAP (LAP, Allevi), 10 kDa poly(ethylene glycol) (PEG, Sigma 92897), 
borosilicate glass sheets (McMaster-Carr 8476K62), 4-well plates (ThermoFisher 
267061), parafilm (Bemis PM-999), glass coverslips (VWR 48366), and permanent lab 
markers (VWR 52877-310) were used to fabricate materials in this study. 
 
IEF was conducted using the immobilines pKa 3.6 and pKa 9.3 acrylamido buffers 
(Sigma 01716, 01738), SinuLyte® pH 4-7 ampholytes (Sigma 05087, lot BCBJ7449V), 
an ABS electrophoresis device designed and printed in-house, graphite electrodes (Bio-
Rad 1702980), 0.5 mm gel spacers (CBS Scientific MVS0510-R), and TritonX-100 
detergent (Sigma X100). Tris-buffered saline with Tween-20 (TBS-T, CST 9997S) was 
used for gel incubation and wash steps. Urea (Sigma U5378), thiourea (Sigma T8656), 
and CHAPS (SAFC RES1300C) were used as detergents. 
 
The proteins and molecules used in this study were fluorescent pI markers 4.5, 5.5, and 
6.6 (Sigma 89149, 77866, 73376), henceforth termed “pI markers,” BSA (Sigma 
A7030), and purified recombinant turboGFP (Evrogen FP522, lot 55201240718) termed 
“tGFP” (a variant of the GFP with increased fluorescence, MW 27 kDa), and secondary 
polyclonal antibody AlexaFluor-647-labeled donkey-anti-rabbit (Invitrogen A-31573) 
termed “IgG*.” The IgG* degree of labeling is reported by the manufacturer as 5 
fluorophores per molecule for lot 1964354 (Invitrogen). 
Wafer and Gel Fabrication 
SU8 fabrication on a borofloat wafer was conducted following a standard protocol.3 
Briefly, a custom mask with rails spaced 22 mm apart was used to fabricate features of 
40 µm in height (confirmed by optical profilometry) in SU8 on the wafer. After wafer 
treatment with GelSlick®, PA gels were fabricated on the wafer and polymerized onto 
silanized half glass slides. Table 4-1 lists the critical components of each gel condition, 
using 10 kDa PEG as the preformed hydrophilic polymer and leveraging porogen gel 
fabrication conditions developed by Righetti and colleagues.70 Chemical polymerization 
was implemented using APS and TEMED as the initiator and catalyst, respectively. 
Photopolymerization was implemented using VA-086 or LAP as the initiator and 
polymerized for 4 or 1 minutes, respectively, at 20 mW/cm2 light intensity using a 390 
nm UV long-pass filter (Edmund Optics) on an OAI Model 30 Collimated UV light 
source. See Appendix 1 for further details.  
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Table 4-1. Composition of polyacrylamide gels with different chemistries. 
Primary components of all gel conditions used in this study, following standard gel fabrication techniques 
in 48. Highlighting and bolding indicate modifications from the 6%T 3.3%C APS/TEMED gel condition, for 
ease of comparison between PA gel conditions. 
 
Gel nomenclature 3.3%C 
APS/TEMED 
8%C 
APS/TEMED 
8%C 
APS/TEMED 
+ 2.0% PEG 
Acrylamide content 6%T 6%T 6%T 
Bisacrylamide : 
acrylamide ratio 
3.3%C 8%C 8%C 
10 kDa PEG 0.0% 0.0% 2.0% 
Polymerization 
chemistry 
APS / TEMED APS / TEMED APS / TEMED 
BPMA photo-
immobilization moiety 
5 mM 5 mM 5 mM 
 
Gel nomenclature 3.3%C 
APS/TEMED 
+ 2.0% PEG 
3.3%C 
VA-086 
+ 2.0% PEG 
3.3%C 
LAP 
3.3%C 
LAP 
+ 2.0% PEG 
Acrylamide content 6%T 6%T 6%T 6%T 
Bisacrylamide : 
acrylamide ratio 
3.3%C 3.3%C 3.3%C 3.3%C 
10 kDa PEG 2.0% 2.0% 0.0% 2.0% 
Polymerization 
chemistry 
APS / TEMED VA-086 LAP LAP 
BPMA photo-
immobilization moiety 
5 mM 5 mM 5 mM 5 mM 
 
Gel nomenclature 8%C 
LAP 
+0.0% PEG 
8%C 
LAP 
+ 0.5% PEG 
8%C 
LAP 
+ 1.0% PEG 
8%C 
LAP 
+ 1.5% PEG 
8%C 
LAP 
+ 2.0% PEG 
Acrylamide content 6%T 6%T 6%T 6%T 6%T 
Bisacrylamide : 
acrylamide ratio 
8%C 8%C 8%C 8%C 8%C 
10 kDa PEG 0.0% 0.5% 1.0% 1.5% 2.0% 
Polymerization 
chemistry 
LAP LAP LAP LAP LAP 
BPMA photo-
immobilization moiety 
5 mM 5 mM 5 mM 5 mM 5 mM 
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After fabrication, gels were incubated for 16-24 hours in 1× TBS-T to allow for diffusion 
of soluble PEG porogen out of the PA gel network, thus forming large water-filled voids, 
then rinsed in DI water for 30 minutes before use. 
 
For this study, we use the canonical notation of %T as the total acrylamide monomer 
concentration (w/v) in solution, and %C as the ratio of bis-acrylamide crosslinker 
concentration to the total acrylamide monomer concentration.47 We distinguish the 
many PA gel conditions by %C, polymerization chemistry, and %PEG content, as 
outlined in Table 4-1. 
Equilibrium Swelling Ratio 
The equilibrium swelling ratio was conducted using Flory-Rehner theory.47,78–80 After 
fabrication of PA gels on glass slides with 500 μm spacers to define gel height, gels 
were weighed immediately on an Ohaus Adventurer Pro weigh station to determine the 
“fabrication” weight, then incubated in 1× TBS-T for 24 hours for PEG diffusion out of 
the gel. After 12 hours of DI water incubation, the equilibrated gel was weighed again 
for the “hydration” weight, dehydrated fully with a nitrogen gas stream, and weighed a 
third time for the “dehydration” weight. 
Thermodynamic Partitioning 
We used the thermodynamic partitioning method using wide-field epifluorescence3,92 to 
interrogate IgG* partitioning into the PA gels. We created a device for gel fabrication on 
a glass slide with 500 μm spacers (CBS Scientific, MVS0510-R) oriented to leave a free 
solution “well” in the center of the gel. This resulted in total gel dimensions of X = 15 
mm, Y = 18 mm, and Z = 500 μm (including the free solution “well”) and free solution 
“well” dimensions of X = 8 mm, Y = 4 mm, and Z = 500 μm. This gel height was 
selected to reduce the relative effect of the IgG*-containing free solution fluid layer 
between the gel and the coverslip during the subsequent imaging. After fabrication of 
PA gels on silanized half glass slides with 500 μm feature heights, gels were rinsed in 
TBS-T solution, and exposed to 50 nM of IgG* solution (from 2 mg/mL stock solution 
from manufacturer, spun down to remove aggregates) in 2% BSA / TBS-T in 4-well 
plates (5 mL per well containing 3 gels on 1/3 glass slides) sealed with parafilm for 51 
hours to equilibrium (3* τ = 22.2 hours). The calculated time to equilibrium (τ = 8.07 hr) 
was calculated using 1D model of diffusion (τ = x2 / 2D), where x = ~500 µm gel height, 
and D=4.3 µm2/s for the diffusivity of IgG* in an 8%T 2.6%C PA gel.102 Blank gels were 
exposed to TBS-T solution in the same method for the same time. 
 
The gels were sequentially removed from solution and assembled for imaging. The 
bottoms of the glass slides were blotted dry; additional solution was added to the free 
solution “well,” and a coverslip was gently slid over the entire gel to inhibit dehydration 
during imaging. The gels were then set on an Olympus IX-71 inverted microscope with 
an Olympus UPlanFi 4× (NA 0.13) objective and an EMCCD Camera iXon2 (Andor), 
with imaging settings loaded into MetaMorph software (7.10.1.161, Molecular Devices). 
The IgG* was imaged using a Cy5 filter cube (49009, Chroma) promptly, and 
subsequently imaged using brightfield imaging to identify features. 
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The same gels were subsequently incubated in a detergent solution designed to disrupt 
hydrogen bonds (7M urea, 2M thiourea, 1% TritonX-100, CHAPS in DI water) in a 4-well 
plate (5 mL per well containing 3 gels on 1/3 glass slides) overnight for 8-12 hours to 
equilibrium. The calculated time to equilibrium (τ = 26.04 min) was calculated using 1D 
model of diffusion (τ = x2 / 2D), where x = ~500 µm gel height, and D=80 µm2/s for the 
diffusivity of TritonX-100 in free solution.19 Of the 4 detergents used in this study, 
TritonX-100 has the lowest free solution diffusivity and therefore the highest time to 
equilibrate in-gel).19 After rinsing the gels in TBS-T, the gels were then exposed to the 
same dilution of IgG* solution as previously described for the same time, assembled, 
and imaged using the same settings. Images were analyzed using an in-house 
MATLAB script to extract the average fluorescence intensity of the gel and the free 
solution. 
IEF 
The ultrathin IEF was conducted as previously described19 with minor modifications to 
accommodate purified protein solutions (further details in Appendix 3). Briefly, gels of 
height 40 µm were briefly rinsed in DI water, with the fluid layer wicked off the top of the 
gel, then incubated in 40 µL of a solution of 1% each of the pI markers 4.5, 5.5, and 6.6 
(from 1-3 mg/mL stock solutions from manufacturer), and 10% tGFP (from 37 µM stock 
from manufacturer) for 30 minutes at room temperature, protected from light. The 3-
component IEF lid was fabricated using a 1:100 dilution of the stock 40% SinuLyte® 
ampholytes for a final concentration of 0.4%. Table 4-2 lists the components of the lid 
gel, which was polymerized for 4 minutes per component (in the order of catholyte, 
anolyte, and focusing region) at 20 mW/cm2 light intensity using a 390 nm UV long-pass 
filter (Edmund Optics) on an OAI Model 30 Collimated UV light source. 
 
The PA gel and lid gel were assembled in the IEF device previously described,19 and 
set on an Olympus IX-71 inverted microscope with an Olympus UPlanFi 4× (NA 0.13) 
objective and a EMCCD Camera iXon2 (Andor), with imaging settings loaded into 
MetaMorph software (7.10.1.161, Molecular Devices). After a 30 s delay for the soluble 
reagents in the focusing lid gel to diffuse into the PA gel, IEF was conducted by 
applying 690 V for 12 minutes using the Power-Pac high-voltage power supply device 
(HVPS, Bio-Rad 1645056). During this focusing period, pI markers were imaged using a 
UV-longpass filter cube (XF100-1, Omega Optical) at 2.5 minute intervals, and tGFP 
was imaged using a GFP filter cube (XF100-3, Omega Optical) 1 minute subsequently. 
After protein photo-immobilization, gels were rinsed in TBS-T for 30 minutes to remove 
uncaptured species, and imaged with the same settings. The lab markers used to 
denote the gel edges along the separation axis is fluorescent in the UV-longpass 
channel and visible in brightfield imaging. 
 
Micrographs were analyzed using an in-house MATLAB (R2015b, MathWorks) 
script6,48,49 adapted to this microwell-free variant of the IEF (code in Appendix 11). 
Briefly, the micrographs were segmented into regions of interest (ROIs), converted into 
line plots averaged across the width of the ROI (maintaining the separation axis), and 
background-subtracted using the average background intensity across the ROI. 
Gaussian curve fitting to the line plots led to the extraction of the peak height, peak 
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location, peak width, area under the curve, SNR, and other assay-specific parameters 
from each ROI. Validation of the Gaussian curve fits is conducted analytically (R2 ≥ 0.7 
and signal-to-noise ratio SNR ≥ 3) and confirmed manually. For the images taken on the 
Olympus microscope setup, 1 pixel corresponds to 4 μm. 
Statistical Analysis 
To compare the means of the 3+ gel conditions assessed in this study, we first 
assessed for normality using a Q-Q test. After identification that the distributions of 
means did not follow a normal distribution, we assessed statistical significance using the 
one-way ANOVA’s with Kruskal-Wallis test. To compare specific pairs of gel conditions, 
we applied a post-hoc Dunn’s multiple comparison test with p<0.05 (*), using GraphPad 
Prism version 8.1.1. Linear regression fit was performed using an in-house MATLAB 
script. 
 
Table 4-2. Composition of IEF lid gel. 
Components of the 3-part lid gel used for lysis and electrophoresis in this study. 
 
Lid gel components pH 4 anolyte Focusing region pH 10 catholyte 
Polyacrylamide gel 15% T 
3.3% C 
0.2% VA-086 
15% T 
3.3% C 
0.2% VA-086 
15% T 
3.3% C 
0.2% VA-086 
IEF reagents and 
detergents 
 
0.4% final SinuLyte® 
ampholytes 
 
1% TritonX-100 
 
Boundary conditions 13.5 mM pKa 3.6 
immobiline 
 
6.4 mM pKa 9.3 
immobiline 
 
5.6 mM pKa 3.6 
immobiline 
 
14.4 mM pKa 9.3 
immobiline 
4.3 Results and Discussion 
Physical Characterization of Highly Porous PA Gels with Different Polymerization 
Chemistries 
For this study, we designed, fabricated, and assessed eleven hydrogel materials. 
Matching the gel condition previously characterized in ultrathin IEF,19 the negative 
control gel contains no PEG porogen and is thus composed of 6%T 3.3%C PA with the 
polymerization reaction initiated by APS and TEMED. We interrogate the effect of 
increasing bis-acrylamide crosslinker concentration to provide additional mechanical 
robustness to the PA gel network (3.3%C versus 8%C). We also interrogate the effect 
of polymerization initiators (chemical polymerization via APS/TEMED, 
photopolymerization via VA-086, and photopolymerization via LAP). Finally, in a subset 
of gel conditions, we incorporated 0.5% to 2% of 10 kDa PEG as the preformed 
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hydrophilic polymer to create increasingly porous PA gels, as reported in Table 4-1. We 
immersed each gel in a 1× TBS-T solution for 16-24 hours for diffusive removal of PEG, 
then rinsed in DI water before use. We observed slightly increased opacity in all of the 
PA gel conditions containing 8%C bis-acrylamide, compared to the gels containing 
3.3%C bis-acrylamide. 
 
First, we used the equilibrium swelling ratio assay (Figure 4-1A) to indirectly 
characterize the porosity of the PA gels in this study. We then calculated the unitless 
metric of swelling ratio (Q) using Equation 4-1.47,77,78 Q was measured for the full set of 
gel conditions (16.5±1.94 in 3.3%C APS/TEMED, 27.1±0.99 in 3.3%C APS/TEMED + 
2.0% PEG, 46.5±5.52 in 3.3%C VA-086 + 2.0% PEG, 33.5±0.95 in 3.3%C LAP + 2.0% 
PEG, 17.3±4.05 in 8%C APS/TEMED, 23.5±0.71 in 8%C APS/TEMED + 2.0% PEG, 
19.2±1.12 in 8%C LAP +0.0% PEG, 21.3±0.81 in 8%C LAP +1.0% PEG, and 23.7±1.00 
in 8%C LAP +2.0% PEG, with mean ± standard deviation; n=3-14 gels, Figure 4-1B). 
The observed Q for four sets of gels were statistically significant from each other: the 
3.3%C APS/TEMED vs the 3.3%C LAP + 2.0% PEG, the 3.3%C APS/TEMED versus 
the 3.3%C VA-086 + 2.0% PEG, the 3.3%C VA-086 + 2.0% PEG versus the 3.3%C 
LAP + 2.0% PEG, and the 3.3%C VA-086 + 2.0% PEG versus the 8%C APS/TEMED. 
 
The incorporation of 2.0% PEG into the 3.3%C APS/TEMED gel condition increased Q 
1.6-fold. Increases in Q were also observed between the 8%C APS/TEMED and 8%C 
APS/TEMED + 2.0% PEG gel conditions, and between the 8%C LAP and the 8%C LAP 
+ 2.0% PEG gel conditions. These match the expected function of PEG as a porogen to 
induce lateral aggregation of the PA chains, resulting in a highly porous PA gel 
network.70 
 
Of the 3 gel conditions with 3.3%C and 2% PEG (the second through fourth conditions 
in Figure 4-1B), the gels polymerized with VA-086 exhibited the highest Q and 
therefore the largest pores, but with increased variation. At this low %C, 
photopolymerization with either VA-086 or LAP distinctly changed the resulting pore 
size for these highly porous PA gels, compared to the chemical polymerization via 
APS/TEMED. Since the polymerization time varies between these two polymerization 
initiation methods (1-4 min vs 20 min), perhaps this rapid gel photopolymerization is 
sufficient to stabilize the large pores generated by the phase separation of PEG and PA 
during polymerization. 
 
Interestingly, this initiator-induced difference in Q did not hold at higher bis-acrylamide 
concentrations. Specifically, the Q for the 8%C APS/TEMED + 2.0% PEG gels is not 
statistically significant from that of the 8%C LAP + 2.0% PEG gels (the fifth and last 
conditions in Figure 4-1B). We observed no significant difference in Q between all of 
the gel conditions with 8%C (the right-most conditions in Figure 4-1B), suggesting that 
this increased bis-acrylamide content might limit the porosity increase observed in the 
porogen-containing gel conditions. 
 
These Q measurements also indicates that by selecting the appropriate polymerization 
chemistry, PA gel porosity may be easily tunable to suit a range of macromolecule sizes 
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for electrophoretic cytometry assays. It is important to note that the equilibrium swelling 
ratio is a bulk measurement taken in open air without control for ambient air 
temperature or gel dehydration, for which the fabrication and hydration measurements 
are disproportionally affected; thus, Q serves as an indirect measurement of gel 
porosity. 𝑄 = 𝑚𝑎𝑠𝑠	=>?/@12?	A2B𝑚𝑎𝑠𝑠	?2=>?/@12?	A2B 
Equation 4-1. Equilibrium swelling ratio in PA gels. 
 
A 
 
B 
 
Figure 4-1. Swelling ratio in PA gels polymerized with different polymerization chemistries.  
(A) Gel weights measured in equilibrium swelling ratio experiment after fabrication (white); after 
incubation in solution to equilibrium (gray), and after drying (black). (B) The swelling ratio (Q) varied 
significantly due to polymerization initiator, bis-acrylamide content, and PEG porogen content at the same 
6%T gel composition. This indirectly indicates a change in gel porosity. Mean and standard deviation 
marked by vertical lines for n=3-12 gels per condition. One-way ANOVA with Kruskal-Wallis test and post-
test Dunn’s multiple comparison test with p<0.05 (*). 
Characterization of Partitioning in Highly Porous PA Gels with Different 
Polymerization Chemistries 
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Next, we sought to characterize the partition coefficient (K) of AlexaFluor-647-labeled 
antibody probes (>150 kDa, IgG*) in multiple gel conditions using Equation 4-2. K 
ranges from 0 (no entry of the soluble species into the gel at equilibrium) to <1 (near-
equivalent concentrations of the soluble species between free solution and the gel at 
equilibrium) for species with no specific interactions with the gel network. Increased K 
directly increases the concentration of immunoreagent available for a subsequent 
immunoassay, affected assay sensitivity.69 K was measured for a range of gel 
conditions (0.14±0.04 in 3.3%C APS/TEMED, 0.29±0.13 in 8%C APS/TEMED, 
0.34±0.09 in 3.3%C LAP, 0.39±0.04 in 8%C LAP +0.0% PEG, 0.41±0.01 in 8%C LAP 
+0.5% PEG, 0.52±0.02 in 8%C LAP +1.0% PEG, 0.59±0.02 in 8%C LAP +1.5% PEG, 
0.74±0.08 in 8%C LAP +2.0% PEG, with mean ± standard deviation; n=3-9 gels pooled 
from multiple experiments, Figure 4-2). We observed a statistically-significant difference 
between the 3.3%C APS/TEMED gel and the 8%C LAP +1.0%, 8%C LAP +1.5%, and 
8%C LAP +2% PEG gels. This significant increase in K in the 8%C LAP +PEG gels not 
only is an indirect indicator of an increase in gel porosity, but allows for tunability in the 
desired partitioning behavior of IgG* in a PA gel fabricated using this particular 
polymerization chemistry, resulting in tunable in-gel immunoblots with IgG*. 
 
A 2.5-fold increase in K was observed between the 3.3%C APS/TEMED and the 3.3%C 
LAP gel condition. This matches the observation with the Q measurement that gel 
polymerization chemistry affects gel porosity. 
 
We also observed a large variation in K measurements in the 8%C APS/TEMED gel 
condition, notably across multiple gels in the same experiment and across multiple 
experimental runs. Further investigation is needed to identify the source of this variation.  
 𝐾 = [𝐼𝑔𝐺∗]	A2B − [𝐼𝑔𝐺∗]	A2B,XB@&Y[𝐼𝑔𝐺∗]Z0B[1%0& − [𝐼𝑔𝐺∗]	Z0B[1%0&,XB@&Y 
Equation 4-2. Partitioning of IgG* in PA gels. 
 
It is important to note that the wide-field microscopy method used here to measure the 
in-gel and in-solution IgG* fluorescence also includes a thin IgG*-containing fluid layer 
between the hydrated gel and the coverslip on top of the gel. As reported in Chapter 5, 
this fluid layer between a 6%T PA gel and a glass substrate has been quantified as ~1.7 
µm. We expect that this IgG*-containing fluid layer on top of the gel would result in a 
much brighter “gel” fluorescence measurement (via wide-field microscopy) than is 
accurate, an effect that would be much more muted for the IgG*-containing fluid layer 
on top of the IgG*-containing free solution “well.” Thus, this particular method of 
measuring K would be slightly skewed high. This hypothesis has been experimentally 
validated via quantification of K in the same gels sequentially via wide-field microscopy 
and confocal laser scanning microscopy (using the latter method, an IgG*-containing 
fluid layer on top of the gel is visible and verifiable in a z-stack and would not skew the 
in-gel fluorescence measurement).68 As reported in Chapter 3, a novel method for 
measuring K reported vastly differing K values for the same PA gel conditions, 
fabricated by the same researcher using the same protocol. Specifically, for the 6%T 
3.3%C APS/TEMED gel condition, K via wide-field microscopy was measured as 
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0.14±0.04, while K via confocal laser scanning microscopy was measured as 0.11±0.01 
(Figure 3-3A). Nevertheless, one still can compare the relative differences in K in PA 
gels polymerized by different gel conditions reported here by this method. 
 
 
Figure 4-2. Partitioning of IgG* in PA gels with different polymerization chemistries. 
Partitioning of AlexaFluor-647-labeled donkey-anti-rabbit antibody (IgG*) into the hydrogel network 
indicates a statistically significant increase in K due to the combinatorial change in gel bis-acrylamide 
content, polymerization initiator, and incorporation of the PEG porogen at the same 6%T gel composition. 
This indirectly indicates a change in gel porosity. Mean and standard deviation marked by vertical lines 
for n=3-9 gels per condition. One-way ANOVA with Kruskal-Wallis test and post-test Dunn’s multiple 
comparison test with p<0.05 (*). 
 
Of the gels reported in Figure 4-2, a subset was maintained for assessment of the 
stability of the gel microarchitecture. During hydrogel polymerization, hydrophilic PEG 
acts as a porogen, resulting in the formation of bundles of laterally aggregated PA 
chains.70,103,104  After hydrogel polymerization, the PEG diffuses out of the PA gel 
network, which should be stably crosslinked. A small fraction of the PEG is thought to 
remain in the PA gel as a semi-interpenetrating network, which may inhibit in-gel 
diffusion of soluble species.72 To characterize the stability of the gel microarchitecture, 
we exposed the gels to a detergent solution (7M urea, 2M thiourea, 1% TritonX-100, 
and 3.6% CHAPS, matching the denaturing lysis condition for the ultrathin IEF assay). 
Chaotropes, such as urea and thiourea, disrupt hydrogen bonding but cannot 
destabilize the covalent bonds of a PA gel. After detergent exposure, we used the same 
partitioning experiment on these gels, with the expectation that any gel 
microarchitecture disruption would reduce IgG* partitioning into the gel. K was 
quantified for the same set of 3 gels per condition before detergent treatment 
(0.39±0.04 in 8%C LAP +0.0% PEG, 0.41±0.01 in 8%C LAP +0.5% PEG, 0.52±0.02 in 
8%C LAP +1.0% PEG, 0.59±0.02 in 8%C LAP +1.5% PEG, 0.74±0.08 in 8%C LAP 
+2.0% PEG, with mean ± standard deviation; n=3 gels, blue data points in Figure 4-3) 
and after detergent treatment (0.38±0.01 in 8%C LAP +0.0% PEG, 0.42±0.02 in 8%C 
LAP +0.5% PEG, 0.53±0.01 in 8%C LAP +1.0% PEG, 0.59±0.01 in 8%C LAP +1.5% 
PEG, 0.75±0.01 in 8%C LAP +2.0% PEG, with mean ± standard deviation; n=3 gels, 
red data points in Figure 4-3). We observed minimal difference in K due to the 
detergent exposure, indicating that the porogen gels were stably crosslinked. 
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Figure 4-3. Gel microarchitecture is not disrupted by exposure to hydrogen-bond-disrupting 
detergents, indicating stable gel crosslinking. 
We observed minimal difference in the partitioning of IgG* into the 6%T 8%C LAP gels before (blue 
circles) and after (red X’s) exposure to hydrogen-bond-disrupting detergents. Mean and standard 
deviation depicted for n=3 gels. 
IEF in Highly Porous PA Gels with Different Polymerization Chemistries 
Next, we interrogated if gels with different gel polymerization chemistries maintained 
their suitability as an anticonvective media for IEF protein separations. 
 
For this, we used a subset of gels studied previously: the 6%T 3.3%C APS/TEMED gel 
condition previously characterized in the ultrathin IEF assay as a negative control,19 the 
6%T 8%C LAP + 0.0% PEG gel condition to investigate the role of bis-acrylamide and 
polymerization initiator, and 6%T 8%C LAP + 2.0% PEG gel condition to investigate a 
large-pore gel condition mimicking those reported in Righetti et al.70 
 
We investigated the formation and stability of the pH gradients formed in the hydrogels. 
To monitor and then characterize the pH gradient formed, we generated pH gradients 
that included three fluorescently-labeled pI markers (pI 4.5, 5.5, and 6.6). As an 
indicator of pH gradient formation – IEF having reached equilibrium – we utilized the pI 
markers (Figure 4-4A) and quantitatively identified the timepoint at which the peak 
center of the Gaussian fit of the focused fluorescent band of each pI marker shifts 
between consecutive measurements by the same rate (defined as cathodic drift), and at 
which the peak width does not significantly decrease between consecutive 
measurements. We measured ~7.5 min for the pH gradient to focus in all 3 gel 
conditions. 
 
To further characterize IEF focusing and stability in the PA gels, the electrical current 
was measured during IEF for all gel conditions (Figure 4-5). The observed drop in 
electrical current within the first 2 minutes of IEF confirms that the ampholytes did focus 
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to their respective pI, reduce their electrophoretic migration, and stack across the 
separation axis to form the pH gradient, as previously reported in IEF.35,84 
 
To characterize the pH gradient at equilibrium, we assessed IEF in each material by 
considering the slope of each pH gradient, dpH/dx. To determine dpH/dx, each of the 3 
focused pI marker concentration distributions were fit to a Gaussian curve at 10 min of 
elapsed separation time (Figure 4-4A). This timepoint was selected to exceed the time-
to-focus measured previously, to measure IEF separation resolution reliably in a stable 
pH gradient across all gel conditions. Using the peak locations and knowledge of the 
ampholyte composition, we then used a linear regression fit of the 3 pI markers to 
estimate the pH gradient properties. The dpH/dx was quantified as 0.35±0.01 mm-1 in 
the 3.3%C APS/TEMED gels, 0.35±0.03 mm-1 in the 8%C LAP + 0.0% PEG gels, and 
0.32±0.01 mm-1 in the 8%C LAP + 2.0% PEG gels (Figure 4-4B, mean ± standard 
deviation; n=3 gels). The 2% PEG gels demonstrated no significant effect on the shape 
of pH gradient. This is as expected, since the focusing of the SinuLyte® ampholytes is 
dependent on the separation axis length and the ampholytes themselves, not the 
hydrogel network.16 For the same separation axis in ultrathin IEF, the dpH/dx was 
measured at 0.40 mm-1 for the Polybuffer® ampholytes over a pH 4-9 gradient.19 
 
To assess the linearity of the pH gradient, we next measured the mean R2 statistic for 
the linear fits. We quantified R2 = 0.89±0.03 in the 3.3%C APS/TEMED gels, 0.83±0.05 
in the 8%C LAP + 0.0% PEG gels, and 0.79±0.01 in the 8%C LAP + 2.0% PEG gels 
(Figure 4-4C, mean ± standard deviation; n=3 gels). There was no significant difference 
in the linearity of the gradient via the R2 statistic to the linear fit of the pH gradient, 
between the 3.3%C APS/TEMED gels and both of the LAP-polymerized gels. However, 
the linearity of the pH gradient should be near 1.00 for a well-designed ampholyte 
solution, and should be independent of the gel microarchitecture. Here we employ 
SinuLyte® ampholytes, for which no information is available from the manufacturer 
about the pH gradient linearity. In comparison, the Polybuffer® ampholytes used 
previously in a similar ultrathin IEF platform demonstrated 1.00±0.00 linearity.19,20 This 
observed non-linear and compressed region in the pH gradient between pI markers 5.5 
and 6.6 in the 8%C LAP + 0.0% PEG and 8%C LAP + 2.0% PEG gels, as well as the 
poor separation resolution between these two pI markers in these two gel conditions, 
indicates that the LAP is disrupting the pH gradient. 
 
We next evaluated the minimum difference in pI for which two neighboring proteins are 
fully resolved (ΔpImin), a unitless metric determined by Equation 4-3.16 Using the pI 
markers (Figure 4-4D), we measured the ΔpImin as 0.16±0.02 in the 3.3%C 
APS/TEMED gels, 0.20±0.03in the 8%C LAP + 0.0% PEG gels, and 0.19±0.03 in the 
8%C LAP + 2.0% PEG gels (mean ± standard deviation; n=3 gels). 
 
 ∆𝑝𝐼$%& = 3 ∗ 𝑑𝑝𝐻𝑑𝑥 ∗ 𝜎./012%&  
Equation 4-3. ΔpImin quantified for proteins focused in an IEF assay. 
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C 
 
 D 
 
Figure 4-4. IEF is disrupted in gels polymerized with the LAP photoinitiator, as characterized using 
pI markers. 
(A) Representative inverted micrographs and intensity plots of the in-gel focused pI 4.5, 5.5, and 6.6 
markers (arrows) in the native IEF platform at 10 minutes. (B) Slope of the pH gradient is not significantly 
different between the gel conditions. (C) R2 statistic for the linear regression fit of the 3 pI markers is not 
significantly significant between the gel conditions. (D) ΔpImin is not significantly significant between the 
gel conditions. For all graphs, mean and standard deviation marked by vertical lines for n=3 gels per 
condition. One-way ANOVA with Kruskal-Wallis test and post-test Dunn’s multiple comparison test was 
conducted with p<0.05 (*). 
 
6%
T 
8%
C 
LA
P 
 
+0
.0
%
 P
EG
 
6%
T 
3.
3%
C 
 
AP
S/
TE
M
ED
 
6%
T 
8%
C 
LA
P 
 
+2
.0
%
 P
EG
 
 45 
 
Figure 4-5. Electrical current during IEF in PA gels of different polymerization chemistries. 
Electrical current measured during IEF experiment for all 3 conditions. Each line indicates a single 
experimental run. Gray lines indicate the 3.3%C APS/TEMED gels, red 8%C LAP + 0.0% PEG, and blue 
8%C LAP + 2.0% PEG. 
 
A 
 
B 
 
Figure 4-6. IEF performance in gels of different polymerization chemistries using tGFP protein. 
(A) Representative inverted micrographs and intensity plots of the focused tGFP (arrow) in the native IEF 
platform at 11 minutes. (B) ΔpImin did not significantly differ between the gel conditions. Mean and 
standard deviation marked by vertical lines for n=3 gels per condition. One-way ANOVA with Kruskal-
Wallis test and post-test Dunn’s multiple comparison test was conducted with p<0.05 (*). 
 
Using the model protein tGFP, we characterized the ΔpImin as 0.18±0.07 in the 3.3%C 
APS/TEMED gels, 0.10±0.05 in the 8%C LAP + 0.0% PEG gels, and 0.06±0.02 in the 
8%C LAP + 2.0% PEG gels (mean ± standard deviation; n=3 gels, Figure 4-6). It is 
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unclear why the focused tGFP protein band (pI ~4.5 via IEF in a microfluidic channel)19 
shifts towards the catholyte in the 8%C LAP + 0.0% PEG and 8%C LAP + 2.0% PEG 
(Figure 4-6A), especially compared to the band location of the pI 4.5 marker run in the 
same experimental run (Figure 4-4A). Inclusion of a fluorescently-labeled purified 
protein IEF ladder with the tGFP protein (Chapter 6) could provide additional 
information on potential disruption of the pH gradient by LAP. 
 
This investigation indicates that the highly porous PA gels polymerized with LAP result 
in nonlinear pH gradients in IEF, notably a compressed gradient near pH 5.5-6.6, and 
as such are unsuitable matrices for IEF. 
4.4 Conclusions and Future Directions 
We investigated the role of gel chemistry in modifying the PA gel microarchitecture, 
while preserving the 6%T content of the PA gels. Notably, with modifications to the bis-
acrylamide content, the method of gel polymerization, and the incorporation of PEG as 
a porogen, we observed a 2.8-fold increase in the swelling ratio of specific PA gel 
conditions. We further observed a 5.3-fold increases in IgG* partitioning in these highly 
porous PA gel matrices. The observed partitioning measurements in the series of 8%C 
LAP +PEG gels were unaffected by exposure to hydrogen-bond-disrupting detergents, 
suggesting that the gels were stably crosslinked. From a subset of PA gel conditions, 
we observed that gel photopolymerization via LAP resulted in a nonlinear pH gradient in 
IEF. PA gels polymerized with LAP are therefore unsuitable as a substrate for IEF 
across pH 4-7, within which the pI’s of ~50-70% of the human proteome lie.45,46 
 
Further research is needed into the mechanism by which the incorporation of LAP into 
the PA gel network would induce nonlinearity of the pH gradient in IEF. During gel 
polymerization, the free radical formed from activation of the LAP photoinitator converts 
unreacted acrylamide monomers into free radicals, that subsequently combine with 
unreacted acrylamide monomers and bisacrylamide crosslinkers to form the PA gel 
network. Thus, the 294 Da LAP itself is not part of the gel network and should rapidly 
diffuse out of the gel after gel polymerization during the extended wash step described 
in these experiments. If some fraction of LAP remains within the gel, two potential 
hypotheses might explain the observed disrupted IEF in the 8%C LAP + 0.0% PEG and 
8%C LAP + 2.0% PEG. One hypothesis is that the LAP might affect the pH of the entire 
PA gel, which might then disrupt the pH 5.5-6.6 region of the pH gradient generated by 
the ampholytes in IEF. Alternatively, perhaps the LAP interacts with the ampholytes that 
stack to form the pH 5.5-6.6 region, thereby disrupting the pH gradient selectively within 
this range. These hypotheses are informed by the observation that the inclusion of 250 
mM imidazole (an ampholyte of pI ~6.1)16 in the focusing region of the IEF lid gel 
disrupted the formation of the pH gradient in this ultrathin IEF assay (0). Perhaps these 
gel compositions might be useful in interrogating proteins with pI’s above pH 7, provided 
a stable and linear pH gradient is observed in these gels above pH 7. 
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Chapter 5: Protein Diffusion from Microwells with Contrasting 
Hydrogel Domains 
This work was performed in collaboration with Dr. Elaine J. Su, and is reproduced with 
permission of AIP Publishing from EJ Su, S Jeeawoody, AE Herr. “Protein diffusion in 
materials with heterogeneous partition coefficients.” APL Bioengineering. 
2019;3:026101. 
5.1 Introduction 
Molecular transport through hydrogels is important across a wide range of 
bioengineering systems, including tissue engineering, drug delivery, and single-cell 
assays. In hydrogels, diffusion of macromolecules from one phase to another (i.e., liquid 
to hydrogel) is hindered by thermodynamic partitioning. The equilibrium partition 
coefficient, Keq, is defined as the ratio of concentration of solute in the gel to that in 
liquid: 
 𝐾2^ = 	 _`ab_bcdecf (1) 
 
Where C is the solute mass per volume, Cgel is the solute concentration in the hydrogel, 
and Cliquid is the solute concentration in the liquid phase.92,105 In the absence of 
attractive interactions (e.g., van der Waals forces or electrostatic interactions77 between 
the solute and the gel), the partition coefficient is described by Ogston’s model, which 
depends on the polymer volume fraction, chain radius, and the size and shape of the 
solute molecule.106 Empirically, the partition coefficient in gels is quantitatively 
determined by measuring the relative concentration of a fluorescent species in the 
solution phase and in the hydrogel phase for a given multi-material system.3,19,92 
 
In addition to equilibrium solute concentrations, time-dependent and diffusion-driven 
solute concentration gradients – both within a single material and between materials – 
are important. For example, understanding drug delivery to the bloodstream or transport 
capabilities of cellular waste products out of capsules both benefit from understanding 
these types of concentration distributions.107–113 Within homogeneous hydrogels such 
as polyacrylamide (PA), which have mobile polymer chains, solute diffusion in hydrogels 
behaves according to a scaled hydrodynamic model110 and can be empirically 
determined.92,111 In hydrogels with immobile polymer chains (e.g., alginate), the 
diffusion coefficient (D) of small molecular species can be described by a hydrogel 
obstruction model.110 When placed in a liquid bath, the transport of solute from the gel 
phase into the liquid phase can be characterized by using non-steady-state 
measurements. Using such approaches, the D of small solute species was found to be 
5-50% lower in gel than in the surrounding water.109 The importance of material type 
and properties on in-gel and out-of-gel diffusion has necessitated development of 
methods to rapidly determine D of a solute in hydrogel systems.114 
 
In general, the diffusion of a solute through a heterogeneous medium depends on the 
solubility and diffusivity of the solute in the different material domains and the geometry 
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of the domains.115 Although various studies have reported on particle diffusion in locally 
heterogeneous hydrogels116,117 and in hybrid [e.g., poly(ethylene oxide)-poly(acrylic 
acid) (PEO-PAA)] hydrogels,118 few studies have reported on solute diffusion through 
more than two different materials. In vivo systems are notably complex and are 
comprised of multiple biological polymer networks (e.g., mucus, extracellular matrix).116 
For example, the study of oxygen permeability through contact lenses to the cornea can 
be represented as two interfacing hydrogels. A fluid (i.e., liquid) film interface exists 
between these hydrogels; this interfacial layer varies in thickness according to the 
topography and morphology of the gel, interfacial tension, interface potential, 
adsorption, partitioning, and chemistry of the gel.119 Fluid films between hydrogels and 
human tissues, such as the cornea, can range from nanometers to tens of microns.120–
124 Characterizing fluid film thickness between sandwiched hydrogels is necessary to 
understand molecular transport at the interface of hydrogels. 
 
Compartmentalization of cells in hydrogels has emerged as a useful approach for 
studying cellular processes. Hydrogel droplets encapsulating cells have facilitated 
biochemical analyses of individual cells.125,126 Similarly, encapsulation of cells in 
microwells allows researchers to scrutinize individual cells to study, in two examples, 
secreted proteins and nucleotides.127,128 In microwell-based studies, macromolecules 
diffuse through from a cell and through free solution to react with antibody probes 
immobilized along the walls or the lid of the microwell,129–132 and the spatial positioning 
of the macromolecules (e.g., proteins) relative to the antibodies in the microwell can 
influence the detected signal strength.133  
 
In our own research group, we have explored single-cell resolution protein 
electrophoresis using thin PA gels as the molecular sieving matrix. Our approach, called 
electrophoretic cytometry, isolates single cells in individual microwells. Cells are then 
chemically lysed in individual microwells, and the intracellular contents are subjected to 
electrophoresis in the hydrogel surrounding the microwell.3,7,19 To mitigate single-cell 
lysate diffusion out of the “open” microwell and electrophoresis gel, researchers have 
used a glass slide as a “lid” on the hydrogel structures. Capping with a glass lid 
improved lysate retention in the hydrogel.134 This particular study demonstrated that 
partitioning and materials permeability can be modulated to maintain high concentration 
of solute in a detection area.130 We have also demonstrated patterning chemistries onto 
the thin microwell-containing PA gel by applying a high density “lid” impregnated with 
the source chemistry, which concurrently mitigates diffusion of the single-cell lysate out 
of open microwells.19,135 Thus, understanding how time-dependent mass transport of 
proteins depends on operational parameters such as Keq, system geometries, and D 
provides a framework for design of bioanalytical tools, such as electrophoretic cytometry 
(single-cell lysate analysis with polyacrylamide gel electrophoresis), with appreciable 
analytical sensitivity. 
 
Here, we seek to understand the role of a lid layer in closing an open microwell used in 
electrophoretic cytometry, be that layer liquid, high-density PA gel, or glass. We have 
demonstrated patterning chemistries onto a thin layer of PA gel by applying a high-
density lid impregnated with the source chemistry. We have also explored lid gels to 
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mitigate diffusion of single-cell lysate out of open microwells.19,135 To understand the 
importance of each material and the role of thin fluid (i.e., liquid) layers that form 
between sandwiched hydrogels, we first characterize the thickness of fluid film layers 
that form between hydro- gels of different densities. We then use our knowledge of fluid 
film thicknesses to create an experimentally validated numerical model that predicts the 
dependence of the microwell-encapsulated protein concentration on the fluid film 
thickness, partition coefficient of the hydrogels, and protein diffusivity in the lid gel for 
model proteins Green Fluorescent Protein (GFP) and Protein G. Understanding 
diffusion-driven transport of intracellular proteins in hydrogels and free solution 
ultimately aids selection of hydrogel properties in multi- material systems, which should 
be useful for applications ranging from drug delivery to high-sensitivity diagnostics. 
5.2 Materials and Methods 
Reagents 
Acrylamide/bis-acrylamide 30% (w/w) solution, ammonium persulfate (APS), N,N,N’,N’-
tetramethylethylenediamine (TEMED), imidazole, sodium phosphate, sodium chloride, 
sodium hydroxide, sodium deoxycholate, sodium dodecyl sulfate, and Triton X-100 were 
obtained from Sigma-Aldrich. 10× Tris-glycine was obtained from Bio-Rad. Tris-HCl, pH 
6.8 buffer was obtained from Teknova. PureProteome nickel magnetic microparticles, 
10 µm, were obtained from Millipore-Sigma. TBS-T was obtained from Cell Signaling 
Technologies. Methacryloxyethyl thiocarbamoyl rhodamine B was obtained from 
Polysciences. VA-086 was obtained from Wako. N-[3-[(3-
benzoylphenyl)formamido]propyl]methacrylamide (BPMA) was obtained from Pharm-
Agra Laboratories. Silicon wafers were obtained from WaferNet. SU-8 developer and 
photoresist (SU-8 3050) were obtained from Microchem. Recombinant Protein G with 
His Tag were obtained from Abcam and labeled in-house with Alexa Fluor 647 NHS 
ester (Life Technologies). 0.5 µm rhodamine-microbeads (FluoSpheres) were obtained 
from Life Technologies. Gel-Slick was obtained from Lonza. 
Fabrication of Rhodamine-Labeled PA Gels 
“Bottom” gels (6%T, 3.3%C) PA gels were synthesized containing 5 mM BPMA and 
0.005% (w/v) methacryloxyethyl thiocarbamoyl rhodamine B. The precursor solution 
was degassed and pipetted between an acrylate-silanized microscope slide or the No. 1 
coverslip and a Gel-Slick treated silicon wafer patterned with 40 µm SU-8 features, as 
previously described.7 PA gels were crosslinked using 0.08% (w/v) APS as the initiator 
and 0.08% (v/v) TEMED as the catalyst. After 20 min of polymerization, the gels were 
peeled off the wafer, rinsed in deionized water, and gently dried under a nitrogen stream 
or stored in 1× TBS-T solution. 15%T, 3.3%C lid gels containing 0.005% (w/v) 
methacryloxyethyl thiocarbamoyl rhodamine B were fabricated using 
photopolymerization, as previously described.19 The 500 µm thickness of the high 
density 15%T gels was obtained by patterning the gel between two glass plates 
separated by a 500 µm thick spacer (CBS Scientific). 
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Image Acquisition 
Confocal imaging experiments were conducted on an inverted Zeiss LSM 710 
AxioObserver (Zeiss, Oberkochen, Germany). Images were acquired at room 
temperature using a 40× water objective (LD C-Apochromat 40× / 1.1 NA W Corr M27, 
Zeiss) with the correction collar set for a No. 1 coverslip. Rhodamine-labeled PA gels 
were fabricated on No. 1 coverslips and imaged using a DPSS-561 laser at 0.25% 
power, using the MBS488/561/633 beam splitter and the Zen 2010 software (Zeiss). Z-
stack images were acquired with 0.42 µm step size with line scanning at x=y=z=0.42 
µm pixel size. 
 
Widefield epifluorescence images for microparticle imaging were obtained on an 
Olympus IX-71 inverted microscope with an Olympus LCPlanFI 40× / 0.6 NA) objectives 
and an EMCCD Camera iXon2 (Andor). For microparticle imaging, brightfield 
microscopy was first utilized to find the field of view including a microparticle in a 
microwell. Microparticles were then imaged with 50 ms exposure times using a Cy5 filter 
cube (Chroma, 49009) using a time series feature in MetaMorph (Molecular Devices). 
Images were collected every 1 s. For particle tracking, microparticles were imaged 
using an Olympus UPlanFi 10× / 0.3 NA objective at 500 ms exposure and an EMCCD 
Camera iXon2 (Andor). 
Numerical Simulations 
Mass transport of proteins during cell lysis were simulated in COMSOL Multiphysics 5.3. 
Input parameters were obtained from literature or were experimentally determined. 
Partition coefficients for GFP were 0.51, 0.24, and 0.10 for 6% T PA gel to free solution, 
15% T PA gel to free solution, and 6% T PA gel to 15% T PA gel, respectively.19 The gel 
lid was 500 µm in height, the bottom gel was 30 µm in height, and the microwell was 30 
µm in height and width. To model an infinitely extending bottom gel, the width of the 
bottom layer, fluid layer, and top layer were 10,000 µm. These geometries were inputted 
into a 2D axisymmetric model. The maximum and minimum mesh element sizes were 
30 and 0.3 µm, respectively. Initial conditions were modeled in the Transport of Dilute 
Species module as a uniform starting concentration of GFP in a 28-µm diameter 
spherical cell, comprising mostly of liquid (free solution). The partition and diffusion 
coefficients of GFP in the cell were thus assumed to be those of liquid (Keq,L = 1 and DL 
= 1.691 × 10-10). The diffusivity of GFP was 4.2 × 10-12 m2 s-1, 3.13 × 10-11 m2 s-1, and 
1.691 × 10-10 m2 s-1 in 15% T gel, 6% T gel, and free solution, respectively.19 The time 
steps for lysis was 1 s. Ct/C0 was estimated by taking a volume integral of the microwell 
at each 1 s interval and dividing by the volume integral of the microwell at t = 0 s.  
 
For microparticle simulations, the same parameters as above were used. To simulate 
what would be measured via widefield microscopy, we included a 30-µm wide rectangle 
directly above the microwell to include the fluid film and lid gel.  For the microparticle, 
we first modeled the species of Protein G released from the microparticle and free to 
diffuse. We assumed that background-subtracted fluorescence intensity was equivalent 
to the number of fluorescent particles. The background-subtracted fluorescence 
intensity of the microparticle fits the function: 
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𝑦(𝑡) = 	1135.8 exp(−0.037𝑡)  (3) 
 
This fluorescence as a function of time was assumed to be the amount of protein 
“bound” to the microparticle. For the free species, the fluorescence was calculated as 
the difference between C0 and Ct. The flux, which represents the amount of free protein 
leaving the microparticle over the surface area per unit time, of the microparticle was 
calculated using the equation: 
 𝑁t/22(𝑡) = ?u>(v)w>(1)x?1 	× yz{/|  (4) 
 
An exponential was fit to N(t), yielding: 
 𝑁(𝑡) = 	44.425exp(−0.037𝑡)  (5) 
 
The final concentration was determined by taking a volume integral of the free species 
over the surface of the microwell, including the column directly above the microwell 
encompassing the fluid layer and lid gel, and summing to the measured fluorescence 
(y(t)) of the microparticle. The summed values were then normalized to the initial 
summed value.  
 
Concentration profiles for the XZ and XY planes were obtained using the linear 
projection operator in COMSOL. To simulate the region surrounding a microwell, a 
rectangle of 100 µm × 70 µm was utilized. For the contour plot, simulations were run 
with a 500 µm thickness lid layer using partition coefficients for GFP in glass, lid gel 
(15% T PA gel), and the bottom gel (6% T PA gel). For each partition coefficient, the 
simulation was run with three different diffusion coefficients for GFP (liquid, the bottom 
gel, and free solution), for a total of nine combinations. The protein solute concentration 
in the microwell was then obtained at t = 15 s and normalized to the initial concentration 
(t = 0 s). These values were inputted into a contour plot in MATLAB (R2017a) using the 
function contour.  
Bead Tracking in Convective Flow 
Bead tracking was performed as previously described.3,136 Briefly, 0.5 µm fluorescent 
beads (FluoSpheres) were diluted 1:50,000 in phosphate buffered saline (PBS). Beads 
were then pipetted onto hydrated bottom gels (6% T PA gels conjugated to glass 
slides). A lid gel (15% T PA gel) was then interfaced to the bottom gel while imaging at 
500 ms exposure time with an image acquisition rate of six frames per second. The 
velocity of the bead was quantified by measuring the length of the streak lines caused 
by the movement of the microspheres over the exposure period, as described 
previously.3 These values were compared to a negative control (no advection, lid, or 
pouring), which resulted in non-detectable velocities (no streaks). The Péclet number 
was calculated as: 
 𝑃𝑒 = 𝐿 [  (6) 
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where L = 30 µm, u is the average measured velocity of the bead, 285 µm/s for lid gel or 
13,000 µm/s for pouring,3 and D = 1.691 × 10-10 m2 s-1, the diffusion coefficient of GFP 
in free solution.19 
Image Processing and Analysis 
Fluid film thicknesses were determined from confocal images in a method described by 
Kuypers et al.137 Briefly, the fluorescence intensity of the XZ profiles were first 
background subtracted. The thickness of the fluid film was obtained by determining the 
“half shoulder” points, i.e., finding the local minima and maxima and determining the 
halfway point. The thickness was calculated as the difference in the Z-position of the 
half shoulder points. 
Microparticle Fluorescence Quantification 
Microparticle fluorescence was quantified using an in-house MATLAB script for 
segmentation of the microparticle. We used a Canny edge detection approach for 
segmentation of the microparticle. After determining the microparticle boundaries and 
generating a binary mask, the mask was applied to all images in the time sequence that 
were first background-subtracted. The fluorescence was measured as the sum of all 
intensity values in the mask region. For microwell quantitation, a brightfield image was 
first taken to determine a region of interest (ROI) encompassing the microwell. The ROI 
was then used to measure background-subtracted fluorescence for each image in the 
time series. 
Statistical Analysis 
Statistical analysis for two-sample Kolmogorov-Smirnov test was performed using the 
kstest2 function in MATLAB. The experimental group was a vector of the mean of four 
separate trials, and the simulation group was a vector containing the simulation data. 
The null hypothesis is that the data in each vector are from the same continuous 
distribution. 
5.3 Results and Discussion 
Model of Diffusion of GFP Through Heterogeneous Materials 
We first sought to understand how protein lysate losses from the closed electrophoretic 
cytometry device are impacted by Keq and D. Lysate losses occur over time via diffusion 
and partitioning between the varying material and solution phases. Analytically, it is 
challenging to identify and quantify losses of lysate in varying geometries (domains) that 
comprise different material properties (and thus, varying partitioning and diffusion 
coefficients). Thus, we created and studied a 2D axisymmetric model (COMSOL) of a 
three-layer device (Figure 5-1A) composed of: (1) a bottom gel, which is a 30-µm thick, 
6% T PA gel conjugated onto a conventional microscope slide and which houses the 
30-µm diameter microwell; (2) a fluid film that arises at the interface of hydrated 
hydrogels and has a thickness H; and (3) a lid, which is 500 µm thick and is composed 
of either a high-density (15% T) PA hydrogel or glass. Material properties are provided 
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in Table 5-1, with D and Keq values obtained from the literature.19 The protein source 
was modeled as a 28-µm diameter sphere. Upon release from the spherical source, the 
concentration of the protein solute in the microwell fluid volume (Ct) decreases with time 
due to diffusion and chemical partitioning between the different material phases. With a 
large fluid reservoir, Ct approaches Cliquid over time. We thus calculated GFP 
concentration distributions as a function of time. For demonstration purposes, the 
figures are labeled as Cartesian (x, y, z) coordinates rather than in cylindrical (r, θ, z) 
coordinates. 
 
 
Figure 5-1. The fluid film is created by capping the bottom gel with a lid layer. 
(A) Schematic of the bottom gel (Keq,1), lid layer (Glass, Keq,G or lid gel, Keq,2), interfacial fluid film 
(thickness, H), and microwell housing a spherical protein source. The 30-µm thick bottom gel houses a 
microwell (black dotted line) containing a spherical source of protein having an initial concentration, C0. 
Cut planes show side and top planes of the layered device, with protein source material diffusing from the 
microwell and into surrounding materials over time. Over time, the diffusion coefficient (D) of protein in 
each surrounding material and Keq of each material determines diffusive losses of protein from microwell 
into respective material. (B) Confocal fluorescence micrographs (inverted, false color) of the fluid film 
created between the bottom gel and lid gel. The median measurable fluid film thickness was 1.7 μm (n = 
9), excluding fluid films lacking a quantifiable thickness (n = 8). PA, polyacrylamide. Keq, equilibrium 
partition coefficient. D, diffusion coefficient of GFP in each material. 
 
Table 5-1. Partition and diffusion coefficient values for GFP in the range of layer materials 
characterized in this study. 
Material name Material 
composition 
Keq D (m2 s-1) 
Glass lid Glass Keq,G = 0 
(liquid, glass) 
DG = 0 
Bottom gel (Hydrogel 1) 6% T, 3.3% C PA Keq,1 = 0.51 
(liquid, bottom gel) 
DH1 = 3.13 × 10-11 
Lid gel (Hydrogel 2) 15% T, 3.3% C PA Keq,2 = 0.24 
(liquid, lid gel) 
DH2 = 4.2 × 10-12 
Liquid layer Liquid Keq,L = 1 
(liquid, liquid) 
DL = 1.691 × 10-10 
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To measure the fluid film thickness in a layered hydrogel device, we incorporated 
rhodamine methacrylamide into the bottom gel and the lid gel (a 15%T, 3.3%C PA gel, 
where %T is the total amount of acrylamide and %C is the ratio of cross-linker mass to 
total monomer mass in the gel), incubated the sandwiched layers in a buffer solution 
(TBS-T) overnight, and then imaged the interface between the sandwiched hydrogels 
using confocal microscopy. We measured the thickness of the void between the bottom 
gel and the lid gel (Figure 5-1B) using a method similar to that employed by Kuypers et 
al.137 Of the 17 total samples, 8 samples had no resolvable decrease in fluorescence in 
the void, and thus the fluid film thickness was not quantifiable. We attribute the lack of a 
signal decrease to the possibility that these samples had fluid film thicknesses smaller 
than our z-axis resolution of 0.42 μm, a resolution that is dictated by the pinhole 
diameter. Given the geometries of our system (tens to hundreds of micrometers), we 
considered the resolution acceptable. Of the quantifiable samples, the range of 
measured fluid layer thicknesses spanned from 1.3 to 1.9 μm with a median fluid layer 
thickness of 1.7 μm (n = 9). Our fluid layer thickness values are larger than the 300-600 
nm fluid layer thickness values previously reported for permeable hydrogels;138 
however, those reported values were for hydrogels with elastic moduli 3 orders of 
magnitude larger and much lower (44%) water content than the hydrogels considered 
here.139 Given that interfacial fluid films vary in thickness according to the topography, 
morphology, interfacial tension, interface potential, adsorption, partitioning, permeability, 
and chemistry of the gel,119,140,141 we anticipate a wide range of possible fluid film 
thicknesses, depending on the specific configuration of the hydrogel system under 
study. Our fluid layer thickness values fall in the range of fluid films thicknesses 
measured for layers that form between hydrogels and human tissues, such as the 
cornea.120–124 
Protein Losses from Closed and Open Microwells 
For a microwell capped with a lid (i.e., closed), we sought to characterize how Keq and D 
of GFP in the lid would affect protein concentration in that microwell over time. Protein 
losses from the microwell occur as proteins diffuse and partition between the different 
media comprising the microwell (i.e., gel, liquid, and glass). We performed numerical 
simulations to determine the degree of protein retention in the microwell fluid volume, as 
a function of the lid material (Figure 5-2A). We opted to scrutinize three lid materials, 
based on our empirical systems; hence, the lid material was simulated as glass 
(assumed to be impermeable, Keq,G = 0, DG = 0 m2 s-1), liquid (i.e. free solution), or lid 
gel (dense gel). For each case, we determined the concentration of GFP in the 
microwell at every 1 s, and normalized to the initial concentration (Ct/C0, Figure 5-2B). 
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Figure 5-2. In the absence of a fluid layer, numerical simulations indicate that the lid material 
determines the concentration distribution of the protein source material diffusing out of the 
microwell.(A) Side-view schematic of 2D-axisymmetric diffusion model for a range of lid materials (glass, 
liquid, or lid gel). (B) Comparison of the protein solute concentration in the microwell as a function of time, 
normalized to the initial protein solute concentration in the microwell, as a function of different lid 
materials. At time t = 15 s, the normalized protein solute concentration in the micro- well, Ct/C0, decreases 
to 0.20 when glass or a lid gel is used, compared to 0.03 in the liquid system. (C) A glass lid layer 
reduces diffusion in the z-axis. (D) A liquid lid layer (open microwell) leads to rapid diffusion-based 
dilution of the protein source material. (E) A lid gel mitigates diffusive losses as compared to the open 
configuration with the same thickness (H = 500 μm) shown in (D). The microwell is outlined in a dotted 
black line. 
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With a closed microwell, Ct/C0 increases compared to an open microwell (liquid bath as 
upper boundary condition) configuration. At time t = 15 s, a time point pertinent to cell 
lysis and protein solubilization in microwells,5 an open microwell configuration yields 
Ct/C0 = 0.03, whereas the presence of either a glass or lid gel yields Ct/C0 = 0.20 
(Figure 5-2B). Application of a glass lid reduces diffusion of solute out of the microwell, 
since protein cannot partition into the lid, and the local solute concentration in the 
microwell fluid volume decreases with time owing to (i) dilution throughout the microwell 
volume and (ii) diffusion out of the microwell into the surrounding bottom gel (Figure 
5-2C). We first estimated a characteristic diffusion time (L2/D) of ~29 s for GFP to 
diffuse from the microwell into the bottom gel layer in the quiescent, closed microwell 
configuration (where L is the microwell diameter; D is the diffusion coefficient of GFP in 
the bottom gel). Using numerical simulation, we then assessed the protein 
concentration profiles at t = 0 s, 15 s, and 30 s, matching the time scales of cell lysis, 
protein solubilization, and the expected diffusion time scale.3 From the simulations, 
within 1 s, the GFP within the microwell becomes uniform. The concentration of GFP 
along the x-axis remains uniform at t = 15 s. The GFP concentration remains highest in 
the microwell fluid volume, since partitioning inhibits protein from entering the 
surrounding medium (bottom gel) and there is no transport into the impermeable glass 
lid. 
 
In the configuration where the microwell is open to a reservoir of fluid, we modeled the 
free solution with Keq,L = 1 and DL = 1.691 × 10-10 m2 s-1 (Figure 5-2D). The 500 μm fluid 
layer thickness approximates a free solution bath, given the time scales of GFP 
diffusion.19 In our model, placing a glass lid 500 μm away from the solute-containing 
microwell did not change the concentration distribution of protein in the microwell fluid 
volume, as compared to the 500-μm free solution bath alone (data not shown). In 
contrast to the glass lid configuration, the protein concentration in the microwell fluid 
volume diminishes quickly for an open microwell (Ct/C0 = 0.03 at t = 15 s), as expected. 
At t = 15 s, the protein concentration is highest at the bottom of the microwell, since no 
flux occurs below the microwell into the glass support. Ct/C0 diminishes to 0.01 by t = 30 
s. 
 
Next, we considered a hydrogel material as the lid layer. We investigated Ct/C0 in the 
microwell fluid volume when a lid gel was applied (Figure 5-2E). In electrophoretic 
cytometry, high-density lid gels have been employed for diffusive delivery of reagents to 
the bottom gel and to mitigate out-of-plane diffusive losses from the microwell.5,19,21,135 
Interestingly, Ct/C0 was similar to that of the glass lid configuration (Figure 5-2B and 
Figure 5-2E). We also investigated the solute concentration across the span of the 
bottom gel (i.e., the microwell and the entire bottom gel). Ct/C0 of the bottom gel at t = 
15 s was 0.96 when a lid gel was used, similar to the Ct/C0 = 1.0 calculated for the glass 
lid configuration.  
 
Overall, the application of a lid layer (glass or high-density gel) that inhibits diffusion of 
protein solute into the lid layer is effective at maintaining high concentrations of solute in 
the microwell fluid volume. Future studies seek to understand how other physico-
chemical properties may also be modulated to further improve solute retention in the 
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microwell. For example, inclusion into the lid layer of interacting particles (e.g., via 
charge116 or hydrophilicity142) that bind to or obstruct proteins could further decrease the 
mass of solute that can enter the lid layer and preserve high solute concentrations in the 
microwell. 
Experimental Validation of the Model 
To experimentally validate our computational model of the electrophoretic cytometry 
device, we used a microparticle-based chemistry for rapid release of proteins from a 
spherical source in a microwell (Figure 5-3A). Microparticles (10-μm diameter) 
conjugated with a Ni surface chemistry were coated with His-tagged proteins. 
Introduction of imidazole releases the protein from the particle surface, owing to 
competition between His and imidazole for the Ni. We have developed the 
microparticles as a means to deliver protein size markers to each microwell in 
electrophoretic cytometry.143 Imidazole can be delivered using a lid gel, as previously 
described in single-cell electrophoretic assays.5,19,135 The Ni-His-imidazole release 
scheme gives short “switching” periods (seconds as compared to minutes to hours), 
appreciable release efficiency, and adequate spatial control for delivery to microwells, 
as compared to protein-PA conjugations144–146 photo-labile polymers,147–149 caged 
particles,150 photo-activatable probes,151 drug-releasing nanogels,152 photo-assembly 
and photo-cleavable microcapsules,153 photo-controlled release micelles,154 protein-
protein conjugations, and click chemistry. We use a median measured fluid film 
thickness of 2 μm (Figure 5-1B). 
 
The kinetics of protein release from the microparticle source must be considered in 
constructing the simulations. To determine release kinetics, we first characterized the 
imidazole-triggered release of Alexa Fluor 647-labeled His-tagged Protein G (26 kDa) 
from microparticles. His-tagged Protein G is commercially available and has the same 
molecular mass as GFP. A magnet was used to actively settle Protein G-coated 
microparticles into microwells; excess microparticles were washed off the gel surface. 
The lid gel was incubated overnight in a 1 M imidazole solution. At t = 0 s, the lid layer 
was seated atop the bottom gel and the microparticle-laden microwells to initiate 
imidazole diffusion into the bottom gel and Protein G release from the microparticles. 
Epifluorescence microscopy was used to monitor the fluorescence intensity in the 
microwell fluid volume (Figure 5-4), thus allowing normalization of fluorescence signal 
to the initial fluorescence intensity of the microparticle. For the fluorescence signal of 
the microparticles, we observed an exponential decay in fluorescence that matched the 
signal observed in our previously observed model of imidazole delivery using a 
convective delivery (pouring) system [𝑦 = 1.2789exp	(−0.035𝑥)], R2 = 0.98, comparable 
to the 𝑦 = 1.18 exp(−0.04𝑥) + 0.08 that was previously reported.143 
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Figure 5-3. Experimental validation of protein release from a spherical source located in a 
hydrogel microwell.(A) Side-view schematic of the model and experiment, with 10-um diameter 
microparticle coated with fluorescently labeled Protein G as the protein source (black circle). H = 2 μm. 
(B) Comparison of simulations (model) and experiment report similar (p > 0.05, Kolmogorov-Smirnov test) 
trends in normalized microwell fluorescence loss over time. For the simulations, an integral of the protein 
mass in the column extending from the microwell through the lid gel (red rectangle in A) was obtained to 
represent the mass of protein that is observed via wide-field microscopy (experiment). Error bars 
represent the standard deviation (n = 4). (C) Time series of simulation results show release of Protein G 
from a microparticle within a microwell (black dotted line). Protein G released per unit area was calculated 
using the number of molecules released per unit time, divided by the surface area of the microparticle. 
The number of Protein G molecules released per unit time was employed as a flux boundary condition in 
the simulations. (D) Time series of experiment results show inverted fluorescence micrographs of 
fluorescently labeled Protein G release at t = 0, 15, and 30 s after the addition of imidazole (“+imid”), 
delivered by incubating the lid gel in a 1 M imidazole buffer solution. The negative control uses 0 M 
imidazole (“-imid”). The fluid layer thickness H is unknown in these experiments. 
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Figure 5-4. His-tagged protein release from Ni surface functionalized magnetic microparticles. 
(A) Time series of fluorescence of the microparticle, normalized to the initial microparticle fluorescence. 
Fluorescence of the microparticle drops exponentially upon addition of imidazole (n = 4). The 
fluorescence fit an exponential 𝑦 = 1.18exp(−0.04𝑥) + 0.08. We calculated the flux of protein molecules 
out of the bead using the equation: Protein	mass	released	per	unit	time = ?u>(v)w>(1)x?1 . We then obtained an 
equation for flux by dividing by the surface area of the microparticle. Flux(𝑡) = 	44.425 exp(−0.037𝑡) /(4𝜋(5 ∗ 10w	𝑚))). (B) Microwell fluorescence as measured by widefield microscopy (experiment) and 
through the volume extending from the microwell through the lid gel. In the experiment, an initial increase 
of fluorescence was observed. In the main text, the fluorescence was normalized to the maximum of the 
experiment (t = 12 s).  The model plot in the main text was also normalized to the t = 12 s time point. 
 
 
Monitoring the fluorescence signal of the microparticle during Protein G release from the 
surface allowed us to establish a flux boundary condition for our simulations. First, we 
assumed the raw fluorescence intensity after background subtraction was equivalent to 
the number of fluorescent molecules or proteins. Since we ultimately normalize the final 
fluorescence signal to the initial signal, absolute quantification of fluorescent molecules 
is not necessary. Next, we defined a flux boundary condition for microparticle protein 
source N(t) as: 
 𝑁(𝑡) = ?([$X2/	$0B2[B2Z	(1v)w[$X2/	$0B2[B2Z(1))?1 × yz{/|Z (2) 
 
where r is the microparticle radius (5 × 10-6 m). We assume that the Keq and D are 
similar for Protein G and GFP in the bottom gel, the liquid in the microwell fluid volume, 
and the lid gel, given the similarity in molecular mass. Advection from the lid gel 
placement was assumed to be negligible, as the Péclet number (𝑃𝑒 = 𝑢𝐿/𝐷, where L = 
30 µm, u is the average measured velocity of the bead, 285 µm/s) was measured to be 
two orders of magnitude lower than with delivery of lysis buffer by pouring (n = 9 from 3 
separate trials, Figure 5-5). Moreover, we assumed that the microparticle was 
impermeable and that protein is conjugated only to the microparticle surface.  
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Figure 5-5. Fluorescent bead tracking reveals advection introduced by lid gel placement.  
Advection during buffer delivery using a hydrogel lid application system was two orders of magnitude 
lower than advection generated by pouring the buffer onto the hydrogel. (mean ± standard deviation, n = 
9). 
 
Comparison of experimental observations and simulations of the Protein G 
concentration in the microwell fluid volume showed reasonable agreement (p > 0.05, 
Kolmogorov-Smirnov test, Figure 5-3B). In our simulations, we measured the volume 
integral of Protein G mass in the column above the microwell to simulate observations 
via epifluorescence microscopy (Figure 5-3A, red dotted line). Interestingly, in our 
experiments, we observed an initial increase of fluorescence signal in the microwell fluid 
volume with a maximum measured fluorescence at t = 12 s (n = 4; Figure 5-4B). The 
increase in fluorescence is likely caused by self-quenching of the fluorescently-labeled 
protein while bound to the microparticle; at higher concentrations, fluorescent dyes can 
aggregate, causing quenching of up to 90% of fluorescence signal until the dye 
molecules are spaced sufficiently far apart.155 We hypothesize that protein released 
from the microparticle surface is sufficiently diluted within the microwell such that self-
quenching no longer occurs. For our simulations and our experiments, we thus 
normalized the concentration values to the maximum signal (i.e., at the 12 s time point).  
 
In addition to the microwell volume, we also scrutinized the concentration distribution in 
the surrounding bottom gel, in the fluid film, and in the lid gel (Figure 5-3C). As 
expected, the highest concentration of Protein G (t = 15 s) was localized to the fluid film, 
which is a material that sees no partitioning-based exclusion of Protein G from microwell 
fluid volume and which affords Protein G a high D as compared to within the hydrogels. 
Because D and Keq for Protein G are highest in the fluid film, the fluid volume rapidly 
accumulates protein. At the hydrogel walls of the microwell, we observe a Protein G 
concentration that drops off sharply, attributable to preferential partitioning of solute into 
the microwell fluid volume and D that is higher in the microwell fluid volume than in the 
surrounding hydrogel. 
 
Both the simulation results and the experimental observations of solute signal released 
from microparticles indicated release of protein solute into the microwell fluid volume, 
with lower concentrations of protein solute in the surrounding hydrogel material (Figure 
5-3D). While useful for illustrative purposes, two major caveats preclude direct 
quantitative comparison of the simulations and the experimental approximation. First, 
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the observed concentration of the released solute is expected to be lower than in the XY 
plane of the simulations, as the XY plane in the simulations is taken through the center 
of the microwell (i.e., a cross-section), where the concentration of protein is maximal. In 
contrast, in the experiment, the entire volume of the microwell, including through the lid, 
is imaged. Second, the thickness of the fluid film was not measurable, as the temporal 
resolution of confocal microscopy exceeds the 0–30 s window of microparticle release. 
Nonetheless, the agreement observed between the experiment and simulations in the 
microwell volume (Figure 5-3B) indicates that the simulations may be used to 
accurately predict protein concentrations within the microwell fluid volume for multiple 
materials, given D and Keq of a given protein into the lid material. 
Protein Loss from Microwells is Dependent on H, Keq, and D. 
Given the simulation results indicating high local concentration of proteins in the fluid 
film, we next sought to assess how H, Keq, and D affect protein concentration in the 
microwell fluid volume (Figure 5-6A). We first varied the thickness of the fluid film (5, 
10, 20, 50, and 500 μm) and observed that, as the fluid film thickness increases, Ct/C0 
decreases from 0.20 to 0.09, 0.06, 0.04, 0.03, respectively at t = 15 s (Figure 5-6B).  
 
We noted a critical fluid film thickness, with regards to protein concentration in the fluid 
film. At H = 20 μm, Ct/C0 = 0.03 and increasing the H beyond 20 μm has a muted effect 
on further reduction in Ct/C0.  In this geometry, we surmise that the fluid film begins to 
behave as a semi-infinite medium at H > 20 μm. This effect can be further seen when 
regarding the concentration profile from the XZ plane (Figure 5-6C). For H = 20 μm, the 
highest concentration of protein at t = 15 s is in the fluid film, whereas for H = 0 μm, the 
highest concentration of protein is in the microwell fluid volume. Within the microwell 
fluid volume, the maximum observed concentration of protein for H = 20 μm is 61% 
lower than that for H = 0 μm. 
 
Comparatively, for H = 500 μm, the concentration of protein within the microwell fluid 
volume is 74% lower than that for H = 0 μm. We conclude that the solute concentration 
in the microwell fluid volume and in the bulk of the bottom gel are sensitive to the fluid 
film thickness, especially when that thickness is smaller than 20 μm for the 
configurations studied here (Figure 5-1B). Consequently, design strategies to minimize 
the fluid film thickness are critical in applications where maintaining a high concentration 
of solute in the microwell fluid volume is necessary.  
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Figure 5-6. The protein solute concentration in the microwell depends on H, Keq,  and D for GFP in 
various materials, as determined by numerical simulations.(A) Side-view schematic of the model for 
a range of H values with a lid gel. H was varied from 0 to 500 μm. (B) Sensitivity analysis of the protein 
solute concentration in the microwell at time t = 15 s as a function of H, maintaining constant D and Keq 
values. As H increases, Ct/C0 decreases from 0.20 to 0.09, 0.06, 0.04, 0.03, for H = 0, 5, 10, 20, and 50 
μm, respectively. At H = 20 μm, the change in Ct/C0 as a function of H decreases to 0.03, indicating the 
fluid film begins to act as a semi-infinite medium. (C) Simulation results show rapid dilution and diffusive 
losses of GFP with increasing H. (D) Contour plot of Ct/C0 at time t = 15 s as a function of Keq and D for 
GFP given H = 2 μm. The asterisk indicates conditions where D and Keq for GFP are consistent with the 
material. 
 
Next, we sought to understand if Ct/C0 is more sensitive to the partitioning effect of the 
lid or to the change in D of the GFP in the lid material.  Previous studies point to the 
hydrogel composition (%T, total acrylamide concentration) having a greater influence on 
Keq than on D for proteins bovine serum albumin (BSA) and RNAse.92 We simulated Keq 
and D for GFP in different materials: liquid, the bottom gel, the lid gel, and glass. We 
assumed a 2-μm fluid film thickness (Figure 5-1B). We calculated Ct/C0 (t = 15 s) in the 
microwell fluid volume for each combination of Keq and D. The simulation data reveal 
that Ct/C0 is sensitive to both Keq and D, albeit with a different degree of sensitivity in 
different regimes. For low Keq, Ct/C0  is relatively insensitive to D, since the protein 
cannot partition into the lid gel. However, as Keq increases, Ct/C0  (t = 15 s) drops 
rapidly. To maintain a constant value of Ct/C0 with increasing Keq, D must 
correspondingly decrease. Similarly, as D in the lid material increases, the Keq must 
decrease to maintain high Ct/C0.  Overall, the use of a lid composed of a dense gel is 
effective for high protein retention to the microwell fluid volume (asterisk on Figure 
 63 
5-6D). Nonetheless, we can imagine further engineering material properties, such as 
decreasing both D and Keq via surface treatments,156 and/or decreasing the effective PA 
pore size to decrease D of the protein in the lid material.92 
5.4 Conclusions 
Molecular transport through hydrogels has implications in cell and tissue engineering, 
drug delivery, and single-cell assays. Here, we used numerical simulations to determine 
how the fluid film thickness, partition coefficient, and diffusion coefficient of GFP in 
multiple materials (liquid, dense hydrogel, and glass) dictate the GFP concentration in 
microwells. We first measured the fluid film thickness between two hydrogels of different 
densities (%T). We found that the application of a low-permeability or impermeable lid 
layer mitigates diffusive losses of proteins from microwells. Further, we find that the 
microwell protein concentration is dependent on the fluid film thickness, the partition 
coefficient, and the diffusion coefficient. Overall, we generated a model that provides a 
framework for how time-dependent protein diffusion depends on operational 
parameters. 
 
From our simulations, we determined that the protein concentration in microwells is 
sensitive to the fluid film thickness; thus, design strategies to minimize or eliminate fluid 
films could result in higher retention of protein in microwells. To minimize the fluid film 
thickness, hydrogel properties such as surface roughness, permeability, or elastic 
modulus could be manipulated.157 Elastic modulus of gels can be tuned by changing 
crosslinking density;158 however, consideration of how modulating this parameter affects 
other properties of the gel, such as molecular sieving, is necessary.  
 
In addition to minimizing the fluid film, material properties of the lid hydrogel may be 
modulated to reduce the diffusion coefficient and/or partition coefficient of the species of 
interest in the lid. For example, modulating protein interactions with the lid layer by 
altering the charge116 or hydrophilicity142 present strategies to tune the partition 
coefficient. In-gel diffusivity can be tuned by incorporating other polymeric materials 
such as poly(ethylene glycol) diacrylate (PEGDA) to form interpenetrating networks that 
decrease solute diffusivity.159 Overall, tuning of the hydrogel free volume, obstructions 
(i.e., rigid or mobile polymer chains), and interactions with proteins could potentially 
provide solutions to maintaining high protein concentrations in microwells, or make 
molecular transport more favorable for the desired application. 
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Chapter 6: Towards the Development of 3D Projection 
Electrophoresis for High-Throughput Single-Cell Isoelectric Focusing 
This work was performed in collaboration with Dr. Samantha M. Grist. 
6.1 Introduction 
Protein expression, post-translational modifications, localization, and activity are 
essential to characterize cell state and function.160 Proteomic measurements of cellular 
populations, especially for understanding dysfunction in cancerous cells, necessitates 
single-cell or low-cell resolution to accommodate cell-to-cell heterogeneity. As a brief 
case study: 15-20% of invasive breast cancers involve increased expression of the 
HER2 (also called ERBB2) protein. Several truncated HER2 isoforms lack the 
extracellular domain for canonical drug treatment; therefore, quantitative assessment of 
the expression of these truncated isoforms provides valuable information on breast 
cancer type and therapeutic options.161–165 Recent characterization of a model breast 
cancer cell line in the single-cell Western blotting assay reported that 7.4% of cells had 
an quantifiable truncated isoform, with significant heterogeneity of expression of this 
truncated isoform.4 Interrogation of HER2 isoform expression therefore necessitates the 
development of high-throughput proteomic assays at single cell resolution capable of 
distinguishing these isoforms. Proteomic separations via capillary IEF with and without 
subsequent immunoblot13,35 has been demonstrated for the lysate equivalent of 25 cells. 
Single-cell mass spectrometry has recently been demonstrated for high-expression 
protein targets.17,18 We posit that the ultrathin scIEF assay with subsequent 
immunoblot19–21 can complement these and other proteomic assays to assessing the 
expression of biologically relevant proteins. 
 
In order to interrogate the proteomic expression of rare or low-abundance sub-
populations of cancer cells, the throughput of the ultrathin scIEF assay with subsequent 
immunoblot19–21 must be expanded to accommodate 1000+ cells per experiment 
(currently 9-50 cells). Thus, we propose a significant modification to the assay itself, 
developing 3D projection electrophoresis for the high-throughput isoelectric focusing 
(HTP IEF) assay. 
6.2 Materials and Methods 
Materials 
Silicon wafers (University Wafer 1156), SU8 3050 photoresist (MicroChem), titanium 
diisopropoxide bis(acetylacetonate) (Sigma 325252), anhydrous isopropanol (Sigma 
278475), a custom in-house-designed mask (CAD/ART Services), GelSlick® (Lonza 
50640), standard glass slides (VWR), dichlorodimethyl silane (Sigma 440272), 3-
(trimethoxysilyl)propyl methacrylate (Sigma 440159), methanol (Sigma 179337), glacial 
acetic acid (Sigma 8817-46), 30%T 29:1 acrylamide/bis-acrylamide solution (Sigma 
A3574), N-[3-[(3- benzoylphenyl)formamido]propyl] methacrylamide (BPMA, custom 
synthesized by PharmAgra Labs), Rhinohide™ (ThermoFisher R33400), ammonium 
persulfate (APS, Sigma A3678), N,N,N',N'-tetramethylethylenediamine (TEMED, Sigma 
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T9281), UV photoinitiator 2,2'-Azobis[2-methyl-N-(2-hydroxyethyl)propionamide] 
(VA086, Wako Chemicals 61551), borosilicate glass plates (McMaster-Carr 8476K62), 
4-well plates (ThermoFisher 267061), parafilm (Bemis PM-999), and permanent lab 
markers (VWR 52877-310) were used to fabricate materials in this study. 
 
Slab IEF was conducted using the Novex IEF buffer set (Invitrogen LC5377), Novex IEF 
gels (Invitrogen EC66452BOX), IEF standard (BioRad 161-0310), proteomics-grade 
Ponceau S stain (Amresco K793, lot 18J0156137), Invitrolon PVDF membrane 
sandwich, 0.45 µm pore size (Invitrogen LC2005), and Western blotting filter paper, 7 
cm × 8.4 cm (Fisher A322). 
 
High-throughput IEF was conducted using the immobilines pKa 3.6, pKa 7.0, and pKa 
9.3 acrylamido buffers (Sigma 01716, 01729, 01738), SinuLyte® pH 4-7 ampholytes 
(Sigma 05087, lot BCBJ7449V), Novex Zoom® pH 4-7 ampholytes (Invitrogen ZM0022, 
lot 813224A), a 3D projection electrophoresis device designed and printed in-house 
(shown in Figure 6-3A),166 electrode plates, standard circular magnets, 0.5 mm, 1 mm, 
1.5 mm, and 2 mm gel spacers (CBS Scientific MVS0510-R, MVS1010-R, MVS1510-R, 
MVS2010-R), TritonX-100 detergent (Sigma X100), urea (Sigma U5378), thiourea 
(Sigma T8656), CHAPS (SAFC RES1300C),1x RIPA buffer (Pierce 89900), and HALT 
protease / phosphatase inhibitor cocktail (ThermoFisher 78444). Tris-buffered saline 
with Tween-20 (TBS-T, CST 9997S) was used for gel incubation and wash steps. 
 
The proteins and molecules used in this study were bovine serum albumin (Sigma 
A7030, abbreviated “BSA”), purified recombinant turboGFP (Evrogen FP522, lot 
55201240718, a variant of the GFP with increased fluorescence, MW 27 kDa, 
abbreviated “tGFP”), myoglobin (Sigma M9267, abbreviated “MYO”), trypsin inhibitor 
(Sigma T1021, abbreviated “TI”), carbonic anhydrase isozyme II (Sigma C3666, 
abbreviated “CA”), and c-phycocyanin (Sigma 52468).  
 
The reagents used in this study for protein labeling were Cyanine 488NS, 555NS, and 
647NS (Biotium 90117, 90118, 90119, abbreviated “CF™-488,” “CF™-555,” and “CF™-
647,” respectively), 1 M pH 8.3 sodium bicarbonate solution (Biotium 99954), 10K 
MWCO and 3K MWCO ultrafiltration vials (Biotium 99956, 22018), Slide-A-Lyzer® MINI 
Dialysis units, 3500 MWCO (Pierce 69552), and 2x reaction and storage vials (Biotium 
99957, 99958). 
Protein Labeling 
Proteins were rehydrated in MilliQ water with 0.1 M sodium bicarbonate, following 
manufacturer instructions. The glycine from the protein solutions was removed either by 
ultracentrifugation with the Allegra 21R Centrifuge (Beckman Coulter) and rehydration in 
1× PBS (initial attempt), or by dialysis using the Slide-A-Lyzer® dialysis membranes for 
72 hours in PBS with agitation and buffer exchanges every 24 hours (second attempt). 
Protein labeling was conducted following the Biotium CF™ dye protocol, with a molar 
ratio of 6, for 1 hour at room temperature, protected from light. To remove unconjugated 
dye, the ultracentrifugation vials with a 3 kDa molecular weight cutoff were used, and 
proteins were resuspended in 1× PBS. Proteins were dialyzed in MilliQ water with 
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agitation and multiple buffer exchanges (second attempt) to remove additional 
unconjugated dye. 
Slab IEF   
Slab IEF was conducted following the Novex pre-case gel electrophoresis guide 
(Invitrogen, IM-1002) using the XCell SureLock Mini-Cell (Invitrogen IM-9003). The 
proteins from the slab IEF gels were immediately transferred to PVDF membranes 
using the pre-set Mixed Range Molecular Weight (25-150 kDa) transfer setting on the 
Pierce Power Blotter (ThermoFisher), following manufacturer instructions. The 
membranes were stored long-term at 4ºC in MilliQ water. 
 
The membranes were imaged on an Olympus IX-71 inverted microscope with an 
Olympus UPlanFi 4× (NA 0.13) objective and an EMCCD Camera iXon2 (Andor), with 
imaging settings loaded into MetaMorph software (7.10.1.161, Molecular Devices). The 
membranes were imaged using a GFP filter cube (XF100-3, Omega Optical), a Cy5 
filter cube (Chroma 49009), and a TRITC filter cube (SNARF-585 emission, ET550/20× 
T570lpxr ET585/20m) for fluorescently-labeled protein targets. The membranes were 
stained with the Ponceau S stain, and imaged using a Molecular Imager ChemiDoc 
XRS+ with Image Lab Software (BioRad) for naturally-colored protein targets, the IEF 
standard, and the total protein stain. Further details are included in Appendix 6. 
Separation Gel Fabrication 
For this study, we use the canonical notation of %T as the total acrylamide monomer 
concentration (w/v) in solution, and %C as the ratio of bis-acrylamide crosslinker 
concentration to the total acrylamide monomer concentration.47 
 
SU8 fabrication on a silicon wafer was conducted following a standard protocol.3 Briefly, 
a custom mask with rails spaced 22 mm apart, and microposts of diameter 32 µm, 
spaced at X = Y = 400 µm in square array blocks of X = Y = 16 mm (Figure 6-3C), was 
used to fabricate features of 40 µm in height (confirmed by optical profilometry) in SU8 
on the wafer, which was then silanized with dichlorodimethyl silane. 
 
After wafer treatment with GelSlick®, PA gels were fabricated on the wafer and 
polymerized onto silanized half glass slides. Table 4-1 lists the critical components of 
each gel condition, using 10 kDa PEG as the preformed hydrophilic polymer and 
leveraging porogen gel fabrication conditions developed by Righetti and colleagues.70 
Photopolymerization was implemented using VA-086 or LAP as the initiator and 
polymerized for 4 or 1 minutes, respectively, at 20 mW/cm2 light intensity using a 390 
nm UV long-pass filter (Edmund Optics) on an OAI Model 30 Collimated UV light 
source. See Appendix 1 for further details.  
 
Separation gels of dimensions X = 18 mm, Y = 18 mm, Z = 1 mm (or X = 9 mm, Y = 9 
mm, Z = 1 mm) were fabricated using 1 mm spacers (CBS Scientific). These gels were 
fabricated on the silanized silicon wafer with microposts of diameter 32 µm (Figure 
6-3C, further details in Appendix 7), on a silanized half glass slide. Gel precursor 
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solutions of 6%T 3.3%C PA with 5 mM BPMA were prepared. Chemical polymerization 
was implemented using APS and TEMED as the initiator and catalyst, respectively, for 1 
hour protected from light. After fabrication, gels were gently detached from the wafer 
and the glass slide using a razor blade, and incubated in a 1% TritonX-100, 2% Zoom® 
pH 4-7 ampholyte solution in MilliQ water in a 4-well plate overnight. The resulting 
separation gel contained microwells of 32 µm diameter and Z = 40 µm height along the 
top surface of the gel. 
Equilibrium Swelling Ratio 
The equilibrium swelling ratio was conducted using Flory-Rehner theory.47,78–80 After 
fabrication of PA gels on glass slides with 500 μm spacers to define gel height, gels 
were weighed immediately on an Ohaus Adventurer Pro weigh station to determine the 
“fabrication” weight, then incubated in 1× TBS-T for 12 hours for PEG diffusion out of 
the gel. After 12 hours of DI water incubation, the equilibrated gel was weighed again 
for the “hydration” weight, dehydrated fully with a nitrogen gas stream, and weighed a 
third time for the “dehydration” weight. 
Boundary Gel Fabrication 
The anolyte (pH 4) and catholyte (pH 7, pH 10) boundary condition gels were fabricated 
individually (further details in Appendix 8). Table 6-1 lists the components of each of 
the anolyte and catholyte boundary condition gels described in this study. Gel precursor 
solution was pipetted onto a GelSlick®-coated glass plate, covered with a Gel-Slick-
coated standard glass slide propped on 0.5 mm spacers (CBS Scientific). Gels were 
polymerized for 4 minutes at 20 mW/cm2 light intensity using a 390 nm UV long-pass 
filter (Edmund Optics) on an OAI Model 30 Collimated UV light source. After cutting gels 
to X = 18 mm, Y = 18 mm, Z = 500 µm dimensions, these boundary condition gels were 
incubated in DI water and used promptly within 24 hours. 
High-throughput IEF (HTP IEF) 
The high-throughput IEF assay (further details in Appendix 9) was implemented after 
the fabrication of the separation and boundary condition gels. The in-house-designed 
3D projection electrophoresis chamber (Figure 6-3A) was placed with both electrode 
plates facing up. An ice pack was placed under each electrode plate. 2 mm spacers 
were added on the positive electrode plate to provide stability and reduce compression 
on the forthcoming gel sandwich. On the positive electrode plate, the anolyte gel was 
placed with tweezers after gentle removal of the fluid layer by a Kimwipe. The 
separation gel was placed similarly on top of the anolyte gel, with microwells oriented 
upwards. 5 µL of protein solution was pipetted into the center of the microwell array, and 
spread quickly and gently across the surface of the separation gel (Figure 6-3B and E).  
 
After a 30 second delay (to simulate diffusion of reagents and lysis of cells in the future 
single-cell variant of this assay), the catholyte gel was placed similarly and rapidly on 
top of the separation gel. The negative electrode plate was rapidly placed on top of this 
2 mm gel sandwich, overlaid with an ice pack. IEF was conducted by applying 34 V for 
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the desired timeframe using the PowerPac basic power supply (BioRad). After the 
desired timeframe of focusing, the catholyte electrode plate and the catholyte boundary 
gel were rapidly removed. Protein photo-immobilization was induced by application of 
UV at 100% intensity for 45 seconds with the Hamamatsu LC8 (Hamamatsu Photonics 
K.K.), sweeping across the gel assembly above the gels. 
 
Immediately after protein photo-immobilization, the separation gels were placed in a 
Petri dish and sliced manually with a razor blade to obtain a thin sliver across the 
diagonal of the gel. The sliver was turned on its side, so that the separation axis was 
oriented parallel to the Petri dish. The Petri dish was set on an Olympus IX-71 inverted 
microscope with an Olympus UPlanFi 4× (NA 0.13) objective and an EMCCD Camera 
iXon2 (Andor), with imaging settings loaded into MetaMorph software (7.10.1.161, 
Molecular Devices). The slivers were imaged using a GFP filter cube (XF100-3, Omega 
Optical), a Cy5 filter cube (Chroma 49009), a TRITC filter cube (SNARF-585 emission, 
ET550/20× T570lpxr ET585/20m), and brightfield. Electrode plates were cleaned 
thoroughly and gently with MilliQ water and Kimwipes between each experimental run. 
 
Micrographs were processed in FIJI ImageJ to extract line plots across the separation 
axis. These line plots analyzed using an in-house MATLAB (R2015b, MathWorks) 
script6,48,49 adapted to HTP IEF (code in Appendix 11). Gaussian curve fitting to the line 
plots led to the extraction of the peak height, peak location, peak width, area under the 
curve, SNR, and other assay-specific parameters from each ROI. Validation of the 
Gaussian curve fits is conducted analytically (R2 ≥ 0.7 and signal-to-noise ratio SNR ≥ 
3) and confirmed manually. For the images taken on the Olympus microscope setup, 1 
pixel corresponds to 4 μm. 
 
Confocal imaging experiments were conducted on an upright Zeiss LSM 880 NLO 
AiryScan with Fast-Airyscan (Zeiss, Oberkochen, Germany). Images were acquired at 
room temperature using a 20× water objective (Zeiss). Separation gels were imaged 
using a 561 laser at 40% power, a 488 laser at 20% power, and a 633 laser at 50% 
power, using the MBS488/561/633 beam splitter and the Zen 2010 software (Zeiss). Z-
stack images were acquired. 
 
Table 6-1. Composition of HTP IEF anolyte and catholyte gels. 
Components of the anolyte and catholyte gels used for electrophoresis in this study. 
 
Components of individual 
boundary gels 
pH 4 anolyte pH 7 catholyte pH 10 catholyte 
Polyacrylamide gel 15% T 
3.3% C 
0.2% VA-086 
15% T 
3.3% C 
0.2% VA-086 
15% T 
3.3% C 
0.2% VA-086 
Boundary conditions 13.5 mM pKa 3.6 
immobiline 
 
6.4 mM pKa 9.3 
immobiline 
6.5 mM pKa 3.6 
immobiline 
 
13.5 mM pKa 7.0 
immobiline 
5.6 mM pKa 3.6 
immobiline 
 
14.4 mM pKa 9.3 
immobiline 
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Statistical Analysis 
To compare the means of the gel conditions assessed in this study, we assessed 
statistical significance using the one-way ANOVA’s with Kruskal-Wallis test. To compare 
specific pairs of gel conditions, we applied a post-hoc Dunn’s multiple comparison test 
with p<0.05 (*), using GraphPad Prism version 8.1.1. Linear regression fit was 
performed using an in-house MATLAB script.  
6.3 Results and Discussion 
Development of a fluorescently-labeled IEF protein ladder 
In order to reliably assess the separation resolution of this platform and control for IEF-
based irregularities in future biological studies, we assessed multiple methods by which 
to create a reliable IEF protein ladder. Canonical IEF assays like slab IEF typically use 
commercially-available solutions of proteins, including those produced by Bio-Rad, 
ThermoFisher, and Amersham,51,167 or fluorescently-labelled peptides.13 Prior research 
by Dr. Elaine J. Su (not included here) to develop an IEF protein ladder compatible with 
the ultrathin IEF assay eliminated the use of the IEF standard solution (Bio-Rad) or the 
IEF protein marker solutions (similar to ThermoFisher 3921201), and indicated the need 
for a set of fluorescently-labeled proteins rather than immunoprobing for multiple protein 
targets or relying on visible light detection.167 Our prior investigation (not included here) 
indicated that the commercially-available fluorescent pI markers (Sigma 89149, 77866, 
73376) are not detectable after attempted immobilization with UV-activated BPMA, 
eliminating these molecules as candidates for the IEF ladder. The attempt to 
incorporate the recently-developed protein bead system into the 2D IEF assay is 
discussed in 0. 
 
In designing an in-house IEF protein ladder, we identified the following design 
parameters. The ideal fluorescently-labeled IEF protein ladder should include 3+ 
proteins spanning the full pH gradient, for interrogation of the linearity of the pH 
gradient. In its final form, the ladder should be fluorescently labeled in one channel, 
preferably the 488 channel to overlap with the BPMA-induced fluorescence background 
(Appendix 13). The fluorescence labeling on these proteins should not disrupt the pI of 
the proteins, nor should it add significantly to the molecular weight of the overall protein-
label conjugate. The ladder should be incorporated into either the separation gel or the 
solution of singularized cells at sufficiently high concentration for easy detection above 
the LLOD without obscuring the fluorescence of adjacent immuno-labeled proteins.  
 
Within the IEF protein ladder, each protein should be on the lower end of molecular 
weights (< 100 kDa), to avoid partitioning-induced issues of in-gel concentration as well 
as low in-gel electrophoretic mobility far from the pI. In addition, each protein should 
feature few to no isoforms, few to no post-translational modifications, a known 
theoretical or experimental pI, and sharply focused bands at the pI. The proteins must 
be immobilized by UV-activated BPMA, and preferably would be targeted in an 
immunoblot with a high-to-medium affinity primary antibody for validation. From a 
practical perspective, we preferred a commercially-available purified protein solution 
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over the need to implement a pulldown assay from lysates of cells genetically modified 
to overexpress the protein in question. 
 
From these parameters, we labeled 3 proteins individually with a different CF™ dye 
(listed in Table 6-2). The CF™ dyes were reported by the manufacturer, Biotium, to not 
affect the isoelectric point of the labelled proteins. Conveniently, these proteins would 
stack in a pH gradient in an IEF assay (pH 4 < TI < CA < MYO < pH 7) in a different 
order than in a Western blot assay (MYO < TI < CA). Since each protein was labeled in 
a different fluorescence channel, this allowed us to swiftly distinguish an IEF separation 
from a size-based separation. 
 
Table 6-2. Proteins and fluorescence labels in the in-house-designed IEF protein ladder. 
 
Protein Abbreviation Molecular 
weight 
(kDa) 
pI 
(manufacturer) 
Experimental pI 
(with fluorescent 
label, slab IEF) 
(Figure 6-1) 
CF™ dye label 
Myoglobin MYO 16.7 6.8 
7.2 
6.75 (streak) CF™-488 
Carbonic 
anhydrase 
isozyme II 
CA 30 5.4 5.54 CF™-555 
Trypsin 
inhibitor 
TI 20.1 4.6 4.45 CF™-647 
 
For validation, we first interrogated the isoelectric point of these labeled proteins, as well 
as AlexaFluor-555-labeled bovine serum albumin (BSA), AlexaFluor-647-labeled 
ovalbumin (OVA), and the naturally-fluorescent phycocyanin. For comparison and 
quantitative identification of the labeled proteins’ pI’s, we included the commercially 
available IEF standard (BioRad) and used the Novex slab IEF kit for robust protein 
separations. After rapid transfer of the slab IEF gels to PVDF membranes, we used 
Ponceau S stain to visualize the IEF standard and used fluorescence widefield 
microscopy to visualize the fluorescently-labeled proteins (Figure 6-3A, B). 
Interestingly, the AlexaFluor labels on BSA and OVA (Figure 6-3A) result in protein 
sub-populations with a range of pI’s spanning over an entire pH unit. We hypothesize 
that different degrees of labeling on the proteins would result in this dramatic shift. 
 
To validate the slab IEF methodology, we assessed IEF in each material by considering 
the slope of each pH gradient, dpH/dx. To determine dpH/dx, each of the detectable 
protein bands in the commercial IEF standard were fit to a Gaussian curve. We then 
used a linear regression fit of the proteins to estimate the pH gradient slope. The 
calculated dpH/dx=0.06 mm-1 (Figure 6-1C, D) for both slab IEF’s match the back-of-
the-envelope estimate of dpH/dx=0.057 mm-1 for a pH 4-7 gradient across a gel of 7 cm 
length. The quantitative analysis of the IEF standard from slab IEF’s are in good 
agreement with each other. 
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B 
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Figure 6-1. Experimental characterization of pI’s of fluorescently-labeled proteins in IEF protein 
ladder. 
(A) Slab IEF of the fluorescently-labeled IEF proteins, BSA and OVA with AlexaFluor labels, and tGFP 
protein. (B) Slab IEF of the fluorescently-labeled IEF proteins in PBS and concentrated in DI water, and 
phycocyanin. (C) Linear fit of the detectable protein peak locations and the reported protein pI’s for the 
slab IEF reported in (A). (D) Linear fit of the detectable protein peak locations and the reported protein 
pI’s for the slab IEF reported in (B). 
 
We extracted the peak locations of each protein in the IEF standard (Figure 6-3A, B), 
and fit the peak locations against the reported pI’s of the proteins. From the linear fit (y = 
-6E-05 * x + 7.09, with R² = 0.9979, Figure 6-3C), the experimental pI’s of the three 
tGFP isoforms in Figure 6-1A were calculated as 4.87, 5.14, and 5.27, compared to the 
experimental pI’s calculated from microfluidic IEF of 4.88, 5.00, and 5.19.19 From the 
linear fit (y = -6E-05 * x + 7.32, with R² = 0.9502, Figure 6-3D) and the peak locations of 
the 3 proteins in our fluorescently-labeled IEF protein ladder, we calculated the 
experimental pI’s for each protein with the CF™ dye (Table 6-2, Equation 6-1). The 
experimental pI’s for the IEF ladder are in good agreement with the manufacturer-
reported pI’s, confirming that the CF™ dyes do not majorly affect protein pI. 
 
y = -6E-05x + 7.3195
R² = 0.9502
4.00
4.50
5.00
5.50
6.00
6.50
7.00
7.50
0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 40,000 45,000 50,000
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anhydrase
β-Lactoglobulin B
Phycocyanin
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∆𝑝𝐼$%& = 3 ∗ 𝑑𝑝𝐻𝑑𝑥 ∗ 𝜎./012%&  
Equation 6-1. ΔpImin quantified for proteins focused in an IEF assay. 
 
The two rounds of labeling proteins with CF™ dyes (Figure 6-3A) yielded different 
labeling efficiencies for each protein, though researcher methodology did not vary 
significantly between the two rounds. Moving forward, the brighter MYO-CF™-488 from 
round 2 was added to the brighter CA-CF™-555 and TI-CF™-647 from round 1, to form 
our fluorescently-labeled IEF protein ladder. These proteins were concentrated by 
dialysis in water (Figure 6-3B) for forthcoming use. Both TI and CA focused into sharp 
protein bands. Resolving the two MYO isoforms proved unreliable, yielding a poorly-
resolved protein band near the cathode. 
 
Future iterations of this fluorescently-labeled IEF protein ladder should replace 
myoglobin with lectin (Sigma L1277, with pI’s of 8.2, 8.6, 8.8), carbonic anhydrase 
isozyme I (Sigma C6653, pI 6.6), and/or trypsinogen (pI 9.3). Since the focused TI band 
is well-resolved, further development of the IEF protein ladder in the pH 4-5 range may 
not be required. If desired, bovine serum albumin (pI 4.6), β-lactoglobulin (pI 5.2, 5.3), 
and α-lactoglobulin (pI 5.0) are viable candidates. The naturally fluorescent phycocyanin 
(pI 4.5) overlaps with the TI band and is therefore not included in this ladder. Additional 
finetuning of the labeling process for accurate characterization of labeling efficiency 
using the NanoDrop is also required. Our attempts to characterize the labeling efficiency 
yielded protein peaks shifted away from the expected absorbance values. We 
hypothesize that this unexpected shift may be due to both a high molar excess of dye 
during the labeling process, and issues with ultracentrifugation both prior to the labelling 
(to remove glycine) and after the labeling (to remove unconjugated dye, Figure 6-2). 
 
 
Figure 6-2. Waste products after 5 ultracentrifugation washes reveals an excess of unconjugated 
dye from the conjugation process. 
From left to right, the first vials are excess free dye, then the waste products from 5 consecutive wash 
steps. 
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Development of the HTP IEF assay 
In order to significantly increase the throughput of the ultrathin single-cell IEF with 
subsequent immunoblot, while maintaining the 9 mm separation length required for high 
IEF separation resolution, we posited an idea to leverage the Z-axis for the separation 
axis. Along the X- and Y-axes, we would implement an array of microwells for a 100-fold 
increase in throughput. It is important to note that this work was conducted in parallel 
with other 3D projection electrophoresis developments in this lab by Dr. Samantha 
Grist, among others.  
 
Given that the immunoblot in its current form relies on passive diffusion for introduction 
of antibodies into the gel matrix, a 9 mm separation length in the Z-dimension would 
render the immunoblotting timeframes excessively long. The calculated time to 
equilibrium (τ = 36 days) was estimated using a 3D model of diffusion (τ = x2 / 6D), 
where x = 9 mm gel height, and D=4.3 µm2/s for the diffusivity of IgG* in an 8%T 2.6%C 
PA gel.102 Over this extended timeframe, considerations of antibody degradation, 
antibody-antigen dissociation rates, contamination risks, and other concerns would 
significantly reduce immunoblotting efficiency. Therefore, as a proof-of-concept, we 
attempted a 1 mm separation lane (Figure 6-3A), while an active immunoblotting 
method was concurrently developed.166 
 
Thus, the high-throughput IEF assay involves three gels (Figure 6-3B). First, the 6%T 
separation gel of dimensions X = 18 mm, Y = 18 mm, and Z = 1 mm serves as both the 
anti-convective substrate for the IEF separation and the PA gel matrix to which focused 
proteins are immobilized using UV-activated BPMA, theoretically for the subsequent 
immunoblot. Second, the anolyte boundary condition gel serves as an acidic (pH 4) 
edge against which the ampholytes stack to form the pH gradient.16,19 Third, the 
catholyte boundary condition gel serves as the basic (pH 10) edge for the other end of 
the pH gradient. 
 
For the IEF separation, we applied 34 V, for an electric field strength of 166 V/cm 
across the 2 mm separation axis (crossing the anolyte, separation, and catholyte gels). 
For comparison, the ultrathin IEF assay using the SinuLyte® ampholytes applies 690V, 
for an electric field strength of 139 V/cm across the 50 mm separation axis (crossing the 
anolyte, focusing, and catholyte components comprising the lid gel, Chapters 2-4). 
 
For these large separation gels of dimensions X = 18 mm, Y = 18 mm, and Z = 1 mm, 
we considered a method to strengthen the gel without significantly increasing gel 
porosity (which would decrease partitioning of large molecular weight species into the 
gel). We investigated the effect of incorporating Rhinohide™ (a solution of high-
molecular-weight linear acrylamide, by best estimate)168–170 into the gel precursor 
solution, on the gel porosity, using the equilibrium swelling ratio assay (Figure 6-4). We 
observed a statistically-significant difference in the equilibrium swelling ratio (Q, 
calculated using Equation 6-2) between the gels without Rhinohide™ and the ones 
containing 4% Rhinohide™ from a more recently purchased bottle (16.7±0.26 in 6%T 
3.3%C APS/TEMED gels, 18.8±0.25 in gels with 4% old Rhinohide™, 19.8±0.25 in gels 
with 4% new Rhinohide™). 
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Figure 6-3. Schematic of high-throughput IEF platform using 3D projection electrophoresis. 
(A) Orthogonal view of the assembly of gels within 3D projection electrophoresis chamber. (B) Side view 
of the assembly of gels in the HTP IEF platform. (C) Mask design for microwells of 32 µm diameter, 
spaced apart at x = y = 400 µm in blocks of length X = Y = 16 mm, for the fabrication of 8 18×18×1 mm 
separation gels on one wafer. (D) The workflow for fabrication of the separation gel. (E) The workflow of 
the HTP IEF assay, from gel fabrication and assembly through protein electrophoretic separation, 
immobilization, and imaging. (F) Orthogonal view of the micropatterned separation gel. Schematics are 
not to scale. 
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𝑄 = 𝑚𝑎𝑠𝑠	=>?/@12?	A2B𝑚𝑎𝑠𝑠	?2=>?/@12?	A2B 
Equation 6-2. Equilibrium swelling ratio in PA gels. 
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Figure 6-4. Rhinohide™ increases porosity of gels, without significant differences between 
Rhinohide™ lots. 
(A) Gel weights measured in equilibrium swelling ratio experiment after fabrication (white); after 
incubation in solution to equilibrium (gray), and after dehydration (black). (B) The swelling ratio (Q) varied 
significantly due to the inclusion of 4% new Rhinohide™. This indirectly indicates a change in gel 
porosity. Mean and standard deviation marked by vertical lines for n=3 gels per condition. One-way 
ANOVA with Kruskal-Wallis test and post-test Dunn’s multiple comparison test with p<0.05 (*). 
 
Due to concerns about dehydration at the exposed edges of the separation gel, which 
might cause uneven separations across the gel, we investigated the impact of the filter 
paper hydration chamber. Repeated experimental runs indicated that the separation 
gels retained sufficient water content after 60s electrophoresis (Figure 6-5). 
 
A 
 
B 
 
Figure 6-5. The filter paper hydration chamber is not required to maintain the hydration state of 
the separation gel after 60 s electrophoresis in the HTP IEF assay. 
Top-down images of the post-experimentation HTP IEF separation gel and anolyte gel sandwich (clear 
stack in the middle of the image) (A) with the filter paper hydration chamber (white) and (B) without the 
filter paper on the electrode plate (beige). The 2 mm spacers are shown at the edges of the electrode 
plate (black). The blue-tinted edges on the separation gel are from excess TI-CF™-647. 
 
After repeated observations of poor partitioning of the IEF protein ladder into newly-
fabricated gels, we investigated the effect of methods for rendering the surface of a 
silicon wafer hydrophobic (dichlorodimethyl silane or GelSlick®). GelSlick® is an 
electrophoresis-compatible hydrophobic surface treatment, documented as an 
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alternative to silane-based coatings, which includes ethanol, propanol, and ethyl 
hydrogen sulphate.171,172 From the manufacturer’s instructions for GelSlick®, 
dichlorodimethyl silane and GelSlick® are incompatible surface treatments. In addition, 
an excess of GelSlick® on the wafer surface transferred to the surface of the microwell-
laden separation gels. After careful experimentation (not shown here) to eliminate other 
potential sources of error, and additional investigation by other researchers in the Herr 
lab, we decided to exclusively use a thin layer of GelSlick® on our silicon wafers (with 
extensive water rinse of the wafers prior to use) for fabrication of the separation gels.  
 
With these modifications, we investigated the reproducibility of the IEF separations both 
within gels and across triplicate gels in the same experiment (Figure 6-6A-C). The 
electrical current decreased within the first 10 s for all gels, indicating the ampholytes 
formed a pH gradient (Figure 6-6E). It is important to note that the separations across 
the length of the gels feature several irregularities (Figure 6-6B, C), which indicates a 
need for more rigorous investigations of separation performance across the gel. 
 
Quantitative assessment of IEF separation performance in the center of these 3 gels 
yielded a dpH/dx of 2.83±0.25 mm-1 (mean ± standard deviation for n=3 gels) for the 
Zoom® ampholytes (Figure 6-6D). We anticipated a dpH/dx of 3 mm-1 for this pH 4-7 
gradient across a 1 mm separation axis. For comparison, the dpH/dx was quantified in 
the ultrathin IEF assay as 0.35±0.01 mm-1 for the SinuLyte® ampholytes over a pH 4-7 
gradient and a 9 mm separation axis (Chapter 3 and Chapter 4) and 0.40 mm-1 for the 
Polybuffer® ampholytes over a pH 4-9 gradient and a 9 mm separation axis.19 
Reduction of the variability in this measurement would be necessary for a robust assay, 
which supports the need for the development of an immobilized pH gradient50,53,54 rather 
than a ampholyte-generated gradient. 
 
As a measure of the linearity of the pH gradient, we measured the mean R2 statistic of 
the linear regression fit as 0.95±0.06 (mean ± standard deviation for n=3 gels) for the 
Zoom® ampholytes (Figure 6-6D). For comparison, the R2 statistic was quantified in the 
ultrathin IEF assay as 0.89±0.03 for the SinuLyte® ampholytes over a pH 4-7 gradient 
and a 9 mm separation axis (Chapter 3 and Chapter 4) and 1.00±0.00 for the 
Polybuffer® ampholytes over a pH 4-9 gradient and a 9 mm separation axis.19 The 
manufacturer of the Zoom ampholytes® does not provide information on the linearity of 
the pH gradient in IEF. 
 
Finally, we estimated the minimum pI difference for which two neighboring protein 
peaks are fully resolved16 (ΔpImin), using the relationship in Equation 6-1, where sprotein 
is a measure of the peak quarter-width (i.e., standard deviation of the Gaussian fit to the 
fluorescence intensity profile when focused). When averaged over all three proteins for 
each gel, ΔpImin was quantified as 1.14±0.57 (mean ± standard deviation for n=3 gels) 
for the Zoom® ampholytes. For comparison, ΔpImin was quantified as 0.16±0.02 in the 
ultrathin IEF assay across a 9 mm separation axis (Chapter 3 and Chapter 4), 
0.13±0.02 in the ultrathin IEF assay across a 9 mm separation axis19; and 0.11 for 
adherent-cell ultrathin IEF in free solution across a 9 mm separation axis21. Though not 
unexpected given the short 1 mm separation axis in the HTP IEF assay, this large ΔpImin 
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may be remedied by careful adjustment of electric field strength and an increased 
separation axis length (Chapter 2) for improved separation performance. 
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Figure 6-6. The HTP IEF assay yields reproducible separations of the fluorescently-labeled IEF 
protein ladder at 60 s electrophoresis. 
(A-C) Widefield microscopy images of the diagonal sliver of three HTP IEF gels (named Gels 1, 3, and 7, 
respectively) with the fluorescently-labeled IEF protein ladder focused at 60 s electrophoresis. Myoglobin 
is false-colored red, carbonic anhydrase green, and trypsin inhibitor blue. Gel is oriented with the pH 4 
anolyte boundary condition interface at the top of the image. White arrows indicate the approximate 
region at which the average fluorescence intensity was generated. (D) The peak centers of the 3 focused 
proteins were plotted against the protein pI’s, and a linear regression fit was applied to extract IEF 
separation performance metrics. (E) The electrical current decreased within the first 10 s for all gels, 
indicating the ampholytes formed a pH gradient. (F) A HTP IEF gel in the same experiment (Gel 5) to 
Figure 6-8 with proteins focused at 120 s electrophoresis yielded bands collapsed at the anode. 
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It is particularly important to note that ΔpImin is dependent on the sprotein for all 3 proteins 
in the IEF protein ladder. s MYO was quantified as 0.16±0.14 mm, compared to s CA = 
0.16±0.07 mm and s TI = 0.08±0.004 mm (mean ± standard deviation for n=3 gels). The 
myoglobin band exhibits both a particularly diffuse band and large variation, especially 
as the two myoglobin isoforms were not resolved in these gels. This further supports our 
working conclusion to replace the myoglobin in the IEF protein ladder, as described 
above. 
 
Interestingly, an n=1 gel in the same experiment underwent electrophoresis for 120 s 
(Figure 6-6D), yielding protein bands collapsed against the anode. It is unclear if this is 
an indication of anodic drift over time, or instability of the IEF pseudo-equilibrium over 
time, or a faulty experimental run.  
 
An initial attempt at HTP scIEF with U251-tGFP cells (not shown here) did not yield 
detectable protein bands. The separation gel was incubated solely in MilliQ water for > 
24 hours to maintain cell viability during the 10 min cell settling period. The anolyte and 
catholyte gels were the selected delivery mechanism for 2% TritonX-100 for cell lysis 
and 4% Zoom® ampholytes for IEF (double the standard IEF solution, for equilibration 
with the separation gel), incubated for > 12 hours in solution. It is unclear whether the 
lack of fluorescent tGFP protein bands is due to a limitation in analytical sensitivity, a 
requirement for immunoblotting for detection, or insufficient delivery of lysis and IEF 
reagents from the anolyte and catholyte gels. 
6.4 Conclusions and Future Directions 
In this study, we developed a fluorescently-labeled IEF protein ladder for reliable 
characterization of IEF immunoblots, and demonstrated a proof-of-concept HTP IEF 
assay using 3D projection electrophoresis. We investigated several avenues for 
optimization of the assay, and characterized the IEF separation performance and 
reproducibility of the gels. 
 
The immediate research questions for this assay involve verification of IEF equilibrium 
and characterization of analytical sensitivity. In addition, it would be important to 
investigate if immobiline degradation upon application of an electric field might be 
inducing anodic drift. Modifications to the composition and/or implementation of the 
boundary condition gels could improve IEF stability (including the inclusion of 
DMAPMA88 or Synperonic® F-108 surfactant15 in the separation gel) and better 
preserve in vitro protein state (including the inhibition of non-native disulfide bond 
formation173 via hen eggwhite lysozyme). Since these separation gels are sufficiently 
large compared to those in ultrathin IEF assay, without the large buffer volumes typically 
used in slab IEF or capillary IEF assays, it would also be important to characterize the 
Joule heating and heat dissipation within the separation gel, especially within the center 
of the gel, and subsequent effects on separation resolution. Numerical simulation of 
diffusion-based protein distribution during lysis and electrophoresis (Chapter 5) would 
provide insight into protein losses and sufficient spacing between individual microwells 
for single-cell resolution. 
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This platform must also be integrated with developments in electrophoretic 
immunoblotting166 and developments in the imaging workflow for 3D projection 
electrophoresis gels, either by confocal laser scanning microscopy, lightsheet 
microscopy, or other faster microscopy platforms with Z-resolution, for increased 
analytical sensitivity by a subsequent immunoblot. As an alternative, we posit that a 
modified separation gel structure, with temporary connectors in between rows of 
microwells, would allow the separation gel to be used as an entire unit for the IEF 
separation and protein immobilization. Subsequently, the temporary connectors could 
be disrupted and removed, rendering the 18 × 18 × 1 mm separation gel into a series of 
smaller 18 × 0.4 × 1 mm gel segments (one row of microwells and separation lanes 
contained within each gel segment), for immunoblotting and imaging via widefield 
epifluorescence. The reduced thickness of these gel segments would allow for standard 
handling of these gels with immunoblotting, thereby avoiding issues of extended 
immunoblotting time, concerns of antibody-antigen dissociation kinetics, etc. The N,N′ -
[(1-methylethylidene)bis(oxy-2,1-ethanediyl)] diacrylamide (diacrylamide ketal, DK) 
cross-linkers174 may serve as these temporary connectors, provided modifications to 
reduce irregular gel swelling (as reported by Dr. Julea M. Vlassakis,175 among others). 
One could design a sufficiently precise device to slice the separation gel with this 400 
µm precision. For better microscale precision and ease of use, photopolymerization en 
masse, or via 3D printing to systematically build the multi-material separation gel, may 
serve this purpose well. 
 
To reduce protein losses and subsequently improve the analytical sensitivity of this 
assay, the modification of the benzophenone immobilization moiety (benzophenone N-
[3-[(3-benzoylphenyl)formamido]propyl] methacrylamide, BPMA) to extend the linker 
between the benzophenone group and the methacrylamide group incorporated into the 
PA gel matrix may be useful. With an extended linker, the BPMA would exhibit an 
increased functional radius of action, wherein the BPMA could interact with and bind to 
proteins during the protein immobilization step. Pairing this with tuning the BPMA 
concentration would preserve the maximum protein content in the IEF-focused bands, 
providing maximum antigen for the subsequent immunoblot, which would be especially 
important for low-expression protein isoforms. 
 
With sufficient separation resolution and analytical sensitivity, this high throughput IEF 
platform could be used to investigate many biologically-relevant proteins. Of particular 
interest are the HER2 isoforms relevant in breast cancer. Recent characterization of the 
full-length P185 and truncated (P110) isoforms in BT474 cells in the single-cell Western 
blotting assay reported that 7.4% of all BT474 cells had an observable truncated 
isoform band (after protein immobilization and immunoblotting in this assay), with a CV 
of 77% in the heterogeneity of expression of this isoform and an estimated expression 
level of 160 femtograms of the truncated isoform.4 From an assessment of the feasible 
size-based and charge-based separations of several HER2 isoforms (Table 6-3), this 
high-throughput IEF platform may be suitable for quantitative characterization of the 
expression of these HER2 isoforms in breast cancer cell lines, banked breast cell lines, 
and primary cell or tissue samples.  
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Furthermore, phosphorylation of proteins is an essential mechanism for protein 
activation, regulating a series of signaling pathways tied to cell cycle regulation, 
proliferation, and activity. The ERK and Akt proteins both require multiple 
phosphorylations for functionality, and prior studies have indicated significant cell-to-cell 
heterogeneity in the activity of these proteins.12,176–179 Given an estimate of 1-10% 
phosphorylation of proteins at any time12 and the shift in pI by a mean of 0.1 from each 
phosphorylation,180,181 it may be feasible to electrophoretically separate biologically-
relevant protein isoforms in different phosphorylation states (phospho-forms) in single 
cells with a DpI of 0.1. IEF separations of ERK phospho-forms was previously 
demonstrated in a similar IEF platform at 25-cell resolution.13 
 
The HTP IEF assay is an endpoint assay that, in its current formulation, does not 
convey information about the timing of protein expression. Mapping specific protein 
isoforms and post-translational modifications, as well as activation of specific protein 
pathways, to proteomic markers of the mitotic cell cycle (including cyclins, Ki67, and 
PCNA) would provide additional insight into the temporal aspect of protein expression 
and activity. The combined interrogation of HER2 isoforms, protein isoforms and 
phospho-forms in other pathways implicated in breast cancer, and cell cycle markers 
would significantly extend the combined analytical value of the HTP IEF assay towards 
interrogations of breast cancer, and computational identification of breast cancer cell 
sub-populations. 
 
In the future, additional developments to this platform to incorporate the porogen gels as 
the separation gel for improved analytical sensitivity (Chapter 3), an immobilized pH 
gradient50,53,54 in the separation gel for improvements in DpImin and reproducibility, and 
assay modifications to accommodate un-trypsinized biological samples21 (including 
novel developments by Dr. Grist and others) would create a particularly viable platform 
for high-selectivity, high-throughput IEF separations of proteins from single cells and 
relevant biological materials. 
 
Table 6-3. The theoretical isoelectric points and molecular weights of several HER2 isoforms 
indicates the need for an IEF assay capable of separating proteins with a DpImin under 
0.04.4,161,162,164,165,182 
 
HER2 isoform Length 
(amino acids) 
Molecular 
weight (kDa) 
Theoretical 
isoelectric point 
P185 1255 185 5.58 
D16 1239 ~ 185 5.62 
P110 645 110 5.18 
P95 ~608 95 5.31 
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Chapter 7: WAT-on-a-Chip: A Physiologically Relevant Microfluidic 
System Incorporating White Adipose Tissue 
This work was performed in collaboration with Dr. Peter Loskill, Thiagarajan Sezhian, 
Dr. Kevin M. Tharp, Dr. Felipe T. Lee-Montiel, Dr. Willie Mae Reese, Dr. Peter-James 
H. Zushin, Dr. Andreas Stahl, and Dr. Kevin E. Healy. This work is reproduced by 
permission of The Royal Society of Chemistry from P Loskill, T Sezhian, K Tharp, S 
Jeeawoody, WM Reese, A Stahl, KE Healy. “WAT-on-a-chip: A microfluidic system 
incorporating physiologically relevant white adipose tissue.” Lab on a Chip. 2017; 
17:1645-54. 
7.1 Introduction 
Engineered tissues have emerged as a powerful tool for translational biomedical 
applications as well as to understand and study disease mechanisms. Although various 
tissue engineering approaches for regenerative medicine have been introduced,183,184 
they typically have restricted usefulness for other applications such as drug screening 
due to three major limitations. First, currently they cannot recapitulate the complex 
circulation of humans which continuously transports nutrients, drugs, and other soluble 
compounds toward the tissue, and clears metabolic waste away from the tissue. 
Second, their macroscale requires a large number of cells preventing the parallelization 
and scale up for commercial applications. Third, they typically have tissue to fluid 
volume ratios that are not physiologic thereby altering the delicate balance of autocrine 
and paracrine factors on tissue function. These limitations can be overcome by 
integrating engineered tissue with physiologically relevant microfluidic systems to create 
organ-on-a-chip systems, which have evolved from a conceptual idea to a feasible new 
paradigm for drug screening.185–190 These microfluidic approaches offer significant 
advances including: unprecedented control of fluid flows; compatibility with high content 
drug screening; miniaturization of large systems for convenient operation; significant 
reduction of very expensive cell reagents used; physiological relevant tissue to media 
volumes, and potential for connection with other organ systems. Recently, a variety of 
promising organ-on-a-chip systems have been developed, also referred to as 
microphysiological systems (MPS), such as models of cardiac,32 pulmonary,191 
hepatic,192 renal,193 and vascular tissues.194 
 
In spite of it comprising approximately 20% body weight of healthy men and up to 25% 
women, and can reach more than 50% body weight in obese adults,195,196 adipose 
tissue has been frequently overlooked for MPS. Like the liver and skeletal muscle, white 
adipose tissue (WAT) is an insulin sensitive organ as well as a critical storage site for 
excess dietary energy. WAT exists in different anatomical locations and is comprised of 
a heterogeneous collection of cell types that are dominated by unilocular adipocytes. 
WAT depots not only serve as storage sites for triacylglycerol, but also have been 
established as a major endocrine organ secreting a variety of cytokines, termed 
adipokines.197–199 Adipokines, such as leptin and adiponectin, are known to play 
significant roles in a variety of human diseases and loss of all WAT, as is observed in 
patients with lipodystrophy, leads to severe metabolic and endocrine abnormalities.200–
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203 Adiponectin concentrations have, for instance, been shown to affect organs such as 
liver,204 heart,205 and kidney.206 Furthermore, the potential of adipose tissue as a direct 
target for pharmacotherapies is becoming recognized,207 especially in the context of 
rapidly increasing prevalence of adipose-related diseases such as obesity and type 2 
diabetes. The Centers for Disease Control and Prevention, for instance, reported in 
2012 that more than 35% of U.S. adults suffered from obesity.208 Besides the direct 
involvement in diseases or as a drug target, the storage character of WAT provides a 
further key aspect. Plasma concentrations of drug compounds and drug exposure 
kinetics in vivo are strongly affected by the “ADME” processes – absorption, distribution, 
metabolism, and excretion. As WAT is known to sequester hydrophobic drug 
compounds,209,210 a WAT-on-a-chip is of utmost importance in the endeavor to mimic in 
vivo ADME properties in integrated multi-organ MPS. 
 
In recent years, a variety of engineered adipose tissue constructs have been 
introduced.195 The majority incorporated adipocytes into three dimensional scaffolds 
consisting of various biomaterials,211 using for instance collagen/alginate,212 silk 
fibroin,213 porous polymers,214 decellularized extracellular matrices,215 or bioinspired 
matrices.216 While these systems have a potential as implants for regenerative 
medicine, their use as in vitro models is restricted by the limitations mentioned above. 
One of the limitations, the lack of circulation, was successfully addressed by 
incorporating the tissue constructs into macroscopic bioreactors,217,218 which were 
successfully downscaled to cm size reactors connected to microfluidic channels.219 
Initial attempts to create microscale, microfluidic systems for the culture of white 
adipose tissue have also been reported.220–222 These attempts used initially open 
systems, which were closed subsequent to seeding cells or inserting entire cover slides 
into them. While this approach elegantly circumvents the challenge of inserting fragile 
and buoyant adipocytes into microscale chambers, it limits the potential for further 
downscaling, parallelization for high content screening and integration with other 
systems. Additionally, although these systems succeeded in establishing a continuous 
flow environment, the degree of structural mimicry of the in vivo physiology is limited 
and they specifically fail in protecting the tissue from shear stresses, thereby missing a 
key element of the in vivo vasculature. 
 
Here we present a WAT-on-a-chip system that creates a physiologically relevant 
microfluidic environment enabling the control of nanoliter fluid volumes and flows that 
are unavailable with other methods. The system consists of separate media channel 
and WAT chambers, which are connected via small micropores. Analogous to the in 
vivo blood circulation, convective transport is thereby confined to the vasculature-like 
channel. The WAT chamber hence provides a recapitulated native physiological niche 
protected from shear forces by an endothelial-like barrier in which adipocytes can be 
injected and supported for long term culture to produce functional adipose tissue. 
7.2 Materials and Methods 
Fabrication and Characterization of WAT-Chip 
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The multilayer WAT-chip consists of two patterned polydimethylsiloxane (PDMS, 
Sylgard 184) slabs sandwiching a polyethylene terephthalate (PET) membrane (r P = 3 
μm; ρ P = 8 × 105 pores per cm2; AR Brown-US, Pittsburgh, PA). To generate the 
PDMS slabs, patterned master-wafers were fabricated via a photolithography process. 
Thereto, a 50 μm thick layer of SU-8 3050 photoresist (MicroChem Corp, Newton, MA) 
was spin coated onto silicon wafers (University Wafer, Boston, MA) and exposed to UV 
light through patterned transparency masks according to the manufacturer's data sheet. 
Wafers were developed in SU-8 developer (MicroChem Corp, Newton, MA), rinsed in 
isopropanol, and blow dried with N2. The patterned wafers were baked, and coated with 
trichloro-1H,1H,2H,2H-perfluorooctylsilane (FOTS, Gelest, PA, USA). The masks for 
both wafers were designed in AutoCAD LT (Autodesk Inc., San Rafael, CA). PDMS 
slabs were then replica molded using uncured PDMS in a 10:1 w/w ratio of prepolymer 
to curing agent. To mold the slab featuring the media channel, a total of 11 g of PDMS 
was poured onto the wafer and cured overnight at 60°C. Similarly, the slab featuring the 
cell chamber was molded using 30 g of PDMS. After peeling the molds from the wafers, 
inlet/outlet holes were punched in the cell chamber PDMS slab using a 0.75 mm biopsy 
punch (Ted Pella). 
 
To prepare the isoporous PET membranes, they were cut to appropriate dimensions 
and cleaned through sonication in isopropyl alcohol for 10 min. The membranes were 
then exposed to oxygen plasma (Plasma Equipment Technical Services, Livermore, 
CA) at 60 W for 60 s. The activated membranes were incubated in a solution of 97% 
isopropyl alcohol, 2% bis(3-(trimethoxysilyl)propyl)amine and 1% Milli-Q water at 80°C 
for 20 min and subsequently rinsed with isopropyl alcohol. After drying at 80°C for 30 
min, the membranes were placed in 2 mL of 70% ethanol in Milli-Q water. 
 
To assemble the multi-layer PET/PDMS hybrid device, the unpatterned backside of the 
PDMS slab featuring media channels was bonded to a microscope glass slide after 
exposure to oxygen plasma at 60 W for 20 s. The patterned faces of both PDMS slabs 
were then once more exposed to oxygen plasma at 60 W for 20 s and sandwiched 
around the previously functionalized PET membrane, which was carefully blow dried 
with N2. To ensure a proper alignment of media channel with cell chambers, the 
assembly was performed under a stereomicroscope. To stabilize bonding, the devices 
were subsequently baked overnight at 80°C. 
 
For the assessment of sealing and fluidic connection, both media channel and cell 
chambers were first prefilled with red food dye (DecACake) colored Milli-Q water 
followed by pumping blue colored Milli-Q water through the media channels. Color 
movies were taken using a Leica M80 stereomicroscope (Leica, Wetzlar, Germany) 
system equipped with a Leica MC170 camera. 
Numerical Modeling 
COMSOL Multiphysics (COMSOL, Stockholm, Sweden) was used to model fluid flow 
and transport of a diluted species. Treating the membrane as an array of cylindrical 
pores could not be achieved due to computational memory limitations. To overcome this 
barrier, we employed a finite element model treating the membrane as a porous media 
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as described previously.223 Briefly, the flow through the membrane was solved using the 
time-dependent solver with a finer physics controlled mesh. The iterative solver was 
employed using multigrid methods to further overcome computational limitations. The 
“Free and Porous Flow” module engaged the Navier–Stokes equation to solve for the 
free flow of the media through the cell and media channels and Darcy's Law to solve for 
the flow of media through the membrane, modeled as a porous medium. The 
membranes used have a porosity of ∼5.6%, pore radius of 1.5 μm, and a thickness or 
pore length of 20 μm. The fluidic resistance of the pores was calculated to RP = 1.097 × 
1016 Ns m−6 by employing Dagan's equation,224 which solves for the entrance and exit 
effects through a short pore via  with fluid viscosity μ, pore radius rP, and 
pore length L. The hydraulic permeability K was calculated to K = 1.45 × 10−14 m2 using 
 whereby ρ is the porosity of the membrane. Simulations are conducted with 
a media flow rate of 5.56 × 10−12 m3 s−1 (20 μL h−1). 
 
Additionally, the “Transport of Dilute Species” module was used to assess the ability of 
the membrane to allow for the diffusion of small molecules solved in the media. 
Therefore, the media channel is pre-filled at time point zero with “media” containing a 
species c in a concentration of 1 μM and constantly perfused with the same media at 20 
μL h−1. When assuming a typical diffusion coefficient of 1 × 10−9 m2 s−1 for a biological 
molecule in water,225 the concentration of the species in most of the cell chamber 
reaches the initial concentration of 1 μM within 30 seconds. 
Analytical Model 
The analytical model approximates the membrane as an idealized system with pores in 
a hexagonally close packed arrangement with rows of pores aligned with the direction of 
media flow and a pore-to-pore distance of  with the membrane porosity pM 
and the pore radius rP. In this system, the flow in the channels can be solved using an 
electrical circuit analogy involving the resistance of the pores RP, the resistances of the 
media and cell channel Rm and Rc respectively, and the input flow rate Q (Figure 
7-3E).223 Applying this analogy to unit segments of length LP, a generalized recurrence 
relation can be obtained whereby the flow rate in the nth segment of the tissue chamber 
(with a total of N segments) is  with 
 and . 
 
The derivation of these formulas is similar to the one reported by Chung et al.223 with 
the difference that due to the circular structure of media and cell chamber, the width of 
the channel is different for each segment. Hence, all resistances RP, RM and RC in 
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principle depend on the chamber width w and the segment index n respectively. 
However, as elucidated in the following these formulas can nevertheless be applied to 
the system by using a slight modification. 
 
The total pore resistance of a membrane cross-section perpendicular to the media flow 
consisting of multiple identical pores is  with the resistance of a single 
pore RSP and the number of pores per cross-section . 
 
RSP can thereby be calculated using Dagan's equation, which accounts for edge effects 
for flow through a short through pore,  with the fluid viscosity μ and the 
membrane thickness (pore length) hM. By defining projected resistances R′ with 
 as well as  and  respectively 
(Hagen–Poiseuille equation of flow in rectangular channels) and considering the fact 
that solely ratios of resistances occur in the formulas, we can cancel out the width 
dependence and replace resistances R in the equations from Chung et al.223 with 
projected resistances R′. By looking at the derivative  it becomes obvious that the 
maximum flow in the cell chamber occurs at n = 0.5 × N. 
Cell Culture and Differentiation 
3T3-L1 fibroblasts (ATCC) were differentiated as described previously.226 Briefly, 
fibroblasts were cultured in DMEM medium containing 10% fetal bovine serum with 2 
mM l-glutamine and 1% penicillin/streptomycin (DMEM/FBS). To induce adipogenesis, 
the cells were cultured in DMEM/FBS for 2 days after reaching confluence and then for 
2 days in DMEM/FBS supplemented with 5 μg mL−1 (0.86 μM) insulin, 0.25 μM 
dexamethasone, and 0.25 mM isobutylmethylxanthine. Subsequently, the medium was 
changed to DMEM/FBS supplemented solely with 5 μg mL−1 insulin and the cells 
cultured for an additional 2 days. Finally, the cells were maintained in DMEM/FBS 
alone. Differentiated cells (at least 95% of which showed an adipocyte phenotype by 
accumulation of lipid droplets) were injected into the MPSs on days 6–10 after initiation 
of differentiation. 
Cell Loading 
To ensure a successful loading of the MPSs, differentiated adipocytes were singularized 
and maintained in suspension by treatment with 0.5% trypsin w/ EDTA for 2 min, 
detached from the surface, and then suspended in DMEM/FBS media. The suspension 
was subsequently centrifuged for 5 min at 400g and the diluted trypsin aspirated off. 
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After that, the cells were resuspended in fresh media such that a solution of 3–5 million 
cells per mL was obtained and the loading process started immediately. 
 
To prepare the loading process, fully assembled MPSs were exposed to O2 plasma at 
180 W for 1 min thereby sterilizing and creating more hydrophilic channel surfaces. 
Immediately thereafter, 100–200 mL of cell solution was applied to the cell inlet ports of 
the MPSs, which were then stored for 15 min in the incubator to allow for sedimentation 
of cells resulting in a high cell density inside the inlet ports. By applying a negative 
pressure to the cell media inlet and outlet port using a PhD Ultra syringe pump (Harvard 
Apparatus) cells were loaded into the cell chamber until a densely packed cell pellet 
was obtained. Subsequent to the actual loading step, the MPSs were stored for 30 min 
in the incubator to allow cell attachment before starting the flow of media through the 
media channels. The media flow was achieved using a PhD Ultra syringe pump at a 
flow rate of 20 μL h−1. 
On-Chip Culture and Characterization 
To assess viability of the WAT on chip, Live/Dead cytotoxicity assays were performed 
using a LIVE/DEAD cell imaging kit (Molecular Probes R37601) to stain viable cells with 
green-fluorescent calcein AM (488 nm) and dead cells with red ethidium homodimer-1 
(570 nm). The live/dead imaging kit was used following the manufacturer protocol: 3T3-
L1 cells in WAT chips were rinsed with 1× PBS, and 60 μL of dye was added to the 
devices and then incubated for 20 min. After this incubation time, images were collected 
using an inverted microscope Nikon TE300 with a Lumencore Spectra X light engine. 
Images were then processed in FIJI ImageJ. Utilizing segmentation analyses and a 
constant area exclusion filter counts of live or dead cells were obtained. An index of cell 
death was constructed from the ratio of the number of dead cell events divided by total 
number of cells. 
 
For long-term culture, loaded MPSs were stored in the incubator and fed by a PhD Ultra 
syringe pump with continuous media flow. For visual characterization, cells were 
imaged daily without detachment from the syringe pump using a Nikon Eclipse TE300 
microscope. To better visualize the lipid droplets, cells were stained using a nonpolar 
fluorophore specific for neutral lipids. Thereto, MPSs were incubated overnight at 4°C in 
a 4% solution of paraformaldehyde (Santa Cruz Biotechnology). Subsequently, a 
solution of PBS with 0.1% Tween (PBST) was flushed through the MPSs for 3 hours 
followed by a 2 hour flush with PBST containing 1 μg mL−1 4,4-difluoro-1,3,5,7,8-
pentamethyl-4-bora-3a,4a-diaza-s-indacene (BODIPY D-3922, Molecular Probes, 
Eugene, OR) and 300 nM 4′,6-diamidino-2-phenylindole (DAPI, Molecular Probes). After 
a final washing step with PBS, the MPSs were imaged with a Zeiss LSM710 laser-
scanning microscope (Carl Zeiss, Jena, Germany). 
 
To characterize the uptake functionality of the adipocytes in the MPS after two weeks 
in-chip culture, the cells were fed with a fluorescently-labeled fatty acid analog. 
DMEM/FBS media was supplemented with 4 μM 4,4-difluoro-5-methyl-4-bora-3a,4a-
diaza-s-indacene-3-dodecanoic acid (BODIPY D-3823, Molecular Probes). After 12 h 
continuous flow feeding in the incubator, the MPSs were imaged using a Nikon Eclipse 
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TE300 fluorescence microscope equipped with an ORCA-Flash 4.0 CMOS Camera 
(Hamamatsu, Hamamatsu-city, Japan). 
 
Confocal immunofluorescence microscopy was conducted on WAT chips that were 
fixed after 3 days and 9 days respectively of on-chip culture using 4% PFA for 30 min 
and a subsequent 1× PBS wash. Triton X-100 was used to permeabilize the cells 
followed by a 3% BSA blocking solution wash. After tissue fixation, 3T3-L1 cells were 
stained with DAPI (nuclei-blue), Phalloidin (Actin-GFP) and LipidTOX (lipid droplets-
red). Confocal images were collected using a Carl Zeiss LSM 710 confocal microscope 
equipped with a plan-apochromat 10×/0.45 objective imaging DAPI (excitation 405 nm, 
emission: 410–494 nm), GFP (excitation 488 nm, emission: 493–550 nm), and 
LipidTOX red (excitation 595 nm, emission: 599–734 nm) channels. 
 
For the visualization of the collagen in the ECM, picrosirius red staining (Polysciences 
Inc. Warrington, PA) was used following the manufacturer protocol. Briefly, WAT chips 
were incubated for 1 hour, followed by two washes with an acetic acid solution. Bright 
field images were then collected using a Zeiss Axio Imager microscope (Carl Zeiss, 
Jena, Germany) equipped with a QImaging MicroPublisher 5.0 color camera (Q 
Imaging, Surrey, BC, Canada). On the images, collagen appears red with a pale yellow 
background. 
7.3 Results and Discussion 
Concept of the Microphysiological WAT-on-a-Chip 
To mimic the physiological environment of adipose tissue inside a microfluidic 
environment we have developed a microphysiological system that has three main 
elements: a media channel, circular cell chambers, and a microporous membrane in 
between. Analogous to the in vivo blood circulation, media travels through the media 
channel as a vasculature-like microcirculation between multiple WAT chambers and 
constantly transports fresh nutrients and other soluble factors (e.g. drug compounds, 
cytokines) to and metabolic waste and secreted factors away from the tissue (Figure 
7-1A). The media channel and WAT chambers are connected via small micropores 
(diameter 3 μm) that act as a perfusion barrier (Figure 7-1B and C). The perfusion 
barrier mimics the in vivo endothelial barrier by allowing nutrients, drugs, and other 
media compounds to diffuse to the tissue while protecting the cells from shear stresses. 
The diffusion properties are regulated by the pore size and pore density. The circular 
geometry of the WAT chambers (diameter 600 μm, height 50 μm) creates a 
homogeneous supply with nutrients for the entire WAT tissue and enables the direct 
exchange of soluble factors with the media for each individual cell, which is important as 
in vivo each adipocyte is attached to at least one capillary.227 Additionally, the 
microfluidic concept enables the temporal and lateral control of nanoliter fluid volumes 
and flows. The much smaller liquid volumes compared to standard cell culture further 
prevents non-physiological dilution of autocrine and paracrine factors. The basic 
principle of a vertically adjacent configuration of separate media and tissue 
compartments enables a large degree of flexibility in terms of circulation architecture 
including in series- or in parallel-connections of multiple tissue chambers (Figure 7-1D) 
 88 
interconnected by low dead-volume microchannels (width 40 μm, height 50 μm). Since 
the footprint of one tissue chamber is below 1 mm2, it is possible to fabricate hundreds 
of cell chambers on a plate with standard multi-well plate dimension and thus enable 
high throughput screening. Another advantage of the microfluidics-based design is that 
the WAT-on-a-chip is amenable for characterization of a variety of structural and 
functional endpoints. For example, the optical accessibility of the tissue chamber 
enables the flexible use of high-resolution microscopy techniques for live cell imaging 
and the continuous media flow allows for temporal collection of the supernatant and 
subsequent analysis using for instance mass spectrometry or colorimetric assays. 
Additionally, the underlying concept permits the integration of the system in multi-organ 
circulations.228 
 
 
Figure 7-1. Schematic concept of the WAT-on-a-chip. 
(A) Scheme demonstrating the underlying idea of separated media channel and multiple individual WAT 
chambers. (B) Schematic design and (C) cross section of the multilayer PDMS–PET hybrid system. The 
MPS is based on a sandwich structure consisting of an isoporous PET membrane in between two PDMS 
layers, whereby the upper one features the WAT chamber (green) and the lower one the media channel 
(red). (D) Examples of different circulation architecture versions connecting multiple cell chambers in 
series or in parallel. 
Fabrication of the Multilayer Hybrid System 
The media channel and the WAT chambers are patterned via UV-lithography and 
replica molded in two polydimethylsiloxane (PDMS) slabs, which constitute the lower 
and upper layers respectively of the three-layer hybrid MPS. The middle layer consists 
of an isoporous polyethylene terephthalate (PET) membrane. By choosing commercially 
available track-etched PET membranes, a variety of pore sizes and pore densities, viz. 
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diffusion properties, can be employed without restriction by aspect-ratio limitations of 
UV-lithography and without changes in the actual fabrication process. Important for 
analysis methods requiring optical transparency, the choice of membranes with 
controlled angles of the pores is critical. To enable long-term tissue culture and the 
choice of a wide variety of fluidic parameters, a strong bonding of the three components 
is required. To achieve a coupling between the PET membrane and the PDMS devices, 
we employed a bis-amino-silane modification of the membrane recently introduced by 
Sip and Folch229 (Figure 7-2A-C). Note that many commercially available PET 
membranes are surface treated with PVP or other hydrophilic coatings, which will 
interfere with the coupling process. The advantage of this silane coupling approach is 
that the process solely requires commercially available reagents, is uniformly applied to 
surfaces and thus mostly feature-independent, and is compatible with PDMS oxygen 
plasma bonding. The silane treated membrane is sandwiched between two PDMS 
slabs, which have been activated via oxygen plasma (Figure 7-2D). The components 
are then carefully aligned, brought into contact, and cured resulting in a bonded and 
sealed PDMS/PET hybrid system (Figure 7-2E). 
 
 
Figure 7-2. Fabrication of the multilayer PDMS–PET hybrid MPS. 
(A) an isoporous PET membrane is activated using O2 plasma and treated with a bis-amino silane 
solution at elevated temperature. The functionalized membrane is subsequently (B) cured to further 
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cross-link the silane layer and (C) hydrophilic coating via immersion in a 70% ethanol/water mixture. (D) 
The silanized membrane is sandwiched between two activated PDMS layers, which are aligned under a 
stereoscope (E) the PDMS/PET hybrid device is bonded, dried and baked. 
Characterization of Transport Processes 
One of the major elements of the MPS is the separation of transport processes. In the 
human body, most tissues do not experience shear forces due to convective blood flow 
since they are protected by the endothelial barrier. Similarly, inside the MPS, the tissue 
is not subject to convective flow but is supplied by diffusive transport while the transport 
within the media channels is predominately convective (Figure 7-3A). This is ensured 
by a narrow cross-section of the isoporous membranes with 3 μm diameter pores 
creating a fluidic resistance into the cell chamber significantly higher than through the 
media channel. The fluidic connection of cell and media channel as well as the different 
timescales of transport processes was shown using DI water colored with food dyes 
(Figure 7-3B). This qualitative characterization demonstrated that pumping a blue liquid 
into the media channels of a system entirely filled with red liquid leads to an immediate 
replacement of the liquid in the media channel and a subsequent color change in the 
cell chambers due to dye diffusion through the membrane. 
 
 
Figure 7-3. Characterization of transport processes inside the MPS. 
(A) Schematic view of the MPS highlighting the two different transport processes: convective flow within 
the media channel and purely diffusive transport to the tissue chamber. (B) Time series of pictures at 
subsequent timepoints (i)–(iv) showing the replacement of red dyed water by injection of blue dyed water 
into the media channels. Note the subsequent change of color in the cell chambers due to diffusion 
through the membrane. (C) COMSOL simulation of the diffusion of small molecules from the media 
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channel in the z-axis to the tissue chamber on physiological timescales. Orthogonal view of flow profile 
across several points in the MPS. (D) Schematic representation of the electrical circuit analogy using an 
idealized membrane on which the analytical model is based on. Adapted from 223. Color bar applies for 
both (C) and (D). (E) Input flow rate fraction in the tissue chamber along the flow axis calculated by the 
analytical model. (F) Simulated velocity profile of flow in the MPS, inset shows the magnified view. Note 
the lack of convection within the diffusive barriers and predominant convective flow through the nutrient 
channels. Thus, mass transport to the tissue is exclusively diffusive. 
 
Additionally, we employed quantitative theoretical models to demonstrate the desired 
transport separation effect. Using numerical analysis employing a “Transport of Diluted 
Species” model we assessed the concentration change in the cell chamber when 
pumping a liquid with a diffusive solute through the media channel. Due to the high 
computational costs of modeling the “small scale” membrane pores individually as well 
as the “large scale” channel structures, we employed a finite element model treating the 
membrane as a porous media. A time series of snapshots of the concentration 
distribution reveals a diffusive supply of media to the tissue on physiological timescales 
(Figure 7-3C). Similarly, we simulated the flow fields in both the media channel and the 
cell chamber revealing the successful confinement of the convective flow as target and 
thereby confirming that the membrane effectively shields cells from the convective flow 
in the media channel and the resulting shear stress (Figure 7-3D). 
 
Independent of the numerical finite element model, we employed an analytical model 
which we developed based on a concept recently introduced by Chung et al.:223 
application of the theoretical equations for our system results in a distribution of the flow 
rate in the cell chamber as shown in Figure 7-3F and a maximum flow rate of less than 
1/100 of the input flow rate in the media channel. Note that this value is independent of 
the width of the chamber and the fluidic viscosity of the media. Furthermore, considering 
that the tissue in the cell chamber will significantly increase the fluidic resistance, the 
actual flow rate in the tissue chamber will be even lower. 
 
Taken together, both models provide qualitatively the same results although different 
approximations for the character of the membrane were used. Each model verified the 
separation of transport processes and thereby the shear stress protective effect of the 
membrane. The separation of transport processes providing a shear-force protection of 
the tissue is a key aspect of our system and serves as a recapitulation of the in vivo 
endothelial barrier. However, while providing mechanical support and controlled passive 
diffusion, the system does not fully mimic active transportation processes displayed by 
endothelial cells. Future systems with endothelial cells on the media-channel-side of the 
membrane can be envisioned to incorporate those processes as well. The choice of 
commercially available membranes, moreover, allows for the change of pore sizes, viz. 
diffusion properties, without changes in the actual fabrication process. 
Injection and Culture of Functional Adipose Tissue 
To create adipose tissue in the MPS, we obtained adipocytes by differentiating murine 
3T3-L1 preadipocytes. Between 6–8 days after induction of adipogenesis, cells were 
harvested and loaded into the cell chambers of the MPS through small tree-like loading 
channels (width 80 μm, height 50 μm). Due to their fragility and buoyancy, adipocytes 
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were more problematic than other cell types in terms of handling and compatibility with 
small-scale dimensions and shear stresses. Hence, an early injection time point was 
chosen, at which lipid droplets were clearly visible, but still small and sparsely 
distributed. Loaded chambers were subsequently fed using a syringe pump induced 
continuous flow through the media channels. Within 24 h of loading, the cells reattached 
and initiated the formation of a tissue. 
 
An important prerequisite for the applicability of a WAT-on-a-chip MPS for drug 
screening applications is the capability to keep the tissue viable and functional over 
longer time periods, which we studied using a variety of approaches: as shown by 
Live/Dead cytotoxicity assays, (Figure 7-4A and B) the MPS was able to keep the 
injected cells viable. Confocal immunofluorescence imaging further confirmed the 3D 
character of the adipose tissue in the MPS (Figure 7-4C). To investigate the 
functionality of cells and the presence of cell-secreted ECM, an essential constituent of 
the 3D tissue, we performed picrosirius red staining visualizing collagen I and III at two 
different time points after cell loading (Figure 7-4D).  
 
 
Figure 7-4. Physiologically relevant adipose tissue in the MPS. 
(A) Fluorescence microscopy image of a Live/Dead cytotoxicity assay after four days of on-chip culture. 
(B) Quantification of the percentage of viable cells in the MPS at different time points of on-chip culture. 
(C) Confocal image of 3T3-L1 adipocytes after 9 days in culture in the WAT MPS revealing a 3D tissue 
like structure. Cells were stained with phalloidin to show part of the cytoskeleton, DAPI to visualize the 
nuclei and LipidTOX red for the neutral lipid droplets. (D) Bright field images of MPS's stained with 
picrosirius red after (i) 3 days and (ii) 9 days of on-chip culture showing a functional secretion of ECM 
(collagen), essential for a physiological tissue structure. 
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Figure 7-5. The MPS enables maintenance of viability and functionality of adipose tissue. 
(A) Series of optical microscopy images of a typical WAT chamber inside the MPS taken at subsequent 
days reveals the formation and growth of lipid droplets indicating functional fatty acid uptake. (B) 
Fluorescent microscopy images inside an MPS stained six days after loading using a Bodipy D3922 dye 
highlights the abundance of lipid droplet. (C) Series of optical microscopy images shows formation and 
growth of lipid droplets for more than two weeks demonstrating the long-term culture capability of the 
MPS. (D) Fluorescence microscopy image subsequent to exposure to the fluorescently labeled fatty acids 
analog C1-Bodipy-C12 confirming the fatty acid uptake ability and functionality of the tissue after two 
weeks on chip culture (scalebars 100 μm). 
 
In situ bright field microscopy characterization in 24 h intervals clearly showed the 
expansion of cells and growth of lipid droplets indicating fully functional lipid metabolism 
by the adipose tissue (Figure 7-5A). To visualize and confirm the lipid droplets, we 
employed a Bodipy 493/503 (D-3922, Molecular Probes) stain allowing us to detect the 
lipid droplets through standard epifluorescence and confocal microscopy (Figure 7-5B). 
Our MPS, moreover, enabled the culture of adipose tissue for more than two weeks as 
demonstrated by the continuous growth of lipid droplets, indicating no loss of fatty acid 
uptake and triacylglycerol synthesis capabilities (Figure 7-5C). 
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To directly assess relevant metabolic function, we visualized fatty acid uptake, a 
transporter mediated process230 by incubating the MPS with medium containing a BSA-
bound fluorescently-labeled long-chain fatty acid analog, i.e. C1-Bodipy-C12 500/510 
(D-3823, Molecular Probes). Standard epifluorescence microscopy revealed that, two 
weeks after loading, large numbers of cells within the MPS showed significant uptake 
functionality (Figure 7-5D). Thus, the MPS was capable of keeping adipose tissue 
viable and functional over longer time periods. Ultimately, our WAT MPS will enable 
additional physiological assays for lipids and glucose metabolism as well as insulin 
sensitivity and, given the small dimensions and potential for massive parallelization, our 
WAT MPS will allow for the rapid screening of adverse drug effects in complex 
metabolic systems. Down the road, the exploitation of microfabrication and microfluidic 
approaches provides the system with the potential for the integration with other 
microfluidic based organ systems. This will make the WAT MPS a powerful testbed 
opening a wide range of opportunities for fundamental biomedical studies as well as for 
translational applications in pharmaceutical industry. 
7.4 Conclusions 
We have developed a WAT-on-a-chip MPS that integrates adipose tissue in an 
environment which features crucial parts of the in vivo physiology such as continuous 
nutrient delivery and media exchange, spatially homogeneous nutrient supply, close 
proximity to the vasculature of each individual cell, separation of transport processes, as 
well as shear force protection for the tissue. Additionally, it has a low-cost character and 
is highly accessible for a variety of endpoint characterizations. The WAT MPS is 
capable of maintaining the viability and function of the tissue over multiple weeks. The 
highly controlled and computationally predictable character of the MPS make it a 
versatile tool for the study of adipose tissue properties and responses to external 
stimulations, as well as adipose tissue associated diseases such as obesity and type 2 
diabetes. 
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Chapter 8: In Vitro Cardiac Tissue Models: Current Status and Future 
Prospects 
This article was written in collaboration with Dr. Anurag Mathur, Dr. Zhen Ma, Dr. Peter 
Loskill, and Dr. Kevin E. Healy. This article was published in Advanced Drug Delivery 
Reviews, 96, A Mathur, Z Ma, P Loskill, S Jeeawoody, KE Healy, “In vitro cardiac tissue 
models: Current status and future prospects,” 203-13, Copyright Elsevier B.V., 2016, e-
publication 2015. 
8.1 Introduction 
Drug discovery and development is a challenging road, and current methods to evaluate 
drug safety and efficacy are costly and inefficient. The average time between drug 
discovery and commercialization is 10-15 years, with median costs over $5 billion.231 
During preclinical and clinical development, cardiotoxicity remains a major cause of 
failure, with high rates of post-approval withdrawal of medicines.232 Furthermore, 
effective pre-clinical evaluation of drugs is essential for treating cardiovascular diseases 
affecting 17.5 million people worldwide and accounting for 31% of all global deaths in 
2012.233 However, major barriers inhibit current research in human drug screening: 
experimental in vivo interventions have unacceptably high risks for humans enrolled in 
clinical trials, and non-human animal models fail to fully recapitulate human physiology. 
For example, the resting heart rate in mice is tenfold higher than in humans, while the 
mouse QT interval is one-fourth of a typical human.234 Due to inter-species differences 
in ion channels, biological pathways, and pharmacokinetic properties, animal models do 
not faithfully predict human cardiotoxicity. Thus, human in vitro models of cardiac tissue 
that are predictive of human drug response would be a significant advancement for 
understanding, studying, and developing new drugs and strategies for treating cardiac 
diseases. 
 
An ideal in vitro cardiac model should accurately recapitulate the physiological or 
pathological conditions of the human heart, including three-dimensional (3D) anisotropic 
tissue structure, orientation of the extracellular matrix (ECM) network, vascularization, 
and circulation (Figure 8-1). Traditional 2D in vitro systems, although informative,24,25 
cannot accurately mimic the complex 3D conditions due to their inability to recapitulate 
the dynamics of the biological and mechanical properties of the in vivo 
microenvironment.26 The 3D models are characterized by establishment of adhesion 
complexes and tissue polarity, and by changes in cytoskeletal structure and cell volume 
that are significantly different from those found in cells cultured as monolayers. As a 
result, the translational results in 2D conditions are fundamentally different from those in 
3D.27 
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Figure 8-1. Overview of in vitro cardiac tissue model. 
New in vitro biomaterial-based cardiac tissue models have the potential to be used for fundamental 
research and translational applications. In particular, the areas of drug discovery, disease modeling, and 
precision medicine could benefit immensely from these emerging technologies. 
 
Human cardiovascular conditions in vitro can be achieved by developing engineered 
physiologically relevant 3D models, for instance by embedding cells in biomaterial 
matrices or microfabricated devices. For the purpose of in vitro modeling, biomaterials 
and microsystems not only serve as scaffolds for tissue formation, but also provide a 
highly-controllable microenvironment that incorporates key niche elements to enable 
precise regulation of cell fate and function.235–237 Specifically, the complex tissue and 
organ architecture of the heart is maintained by extensive 3D ECM networks, including 
fibrous proteins (e.g. collagen, elastin), adhesive glycoproteins (e.g. laminin, fibronectin) 
and proteoglycans.238 This ECM network, primarily in the form of perimysial collagen 
fibers, guides the anisotropic alignment of cardiomyocytes (CMs), mechanically 
confines the cells to connect each other, and contributes to stress-strain relationships 
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for the heart.239 Perimysial collagen fibers are comprised of bundles of twisted 
constituent fibrils (~40-50 nm in diameter), forming fibers that range from ~0.5-10 μm in 
diameter and ~100-200 μm in spacing, allowing several CMs to fit in-between.240 
Furthermore, the perimysial collagen fibers are arranged parallel with the long axis of 
cardiac muscle and therefore are one of the most significant components of the 
myocardium that contributes to its non-linear passive stiffness in the direction of the 
cardiac muscle fibers.241 The perimysial fibers interact with the CMs via various 
mechanotransduction pathways, and ultimately affect normal cardiac function. For 
example, the fibrillar collagen networks register sarcomere Z-line across the CM 
membrane, and thereby ensure equal stretching of contiguous cells and maintenance of 
the mechanical continuity between CMs.242 Given the key role of ECM in heart 
development and mechanical functions, development of an in vitro cardiac model 
requires biomaterials, methods, and systems to host the cells, control the cell-cell and 
cell-ECM interactions, and regulate the cell fate and functions. 
 
In this review, we focus on the important role of biomaterials and microsystems used for 
in vitro cardiac models. First, we briefly discuss the cell source used for cardiac tissue 
models, and emphasize human induced pluripotent stem cells (hiPSCs) as the most 
promising cell type for generation of human CMs. Then, we highlight key properties of 
different in vitro models, along with their advantages and limitations for applications, 
such as drug cardiotoxicity screening and human heart disease modeling. 
8.2 Cell Sources for Cardiac Tissue Models 
In the adult human heart, CMs account for roughly 75% of the heart volume, although 
they represent only about 33% of the total cell number.243,244 Therefore, identifying the 
optimal source of beating CMs is the first step in the development of a functioning in 
vitro cardiac model. Early cardiac tissue models depended on either immortalized 
human cell lines or primary cells isolated from multiple species. The immortalized 
human ventricular AC cell line was developed using fusion of primary ventricular CMs 
with a SC-40 transformed fibroblast cell line.245 Primary CMs isolated from embryonic 
chicken and neonatal mice and rats were the next most common cell sources for 
cardiac models,246–248 but increased awareness that animal cell-based models cannot 
truly recapitulate human physiology has led to the development of more sophisticated 
cells to build human-like tissue models. 
 
The advancement of stem cell biology has spearheaded the development of in vitro 
cardiac models that employ differentiated pluripotent stem and progenitor cells.249 
Originally, mesenchymal stem cells (MSCs) were widely used for cardiac tissue models 
to investigate their beneficial effects on damaged cardiac tissues, either through 
transdifferentiation or paracrine signaling.250–252 However, MSC's suboptimal capability 
for cardiac differentiation has limited the use of these cells in cardiac tissue models. 
 
For better recapitulation of human physiology and pathology, in vitro cardiac models 
now focus on human pluripotent stem cells, including human embryonic stem cells 
(hESCs) and hiPSCs253,254 (Table 8-1). Contracting CMs were first generated from 
hiPSCs through co-culture with END2 mouse endoderm-like cells, a methodology 
 98 
restricted by its reliance on animal cells.255 hiPSCs suspended in fetal bovine serum to 
make 3D aggregates of embryoid bodies was later used to generate CMs. Initial 
protocols produced contracting embryoid bodies with only 5-15% efficiency,256 and 
subsequent optimization with timely addition of growth factors (such as Activin A, BMP4 
and FGF) improved this efficiency to over 70%.257 Nowadays, monolayer differentiation, 
which involves simple, serum-free, and scalable protocols, has largely replaced 
embryoid body formation.258,259 Meanwhile, Activin A and BMP4 have been replaced by 
small molecules CHIR99021 and IWP4, which leads to greater reliability and higher 
efficiency.260 Recently, chemically defined method to replace Matrigel-coating with 
synthesized vitronectin peptide, and “B27” with l-ascorbic acid 2-phosphate and 
recombinant human albumin has been used to generate CMs at 85% purity, that can be 
enriched to 95% with sodium lactate.261 Based on these advances, City of Hope 
scientists funded by California Institute of Regenerative Medicine (CIRM) are currently 
developing a bag-based bioreactor system for scalable and controllable production of 
Good Manufacturing Practices (GMP)-level hESC-CMs, which will remove a key barrier 
to developing regenerative medicine products, especially for cardiac repair requiring for 
high doses of human CMs.262 
 
Table 8-1. Generation of cardiomyocytes from human pluripotent stem cells. 
Methods Media Yield Disadvantage 
Feeder layer Serum-based media 
Mouse END-2 cells255 
35% Low yield 
Serum media 
Requirement of mouse feeder cells 
Embryoid 
Bodies 
Serum-based media256 5-15% Low yield 
Serum media 
RPMI + B27 supplement 
ActivinA + BMP4257 
60% Medium yield 
Requirement of EB formation 
Batch variability of growth factors 
Chemical undefined “B27” 
Bioreactor suspension 
culture262 
RPMI + B27 supplement 
Small molecules 
90% Chemical undefined “B27” 
Monolayer RPMI + B27 supplement 
ActivinA + BMP4259 
35% Low yield 
Batch variability of growth factors 
Chemical undefined “B27” 
RPMI + B27 supplement 
Matrigel Sandwich 
ActivinA + BMP4258 
90% Batch variability of Matrigel and growth 
factors 
Chemical undefined “B27” 
RPMI + B27 supplement 
Small molecules260 
90% Chemical undefined “B27” 
RPMI + human albumin 
l-ascorbic acid 2-phosphate 
(AA 2-P) 
Small molecules261 
85%  
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Exciting advances in genome-editing methods by endonuclease (ZFN or TALEN) or 
palindromic repeat (CRISPR) are being introduced to engineer cardiac disease-
associated gene mutations into hiPSC lines with the same genetic background, which 
will be instrumental for generating libraries of disease-specific CMs for drug testing and 
disease modeling.263,264 To work effectively in the area of patient-specific cells and 
disease models, a high degree of collaboration and coordination amongst academic 
laboratories and industry is required. To this end, various institutions, like CIRM, 
Cellular Dynamics International (CDI), Coriell Institute for Medical Research, 
Axiogenesis, and Stanford University, are working cohesively to establish a bank of 
hiPSCs, which will ensure the development of standard operating procedures and 
practices in order to achieve efficiency, consistency, and high throughput.265,266 Making 
this hiPSC bank available to a broader base of researchers would strongly support a 
more thorough understanding of the nature of cardiovascular diseases, and the 
development of cures and stem cell therapies for said diseases. 
 
One key area of research that needs to be addressed prior to full-scale use of iPSCs for 
cardiac drug screening and development is the maturity of the CMs. During heart 
development, cardiac muscle cells undergo a complex series of structural changes that 
ultimately result in their adult phenotype.267 CM maturation in vivo is also regulated by 
diverse factors, including topographical, electrical, mechanical, biochemical, and cellular 
interaction cues. However, hiPSC-CMs in vitro retain a relatively immature phenotype 
and exhibit relatively small size, reduced electrical excitability, impaired excitation-
contraction coupling, and incomplete adrenergic sensitivity.268 This is one of the critical 
obstacles to the successful development of predictive drug and toxicology screens, as 
well as safe and efficient cardiac therapies. Currently, efforts focus on dissecting the 
external cues (e.g., chemical, physical, electrical), deciphering signaling pathways, and 
harnessing this information to accelerate the maturation process.269 Hereby, 
engineering methods will play a crucial role to stimulate the in vitro processing of 
hiPSC-CMs maturation by providing relevant environmental motifs, such as anisotropic 
morphology, external electrical stimulation, mechanical loading, and extracellular 
matrices. 
8.3 Cell Micropatterning for 2D Cardiomyocyte Alignment 
An optimal in vitro model would incorporate the aforementioned hiPSCs into an in vivo-
like tissue structure while providing researchers with precise control over cell types, 
ECM composition, cell-cell interactions, and microenvironment geometry. In early 
studies on the effect of CM anisotropic morphology, cardiac cells were aligned on a thin 
collagen surface coating that was spread using a cell scraper and polymerized while 
slowly being poured within a slightly tilted dish.270 Later, microabrasion was employed to 
create aligned CMs with anisotropic sarcomeric structure, by unidirectional abrading 
polyvinyl chloride (PVC) coverslips using lapping papers with different grit sizes.271 
 
More recently, microfabrication-based patterning techniques (Figure 8-2) have been 
used to establish in vitro culture models and investigate the fundamental physiological 
and pathological characteristics of CMs. Cell alignment can be controlled by surface 
topography272–276 by micromolding with microchannels fabricated from PDMS.277–279 
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Microcontact printing ECM proteins created cell-adhesive areas of various shapes on 
cell-repelling surfaces, using, for instance, laminin onto polyacrylamide thin films,280,281 
fibronectin onto alginate,282 laminin onto PDMS,283 or repelling areas on adhesive 
surfaces using chitosan and hyaluronic acid onto PDMS and glass.284,285 Significant 
observations in calcium handling, action potentials, and conductional velocities were 
more similar to adult mouse myocardium in aligned CMs as compared to those grown in 
randomly oriented cultures.286,287 Monolayer of aligned neonatal rat CMs created by 
microcontact-printing method was found to undergo fibrosis after activation of TGF-β 
signaling pathway and reduce electrical conduction due to the mechanical interactions 
between myofibroblasts and CMs.288 
 
Micropatterning hiPSC-derived CMs (hiPSC-CMs) by microcontact printing collagen 
onto polyacrylamide has been used to increase the maturity level of hiPSC-CMs with 
optimized culture media.289 A similar microcontact printing approach with laminin was 
used to generate hESC-CM microarrays for functional analysis and drug screening, 
assessing the effects of treatment with H2O2 on CM viability and contractility.290 
 
Micropatterning techniques also enable precise control over the shape and size of cell 
colonies and are regularly used to generate uniform embryoid bodies (EBs) for studies 
of embryogenesis and cardiomyogenesis. Contained in poly(ethylene glycol) (PEG) 
hydrogel microwells, mouse ESCs formed homogeneous EBs of different sizes. The 
size of the EBs modulated differential expression of WNT5a and WNT11, leading to 
higher CM differentiation in large EBs, compared to higher endothelial differentiation in 
small EBs.291 The size of 3D polyurethane microwells was also found to modulate cell-
cell contact and canonical Wnt/β-catenin signaling in human ESCs, resulting in higher 
CM differentiation in larger wells.292,293 A more extensive study of microwells in silicone 
rubber sheets fabricated via laser cutting revealed that cell patterning resulted in 
homogeneous expression of pluripotent markers in hiPSCs and improved yield and 
reproducibility of cardiac differentiation.294 Studies on the effects of patterning sizes on 
embryogenesis and cardiogenesis were also conducted by microcontact printing 
Matrigel to generate uniform EBs. Patterned EBs revealed that the ratio of Gata6 
(endoderm-associated marker) to Pax6 (neural-associated marker) expression 
increased with decreasing colony size. Larger EBs with endoderm-biased (high 
Gata6/Pax6) gene expression at early stages exhibited higher mesoderm and cardiac 
induction.295 This approach was further used for high-throughput analysis of cell fate 
determination and endogenous signaling pathway activation and differentiation bias.296 
 
Recently, researchers found that the geometric confinement from the micropatterned 
substrate was able to trigger self-organization of hESCs, which recapitulated spatial cell 
fate patterning during early embryonic development. In response to BMP4, colonies 
reproducibly differentiated to an outer trophectoderm-like ring, an inner ectodermal 
circle, and a ring of mesendoderm expressing primitive-streak markers in between.297 
Synergism of biochemical cues and geometric confinement on micropatterned hiPSCs 
can induce self-organizing lineage specification and creation of a 3D beating human 
cardiac microchamber, which resembles the developing primitive human heart. These in 
vitro cardiac microchambers were used to screen drugs likely to generate cardiac 
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malformations during development. For example, applying thalidomide during the 
cardiac differentiation not only reduced differentiation efficiency, but also significantly 
damaged the formation of cardiac microchambers with smaller size, lower contractility, 
and decreased beat rates compared to the control.298 
 
Although micropatterning methods can confine colony geometry, regulate cell 
morphology and functions, and support high-throughput analysis, these 2D culture 
platforms lack the full architecture and functional properties of 3D human tissues and 
organs, and thus are of limited use for cardiac research. These 2D results have been 
seen as the first step towards engineering cardiac models, which can be used as 
templates for 3D tissue structure. Ongoing 2D research would focus on single-cell 
micropatterning and analysis, which can provide insight on cellular machinery, 
characterize the heterogeneity of cell population, and enable high-throughput screening 
for single-cell response to different environmental factors. Compared to CM alignment 
for mimicking heart muscle tissue, single CM micropatterning is extensively involved in 
exploring myofibrillogenesis and its relationship with extracellular factors. By 
microcontact printing ECM protein on the coverslip to shape single CM into the 
predesigned patterns, researchers found that not only cell shape was defined but also 
the cytoskeleton was under reorganization into the predicted architecture.299 It was 
noticed that the spatial configuration of ECM played a key role in regulating the other 
three factors: cell shape,246 sarcomere orientation,300 and nuclear morphology.301 
 
 
Figure 8-2. Micropatterned 2D cardiac models. 
Topographical alignment of CMs with (A) Microfabricated nanostructured surface;276 (B) Prestressed 
thermoplastic shrink film with tunable multi-scaled wrinkles;275 and (C) Microcontact-printed patterns of 
pattern CMs into (D) Aligned stripes to mimic adult cardiac tissue structure281 and (E) Circular colonies for 
high-throughput screening.290 (F) Using oxygen plasma to etch PEG surfaces under a PDMS stencil 
protection allows micropatterning hiPSCs and determining stem cell fate during cardiac differentiation.298 
8.4 Biomaterials Used to Generate 3D Cardiac Models 
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Engineering a 3D cardiac tissue with physiologically relevant microenvironment and cell 
morphology presents a significant challenge for in vitro cardiac modeling. Biomaterials 
have played a major role in creating 3D tissue models, since they not only support cell 
attachment and alignment, but also transmit load, provide physiologically relevant 
stiffness, and ideally can be degraded and replaced over time by cell-secreted ECM 
proteins. Several representative natural and synthetic biomaterials-based engineered 
heart tissue (EHT) systems are shown in Figure 8-3. We have classified them as either 
hydrogel based or fibrous cardiac models, each is discussed in greater detail below. 
8.4.1 Natural Hydrogel-Based Cardiac Models 
Hydrogels consisting of two naturally occurring proteins, collagen and fibrin, have been 
widely used to generate EHT. Matrigel was often used as a supplemental material to 
increase cell viability and attachment due to its various growth factors and matrix 
components. The first EHT consisted of a 3D scaffold of collagen I with embryonic chick 
CMs.302 Later, they were further developed into ring structures with neonatal rat CMs,303 
which could be stacked and implanted for successful improvement of the function of 
infarcted rat heart.304 Currently, EHTs are primarily designed in a two-post configuration, 
allowing for characterization of contraction forces. Parallel EHT arrays consisting of a 
mixture of fibrinogen, Matrigel, thrombin, and neonatal rat CMs305 or hESC-CMs306, on a 
silicone post rack casted from Teflon molds, were used for preliminary drug screening. 
Proarrhythmic compounds chromanol and erythromycin was shown to affect EHT 
repolarization inhibition, and the cardiotoxic drug doxorubicin affected EHT force 
generation in a time- and dose-dependent manner.305 Isoprenaline and carbachol were 
found to affect the spontaneous contractile rate. Repolarization was inhibited by E-4031 
(3 nM IC50), procainamide (100 μM IC50), sertindole (10 nM IC50), quinidine (1000 nM 
IC50), and cisapride (30 nM IC50).306 
 
EHTs of collagen I and fibrinogen were also generated on microfabricated devices with 
micron-scale standing posts, and researchers found that the matrix composition 
affected the dynamic and static contractility of the cardiac tissues.307 Using these micro-
EHTs, researchers were able to model dilated cardiomyopathy caused by titin mutation, 
and demonstrated that 3D titin-mutant EHTs exhibited lower contraction forces 
compared to WT EHTs, such difference in contractile function was not possible to be 
detected by single-cell assays.308 This configuration was further employed to generate 
EHTs based on a mixture of collagen I, Matrigel, and hESC-CMs for preclinical drug 
screening and gene transfer. The 610 nM IC50 value generated for verapamil in these 
EHTs surpassed the 160 nM IC50 for traditional iPSC cells in 2D culture, indicating 
better recapitulation of human physiology compared to a 2D culture system. However, 
an insufficient response to isoproterenol suggested cardiac tissue immaturity.309 A multi-
post configuration with collagen I and Matrigel was used to design and formulate 
cardiac microtissues using hiPSC-CMs, and researchers found that tissue structure and 
non-CM population played important roles in tissue integrity and maturation.310 This 
multi-post platform was further applied to establish a tachycardiac model of 
arrhythmogenesis for in vitro patient-specific disease modeling. 
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The 3D cardiac tissue structure was also created using fibrin-based hydrogel matrix 
generated by soft lithography technique with controllable size and architecture; these 
EHTs demonstrated increased spontaneous beat rate and twitch amplitude upon 
exposure to isoproterenol, with an EC50 of 95 nM falling within the reported 30-160 nM 
range for adult human ventricular tissue. CMs differentiated from ESCs and from 
cardiac progenitor cells (CPCs) were seeded into this engineered hydrogel to yield 
highly aligned CMs and robust intercellular coupling with rapid action potential 
conduction (22-25 cm/s) and significant contractile forces (up to 2 mN).311,312 
 
In all post-based in vitro cardiac microtissues, various natural biomaterials (e.g. collagen 
I, fibrin, Matrigel) served as an initial scaffold and ECM to support cell attachment, 
whereas the posts stabilized the developing tissue as the cells condensed and 
remodeled the scaffold, which had the effect of 3D alignment of the encapsulated CMs. 
The flexible PDMS posts additionally served as the sensor enabling the measurement 
of contraction force generated by the beating CMs. These contractile forces are a key 
output of EHTs and are coupled with CM electrophysiology and hypertrophy within 
EHTs; however, these forces are highly dependent on the biomaterial composition, 
making it difficult to compare drug responses among different EHTs developed by 
different research groups. A high degree of natural material variability is of major 
concern in efforts to establish standardized assays for drug screening with the 
requirements of consistency, reproducibility, and high-throughput capability. Such 
material variability will affect tissue formation and cellular responses, which will 
eventually lead to the variation of functional readout, such as contractile force measured 
by the posts. 
8.4.2 Synthetic Fibrous Cardiac Models 
Synthetic biomaterials provide an attractive alternative to natural materials, as 
researchers can control the entire synthesis process as well as the materials' 
mechanical properties, topography, and structure. A number of synthetic polymers have 
been used to create 3D cardiac scaffolds for either in vitro models or implantable 
patches to repair and regenerate the infarcted tissue. Key requirements for synthetic 
scaffolds are that they recapitulate the native 3D hierarchical fibrillar structure, possess 
biomimetic surface properties, and demonstrate mechanical integrity. The most 
frequently used synthetic polymers for cardiac tissue engineering are polyurethane, poly 
ε-caprolactone (PCL), polylactic acid (PLA), polyglycolic acid (PGA), and their 
copolymers. One example of synthetic material-based cardiac constructs were 
generated with neonatal rat CMs and poly(glycerol sebacate) (PGS) and maintained in 
a bioreactor with simultaneous culture medium perfusion and electrical conditioning, 
which led to enhanced organization and functionality of engineered cardiac tissue.313 
 
Cell alignment can be obtained with electrospun nanofiber-based scaffolds, which 
provide flexible matrices and topographic properties offering support and guidance for 
the CMs. CMs organized into anisotropic cardiac tissue on aligned PCL/gelatin 
composite electrospun nanofibrous scaffolds to structurally mimic the oriented ECM in 
myocardium.314 The orientation and density of electrospun polymethylglutarimide 
(PMGI) nanofibers defined the overall architecture of the cardiac tissue, which was 
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optimized for best alignment with 30-50 fibers/mm and an average distance between 
fibers of under 30 μm.315 An aligned fibrous mesh of electrospun polyester blend, 
poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV), P(L-D,L)LA, and poly(glycerol 
sebacate) (PGS) was shown to enhance cardiomyogenic differentiation of human 
umbilical cord mesenchymal stem cells.316 Similarly, rotary jet spinning was used to 
fabricate highly aligned nanofiber constructs from a blend of collagen, gelatin, and PCL 
polymer, which promoted better sarcomere formation in CMs.317 
 
Electrospun 3D scaffolds with aligned nanofibers using synthetic polymers successfully 
mimic the structure and orientation of native ECM in the myocardium and help CMs self-
organize with anisotropic structure. However, the micron scale porosity of these 
scaffolds limits cell infiltration into the matrix and thereby the creation of a 3D tissue. As 
such, the scaffolds are 3D in nature, but the tissue is really a 2D structure similar to 
those created on micropatterned surfaces. To address this limitation, a highly defined 
scaffold structure was fabricated by two-photon initiated polymerization (TPIP) with 
unprecedented control over a wide range of matrix features. A 3D human cardiac 
disease model was created by seeding hiPSC-CMs, with long QT syndrome type 3 
(LQT3), on the TPIP-fabricated synthetic filamentous scaffolds. Tailoring the mechanical 
properties of the scaffolds modulated the contractility of residing hiPSC-CMs and, more 
importantly, recapitulated the abnormal contractility of long QT syndrome. Treatment 
with caffeine increased the spontaneous contractile rate and maximum contractile 
velocity and high doses of caffeine and nifedipine both caused cessation of beating. In 
contrast, treatment with E-4031 indicated irregular beating patterns, and propranolol 
induced significant uncoordinated beating, suggestive of cardiac arrhythmias, in a dose-
dependent manner.318 
 
A collagen-based cardiac tissue model, termed “biowire,” combined architectural and 
electrical cues to generate a microenvironment conducive to maturation of hiPSC-
derived cardiac tissues.319 The hiPSC-CMs were seeded with collagen type I into a 
microfabricated well and subjected to electrical stimulation with a progressive increase 
in frequency. Biowires submitted to electrical stimulation had markedly increased 
myofibril ultrastructural organization, elevated conduction velocity, and improved both 
electrophysiological and Ca2+ handling properties compared to non-stimulated controls. 
These changes suggested enhanced CM maturation that depended on the stimulation 
rate. The biowire maturation represented an intermediate phenotype as CMs undergo 
maturation from the embryonic state, as evidenced by low membrane conductance. The 
use of electrical stimulation in conjunction with stretch as a mimic of cardiac load, 
concurrently or sequentially, might be required to induce terminal differentiation and 
maturation in hiPSC-CMs.320,321 
 
These findings collectively suggest that 3D tissue engineered models with defined 
cellular microenvironments hold great promise for high-content drug screening and 
cardiotoxicity testing. The integration of biomaterials with existing iPSC-based disease 
models could better recapitulate disease pathology and may represent superior 
scalability and flexibility for creating large numbers of personalized models to meet 
diverse and urgent patient needs. 
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Figure 8-3. Biomaterial-based 3D cardiac models. 
(A) Engineered heart mini-tissues (millimeter scale) were made from fibrin and hiPSCs for implantation304 
and drug-screening purpose.305 (B) Engineered heart micro-tissues (micron scale) made from collagen 
were used to model the dilated cardiomyopathy caused by titin mutation.308 (C) Fibrin-based cardiac 
tissue patch was generated by soft lithography with controllable size and architecture and its drug 
response to isoproterenol.311 (D) A biowires platform combining architectural and electrical cues 
generated a microenvironment conducive to the maturation of hiPSC-derived cardiac tissues.321 (E) 
Electrospun nanofiber scaffolds were made for creating the continuous anisotropic cardiac tissue.315 (F) 
Aligned nanofiber scaffolds made by rotary jet spinning promoted better sarcomere formation in CMs.317 
(G) High-defined filamentous scaffolds made by two-photon initiated polymerization were used to create 
an aligned hiPSC-CMs-based cardiac model for drug screening.318 
8.5 Microdevices for 3D Cardiac Models 
Moving away from scaffold-based cardiac models, highly miniaturized and integrated 
microphysiological systems are currently being developed as “heart-on-a-chip” 
technology to provide more controlled 3D microenvironments, with enhanced multiple 
functionalities and increased throughput. Such microphysiological systems (Figure 8-4) 
combined with hiPSC technology are expected to not only better predict on toxicity and 
efficacy of potential drugs in human physiologically relevant conditions, but also provide 
a more in-depth understanding of human cardiac disease in complex and 
heterogeneous microenvironments. 
 
An engineered anisotropic ventricular myocardium was first developed by 
micropatterning neonatal rat CMs on poly(N-isopropylacrylamide) (PIPAAm)/PDMS-
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based thin elastomeric film, which can simultaneously measure the contractile function, 
quantify the electrical propagation, and evaluate cytoskeletal architecture in cardiac 
tissues during pharmacological interventions. A dose-dependent increase in 
spontaneous beat rate and stress was reported in response to epinephrine.322 This 
microsystem was further incorporated with fluidic control for drug washout, a heating 
element for temperature control, and embedded electrodes for electrical field 
stimulation.323 This system was not only used to characterize the cardiac tissue derived 
from various cell types (primary neonatal mouse CMs, mouse iPSC-CMs, and human 
iPSC-CMs),324 but also to model maladaptive cardiac hypertrophy325 and patient-
specific mitochondrial cardiomyopathy, specifically, the Barth Syndrome (BTHS) – a 
mitochondrial disorder caused by mutation of the gene encoding tafazzin (TAZ).326 To 
study the pathophysiology underlying BTHS, the group generated hiPSC-CMs from two 
patients with BTHS and discovered metabolic, structural and functional abnormalities 
associated with TAZ mutation. This elegant study provided new insights into the 
pathogenesis of Barth syndrome, and pointed to a new treatment strategy for BTHS. 
 
For improved modeling specific types of cardiac disease, unique platforms should be 
designed to mimic the pathological microenvironment occurring during the disease 
progression. A paper-based culture system was developed with multiple layers of 
paper-containing cells, suspended in hydrogels, stacked to form a layered 3D model of 
a cardiac tissue. Mass transport of oxygen and glucose into this 3D system was 
modulated to induce an ischemic environment in the bottom layers of the stack. This in 
vitro cardiac model mechanistically studied cellular motility and viability, and 
recapitulated the cellular interactions and gradients of molecules in the heart under 
ischemia. However, the cardiospheres in the stacked papers lacked the aligned 
structure to mimic the in vivo tissue structure. Moreover, this system currently makes it 
difficult to determine the concentration of small molecules (e.g., oxygen, glucose, or 
cytokines) in situ and to measure the contractility of CMs without complex optics.327 
 
To allow accurate prediction of drug cardiotoxicity, a microfluidic-based 
microphysiological system was designed to recapitulate a minimal organoid of the 
human myocardium.32 Pharmacological studies on this system with verapamil (950 nM 
IC50), isoproterenol (315 nM EC50), metoprolol (244 μM IC50), and E-4031 (392 nM IC50) 
predicted a higher safety margin and had better concordance with tissue-scale values 
and clinical observations, compared to those in cellular-scale studies and large-scale 
animals. The human cardiac microphysiological system was proposed to complement 
animal models, and in the future may have the potential to replace animal studies, 
which often are expensive, unethical, and unable to accurately predict the drug's actual 
effect. 
 
Since the discovery of Moore's law, the semiconductor industry has come a long way, 
and the development of new microfabrication techniques has equipped the 
bioengineering community with tools, which can be employed for basic and translational 
applications. Microengineered in vitro models with multiple readouts have a great 
potential to better mimic the in vivo physiology and provide a deeper understanding of 
the physiological events that characterize cardiac development and function. These 
 107 
systems provide fine control over fluid flow, creating microcirculation mimicking the in 
vivo transport; massive parallelization for high content readouts; miniaturization of large 
systems for convenient operation and reduction of reagent use, leading to lower 
operational costs; and unprecedented control of system architecture and dimensions at 
the biological scale (nm to μm). We envision the use of microtechnologies coupled with 
hiPSC biology to revolutionize the areas of drug screening, disease modeling, and 
personalized medicine. 
 
 
Figure 8-4. Microdevice-based 3D cardiac models. 
(A) PIPAAm-based “heart-on-chip” microsystem323 can measure the deformation of the elastomeric thin 
film to characterize the contractility of cardiac tissue derived from various cell types and assess the drug 
response to isoproterenol.324 (B) A stacked-paper culture system containing CMs was used to mimic the 
pathological microenvironment occurring during cardiac ischemia.327 (C) A microfluidic-based 
microphysiological system was designed to recapitulate a minimal organoid of the human myocardium 
with highly aligned tissue architecture and anisotropic beating behavior, allowing for accurate prediction of 
drug cardiotoxicity.32 
8.6 Perspective and Conclusions 
The heart is a powerful, complex organ that has intrigued both artists and scientists for 
millennia. In vitro cardiac tissue models present great opportunities for regenerative 
medicine, drug screening, and disease modeling. The opportunities, however, coincide 
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with enormous challenges due to the complexity of cardiac structure and function. A 
standardized, reproducible, and scalable process for differentiating hiPSCs to CMs is 
required for consistent cell quality. Recent developments in the cardiogenic 
differentiation open the possibility of obtaining such human CMs in the laboratory.260,261 
 
The immaturity of hiPSC-CMs complicates the cells' adoption as a reliable readout for 
translational applications. Such immature embryonic or neonatal-like CMs cannot 
compare morphologically with large and stiff ventricular CMs in the adult human 
heart.328 Thus, cardiac tissues constructed from hiPSC-CMs have significantly lower 
field potentials and contraction forces than adult ventricular tissue, so at this point 
cannot be considered an exact in vitro model of mature myocardium. It has been 
suggested that tissue-engineering methods would necessitate the maturation of hiPSC-
CMs in a physiologically mimicked microenvironment.289,312,319 This suggests that 
genetic and environmental factors interact and lead to CM maturation, though the 
mechanism and process is not fully understood. 
 
We summarize the current in vitro cardiac tissue models, along with their advantages 
and limitations for applications, such as drug cardiotoxicity screening and human heart 
disease modeling (Table 8-2). An ideal in vitro cardiac tissue model should be 
physiologically relevant with multiple biological, mechanical, and electrical readouts, 
ensuring different functional endpoints for a particular application. Appropriate 
biomaterials used for the cardiac tissue models need to be chosen carefully according 
to the specific applications. For example, microsystems with conventional PDMS as a 
substrate result in drug stability problems and unpredictable device performance, due to 
its absorption and retention of highly hydrophobic compounds.329,330 Acceptance of 
these models will require automation, robustness, and easy integration into the workflow 
at pharmaceutical companies. Specifically for drug development and testing, the 
microfluidic-based system with standardized fabrication and process holds great 
promise on high-content screening with electrical and mechanical measurement and 
integration with multiple organs to achieve “human on a chip.” 
 
A more futuristic application is envisioned in the area of precision medicine, an 
emerging approach for disease treatment and prevention that takes into account 
individual variability in genes, environment, and lifestyle for each person.331,332 The 
promise of precision medicine for cancer therapeutics is already being realized with the 
recent introduction of several targeted therapies, some with companion diagnostic tests 
that identify patients most likely to benefit from treatment.333 Moving forward, we hope to 
see physiologically functional in vitro cardiac models of individual- and disease-specific 
hiPSCs on chips, which can be termed as “patient on a chip.” This approach will help to 
diagnose and design better treatment strategy for individual patients. Success, 
however, will depend on how effectively and how efficiently engineering and biology can 
be integrated to create such systems. 
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Table 8-2. Analysis of in vitro cardiac tissue models and the corresponding mechanical, 
electrophysiological, and biological outcomes. 
Characteristics Outcomes 
Platform Cell Type Materials Coating Mechanical Beat 
rate 
(bpm) 
Biological 
Micro-
patterning 
Surface 
topography 
 
nrCM PVC cover slips Fibronectin 
271 
 ☆ + 
nrCM PDMS Laminin272  ☆ ++ 
nrCM Polyurethane, 
polystyrene 
273  15-50 + 
nmCM PDMS Fibronectin, 
laminin, 
collagen I 274 
 ☆ ++ 
Microcontact 
printing 
nrCM Polyacrylamide Laminin, 
Matrigel280 
Young’s modulus 5-
35 kPa 
☆ ++ 
nrCM Alginate Fibronectin 
282 
Young’s modulus 57 
kPa 
60-240 
(pacing) 
++ 
nrCM PDMS, Stretch 
device 
Collagen283  ☆ + 
nrCM Polystyrene Chitosan284  ☆ ++ 
nrCM PDMS Hyaluronic 
acid, 
fibronectin285 
 60-100 + 
nmCM Glass, 
polyresist 
286  ☆ ++ 
hESC-CM, 
hiPSC-CM 
Polyacrylamide Gelatin289 Contractile stress 
0.2-0.5 mN/mm2 
60-180 
(pacing) 
++ 
hESC-CM Polyacrylamide Laminin290 Elastic modulus 15-
35 kPa 
50 ++ 
Micro-
fabrication 
Microposts hESC-CM, 
nrCM 
Silicone post 
racks 
Fibrin, 
Matrigel306 
Contractile force 
100-300 µN 
300 ++ 
nrCM, 
hiPSC-CM 
PDMS Collagen, 
fibrinogen 
307,308 
Contractile force 2-6 
µN 
33-60 ++ 
hESC-CM PDMS posts Collagen, 
Matrigel309 
Contractile force 0.3 
mN 
70 ++ 
hESC-CM, 
nrCM 
PDMS posts Collagen, 
Matrigel310 
 ☆ ++ 
hESC-CM PDMS posts Fibrin311 Contractile force 2 
mN 
☆ ++ 
hESC-CM PDMS posts, 
patch 
Fibrin, 
Matrigel312 
Contractile force 3 
mN 
60-180 
(pacing) 
++ 
Perfusion 
bioreactor 
nrCM Poly(glycerol 
sebacate), 
channels 
Laminin313 Elastic modulus 
34.55 ± 1.26 kPa, 
Pore size 
75–150 μm 
180 
(pacing) 
++ 
Biowires hESC-CM 
 
PDMS Collagen 
319,320 
Conduction velocity 
11–16 cm/s, 
Young's modulus1–6 
kPa 
60–360 
(pacing) 
++ 
Two-photon 
polymerization 
hiPSC-CM, 
Long QT3 
syndrome 
Filamentous 
matrix 
Fibronectin 
318 
Maximal contraction 
velocity 
15–25 μm/s 
90 ++ 
MPS systems nrCM, 
hESC-CM, 
hiPSC-CM, 
Barth 
syndrome 
 
PDMS, 
PIPAAm 
Fibronectin 
Gelatin 
322,323,325,326 
Young's modulus 
1.52 MPa, 
Systolic stress 
15–20 kPa, 
Diastolic stress 
8.0 kPa 
120 
(pacing) 
++ 
hiPSC-CM 
 
PDMS Fibronectin 32 Average 
contraction velocity 
3 μm/s 
55-80 ++ 
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Abbreviations in Table 2 
 
CM Cardiomyocytes 
nrCM Neonatal rat cardiomyocytes 
nmCM Neonatal mouse cardiomyocytes 
hESC-CM Human embryonic stem cell-derived CMs 
hiPSC-CM Human induced pluripotent stem cell-derived CMs 
Beat rate Beat per minute (BPM) 
☆ Spontaneous contractions reported without beat rate 
+ Indications of CMs are limited to: cell alignment and elongation, morphological 
assessment, genetic assessment 
++ Indications of CMs include: sarcomeres, functional gap junctions, appropriate 
responses to drug treatments, as well as indications from ‘+’ 
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Chapter 9: Conclusions and Future Directions 
In this dissertation, we sought to develop high-selectivity, high-throughput proteomic 
analytical tools at single- to low-cell resolution. We characterized the contribution of 
ampholytes on IEF separation resolution, and leveraged IEF separation theory to 
optimize assay performance. We investigated the performance of highly-porous 
polyacrylamide hydrogel matrices in the ultrathin IEF assay with subsequent 
immunoblot. To further understand analytical sensitivity limitations in ultrathin 
electrophoretic cytometry assays, we modeled protein diffusion in multi-material 
substrates. Finally, we demonstrated a proof-of-concept variant of the single cell IEF 
assay with increased throughout for interrogation of proteomic expression from arrays of 
single cells. The expansion of these proteomic assays towards high sensitivity, high 
selectivity, and high throughput platforms interrogating single cell function expands the 
biological toolkit with which one can quantify and understand the biological functions of 
cells and tissues at the micro scale. Building databases of proteomic function and 
dysfunction, in line with the Human Protein Atlas,334 provides a roadmap for the design 
of therapeutic interventions. 
 
In addition, we sought to develop in vitro microscale tissue models better recapitulating 
human physiology for drug screening. We developed and characterized the adipose in 
vitro model “WAT-on-a-chip” for drug screening applications. We also reviewed the in 
vitro cardiac model space. It is particularly intriguing to envision the further development 
of in vitro organ models, with complex mechanical and biological microarchitectures 
characteristic of in vivo organs. Recreating the in vivo niche for multiple cell types acting 
in synergy would provide valuable information on organ function at the micro- to 
mesoscale as well as modeling tissue response to drugs.32,189 Furthermore, linking228 
these organ models into a facsimile of the human body, with multiple quantitative, non-
terminal assessment modalities integrated throughout the linked model system, 
provides a more wholistic view of human drug response not currently available in the in 
vitro setting. 
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Appendices 
Appendix 1: Protocol: fabrication of porogen separation gels 
Materials: 
For all materials except BPMA, I used a single bottle for this research work as much as 
possible. Lot numbers are noted in lab notebooks. For BPMA, I used the same lot 
throughout this research, prepared by various lab members in DMSO to create 100 mM 
stock vials. 
 
- 30% 3.3%C acrylamide stock solution:  
o Personal stocks at 4ºC, brown plastic bottles, dated 2016 and 2019 
- 20%T 8%C acrylamide stock solution:  
o Personal stock at 4ºC, labeled glass bottle with orange top + foil. 
Previously made from 40% acrylamide solution + bisacrylamide powder. 
- 5% PEG stock solution:  
o Personal stock at RT, labeled glass bottle with orange top. Vortex 
extensively and let bubbles settle out. 
- TrisHCl stock solution:  
o Shared stock bottle. No dilution. 
- APS:  
o Shared bottle in flammables cabinet, dated 2016. Weigh out into 
Eppendorf tube, and make a 10% solution in MilliQ water. 
- TEMED:  
o Shared bottle on shared materials shelf in the 4ºC fridge (with the TBS-T, 
antibodies, and shared IEF materials), dated 2016. Use 100% solution (no 
dilution). 
- VA-086: 
o Shared bottle, covered with aluminum foil, at 4ºC. Make 2% stock solution. 
- LAP (from startup company Allevi, formerly named Biobots): 
o Shared bottle, covered with aluminum foil, in clear box, at -20ºC (in door). 
Make 1% stock solution. 
- BPMA:  
o Most recent aliquot from shared stock at -20ºC. Make sure the vial has not 
been previously thawed. No dilution. Thaw at RT under foil, and triturate. 
Precursor solutions with APS/TEMED 
6%T 3.3%C APS/TEMED PA gel -- negative control 
50 100 160 30%T 3.3%C 29:1 acrylamide solution  
12.5 25 40 TrisHCl pH 8.8 (1.5 mM) 
12.5 25 40 BPMA 
172.8 345.6 553 MilliQ water 
0.2 0.4 0.64 TEMED 100% 
2 4 6.4 APS 10% in MilliQ water 
        
250 500 800 total 
 130 
Note: different acrylamide solution for all gels below! Use 20% 8%C stock solution. 
PEG 0% 6%T 8%C APS/TEMED PA gel + 0.0% PEG 
Total Volume [µL]  250 800 1000 
Reagent Stock conc. Final Conc. Vol. [µL] Vol. [µL] Vol. [µL] 
Acrylamide soln  [%T] 20 6 75 240 300 
PEG [%} 5 0 0 0 0 
Tris-HCl pH 8.8 [mM] 1.5 0.075 12.5 40 50 
BPMA [mM] 100 5 12.5 40 50 
APS [%] 10 0.08 2 6.4 8 
TEMED [%] 100 0.08 0.2 0.64 0.8 
Water (MilliQ) -   147.8 472.96 591.2 
      
PEG 0.5% 6%T 8%C APS/TEMED PA gel + 0.5% PEG 
Total Volume [µL]  250 800 1000 
Reagent Stock conc. Final Conc. Vol. [µL] Vol. [µL] Vol. [µL] 
Acrylamide soln  [%T] 20 6 75 240 300 
PEG [%} 5 0.5 25 80 100 
Tris-HCl pH 8.8 [mM] 1.5 0.075 12.5 40 50 
BPMA [mM] 100 5 12.5 40 50 
APS [%] 10 0.08 2 6.4 8 
TEMED [%] 100 0.08 0.2 0.64 0.8 
Water -   122.8 392.96 491.2 
      
PEG 1.0% 6%T 8%C APS/TEMED PA gel + 1.0% PEG 
Total Volume [µL]  250 800 1000 
Reagent Stock conc. Final Conc. Vol. [µL] Vol. [µL] Vol. [µL] 
Acrylamide soln  [%T] 20 6 75 240 300 
PEG [%} 5 1 50 160 200 
Tris-HCl pH 8.8 [mM] 1.5 0.075 12.5 40 50 
BPMA [mM] 100 5 12.5 40 50 
APS [%] 10 0.08 2 6.4 8 
TEMED [%] 100 0.08 0.2 0.64 0.8 
Water -   97.8 312.96 391.2 
      
PEG 1.5% 6%T 8%C APS/TEMED PA gel + 1.5% PEG 
Total Volume [µL]  250 800 1000 
Reagent Stock conc. Final Conc. Vol. [µL] Vol. [µL] Vol. [µL] 
Acrylamide soln  [%T] 20 6 75 240 300 
PEG [%} 5 1.5 75 240 300 
Tris-HCl pH 8.8 [mM] 1.5 0.075 12.5 40 50 
BPMA [mM] 100 5 12.5 40 50 
APS [%] 10 0.08 2 6.4 8 
TEMED [%] 100 0.08 0.2 0.64 0.8 
Water -   72.8 232.96 291.2 
      
PEG 2.0% 6%T 8%C APS/TEMED PA gel + 2.0% PEG 
Total Volume [µL]  250 800 1000 
Reagent Stock conc. Final Conc. Vol. [µL] Vol. [µL] Vol. [µL] 
Acrylamide soln  [%T] 20 6 75 240 300 
PEG [%} 5 2 100 320 400 
Tris-HCl pH 8.8 [mM] 1.5 0.075 12.5 40 50 
BPMA [mM] 100 5 12.5 40 50 
APS [%] 10 0.08 2 6.4 8 
TEMED [%] 100 0.08 0.2 0.64 0.8 
Water -   47.8 152.96 191.2 
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Precursor solutions with VA-086 
PEG 0% 6%T 8%C VA-086 PA gel + 0.0% PEG 
Total Volume [µL]  250 800 1000 
Reagent Stock conc. Final Conc. Vol. [µL] Vol. [µL] Vol. [µL] 
Acrylamide soln  [%T] 20 6 75 240 300 
PEG [%} 5 0 0 0 0 
Tris-HCl pH 8.8 [mM] 1.5 0.075 12.5 40 50 
BPMA [mM] 100 5 12.5 40 50 
VA-086 [%] 2 0.2 25 80 100 
Water (MilliQ) -   125 400 500 
      
PEG 0.5% 6%T 8%C VA-086 PA gel + 0.5% PEG 
Total Volume [µL]  250 800 1000 
Reagent Stock conc. Final Conc. Vol. [µL] Vol. [µL] Vol. [µL] 
Acrylamide soln  [%T] 20 6 75 240 300 
PEG [%} 5 0.5 25 80 100 
Tris-HCl pH 8.8 [mM] 1.5 0.075 12.5 40 50 
BPMA [mM] 100 5 12.5 40 50 
VA-086 [%] 2 0.2 25 80 100 
Water (MilliQ) -   100 320 400 
      
PEG 1.0% 6%T 8%C VA-086 PA gel + 1.0% PEG 
Total Volume [µL]  250 800 1000 
Reagent Stock conc. Final Conc. Vol. [µL] Vol. [µL] Vol. [µL] 
Acrylamide soln  [%T] 20 6 75 240 300 
PEG [%} 5 1 50 160 200 
Tris-HCl pH 8.8 [mM] 1.5 0.075 12.5 40 50 
BPMA [mM] 100 5 12.5 40 50 
VA-086 [%] 2 0.2 25 80 100 
Water (MilliQ) -   75 240 300 
      
PEG 1.5% 6%T 8%C VA-086 PA gel + 1.5% PEG 
Total Volume [µL]  250 800 1000 
Reagent Stock conc. Final Conc. Vol. [µL] Vol. [µL] Vol. [µL] 
Acrylamide soln  [%T] 20 6 75 240 300 
PEG [%} 5 1.5 75 240 300 
Tris-HCl pH 8.8 [mM] 1.5 0.075 12.5 40 50 
BPMA [mM] 100 5 12.5 40 50 
VA-086 [%] 2 0.2 25 80 100 
Water (MilliQ) -   50 160 200 
      
PEG 2.0% 6%T 8%C VA-086 PA gel + 2.0% PEG 
Total Volume [µL]  250 800 1000 
Reagent Stock conc. Final Conc. Vol. [µL] Vol. [µL] Vol. [µL] 
Acrylamide soln  [%T] 20 6 75 240 300 
PEG [%} 5 2 100 320 400 
Tris-HCl pH 8.8 [mM] 1.5 0.075 12.5 40 50 
BPMA [mM] 100 5 12.5 40 50 
VA-086 [%] 2 0.2 25 80 100 
Water (MilliQ) -   25 80 100 
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Precursor solutions with LAP 
PEG 0% 6%T 8%C LAP PA gel + 0.0% PEG 
Total Volume [µL]  250 800 1000 
Reagent Stock conc. Final Conc. Vol. [µL] Vol. [µL] Vol. [µL] 
Acrylamide soln  [%T] 20 6 75 240 300 
PEG [%} 5 0 0 0 0 
Tris-HCl pH 8.8 [mM] 1.5 0.075 12.5 40 50 
BPMA [mM] 100 5 12.5 40 50 
LAP [%] 1 0.2 50 160 200 
Water (MilliQ) -   100 320 400 
      
PEG 0.5% 6%T 8%C LAP PA gel + 0.5% PEG 
Total Volume [µL]  250 800 1000 
Reagent Stock conc. Final Conc. Vol. [µL] Vol. [µL] Vol. [µL] 
Acrylamide soln  [%T] 20 6 75 240 300 
PEG [%} 5 0.5 25 80 100 
Tris-HCl pH 8.8 [mM] 1.5 0.075 12.5 40 50 
BPMA [mM] 100 5 12.5 40 50 
LAP [%] 1 0.2 50 160 200 
Water (MilliQ) -   75 240 300 
      
PEG 1.0% 6%T 8%C LAP PA gel + 1.0% PEG 
Total Volume [µL]  250 800 1000 
Reagent Stock conc. Final Conc. Vol. [µL] Vol. [µL] Vol. [µL] 
Acrylamide soln  [%T] 20 6 75 240 300 
PEG [%} 5 1 50 160 200 
Tris-HCl pH 8.8 [mM] 1.5 0.075 12.5 40 50 
BPMA [mM] 100 5 12.5 40 50 
LAP [%] 1 0.2 50 160 200 
Water (MilliQ) -   50 160 200 
      
PEG 1.5% 6%T 8%C LAP PA gel + 1.5% PEG 
Total Volume [µL]  250 800 1000 
Reagent Stock conc. Final Conc. Vol. [µL] Vol. [µL] Vol. [µL] 
Acrylamide soln  [%T] 20 6 75 240 300 
PEG [%} 5 1.5 75 240 300 
Tris-HCl pH 8.8 [mM] 1.5 0.075 12.5 40 50 
BPMA [mM] 100 5 12.5 40 50 
LAP [%] 1 0.2 50 160 200 
Water (MilliQ) -   25 80 100 
      
PEG 2.0% 6%T 8%C LAP PA gel + 2.0% PEG 
Total Volume [µL]  250 800 1000 
Reagent Stock conc. Final Conc. Vol. [µL] Vol. [µL] Vol. [µL] 
Acrylamide soln  [%T] 20 6 75 240 300 
PEG [%} 5 2 100 320 400 
Tris-HCl pH 8.8 [mM] 1.5 0.075 12.5 40 50 
BPMA [mM] 100 5 12.5 40 50 
LAP [%] 1 0.2 50 160 200 
Water (MilliQ) -   0 0 0 
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Fabrication steps 
250 μL is sufficient for a full glass slide (25 × 75 mm) of PA gel of height 40 μm. 
 
1. Add all components to the precursor solution (include LAP or VA-086, do not 
include APS/TEMED), and make sure solution is at RT (to avoid gas entrapment 
within cold solution). 
2. Vortex 30 s (to make sure PEG is well-mixed into precursor solution). 
3. Degas 5 min. Use immediately. 
4. (APS/TEMED: chemical polymerization) 
a. Add TEMED with P1 pipette. Triturate ~10 times. 
b. Add APS with P10 pipette. 
c. Switch to P200 pipette. Triturate extensively for ~20-30 s (to mix PEG in 
solution). 
d. Pipet immediately into polymerization setup (wafer, glass slide, etc.). 
e. Immediately cover with foil-covered plastic dish, with a wet Kimwipe (to 
avoid dehydration). 
f. (APS/TEMED) Polymerize for 20 min. 
5. (LAP or VA-086: photo-polymerization) 
a. Triturate extensively for ~20-30 s (to mix PEG in solution). 
b. Pipet immediately into polymerization setup (wafer, glass slide, etc.). 
c. Polymerize on the OAI for 4 minutes (VA-086) or 1 minute (LAP). 
6. Note: All 8%C gels should look distinctly white rather than clear. Distinct opacity 
difference. 
7. Use water to rehydrate gel for 1-2 min, then lift off of polymerization setup. 
a. Gels should lift off cleanly. 
8. Rinse in TBS-T (16-24 hours, note time, to allow for PEG diffusion out of gel). 
Exchange solution every ~8 hours. 
a. If gels are polymerized on glass slides, place in 4-well dish, with at least 
10 mL TBS-T per well (to create a sink). 
9. Rinse in TBS-T briefly. 
10. Rinse in DI water for 30 min before use (to remove TBS-T). 
Appendix 2: Ultrathin IEF training bootcamp 
Literature 
To read first: 
• Righetti textbook 1983 “Isoelectric focusing: theory, methodology, and 
applications” 
• Herr dissertation, Chapter 1 
• Yamauchi dissertation, Chapter 1 
• Tentori, Yamauchi, Herr 2016 Angew Chemie (scIEF) 
• Yamauchi, Tentori, Herr 2018 Electrophoresis (back to back pH gradient) 
• Su, Herr 2018 Lab on a Chip (adherent cell IEF) 
• O’Neill et al 2006 (25-cell IEF) 
• Giddings textbook “Unified Separation Science” 
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• Kirby textbook 
• Glantz textbook “Primer of Biostatistics” 
 
To read promptly (non-exhaustive list): 
• Herr, Molho, 2003 Analytical Chemistry (microfluidic IEF + free solution EP) 
• Tia, Herr 2009 Lab on a Chip (review paper) 
• Tia, Brown, Chen, Herr 2013 (microfluidic IEF) 
• Hughes, Lin, Peehl, Herr 2012 PNAS (microfluidic IEF) 
• Hughes, Tentori, Herr 2013 JACS (IEF and GFP) 
• Tentori, Hughes, Herr 2013 Analytical Chemistry (2DE) 
• Silvertand et al 2008 (cIEF review paper) 
• Zhu et al 2005 Analytical Chemistry 
• Johlfs et al 2015 PLOS One 
• Hruska et al 2006 Electrophoresis (Simul5 software) 
• Wang et al 2007 Electrophoresis 
• Macounova et al 2000 Analytical Chemistry 
• Macounova et al 2001 Analytical Chemistry 
• Anderson 2008 Plant Journal 
• the Righetti body of literature 
 
Other researchers in the IEF space (non-exhaustive list) 
• Rilbe/Svensson 
• Gelfi 
• Thormann 
• Gorg 
• Stoyanov 
• Ivory 
• Minerick 
• Pawliszyn 
 
On immobilized pH gradients (IPG) (non-exhaustive list) 
• Righetti textbook 1990 “immobilized pH gradients: theory and methodology” 
• Bjellqvist et al, 1982 IPG 
• Sommer 2008 
Superuser trainings 
• Safety tour 
• BNC  
• BNC wafer fabrication 
• Tissue culture 
• OAI 
• Onyx microscope 
• Hamamatsu 
• HVPS 
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• GenePix 
• scWB training (potentially through Cold Spring Harbor Labs preparation in the 
summer) 
Critical lab processes 
• Wafer fabrication 
• Well gel fabrication 
• Lid gel fabrication 
• scIEF 
• scIEF worksheet and protocol 
• MATLAB analysis script 
• Immunoprobing 
Bootcamp 
1. scIEF with pI markers 
a. Run 1: mentor runs, mentee observes 
b. MATLAB analysis training 
c. Run 2: mentee runs with mentor 
d. Run 3: mentee runs, mentor observes 
e. Run 4: mentee runs independently 
f. MATLAB analysis comparison 
g. Independent replicate runs by mentee to reach n=3 replicates matching 
mentor’s data 
i. Use EJS bootcamp results_summary pptx file as guideline 
ii. Experiment type 
iii. Assay parameters 
iv. Key changes from previous experiments 
v. Results 
vi. Comments and main findings 
2. scIEF with purified protein ladder 
3. scIEF with U251-tGFP or MCF7-GFP + immunoblot for tGFP or GFP 
4. slab IEF 
Metrics for success 
• Comfort with scIEF workflow 
• Knowledge of IEF literature 
• Knowledge of IEF metrics 
• Validate MATLAB analysis: same metrics extracted from mentor’s data sets 
• Validate IEF training: reproducible replicates  
• Validate IEF training: mentee’s data with quantitative metrics matching those 
from mentor’s data 
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Appendix 3: Protocol: Ultrathin IEF assay with pI markers and tGFP protein 
(native lysis) 
 
scIEF + pI Markers + tGFP protein Runs #______  Date:___________   Time: ____________  SJ 
 
(Separation) Well Gel (6% T) 
Slide design =  
 
 
Gelslick wafer & rinse  
Cut silanized glass slide to size (1/2 length)  
GEL TYPE =  
 
 
 
 
Fab gel  
(porogen) rinse in TBS-T at 4°C for 16-24 hours (       )  
Rinse in DI H2O for 30 minutes  
Cut to focusing region pre-solution  
Draw imaging zone on glass slide  
 DI H2O 32.5 μL  
1:100 pH  4.5  marker (12/16) 2.5 μL   
1:100 pH  5.5  marker (12/16) 2.5 μL  
1:100 pH  6.6  marker (12/16) 2.5 μL  
 tGFP-488 protein  μL   
Incubate in 30 uL solution for 30 minutes  
Do not dehydrate; use immediately  
 
OAI 
Turn on  
Warm up for >10 minutes  
20 mW/cm2, longpass filter, 240 seconds  
 
(Anolyte pH 4) Acid Lid Gel (15% T) 
GelSlick glass board  
Cut glass slide to size (3/4 length)  
GelSlick glass slide  
Uncoated spacer  
Assemble & tape  
Test with DI H20                                       □ no leak  
A3574 30% T 500.0 μL  
13.5 mM pKa 3.6 
Immobiline 
68.0 μL  
6.4 mM pKa 9.3 
Immobiline 
32.0 μL  
 DI H2O 300.0 μL  
Fresh (2%) 
20 mg/ml  
VA-086 100.0 μL   
Degas 5 minutes (Σ = 1000 μL)  
Cast gel  
UV 240 seconds, longpass filter  
Aspirate out remaining liquid                    □ gel  
Test with DI H2O                                      □ no leak  
 
Order of operations: 
Well gel in solution à base gel à acid gel à focusing gel 
 
Slides =  
 
 
TIMING MATTERS! This protocol makes sufficient quantities 
of reagents for two consecutive runs. 
 
Test the pH of all 3 lid gel precursor solutions before use. 
 
 
 
(Catholyte pH 10) Base Lid Gel (15% T) 
A3574 30% T 500.0 μL  
5.6 mM pKa 3.6 Immobiline 28.0 μL  
14.4 mM pKa 9.3 Immobiline 72.0 μL  
 DI H2O 300.0 μL  
Fresh (2%) 
20 mg/ml  
VA-086 100.0 μL   
Degas 5 minutes (Σ = 1000 μL)  
Cast gel  
UV 240 seconds, longpass filter  
Aspirate out remaining liquid                    □ gel  
Remove spacer & tape                            □ no leak  
Rinse with DI H2O  
Remove any remaining gel from center area  
Maintain in DI H2O                                          min  
 
ONYX MICROSCOPE 
Microscope Room: Metamorph, HVPS 
Purple scIEF container  Tweezers  Razor  
Well gel on wafer  Timer  Pen  
Calibration slide  Tape  Doc  
Lid gels on glass slide  Box  Onyx 16 
HVPS 
 
Cooling block  TBS-T  
Turn on microscope  
Warm up for > 10 minutes  
Hours =  
Set up & tape down scIEF container onto 
microscope 
 
Set up & tape down HVPS electrodes  
Metamorph  
Calibrate (4x mag, 2x bin, ____ exp, ___ gain, UV-LP) 
Calibrate (4x mag, 2x bin, ____ exp, ___ gain, GFP)  
Calibrate (____ exp, ___ gain, Brightfield)  
 
Set up scan slide  
Set up folder for saving images  
Turn on Hamamatsu LC8 + warm for > 10 minutes  
 
Focusing Lid Gel (15% T) 
A3574 30% T 250.00 μL  
18% Triton X-100 27.75 μL  
1:100 Sinulyte pH 4-7 CA 5.00 μL  
 DI H2O 167.25 μL  
Fresh (2%) 
20 mg/ml  
VA-086 50.00 μL   
Degas 5 minutes (Σ = 1000 μL)  
Cast gel  
UV 240 seconds, longpass filter  
Aspirate out remaining liquid                    □ gel  
 
Microscope 
Lights OFF  
Place well gel on scIEF chamber  
Lid gel -- CAREFULLY  
Glass slide on top  
Electrodes + 30 sec “lysis” and diffusive loading  
Turn on HVPS à manual, 690 V, constant voltage  
Scan slide 0 minutes  
Voltage on  
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+ 30 sec “lysis” 
 
Run A 
 
Time Voltage Current Power Bands Observations Imaging Notes 
0 sec 690 V     0.0 min UV-LP  
10 sec       
20 sec       
30 sec       
40 sec       
50 sec       
1 min      1.0 min UV-LP  
1.5 min       
2 min       
2.5 min 
3 
3.5 
4 
4.5 
     2.5 min UV-LP 
 
3.5 min GFP 
 
 
5 min 
5.5 
6 
6.5 
7 
     5.0 min UV-LP 
 
6.0 min GFP 
 
Set up for Hamamatsu use 
7.5 min 
8 
8.5 
9 
9.5 
     7.5 min UV-LP 
 
8.5 min GFP  
 
Set up for Hamamatsu use 
10 min 
10.5 
11 
11.5 
12 
     10.0 min UV-LP  
 
11.0 min GFP  
 
 
Draw: 
1. precisely where the imaging region is on the slide (for post-TBS-T imaging) 
2. alignment of focusing region to the top edge of the separation gel 
Stop electric field at 12 minutes 
Close shutter 
UV 100% intensity / 45 s 
Open shutter 
 
Image immediately, if desired 
 
Post-UV   GFP  
Post-UV   UV-LP  
Post-UV   Brightfield 
 
Remove glass slide 
Post-UV   Brightfield 
 
Rinse in TBS-T 30 min 
 
Find ROI 
Image again (post-immobilization) 
Post-TBST   GFP 
Post-TBST   Brightfield 
 
 
DI water on shaker for 5 minutes 
Dehydrate completely with nitrogen stream 
 
Genepix: tGFP native fluorescence (488) 
 
Immunoprobing for tGFP: 
 
 
 
 
 
Store in slide-holder in the dark at RT 
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Appendix 4: Protocol: Ultrathin scIEF assay with cells (native lysis) 
 
Native scIEF + ________________ cells  Runs #_______  Date:_____________ Time: ______________ SJ 
 
Well Gel (6% T) 
Slide design =  
 
 
 
Silanize wafer  
Rinse  
Cut silanized glass slide to size (1/2 length)  
Draw imaging zone on glass slide  
A3574 30% T 50.0 μL  
1.5 M TrisHCl 12.5 μL  
 BPMA-C 12.5 μL  
 DI H2O 172.8 μL  
Degas 10 minutes (Σ = 250 μL)  
fresh TEMED 0.2 μL   
fresh 10% APS 2 μL  
Cast gel  
Silanized slide  
Wet kimwipe  
Foil  
Time =                                                                      min 
Cut well gel to imaging zone  
Dehydrate gel completely & store in dark  
 
OAI 
Turn on  
Warm up for > 10 minutes  
Check 20 mW/cm2  
Add longpass filter  
Time = 240 seconds  
 
Acid Lid Gel (15% T) 
GelSlick glass board  
Cut glass slide to size (3/4 length)  
GelSlick glass slide  
Uncoated spacer  
Assemble & tape  
Test with DI H20                                       □ no leak □  
A3574 30% T 500.0 μL  
13.5 mM pKa 3.6 
Immobiline 
68.0 μL  
6.4 mM pKa 9.3 
Immobiline 
32.0 μL  
 DI H2O 300.0 μL  
20 mg/mL 
stock  
VA-086 100.0 μL   
Degas 5 minutes (Σ = 1000 μL)  
Cast gel  
UV 240 seconds, longpass filter  
Aspirate out remaining liquid                    □ gel        □  
Test with DI H2O                                       □ no leak □  
 
 
 
 
 
 
 
Slides = 
 
Base Lid Gel (15% T) 
A3574 30% T 500.0 μL  
5.6 mM pKa 3.6 Immobiline 28.0 μL  
14.4 mM pKa 9.3 Immobiline 72.0 μL  
 DI H2O 300.0 μL  
20 mg/mL 
stock  
VA-086 100.0 μL   
Degas 5 minutes (Σ = 1000 μL)  
Cast gel  
UV 240 seconds, longpass filter  
Aspirate out remaining liquid                    □ gel       □  
Remove spacer & tape                             □ no leak □  
Rinse with DI H2O  
Remove any remaining gel from center area  
Maintain in DI H2O                                 /           min  
 
 
Microscope Room: Hamamatsu, HVPS 
Purple scIEF container  Tweezers  Razor  
Dehydrated well gels  Timer  Pen  
10 mL 1:100 CA : H2O  30 ml PBS  Doc  
60mm, 4-well dishes  Foil  Tape  
Cooling block  TBS-T  Onyx 16 
HVPS 
 
Lid gels on glass slide  Ice  
Turn on Hamamatsu LC8 (2 steps)  
Warm up for > 5 minutes  
Hours =  
Setting = 100% intensity  
Setting = 45 seconds  
Set up & tape down scIEF container  
Set up & tape down HVPS electrodes  
 
 
Order of operations 
 
Well gel à base gel à settle cells à acid gel à focusing gel 
à rehydrate à rinse à CA à lysis à EP à UV 
 
Native scIEF 
 
1% Sinulyte 1:100, base pH 10, 9 mm, 690 V 
 
 
 
TIMING MATTERS! This protocol supports two consecutive 
runs. 
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Cells 
Dissociate cells  
Cell type =  
Passage = 
 
 
Resuspend _____M/mL, 100 μL/well gel + cell strainer  
Store on ice  
Place 10 μL cell drop onto microwell line on well gel   
Place on cooling block for 10 MIN  
 
Focusing Lid Gel (15% T) 
A3574 30% T 500.0 μL  
18% stock Triton X-100 55.5 μL  
1:100 Sinulyte pH 4-7 CA 10.0 μL  
 DI H2O 154.5 μL  
20% w/v stock  
 
CHAPS 180.0 μL  
(40 mg) 
 
20 mg/mL stock  VA-086 100.0 μL   
Degas 5 minutes (Σ = 1000 μL)  
Cast gel  
UV 240 seconds, longpass filter  
Aspirate out remaining liquid                    □ gel  □  
Maintain alone                           /                    min  
 
Microscope Room 
Check under scope for cells  
Wick off fluid  
Rinse with PBS (5 mL)  
Rehydrate in PBS (10 mL)                  for 5 MIN  
Recheck under scope for cells  
Rinse with PBS (5 mL)  
Wipe off excess liquid from edges  
Place well gel in C.A. solution (5 mL) for 30 S  
Wipe off excess liquid from edges  
Well gel onto scIEF container  
Lid gel – CAREFULLY                         for 30 S  
Glass slide on top  
Electrodes  
Turn on HVPS à manual, 690 V, constant voltage  
Voltage on                                          for 6 MIN  
Voltage off  
Select tape-covered button  
UV photocapture (sweep)                    for 45 S  
TBS-T on shaker                                 for 30 MIN  
DI water on shaker                              for 5 MIN  
Dehydrate à Genepix à store at RT (long-term) + foil  
 
Cleanup 
Cooling block back to fridge / freezer  
All liquids and containers à bleach à biohazard  
All cells à bleach à biohazard  
Wipe down all surfaces with bleach à ethanol à dry  
No cycling Hamamatsu à on for use within 4 hours  
No cycling OAI à on all day  
 
 
 
…………………………… 
 
 
 
 
…………………………… 
 
 
Run B 
 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
Run A 
 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
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Appendix 5: Protocol: Ultrathin scIEF assay with cells (denaturing lysis) 
 
Denaturing scIEF + ________________ cells Runs #_________ Date:_____________ Time: ______________ SJ 
 
Well Gel (6% T) 
Slide design =  
 
 
 
Silanize wafer  
Rinse  
Cut silanized glass slide to size (1/2 length)  
Draw imaging zone on glass slide  
A3574 30% T 50.0 μL  
1.5 M TrisHCl 12.5 μL  
 BPMA-C 12.5 μL  
 DI H2O 172.8 μL  
Degas 10 minutes (Σ = 250 μL)  
fresh TEMED 0.2 μL   
fresh 10% APS 2 μL  
Cast gel  
Silanized slide  
Wet kimwipe  
Foil  
Time =                                                                      min 
Cut well gel to imaging zone  
Dehydrate gel completely & store in dark  
 
 
OAI 
Turn on  
Warm up for > 10 minutes  
Setting = 20 mW/cm2  
Setting = longpass filter  
Setting = 240 seconds  
 
Acid Lid Gel (15% T) 
GelSlick glass board  
Cut glass slide to size (3/4 length)  
GelSlick glass slide  
Uncoated spacer  
Assemble & tape  
Test with DI H20                                       □ no leak □  
A3574 30% T 500.0 μL  
13.5 mM pKa 3.6 
Immobiline 
68.0 μL  
6.4 mM pKa 9.3 
Immobiline 
32.0 μL  
 DI H2O 300.0 μL  
Fresh (2%) 
20 mg/ml  
VA-086 100.0 μL   
Degas 5 minutes (Σ = 1000 μL)  
Cast gel  
UV 240 seconds, longpass filter  
Aspirate out remaining liquid                    □ gel        □  
Test with DI H2O                                       □ no leak □  
 
 
 
 
Slides =  
 
 
Base Lid Gel (15% T) 
A3574 30% T 500.0 μL  
5.6 mM pKa 3.6 Immobiline 28.0 μL  
14.4 mM pKa 9.3 Immobiline 72.0 μL  
 DI H2O 300.0 μL  
Fresh (2%) 
20 mg/ml  
VA-086 100.0 μL   
Degas 5 minutes (Σ = 1000 μL)  
Cast gelAQ  
UV 240 seconds, longpass filter  
Aspirate out remaining liquid                    □ gel       □  
Remove spacer & tape                             □ no leak □  
Rinse with DI H2O  
Remove any remaining gel from center area  
Maintain in DI H2O                                   /          min  
 
 
Microscope Room: Hamamatsu, HVPS 
Purple scIEF container  Tweezers  Razor  
Dehydrated well gels  Timer  Pen  
20 mL 1:100 CA : H2O  30 ml PBS  Doc  
60mm, 4-well dishes  Foil  Tape  
Cooling block  TBS-T  Onyx 16 
HVPS 
 
Lid gels on glass slide  Ice  
Turn on LC8 (2 steps)  
Warm up for > 5 minutes  
Hours =  
Setting = 100% intensity  
Setting = 45 seconds  
Set up & tape down scIEF container  
Set up & tape down HVPS electrodes  
 
 
 
15 minutes to weigh detergents  
 
Order of operations:  
 
Well gel à base gel à settle cells à acid gel à focusing gel 
à rehydrate à rinse à CA à lysis à EP à UV 
 
 
TIMING MATTERS! This protocol can be used for two 
consecutive experimental runs. 
 
 
Denaturing scIEF 
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Cells 
Dissociate cells  
Cell type =  
Passage = 
 
 
Resuspend _____M/mL, 100 μL/well gel + cell strainer  
Store on ice  
Place 10 μL cell drops onto microwell line on well gel  
Place on cooling block for 10 MIN  
 
Focusing Lid Gel (15% T) 
A7802 40% T 375.0 μL  
18% Triton X-100 55.5 μL  
1:100 Sinulyte pH 4-7 CA 10.0 μL  
 DI H2O 559.5 μL  
Fresh, solid CHAPS 40 mg  
Fresh, solid Urea 420 mg  
Fresh, solid Thiourea 152 mg  
Fresh, solid VA-086 2 mg   
Dissolve all chaotropes and detergents thoroughly  
Degas 5 minutes (Σ = 1000 μL)  
Cast gel  
UV 240 seconds, longpass filter  
Aspirate out remaining liquid                    □ gel  □  
Maintain alone                                   /           min  
 
 
Microscope Room 
Check under scope for cells  
Wick off fluid  
Rinse with PBS (5 mL)  
Rehydrate in PBS (10 mL)                  for 5 MIN  
Recheck under scope for cells  
Rinse with PBS (5 mL)  
Wipe off excess liquid from edges  
Place well gel in C.A. solution (5 mL) for 30 S  
Wipe off excess liquid from edges  
Well gel onto scIEF container  
Lid gel – CAREFULLY                         for 30 S  
Glass slide on top  
Electrodes  
Turn on HVPS à manual, 690 V, constant voltage  
Voltage on                                          for 6 MIN  
Voltage off  
Select tape-covered button  
UV photocapture (sweep)                    for 45 SEC  
TBS-T on shaker                                  for 30 MIN  
DI water on shaker                               for 5 MIN  
Dehydrate à Genepix à store at RT (long-term) + foil  
 
Cleanup 
Cooling block back to fridge / freezer  
All liquids and containers à bleach à biohazard  
All cells à bleach à biohazard  
Wipe down all surfaces with bleach à ethanol à dry  
No cycling Hamamatsu à on for use within 4 hours  
No cycling OAI à on all day  
 
 
Run B 
 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
Run A 
 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
       mA @      min     sec 
 
 
…………………………… 
 
 
 
 
…………………………… 
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Appendix 6: Protocol: slab IEF with purified protein ladder 
Protocol adapted from ThermoFisher: https://assets.thermofisher.com/TFS-
Assets/LSG/manuals/electro phoresisguide_man.pdf, Invitrogen Novex pre-case gel 
electrophoresis guide, IM-1002, revised 07 Oct 2010 
 
Refer to XCell SureLockTM Mini-Cell manual (IM-9003) for device instructions. 
Purchase IEF materials 
- Novex IEF buffer set (Invitrogen LC5377) 
o Novex IEF anode buffer 
o Novex IEF cathode buffer 
o Novex IEF sample buffer 
- Novex IEF gels (Invitrogen EC66452BOX for pH 3-7) 
o 5%T 2.6%C polyacrylamide gel + 2% Novex ampholytes  
o The 5 gels in this order are viable for 2 months from date of receipt. Plan 
experiments accordingly. 
o Store at 4ºC 
- IEF standard, pH range 4.45-9.6 (BioRad 161-0310) 
- XCell SureLock Mini-Cell (Invitrogen IM-9003, also used for slab Western blot in 
the Herr lab) 
- (if transfer is desired) Rapid transfer system, PVDF membrane, filter paper, 
methanol 
- (if fixation is desired) Fixative 
- (if total protein stain is desired) Ponceau or Coomassie total protein stain 
- (if immunoblot is desired) selected primary antibody, selected secondary 
antibody conjugated with HRP, Western Lightning solution, BSA, TBS-T 
- Before proceeding, check lab stocks of all other materials. 
Prepare cell lysate 
1. Trypsinize cells, spin down, resuspend in 1× PBS, count. 
2. Wash 2x in 1× PBS 
3. Make IEF buffer of choice. 
a. Native IEF buffer (1% TritonX-100, 3.6% CHAPS, 1% HALT inhibitor, in DI 
water, 20 mL) 
i. 1.111 mL of stock 18% TritonX-100 solution 
ii. 40 mg of CHAPS powder 
iii. 18.689 mL of DI water 
iv. 200 μL of HALT protease/phosphatase inhibitor (1:100 dilution final) 
b. Denaturing IEF buffer with DTT (7M urea, 2M thiourea, 1% TritonX-100, 
3.6% CHAPS, 20 mM DTT solution, 1% HALT inhibitor, in 20 mL DI water) 
i. 1.111 mL of stock 18% TritonX-100 solution (1% final) 
ii. 40 mg of CHAPS powder (3.6% final) 
iii. 8400 mg of urea (7M final) 
iv. 3040 mg of thiourea (2M final) 
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v. 18.689 mL of DI water 
vi. 61.7 mg of DTT powder (20 mM final) 
1. 154.253 g/mol 
2. from Wang et al  Proteomics 2004 – not stable in water. 
Make fresh and use promptly. 
vii. 200 μL of HALT protease/phosphatase inhibitor (1:100 dilution final) 
4. Spin down, resuspend cells in IEF buffer of choice. 
a. Use biohazard-compatible centrifuge. 
b. Make sure to orient all Eppendorf tubes the same way, in case cell pellet 
is difficult to visually identify. 
c. Make sure to close Eppendorf tubes completely. 
5. Allow cells to lyse for 60 minutes, vortexing every 5-10 min. 
6. Centrifuge 14,000 g, 15 min, 4ºC. 
7. Claim supernatant. 
a. Store viscous remaining solution at -20ºC until final results are collected. 
8. Freeze -20ºC overnight if needed.  
9. * Consider desalting protocol for IEF. 
10. Thaw on ice. 
11. Dilute 1:1 with appropriate sample buffer (below). Load into slab IEF gel (below). 
12. Store remaining lysate in -20ºC freezer. 
Prepare anode buffer 
Prepare 1× IEF Anode Buffer using Novex® IEF Anode Buffer (50X).  
 
1. Prepare 1000 mL of IEF Anode Buffer as follows:  
Reagent  Amount 
Novex IEF Anode Buffer (50×) 20 mL 
MilliQ water 980 mL 
Total Volume 1000 mL 
2. Mix thoroughly. Use this buffer to fill the Lower Buffer Chamber of the XCell 
SureLockTM Mini-Cell for electrophoresis. 
Prepare cathode buffer 
Prepare 1× IEF Cathode Buffer using the appropriate Novex® IEF Cathode Buffer pH 
3–10 (10×) or pH 3–7 (10×)  
 
1. Prepare 200 mL of IEF Cathode Buffer as follows:  
Reagent  Amount 
Novex IEF Cathode Buffer (10×) 20 mL 
MilliQ water 180 mL 
Total Volume 200 mL 
2. Mix thoroughly. Use this buffer to fill the Upper Buffer Chamber of the XCell 
SureLockTM Mini-Cell for electrophoresis.  
Prepare samples 
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Samples for IEF Gels are prepared without SDS to avoid affecting the pI of the protein. 
Reducing agents are also not recommended for the same reason.  
 
1. Prepare samples for IEF Gels as described below (on ice): 
Reagent  Amount 
Sample 5 μL 
Novex IEF Sample Buffer pH 3–7 (2×) 5 μL 
Total 10 μL 
2. Load the sample immediately. Do not heat samples for IEF Gels. 
Sample order 
For ease of subsequent analysis, fill at least 2 lanes with undiluted IEF standard, and 
stagger these lanes such that the gel orientation is not reversible. 
 
Lane Sample 
1  
2  
3 IEF standard 
4  
5  
6  
7 IEF standard 
8  
9  
10  
11  
12  
Slab protocol 
Wear gloves and safety glasses when handling gels. XCell SureLockTM Mini-Cell 
requires 200 mL for the Upper Buffer Chamber and 600 mL for the Lower Buffer 
Chamber.  
 
1. Before starting, make sure HVPS has slab IEF electrophoresis settings loaded. 
2. Remove the Novex® Pre-Cast Gel from the pouch.  
3. Rinse the gel cassette with deionized water. Peel off the tape from the bottom of 
the cassette.  
4. Gently pull the comb out of the cassette in one smooth motion.  
5. Rinse the sample wells with the appropriate 1× Running Buffer (Cathode 
Buffer). Invert the gel and shake the gel to remove the buffer. Repeat two more 
times.  
6. Orient the two gels in the Mini-Cell such that the notched “well” side of the 
cassette faces inwards toward the Buffer Core. Seat the gels on the bottom of 
the Mini-Cell and lock into place with the Gel Tension Wedge. Refer to the XCell 
SureLockTM Mini-Cell manual (IM-9003) for detailed instructions. 
1. Note: If you are running just one gel, use the plastic Buffer Dam in place 
of the second gel cassette to form the Upper Buffer Chamber.  
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7. Fill the Upper Buffer Chamber with a small amount of the Running Buffer to 
check for tightness of seal. If you detect a leak from Upper to the Lower Buffer 
Chamber, discard the buffer, reseal the chamber, and check the seal again.  
1. Cathode buffer 
8. Once the seal is tight, fill the Upper Buffer Chamber (Inner) with the appropriate 
1× Running Buffer. The buffer level must exceed the level of the wells.  
9. Load an appropriate volume of sample at the desired protein concentration onto 
the gel (see page 8 of IM-1002 manual for recommended loading volumes).  
10. Load IEF protein standard.  
11. Fill the Lower Buffer Chamber with 600 mL of the appropriate 1× Running Buffer.  
1. Anode buffer 
12. Place the XCell SureLockTM Mini-Cell lid on the Buffer Core. With the power on 
the power supply turned off, connect the electrode cords to the power supply [red 
to (+) jack, black to (–) jack].  
1. Use new lid, connected to HVPS electrodes, connected to HVPS 
Electrophoresis conditions 
Before starting to assemble the slab IEF, make sure to add the following steps as a 
method to the HVPS. 
 
HVPS >> IEF >> slab IEF method 
• 100 V constant for 1 hour 
• 200 V constant for 1 hour 
• 500 V constant for 30 minutes 
 
Note start time. 
 
Start to prepare for rapid transfer > 10 minutes before the 500 V IEF step ends (once 
the electric field is turned off, the proteins will diffuse out of their focused bands. Any 
extraneous time before transfer results in losses in separation resolution). 
Transfer 
Use rapid transfer system! Prepare membranes/filter papers during 500V stage. 
1. Follow instructions on system 
2. Here, we used PVDF membrane and 4 pieces filter paper (2 pieces around 
PVDF in package, 2 extra) 
3. During 500V stage 
o Place 4 pieces of filter paper in Ziploc container to equilibrate. 
o Place PVDF membrane in pipette tip lid and cover in cold MeOH (in fridge) 
for 1 min.  Then pour back and add transfer buffer.  Use tweezers to 
handle membrane. 
o Pry open gel holder 
o Cut off comb region and thicker region at bottom 
o Rinse in transfer buffer 
4. After 500V stage 
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o Disassemble IEF gel from Mini-Cell and from containment. 
o Place 2 pieces of wetted filter paper on bottom electrode 
o Place membrane over filter paper (place down slowly from one corner to 
avoid introducing bubbles) 
o Peel gel off of edge while gel is under transfer buffer.  Place directly on 
membrane 
o Add more buffer, ensure no bubbles (can press on gel with gloves) 
o Add 2 pieces of filter paper on top and use roller to ensure no bubbles 
o Start transfer (mixed MW program is typically sufficient) 
o Prepare small plastic box for membrane (available from Stanley 
Stockroom) 
Imaging pre-stain 
1. Take pictures of the membrane and the gel to gauge color 
2. Image the membrane using white light epi on the Chemidoc.  
3. Image the membrane (UV-longpass for pI markers, fluorescence for purified IEF 
protein ladder) on Onyx. 
Ponceau stain 
1. Use Amresco Ponceau S stain. 
2. 1x solution in square dish 
3. Stain for 2-10 minutes (longer = more intense stain). 
4. Stop stain by rinsing in DI water. 
Imaging post-stain 
1. Image the membrane using white light epi on the Chemidoc, and take pictures. 
Blot and probe 
Following immunoprobing protocol from slab Western blot 
 
1. Rinse out Ponceau stain extensively (multiple solution exchanges until the DI 
water is clear). 
2. Block in 5% BSA in TBS-T 
3. Primary antibody probing in small plastic box, 10 mL of 0.5% BSA/TBS-T solution 
with set of antibodies, 4ºC overnight 
4. Save primary antibody solution for future use 
5. Rinse 3x in TBS-T for 10 min each on shaker 
6. Sequential secondary antibody probing 
a. Secondary antibody probing in small plastic box, 10 mL of 0.5% BSA/TBS-
T solution with single antibody type, 1h on shaker 
b. Save secondary antibody solution for future use 
c. Rinse 3x in TBS-T for 10 min each on shaker 
d. Set up Chemidoc 
i. Turn on system and camera 
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ii. Open ImageLab software 
iii. Create new protocol 
iv. Choose Application à Blots à Chemi 
v. Could also create custom application 
vi. If doing UV, can add Xciteblue conversion screen 
vii. Usually set to Bio-Rad ready gel, which has similar size to 
membrane 
viii. Usually set exposure time to 10-30s 
e. Chemiluminescence on Chemidoc 
i. Mix 2 components of Western Lightning solution 1:1, 8 mL 
ii. Go to Chemidoc, wait ~90s 
iii. Wipe plate with Kimwipe 
iv. Use tweezers to place membrane (centered) on plate 
v. Use ‘position gel’ to show brightfield and move the membrane until 
it’s in field 
vi. Take images at different exposures (10s, 30s, 1 min, 5 min) 
vii. Take white light epi image to see ladder for positioning 
viii. If signal degrades too much, can place membrane back into 
detection reagent and image again 
ix. Remove membrane, place in dish, clean tray with Kimwipe and 
water 
x. Export TIFs and save files 
f. Wash membrane in DI water 
g. Wash membrane in TBS-T 1h 
h. Repeat secondary immunoprobing and imaging for remaining antibodies 
Storage 
Store membrane short-term in 1× TBS-T, parafilm, aluminum foil, 4°C 
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Appendix 7: Protocol: HTP scIEF fabrication of separation gels 
Use HTP IEF wafer (silanized, no GelSlick®) with 32-µm-diameter, 40-µm-height 
microposts at 400x400 µm spacing in 16x16 mm blocks 
 
Typically, 8 microwell gels of 18x18 mm size is sufficient for an experiment. 
Materials: 
- 30% acrylamide stock solution 
- APS 
o Weigh out into Eppendorf tube, and make a 10% solution in MilliQ water. 
- TEMED 
o Use 100% solution (no dilution). 
- BPMA:  
o Most recent aliquot from shared stock at -20ºC. Make sure the vial has not 
been previously thawed. No dilution. Thaw at RT under foil, and triturate. 
- Novex Zoom® ampholytes pH 4-7 
- Rhinohide™ 
- 18% TritonX-100 stock solution 
o Make 5+ mL of 18% stock solution. First, pipet requisite MilliQ water into 
15 mL Falcon tube. Cut end 1000 mL pipet tip for a wider opening. Slowly 
(avoid bubbles or damage to pipette) pipet requisite 100% TritonX-100 
from stock bottle into Falcon tube. Leave pipet tip in Falcon tube. Heat in a 
water bath at 55ºC for an hour. Pipet gently to mix. 
o Store at RT under foil for <1 month 
- 1 mm spacers 
- Silanized glass slide 
- Z-projection IEF wafer 
- Razor blade (NEW! Make sure this is sharp) 
- 4-well plate 
Precursor solutions 
6%T 3.3%C PA gel + 10% new Rhinohide™ 
200 30%T 3.3%C 29:1 polyacrylamide           
50 BPMA           
641.2 DI water           
100 10% Rhinohide™ final (new)           
0.8 TEMED 100%           
8 APS 10%           
              
1000 total           
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Fabrication steps 
1000 μL is sufficient for a single 18x18x1 mm gel (X-Y-Z). 
 
1. Add all components to the precursor solution except APS and TEMED, and make 
sure solution is at RT (to avoid gas entrapment within cold solution). 
2. Set up wafer + 1 mm spacers. Tape down spacers at the edges. 
3. Mix well. Degas 5 min. Use immediately. 
4. Add TEMED with P1 pipette. Triturate ~10 times. 
5. Add APS with P10 pipette. 
6. Switch to P200 pipette. Pipet immediately onto wafer. Overlay silanized glass 
slide. 
7. Immediately cover with foil-covered plastic dish, with a wet Kimwipe (to avoid 
dehydration). 
8. Polymerize for 1 hour. At 30 min mark, check hydration of Kimwipe. 
9. Use water to rehydrate gel for 1-2 min, then lift off of polymerization setup. 
a. Gels should lift off cleanly, without damaging microposts. 
10. Cut gels to desired dimensions and gently remove from glass slide. 
a. 18 × 18 mm in X-Y 
b. 9 × 9 mm in X-Y 
11. Place free-standing separation gels well-up in 4-well plate. Place multiple gels 
into a single well, without stacking. Minimize well usage. 
12. Rinse in MilliQ water. 
13. Create IEF solution (7 mL per well of 4-well plate) 
a. 2% Zoom® ampholyte pH 4-7 solution 
b. 1% TritonX-100 (from 18% stock solution) 
c. In MilliQ water 
14. Incubate gels in 7 mL solution for each well of a 4-well plate; aluminum foil; 4°C 
overnight 
a. IEF solution should diffuse into gel to equilibrium. 
15. Use promptly the next day. 
 
Appendix 8: Protocol: HTP scIEF fabrication of anolyte and catholyte gels 
The anolyte and catholyte boundary gels for the HTP IEF assay are featureless 
18×18×0.5 mm or 9×9×0.5 mm PA gels with immobilines incorporated into the hydrogel 
matrix for embedded pH. 
Materials: 
- 30% T acrylamide solution 
- pKa 3.6 immobiline 
- pKa 9.3 immobiline 
- pKa 7.0 immobiline 
- VA-086 
- DI water + squirt bottle 
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- Glass plate 
- Silanized glass slide 
- 0.5 mm spacers 
- Schematic of 18×18 and 9×9 gel dimensions 
- Razor blade (NEW! Make sure this is sharp) 
- 4-well plate 
Precursor solutions 
Anolyte Gel (6% T) pH 4 
A3574 30% T Acrylamide solution   500.00   
13.5 mM pKa 3.6 Immobiline 68.00   
6.4 mM pKa 9.3 Immobiline 32.00   
  DI H2O 300.00   
Fresh (2%) 
20mg/mL 
VA-086 100.00   
Degas 5 minutes (Σ = 1000 μL)       
Catholyte Gel (6% T) pH 7 
A3574 30% T Acrylamide solution   500.00   
6.5 mM pKa 3.6 Immobiline 32.50   
13.5 mM pKa 7.0 Immobiline 67.50   
  DI H2O 300.00   
Fresh (2%) 
20mg/mL 
VA-086 100.00   
Degas 5 minutes (Σ = 1000 μL)       
Catholyte Gel (6% T) pH 10 
A3574 30% T Acrylamide solution   500.00   
5.6 mM pKa 3.6 Immobiline 28.00   
14.4 mM pKa 9.3 Immobiline 72.00   
  DI H2O 300.00   
Fresh (2%) 
20mg/mL 
VA-086 100.00   
Degas 5 minutes (Σ = 1000 μL)   
Fabrication steps 
Remember to make a set of anolyte gels (pH 4) and a set of catholyte gels (pH 10 or pH 
7). It is recommended to briefly set up a work station at a bench next to the OAI. 
 
1. GelSlick® glass plate and glass slide. 
2. Place the glass slide on top of the glass plate, propped up on the 0.5 mm 
spacers. Tape down the edges of the spacers, but make sure the tape does not 
interfere with the 0.5 mm height of this assembly. Check that the spacers are 
maximally spaced apart to maximize the number of gels obtained from each 
round of polymerization. 
3. Add all components to the precursor solution, and make sure solution is at RT (to 
avoid gas entrapment within cold solution). Mix thoroughly. 
4. Use pH strips to test pH of each solution. 
5. Degas solution for 5 minutes. 
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6. Pipet the degassed PA solution between the glass slide and glass plate. Make 
sure there are no air bubbles. 
7. After polymerization, remove from OAI. Place glass plate over the 18x18 or 9x9 
gel schematic. Gently remove glass slide without disrupting gel. Add a small 
amount of DI water to maintain hydrated state of gel. 
8. Hold the razor blade perpendicular to the glass slide. Slide through the gel to 
remove edges, then to cut gel to desired dimensions (18×18×0.5 or 9×9×0.5 
mm), using the schematic underneath as a guide. 
9. Place gels in DI water in the 4-well plate. 
10. Use pH strips to test pH of each gel (dry gently with edge of Kimwipe to remove 
fluid layer). 
11. Rinse glass plate thoroughly before reuse or storage. Use fresh silanized glass 
slides for each round of gel polymerization. 
12. Use promptly that day. 
Appendix 9: Protocol: HTP scIEF with purified protein ladder (native lysis) 
Last updated 11-06-2018 
Experimental Goal on 11-06-2018 
Investigate ability to focus proteins in the ZEP system with our semi-validated IEF 
protein ladder. Investigate source of unusual focusing in HTP scIEF gels.  
• Test catholyte gel    à 4/7 vs 4/10 
• Test separation time   à 45, 60, 90, 120 sec 
 
Learning moments from previous experiments: 
• Use anolyte/catholyte shield gels to form the boundary conditions. 
• This time, use larger (18×18 mm) gels to reduce edge effects. 
• Choose a 6%T gel for focusing, and use Zoom® ampholyte buffers in thick 
separation gel. 
• Leave gels in ampholyte buffer overnight to allow any unpolymerized 
acrylamide/Rhinohide™/BPMA to diffuse away. 
• Attempt to focus new labeled ladder of TI, CA, and MYO in native conditions at 
34 V/cm (pending current limitations). 
• Aim for a field of 166 V/cm (34V for BCs) (scIEF uses 139 V/cm). 
• Remember to place the spacers on the (+) electrode plate. 
• The filter paper hydration chamber is not required. 
 
Stack: benchtop << (+) electrode plate << 500 µm anolyte gel << 1 mm separation gel 
<< protein solution << 500 µm catholyte gel << (-) electrode plate 
 
Experimental groups = 6%T 10% Rhinohide™ in MilliQ water, 60s electrophoresis, 
ladder, no filter paper (8 gels) 
Reagents and Equipment 
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• IEF buffer, from Appendix 8 
o MilliQ water 
o 18% Triton X-100 solution 
o Zoom® pH 4-7 ampholytes 
• 2 mm spacers 
• Labeled protein solutions in 1× PBS 
o Myoglobin from 7/3/18 labeling round 
o TI and CA from 6/28/18 labeling round 
• Naturally fluorescent proteins 
o Phycocyanin 
o tGFP 
• 18×18 mm separation gels fabricated, with IEF buffer diffused into gel overnight 
at 4°C, from Appendix 7 
• Anolyte and catholyte gels, freshly fabricated, from Appendix 8 
o pH 4 anolyte 
o pH 7 catholyte 
o pH 10 catholyte 
• New electrode system with magnetic closures (for projection electrophoresis) 
• Hamamatsu 
 
Expectations: 
1. All gels: We will see spots of protein in the gel corresponding to the microwells. 
2. HTP IEF gels: If we are focusing, the protein bands should approach a pseudo-
equilibrium position, that is not disrupted by extended time. 
 
Testing after experiment: 
1. Rinse the gels in DI water before placing in 2 mL 1× TBS-T. 
2. Leave gel in 1× TBS-T overnight to rinse away any non-photocaptured protein, 
and image using Onyx and ScanSlide after this incubation. 
3. Use a razor blade to slice the gel to image cross-sections.  
a. Characterize slope of pH gradient, linearity of pH gradient, separation 
resolution between each fluorescent protein, and DpImin. 
4. Next steps: Image the gel with confocal. Confirm reproducibility of this result. 
Characterize IEF stability with timelapse experiment. 
Preparation of purified protein solutions 
For 40 µL mixed IEF protein ladder solution, mix:  
• 13.33 µL TI-647  (2018-06-28) 
• 13.33 µL MYO-488 (2018-07-03) 
• 13.33 µL CA-555 (2018-06-28) 
 
 
Electrophoresis 
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1. Make sure Hamamatsu is turned on and cap is off 
2. Stack: 
a. Anolyte gel (in DI water) 
b. Separation well gel  
i. Partly dry (Kimwipe) 
ii. Add 5 μL protein solution to each gel. Spread with flat edge of 10 
µL pipette tip. 
c. Catholyte gel (in DI water) 
3. Stack on bottom electrode and assemble electrode system 
4. Run electrophoresis at 34 V (BCs). 
5. Quickly open the electrodes, remove the filter paper, and photocapture 45s using 
the Hamamatsu. Record the time to photocapture start, and gel orientation with 
respect to the electrodes. 
Imaging 
1. Cut the gel through wells, creating a slice to image with widefield fluorescence. 
2. Image the gel using fluorescence microscopy (multi-dimensional imaging on 
Onyx) and ScanSlide. 
3. If Onyx images look good, image the gel with confocal microscopy to more 
quantitatively measure the protein migration properties. 
Notes during experiment 
Trial Conditions IEF & Photocapture  Observations 
1 10% Rhinohide™ 
 
60s electrophoresis, 
ladder, no filter paper 
 
pH 4 acid BC 
pH 7 base BC 
0s  10s  20s  30s  40s  50s  60s 
 
tphotocapture    Direction 
 
 
2 10% Rhinohide™ 
 
60s electrophoresis, 
ladder, no filter paper 
 
pH 4 acid BC 
pH 10 base BC 
0s  10s  20s  30s  40s  50s  60s 
 
tphotocapture    Direction 
 
 
3 10% Rhinohide™ 
 
90s electrophoresis, 
ladder, no filter paper 
 
pH 4 acid BC 
pH 7 base BC 
0s  10s  20s  30s  40s  50s  60s 
 
70s  80s  90s 
 
tphotocapture    Direction 
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4 10% Rhinohide™ 
 
90s electrophoresis, 
ladder, no filter paper 
 
pH 4 acid BC 
pH 10 base BC 
0s  10s  20s  30s  40s  50s  60s 
 
70s  80s  90s 
 
tphotocapture    Direction 
 
 
5 10% Rhinohide™ 
 
120s electrophoresis, 
ladder, no filter paper 
 
pH 4 acid BC 
pH 7 base BC 
0s  10s  20s  30s  40s  50s  60s 
 
70s  80s  90s  100s  110s  120s 
 
tphotocapture    Direction 
 
 
6 10% Rhinohide™ 
 
120s electrophoresis, 
ladder, no filter paper 
 
pH 4 acid BC 
pH 10 base BC 
0s  10s  20s  30s  40s  50s  60s 
 
70s  80s  90s  100s  110s  120s 
 
tphotocapture    Direction 
 
 
7 10% Rhinohide™ 
 
45s electrophoresis, 
ladder, no filter paper 
 
pH 4 acid BC 
pH 7 base BC 
0s  10s  20s  30s  40s  45s 
 
tphotocapture    Direction 
 
 
8 10% Rhinohide™ 
 
45s electrophoresis, 
ladder, no filter paper 
 
pH 4 acid BC 
pH 10 base BC 
0s  10s  20s  30s  40s  45s 
 
tphotocapture    Direction 
 
 
 
Appendix 10: Protocol: desalted IEF cell lysate 
Last updated in November 2016 
Cell Lysate 
Source (with modifications): 2D Gel Sample Preparation using Amersham kit, protocol 
provided online by Rutgers New Jersey Medical School 
 
One may also refer to the cell lysate protocol in Appendix 6. 
 
Estimated Time: 1 hour (not including pre-procedure cell singularization).  
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Materials: 
- Denaturing lysis buffer (5 mL), thoroughly mixed and dissolved 
o 2100 mg urea 
o 760 mg thiourea 
o 200 mg CHAPS 
o 277.5 μL of 18% v/v TritonX-100 (final 1%) 
o 4.7225 mL of DI water 
o * Note that these are the same concentrations as in the denaturing 
focusing gel! 
o * Incorporate phosphatase/kinase/protease inhibitors as needed (1:100 
HALT). 
o * Do not freeze this buffer! Chaotropes degrade over time when hydrated. 
- RIPA buffer (5 mL) 
o Pierce RIPA buffer, catalog #89900 
o * Incorporate phosphatase/kinase/protease inhibitors as needed. 
- Dissociated cells 
- Vortex 
- Centrifuge 
- Eppendorf tubes (1.5 mL) blocked with 5% BSA in TBS-T 
 
Steps: 
1. (during cell dissociation) Turn on Beckman Coulter Allegra 21R Centrifuge. Set to 
4°C. Close and allow to cool to goal temperature. 
2. (recommended) Block 4+ Eppendorf tubes (1.5 mL) with 5% BSA in TBS-T for 1 
hour. Use these tubes for all procedures. 
a. This should inhibit protein adsorption. 
 
3. Transfer appropriate quantity of cells to 2  1.5 mL Eppendorf tubes. 
a. 1 M / mL is effective (SJ Oct 2016). 
b. Vial #1 = denaturing lysis buffer condition 
c. Vial #2 = RIPA buffer condition 
4. Pellet cells. 
5. Resuspend cell pellets in the respective lysis buffer. 
a. You need the RIPA buffer sample for BCA assay. All of the chaotropes 
and detergents in the denaturing lysis buffer affect the readout of the BCA 
assay. 
b. Note: you will need at least 1.5 mL of each lysis solution for the upcoming 
desalting and BCA assay procedures. I recommend freezing down all 
excess lysis solution with your lysates in -20°C. 
6. Sonicate for 3 rounds of 5 seconds. 
7. Move Eppendorf tubes to centrifuge. Spin down at 14,000 g for 30 min at 4°C. 
a. DNA should collect at the bottom of the tube (semi-transparent viscous 
material). Be careful when moving Eppendorf tubes. 
8. Transfer supernatant to clean Eppendorf tubes Vials #3 and #4. 
9. <<PAUSE>> Store at -20°C. 
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Desalting 
Source (with modifications): ReadyPrep 2-D Cleanup Kit Instruction Manual, Bio-Rad 
 
Estimated Time: 1.5 hours (not including pre-procedure preparation).  
Numerous short incubation steps! 
 
Materials: 
- ReadyPrep 2-D Cleanup Kit, catalog #163-2130, Bio-Rad 
- Centrifuge and vortex 
 
Note: there are other mechanisms by which to desalt a lysate. Bio-Rad’s Bio-Spin 
Columns with Bio-Gel P-30 is also effective (see Tentori, Yamauchi, Herr Angew Chem 
2016,19 supplement page 9, section entitled “Cell Lysate Microfluidic IEF”). 
 
Steps: 
1. (at least 1 hour before) Put the large Wash Reagent 2 bottle in the -20°C freezer. 
Failure to do so will drastically affect protein yield. 
2. (recommended) Block 2+ Eppendorf tubes (1.5 mL) with 5% BSA in TBS-T for 1 
hour. Use these tubes for all procedures. 
a. This should inhibit protein adsorption. 
3. (30 minutes prior) Turn on Beckman Coulter Allegra 21R Centrifuge. Set to 4°C. 
Close and allow to cool to goal temperature. 
 
4. Thaw lysate solutions. Mix thoroughly. 
5. Transfer 100 μL of cell lysate (in denaturing lysis buffer, Vial #3) to a new 
Eppendorf tube (Vial #5).  
6. Transfer 100 μL of cell lysate (in RIPA buffer, Vial #4) to a new Eppendorf tube 
(Vial #6). 
a. Goal concentration = 1 – 500 μg protein in 100 μL lysate solution.  
b. Use BCA assay to quantify. 
7. Use Vials #5 and #6.  
8. Follow steps 2-14 (pages 5-8 of the ReadyPrep manual). 
9. Post-desalting, you should have Vials #5 and #6 for the desalted cell IEF lysate 
in denaturing lysis buffer and RIPA buffer, respectively. 
10. <<PAUSE>> Store at -20°C. Make sure to vortex extensively before use. 
BCA Assay 
Source (with modifications): Hector Neira (July 2015) and Pierce BCA Protein Assay 
instruction manual 
 
Estimated Time: 1 hour 
 
Materials: 
- Pierce BCA Protein Assay Kit (catalog #23225) 
- 96-well plate, clear flat bottom 
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- Microplate covers (Titer-Tops pre-cut, adhesive-backed polyethylene film, 
catalog #9188-6775) 
- Warm room (328 Stanley) and plate reader 
 
Steps: 
1. (recommended) Block 10+ Eppendorf tubes (0.65 mL) with 5% BSA in TBS-T for 
1 hour. Use these tubes for all procedures. 
a. Protein adsorption of standard curve solutions will affect your readings. 
2. Prepare layout of samples in 96-well plate. 
 
 
3. Prepare standard curve solutions. Start with 200 μL of 2 mg/mL BSA (glass vial 
from kit). 
Standard # BSA (μL) RIPA Buffer 
(μL) 
Final 
Volume 
Final 
Concentration 
(μg/mL) 
1 100 0 100 μL 2000 
2 50 50 100 μL 1000 
3 25 75 100 μL 500 
4 12.5 87.5 100 μL 250 
5 6.25 93.75 100 μL 125 
6 3.12 96.88 100 μL 62.5 
7 0 100 100 μL 0 
 
4. If you’re working with phosphatase / kinase / protease inhibitors, add them in 
LAST to the standard.  
a. If you mix them into the RIPA buffer before, you will end up with different 
inhibitor concentrations in your final standard solutions, which WILL affect 
your BCA results. 
5. Thaw Vial #4 (IEF cell lysate in RIPA buffer) and Vial #6 (desalted IEF cell lysate 
in RIPA buffer). 
a. Denaturing lysis buffer produces a colorimetric change stronger than the 
highest standard. 
6. Mix thoroughly. 
7. Prepare 1:10 and 1:20 dilutions of both samples. 
8. Freeze down the stock sample solutions again at -20°C. 
 
 
1 2 3 4 5 6 7 8 9 10 11 12
A
B Standard #1
Standard 
#2
Standard 
#3
Standard 
#4
Standard 
#5
Standard 
#6
Standard 
#7
Pre-
desalt 
1:10
Pre-
desalt 
1:20
Post-
desalt 
1:10
Post-
desalt 
1:20
C
D
E
F
G
H
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9. Prepare BCA Working Reagent. 
a. (7 standards + 4 unknowns) * (3 replicates) * (200 μL per well) = 6.6 mL 
b. 7 mL of BCA working reagent = 6.86 mL BCA reagent A + 140 μL BCA 
reagent B. 
10. Add 200 μL of BCA working reagent to each well. 
a. The microchannel pipette introduces error (imperfect volume handling). It 
is preferable to do this with an individual pipette. 
11. Seal plate with microplate cover to minimize evaporation. 
12. Quickly add 25 μL of standard or diluted sample to each well. 
a. Minimize bubbles! Speed is important. 
13. Seal the plate with the same microplate cover. Place it in the warm room for 30 
minutes. 
14. Meanwhile, set up for absorbance read at 562 nm. 
15. Read absorbance at 30 and 35 minutes. 
a. Export data as Excel file. 
b. At this point, you can either save this plate (for future use of unused wells) 
or dispose of it, depending on the layout of your samples. 
16. Fit linear regression to the data & calculate protein concentrations. 
 
Note: the plate reader reads each lane horizontally, then travels in an S-format across 
the rest of the plate. Put your samples in the same row as the standards for most 
accurate measurements (minimal time delay). 
 
Note: triplicates! 
 
Expected Yield: 50% losses from desalting protocol (SJ Nov 2016) 
Use of Desalted IEF Cell Lysate 
Optimal = use in scIEF, similarly to pI markers or purified protein solution 
• Dehydrate well gel completely. 
• Prepare solution of desalted IEF cell lysate with ampholytes. 
• Rehydrate in lysate-ampholyte solution (40 μL / 9 mm well gel) over ~30 minutes 
on cooling block with aluminum foil cover and hydrated Kimwipe. 
• Use immediately in scIEF platform. No rinsing! 
 
Alternate = incorporate desalted IEF cell lysate into well gel precursor solution.  
• Note: may affect gel polymerization (SJ Oct 2016). 
 
Alternate = pipet desalted IEF cell lysate on top of hydrated well gel, over  ~30 minutes 
on cooling block with aluminum cover.  
• Note: 10 minutes is insufficient (SJ Oct 2016). Resulting protein concentration 
both in well gel and in fluidic layer between well gel and lid gel may affect IEF 
results. 
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Appendix 11: MATLAB script for ultrathin IEF assay with pI markers and purified 
proteins 
These MATLAB scripts were modified from the scWB analysis scripts written and 
provided by Dr. Julea M. Vlassakis and Dr. Kevin A. Yamauchi. Modifications within 
each script are typically annotated with a descriptive note preceded by “ %TODO ”. 
Commands 
% Shaheen Jeeawoody 
% Last updated March 7, 2019 
% scWB analysis script, modified for scIEF, modified for pI markers 
 
% TODO change all instances of "filename"  
 
diary filename % record all actions 
 
struct = scIEF_roiGeneration_pI('filename.tif', 100, 3000, 0); 
% modifications: no rotation, no microwells 
 
num_peaks = 1; snr_threshold = 0.7; r2_threshold = 0.7; 
backgroundWidth = 0; struct = intProf_pI(struct, backgroundWidth); 
% modifications: manual background subtraction, manual pixel conversion 
% TODO remember to background subtract! 
% TODO remember to check the pixel conversion in intProf_pI 
 
close all 
 
% pI marker 4.5 
struct = fitPeaks (struct, num_peaks, snr_threshold); struct.R2 
struct = goodProfiles(struct, r2_threshold); 
% modifications: plot the Gaussian fits overlaid on the line-plots 
% modifications: fit one peak at a time 
 
% pI marker 5.5 
struct2 = fitPeaks (struct, num_peaks, snr_threshold); struct2.R2 
struct2 = goodProfiles(struct2, r2_threshold); 
 
% pI marker 6.6 
struct3 = fitPeaks (struct, num_peaks, snr_threshold); struct3.R2 
struct3 = goodProfiles(struct3, r2_threshold); 
 
% POST-ANALYSIS: characterize pH gradient linearity dpH/dx and R^2 of linear regression fit 
 
% extract peak centers 
pI45=struct.fit_coefficients(:,:,1); pI55=struct2.fit_coefficients(:,:,1); pI66=struct3.fit_coefficients(:,:,1); 
b(1) = pI45(2); b(2) = pI55(2); b(3) = pI66(2); b=b/1000; % convert from microns to millimeters 
pI=[4.5 5.5 6.6]; 
 
% plot linearity 
figure(5);hold on; pH=pI(1:3); gssb=b(1:3); plot(gssb, pH, 'bd-') 
xlabel('Position (mm)'); ylabel('pI marker'); title('Linearity of pH gradient at X minutes - filename'); 
lin=polyfit(gssb,pH,1); 
slope=lin(1)   % print slope of linear regression fit 
yintercept=lin(2) % print y intercept of linear regression fit 
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yfit=polyval(lin,gssb); plot(gssb,yfit,'r') 
yresid=pH-yfit; 
rsq=1-(sum(yresid.^2)/((length(pH)-1)*var(pH)))     % print R^2 of linear regression fit 
text(gssb(1)+0.1,pH(2)-0.1,strcat(['dpH/dx = ' num2str(lin(1))])); 
text(gssb(1)+0.1,pH(2)-0.2,strcat(['R^2 = ' num2str(rsq)])); 
hold off 
% TODO remember to save figure as .tif and .fig 
 
% print all relevant values 
struct.fit_coefficients 
struct2.fit_coefficients 
struct3.fit_coefficients 
% remember, sigma = c / sqrt(2) 
 
save AllVariables_filename.mat % save all variables for future use 
diary off % turn off diary 
scIEF_roiGeneration_pI 
function [struct] = scIEF2_roiGeneration_pI(filename,horzspacing,vertspacing, vert_offset) 
% This function rotates/aligns the raw image and segments the image into ROIs 
%   Outputs:   
% Struct [structure]: A data structure containing objects (3D matrix 
%   with each ROI contained in a different z, and coordinates of the ROIs) 
%   Inputs: 
% filename [string]: A string containing the name of the fluorescence image to be processed 
% horzspacing [num]: Well-to-well spacing (horizontal) 
% vertspacing [num]: Well-to-well spacing (vertical) 
% vert_offset [num]: Offset from the well center to the end of the separation  (vertical) 
  
%% versions 
% 0.1-Created April, 2016 
% 0.2 (5.15.16): Updated to apply same transform for ROI generation if user 
% inputs a struct with the fields "angle" and "rotate". 
% 0.3 (5.20.16): Added "rows" and "wells per row" fields to structure. 
% 0.4  (2017): Modified for pI markers (no rotation) 
 
% TODO deleted option for inputting script 
  
% TODO suppress warning on resizing image 
warning('off','images:initSize:adjustingMag')  
  
%TODO set protein target 
str=char('pI'); 
struct.name=str; 
  
%Load the image file in Matlab 
img=imread(filename); 
%Display more contrasted img in window 
contrasted_img=histeq(img); 
imshow(contrasted_img); 
  
% TODO no rotation 
imgrotated=img; 
size(img) 
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% TODO 
%size(img) 
  
test=1; 
% TODO modified to accommodate only 1 row of microwells 
% TODO no rotation 
    x_upperleftwell=1+horzspacing/2; 
    y_upperleftwell=1; 
    x_upperrightwell=size(img,2)-1; 
    y_upperrightwell=1; % TODO FIX 
  
%store the coordinates of the direction vector that extends from the upper left well to the right most point 
of the array 
dir_vector1=[x_upperrightwell,y_upperleftwell]-[x_upperleftwell,y_upperleftwell]; 
%store the coordinates of the direction vector that extends from the upper left well to the upper right well  
dir_vector2=[x_upperrightwell,y_upperrightwell]-[x_upperleftwell,y_upperleftwell]; 
%Find angle between the two direction vectors [angle in degrees] 
cosangle=dot(dir_vector1,dir_vector2)/(norm(dir_vector1)*norm(dir_vector2)); 
angle=acosd(cosangle); 
    if (y_upperrightwell<y_upperleftwell) 
        angle=-angle; 
    end 
     
%Rotate the image so the array is aligned 
b=imrotate(imgrotated,angle,'nearest','crop'); 
b_contrasted=histeq(b); 
imshow(b_contrasted); % TODO changed for ease of visibility from % imshow(b); 
hold on 
sz=size(b)/2; 
rotation_matrix=[cosd(-angle),-sind(-angle);sind(-angle),cosd(-angle)]; 
new_upper_left=rotation_matrix*[(x_upperleftwell-(sz(2)));(y_upperleftwell-sz(1))]; 
new_upper_right=rotation_matrix*[(x_upperrightwell-sz(2));(y_upperrightwell-sz(1))]; 
  
x_new_upper_left=new_upper_left(1)+sz(2); 
y_new_upper_left=new_upper_left(2)+sz(1) - vert_offset; 
x_new_upper_right=new_upper_right(1)+sz(2); 
y_new_upper_right=new_upper_right(2)+sz(1) - vert_offset; 
  
%generate matrix to store ROIs 
%Determine number of wells per row 
wells_per_row=round((x_new_upper_right-x_new_upper_left)/horzspacing) 
% TODO 
  
  
%Determine number of rows 
rows=1; 
  
%Determine total number of wells 
total_wells=wells_per_row*rows; 
b=imgrotated; 
%for loop to fill in the 3D matrix with ROIs from the image (proceeds row by row of the microwell array 
from left to right) 
mat=zeros(vertspacing,horzspacing,total_wells); 
for i=1:rows 
    for j=1:wells_per_row 
        z=(wells_per_row)*(i-1)+j; 
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        row_start=(round(x_new_upper_left)-horzspacing/2)+((j-1)*horzspacing); 
        row_end=row_start+horzspacing; 
        col_start=(round(y_new_upper_left)+((i-1)*vertspacing)); 
        col_end=col_start+vertspacing; 
        x=row_start:1:(row_end-1); 
        y=repmat(col_start,1,length(x)); 
        y2=col_start:1:(col_end-1); 
        x2=repmat((row_end-1),1,length(y2)); 
        mat(:,:,z)=b(col_start:(col_end-1),row_start:(row_end-1)); 
         
                plot(x',y','Color','w','LineStyle','-'); 
        plot(x',y','Color','k','LineStyle',':'); 
        plot(x2',y2','Color','w','LineStyle','-'); 
        plot(x2',y2','Color','k','LineStyle',':'); 
         
        % TODO label lane 
        text(row_start,col_start,num2str(j)); 
    end 
        % TODO label pixel values (start, 1/3, 1/2, 2/3, end) 
    text(row_end,col_start,num2str(col_start)); 
    col_t13 = (col_end - col_start) / 3 * 1 + col_start; 
    text(row_end,col_t13,num2str(col_t13)); 
    col_t12 = (col_end - col_start) / 2 * 1 + col_start; 
    text(row_end,col_t12,num2str(col_t12)); 
    col_t23 = (col_end - col_start) / 3 * 2 + col_start; 
    text(row_end,col_t23,num2str(col_t23)); 
    text(row_end,col_end,num2str(col_end)); 
end 
  
struct.rois=mat; 
struct.vert_offset = vert_offset; 
  
% TODO save image, using protein target name & filename, assuming .tif 
fn = strsplit(filename,'.tif'); 
struct.filename = strjoin(strcat(fn(1), '_', str)); 
imgname = strjoin(strcat(fn(1), '_', str, '_roiGeneration')); 
print(figure(1),imgname,'-dtiffn'); 
 
end 
intProf_pI 
function [struct] = intProf_pI(struct,subtract) 
%Generate intensity profiles from the ROI stacks in the output of roiGeneration 
% and perform background subtraction on the profiles 
% Outputs 
%Struct [structure]: A data structure containing objects (Intensity profiles for each ROI, 3D matrix  
% with each ROI contained in a different z, and coordinates of the ROIs) 
% Inputs 
%Struct [structure]: The data structure from roiGeneration containing the ROIs for each lane 
mat=struct.rois; 
[x_dim,y_dim,z_dim]=size(mat); 
int_profiles=zeros(x_dim,2,z_dim); 
  
%pix_conversion is the number of microns per pixel 
pix_conversion=4; % ONYX 4X objective with 2x binning, confirmed SJ 
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%pix_conversion=1.6; % ONYX 10X objective with 2x binning, confirmed SJ 
 
% for loop to generate the intensity profiles for each ROI in the z-stack of the matrix Mat. 
% The intensity profile is an average of the pixel intensities across the short-axis of the ROI.  
figure 
for i=1:z_dim 
    lane=mat(:,:,i); 
    dist=(0:pix_conversion:pix_conversion*(x_dim-1)); 
    int=sum(lane,2); 
    avg_int=int/(y_dim); 
    bsub_int=avg_int-subtract; % TODO changed for pI markers: manual background subtraction 
    lane_profile=[dist',bsub_int]; 
    int_profiles(:,:,i)=lane_profile; 
    plot(dist',bsub_int); 
    hold on 
end 
struct.int_prof=int_profiles; 
end 
fitPeaks 
%% Header 
%   Inputs: data_struct: data structure containing the data set with the following fields: 
%   - int_prof: matrix containing the intensity profiles 
%   - num_peaks (optional): number of expected peaks can be 1, 2, or 3. Default is 1 
%   - snr_threshold(optional): Threshold value of signal-to-noise ratio (SNR). Lanes with at least 1 peak  
%     with an estimated SNR greater than the threshold value will be curve fit. Typical threshold value is 3. 
  
%   Outputs: data_struct: data structure containing the data set with the following fields: 
%    - int_prof: matrix containing the intensity profiles (unchanged) 
%    - good_devices: boolean vector indicating the good devices  
%    - fit_coefficients: m x 3 x p matrix containing the gaussian fit coefficients. m is the number of peaks  
%      and p is the number of good devices (good_devices) 
%    - R2: m x 1 matrix containing the R^2 values of the Gaussian fits. m is the number of good devices  
%      (good_devices) 
%   Versions: - 0.1 (4.7.16) Function created 
%     - 0.2 Now should be called before goodProfiles() 
%     - 0.3 (5.15.16) Data between the user selected  peak boundaries is now used for the gaussian fit  
%       (instead of the entire intensity profile). 
 
function data_struct = fitPeaks(data_struct, num_peaks, snr_threshold) 
%% Check input arguments 
switch nargin 
    % If only the data_structure is provided, set num_peaks = 1 
    case 1 
        num_peaks = 1; 
    % If provided, ensure the number of peaks is valid 
    case 2 
        % Exit function if an invalid number of peaks is input 
        if ((num_peaks > 3) || (num_peaks < 1)) 
            error('Invalid number of peaks'); 
            return 
        end 
        %If only 2 input arguments provided, user does not want to run the SNR threshold 
        apply_snr_threshold=0; 
    case 3 
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        apply_snr_threshold=1; 
    otherwise 
        error('Invalid number of input arguments'); 
        return 
end 
 
%% Get the peaks 
% Get the intensity profiles 
try  
    intensity_profiles = data_struct.int_prof; 
catch  
    error('Error accessing data_struct.int_prof'); 
end 
  
% Find all of the good wells 
[x_dim,y_dim,z_dim]=size(intensity_profiles); 
%store to the structure the starting number of wells analyzed 
struct.total_wells=z_dim; 
 
if apply_snr_threshold==1     
    % for loop to filter out SNR<3 lanes with a conservative SNR estimate calculated from the max  
    % intensity of a smooth data set and the standard deviation of the last 5 pixels of the lane. 
    snr3_devices=zeros(z_dim,1); 
    snr_est=zeros(z_dim,1); 
    %figure 
        for i=1:z_dim 
            device=intensity_profiles(:,:,i); 
            xval=device(:,1); 
            yval=device(:,2); 
            yvalsmooth=smooth(yval); 
            noise_est=std(yval(end-5:end)); 
            signal_est=max(yvalsmooth); 
            snr_est(i)=signal_est/noise_est; 
                if snr_est(i)<snr_threshold 
                    snr3_devices(i)=0; 
                else 
                    snr3_devices(i)=1; 
                    %plot(xval,yval); 
                    %hold on 
                end 
        end 
    struct.snr_est=snr_est; 
     
    % Get the number of good wells 
    num_good_devices = sum(snr3_devices); 
    good_indices=find(snr3_devices==1); 
 
    % Exit if there are no good wells 
    if (num_good_devices == 0) 
        error('No good wells in data_struct'); 
    end 
else 
    num_good_devices=ones(z_dim,1); 
    good_indices=find(num_good_devices==1); 
end 
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% Save the good indices 
data_struct.good_indices = good_indices; 
  
%% Get the seed parameters 
% Let the user select the points for the parameter estimation 
bounds_set = false; 
while (~bounds_set) 
    % Plot the good devices 
    figure(1); 
    hold on 
    for i = 1:num_good_devices 
        device_index = good_indices(i); 
        plot(intensity_profiles(:,1, device_index),... 
            intensity_profiles(:,2, device_index), '-k'); 
    end 
    hold off 
    uiwait(msgbox('Please select left and right boundaries of each peak')); 
     
    % Get the limits of the plot 
    y_lim = get(gca, 'YLim'); 
     
    % Preallocate the nx2 matrix to hold the peak bounds, where n is the 
    % number of peaks. Col 1 is the left bound, col 2 is the right bound 
    peak_bounds = zeros(num_peaks, 2); 
    for peak = 1:num_peaks 
        % Get the left peak boundary 
        [x1, y1] = ginput(1); 
        % Draw the selected peak boundary 
        line([x1, x1], y_lim, 'Color', [0, 0, 1]); 
        % Get the right peak boundary 
        [x2, y2] = ginput(1); 
        % Draw the selected peak boundary 
        line([x2, x2], y_lim, 'Color', [0, 1, 0]); 
        % Save the selected bounds 
        peak_bounds(peak, :) = [x1, x2]; 
    end 
     
    % Ask if the peaks are correct 
    choice = questdlg('Are the peak bounds correct?',  'Done with bound selection?', 'Yes', 'No','No'); 
    close 
    % If they are done, exit loop 
    if (strcmp(choice, 'Yes')) 
        bounds_set = true; 
    end 
end 
  
% TODO save fitPeaks image 
%fn = struct.filename; 
%imgname = strjoin(strcat(fn, '_fitPeaks')); 
%print(figure(2),imgname,'-dtiffn'); 
 
close all; 
  
% Save the bounds 
data_struct.fit_bounds = peak_bounds; 
%% Create the fit options 
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% Create the fit options object with the specified number of peaks 
switch num_peaks 
    case 1 
        fit_type = 'gauss1'; 
    case 2 
        fit_type = 'gauss2'; 
    case 3 
        fit_type = 'gauss3'; 
end 
fit_options = fitoptions(fit_type);   
  
% Assign the locations to the fit options object 
for peak = 1:num_peaks 
    % Get the left and right bound for the peak 
    left_bound = peak_bounds(peak, 1); 
    right_bound = peak_bounds(peak, 2); 
    % Set the sigma bounds 
    sigma_min = 0; 
    sigma_max = right_bound - left_bound; 
    % Set the peak center bounds 
    x_min = left_bound; 
    x_max = right_bound; 
    % Set the amplitude bounds 
    a_min = 0; 
    a_max = y_lim(2); 
    % set the upper and lower bounds. correct for difference in c and sigma terms 
    fit_options.Lower = [a_min, x_min, (sigma_min * sqrt(2))]; 
    fit_options.Upper = [a_max, x_max, (sigma_max * sqrt(2))]; 
end 
  
%% Fit each peak 
% Preallocate the m x 3 x p matrix for the fit coefficients were m is the number of peaks per roi and  
% p is the number of ROIs and col 1 is the amplitude, col 2 is the peak center, and col 3 is sigma 
data_struct.fit_coefficients = zeros(num_peaks, 3, length(good_indices)); 
  
% Preallocate the m x 1 matrix for the R^2 values for each fit where m is the number of good devices 
data_struct.R2 = zeros(num_good_devices, 1); 
  
for i = 1:num_good_devices 
    device_index = good_indices(i); 
         %Display the device number every 50 devices 
    %if(mod(i, 10) == 0) 
        %fprintf('Fitting lane %d/%d\n', i, num_good_devices); 
    %end 
 
    % Get the x and y values 
    x = intensity_profiles(:,1, device_index); 
    y = intensity_profiles(:,2, device_index); 
    %Determine index of x_min and x_max for selection of x and y values in the region of the peak 
    left_diff=abs(x-x_min); 
    left_data=find(left_diff==min(left_diff)); 
    right_diff=abs(x-x_max); 
    right_data=find(right_diff==min(right_diff)); 
    %Get the x and y values in the peak region 
    x_fit=x(left_data:right_data); 
    y_fit=y(left_data:right_data); 
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    % Fit the peaks 
    [fit_object, gof] = fit(x_fit, y_fit, fit_type, fit_options); 
    % Get the coefficients 
    fit_coeffs = coeffvalues(fit_object); 
    % Save the coefficients 
    for peak = 1:num_peaks 
        coeff_index_start = (peak - 1)*3 + 1; 
        coeff_index_end = peak * 3; 
        %get peak center and width for AUC calculation 
        center=fit_coeffs(coeff_index_end-1); 
        sigma=fit_coeffs(coeff_index_end); 
        width=sigma/sqrt(2); 
        %determine location of +/- 2 peak widths from the peak center 
        auc_left_bound=center-2*width; 
        auc_right_bound=center+2*width; 
        %Determine index of auc_left_bound and auc_right_bound for selection of x and y values in 
        %the region of the peak 
        left_diff_auc=abs(x-auc_left_bound); 
        left_data_auc=find(left_diff_auc==min(left_diff_auc)); 
        right_diff_auc=abs(x-auc_right_bound); 
        right_data_auc=find(right_diff_auc==min(right_diff_auc)); 
        % Make sure the left bound is within the array 
        if (left_data_auc < 1) 
           left_data_auc = 1;  
        end 
        % Check to make sure the AUC bounds are within the bounds of the array 
        if (right_data_auc > length(y)) 
            right_data_auc = length(y); 
        end 
        %Sum data within the peak bounds 
        peak_region_intensities=y(left_data_auc:right_data_auc); 
        AUC(peak,1,i)=sum(peak_region_intensities); 
        data_struct.fit_coefficients(peak, :, i) = fit_coeffs(coeff_index_start:coeff_index_end); 
        data_struct.AUC(peak,1,i)=AUC(peak,1,i); 
    end 
    data_struct.R2(i) = gof.rsquare; % Save the R^2 value 
end 
end 
goodProfiles 
function [data_struct] = goodProfiles(data_struct,r2_threshold) 
%perform quality control on intensity profiles, removing lanes with SNR<3 
%and allowing the user to select lanes to remove upon visual inspection 
%   Outputs 
%Struct [structure]: A data structure containing objects (indices of “good” lanes, intensity profiles for each  
% ROI, 3D matrix with each ROI contained in a different z, and coordinates of the ROIs) 
%Inputs 
%struct [structure]: A structure containing the intensity profiles generated in intProf 
% v04 
  
%% Check input arguments 
switch nargin 
    % If only the data_structure is provided, set r2_threshold = 0.7 
    case 1 
        r2_threshold = 0.7; 
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    % If provided, ensure the r2 value is valid 
    case 2 
        % Exit function if an invalid r2 value is input 
        if ((r2_threshold<0) || (r2_threshold > 1)) 
            error('Invalid R^2 value'); 
            return 
        end 
end        
  
int_prof_all=data_struct.int_prof; 
[x_dim,y_dim,z_dim]=size(int_prof_all); 
r2=data_struct.R2; 
good_r2=find(r2>=r2_threshold); 
  
%determine array position of high r2 value fit lanes 
good_indices=data_struct.good_indices; 
good_fits=good_indices(good_r2); 
  
good_int_profiles=zeros(x_dim,y_dim,length(good_r2)); 
for i=1:length(good_r2) 
    good_int_profiles(:,:,i)=int_prof_all(:,:,good_fits(i)); 
end 
  
%set number of rows/columns of subplots to display in each figure window 
n=1; % TODO changed for scIEF, original n=5 (too few lanes in scIEF) 
num_subplots=n*n; 
plots_display=length(good_r2); 
good_devices=ones(length(good_r2),1); 
number_subplots=ceil(plots_display/(n*n)); 
dev_to_analyze=zeros(z_dim,1); 
good_subplots = ones(plots_display,1); 
disp(number_subplots); 
  
% for loop to generate subplots for user inspection of the intensity profiles 
for i=1:number_subplots 
    disp(i); 
    figure 
    if i==1 
        devices_subplot=(1:(n*n)); 
    elseif i*n*n<=plots_display 
        devices_subplot=((i*n*n)-(n*n)+1):((i*n*n)); 
    else  
        devices_subplot=((i*n*n)-(n*n)):(plots_display); 
    end 
    next=0; 
   for j=1:length(devices_subplot) 
            dev_number=devices_subplot(j); 
            device=good_int_profiles(:,:,dev_number); 
            xval=device(:,1); 
            yval=device(:,2); 
            subplot(n, n, j); 
            plot(xval,yval,'LineWidth',2,'Tag', sprintf('%d', dev_number), 'buttondownfcn',... 
            @clickTest); 
  
            % TODO label lane & R2 
            hold on 
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            lane = good_fits(dev_number); 
            r2_lane = r2(lane); 
            title(strcat('lane=',num2str(lane),' and r2=',num2str(r2_lane))); 
             
            % TODO show Gaussian fits 
            % f(x)=a1*exp(-((x-b1)/c1)^2) 
            pgggg = length(data_struct.fit_coefficients(:,1,lane)); 
            for pGSS = 1:1:pgggg 
                a=data_struct.fit_coefficients(pGSS,1,lane); 
                b=data_struct.fit_coefficients(pGSS,2,lane); 
                c=data_struct.fit_coefficients(pGSS,3,lane); 
                x=data_struct.int_prof(:,1,lane); 
                gaussFit=a*exp((-((x-b)./c).^2)); 
                plot(x,gaussFit); 
            end 
            legend ('lane','Gaussian fit'); 
            % axis([2500 4000 0 5000]); 
             
            hold off 
    end 
    next=0; 
     
    btn = uicontrol('Style', 'pushbutton', 'String', 'Next', 'Position', [500 15 50 30],... 
        'Callback',@continueButton2); 
    while next==0    
        pause(0.01); 
    end 
    %good_devices(devices_subplot(1):devices_subplot(end))=good_subplots; 
close(gcf)     
end  
  
data_struct.dev_to_analyze = good_subplots; 
good_subplot_ind=find(good_subplots==1); 
data_struct.index_dev_to_analyze=good_r2(good_subplot_ind); 
end 
 
function [next]=continueButton2(qstring,title,str1,str2,default) 
qstring='Are you done selecting devices to throw out?'; 
title='Device Quality Control'; 
str1='Yes'; 
str2='No'; 
default='Yes'; 
choice = questdlg(qstring,title,str1,str2,default); 
                % Handle response 
                    switch choice 
                        case 'Yes'; 
                            disp([choice 'Great, let''s keep going then!']) 
                            next=1; 
                        case 'No'; 
                            disp([choice 'Okay, please finish selecting devices to throw out']) 
                            next=0; 
                    end 
assignin('caller', 'next', next); 
end 
 
function clickTest(line_handle, event) 
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  good_subplots = evalin('caller', 'good_subplots'); 
  current_tag = get(line_handle, 'Tag'); 
  %split_tag = strsplit(current_tag, ','); 
  subplot_num = str2num(current_tag); 
  %subplot_state = str2num(split_tag{1, 2}); 
  subplot_state = good_subplots(subplot_num); 
  disp(sprintf('%d, %d', subplot_num, subplot_state)); 
  % Toggle the selection based on the last character in the tag  
  % (0 = off, 1 = on) 
  if (subplot_state) 
     set(line_handle, 'Color', [1, 0, 0]); 
     good_subplots(subplot_num) = 0; 
  else 
     set(line_handle, 'Color', [0, 0, 1]); 
     good_subplots(subplot_num) = 1; 
  end 
%  disp(good_subplots); 
  assignin('caller', 'good_subplots', good_subplots); 
end 
Appendix 12: MATLAB script for ultrathin scIEF assay with cells 
These MATLAB scripts were modified from the scWB analysis scripts written and 
provided by Dr. Julea M. Vlassakis and Dr. Kevin A. Yamauchi. Modifications within 
each script are annotated with a descriptive note preceded by “ %TODO ”. 
Commands 
diary on 
struct = scIEF_roiGeneration('run001.tif', 100, 1700, 0); 
Wells are right of bands  
 
num_peaks = 3; % I usually analyze 1 peak at a time. This is set up for 3 tGFP peaks. 
snr_threshold = 0.5; r2_threshold = 0.5; % set to 0.7 for high selectivity 
struct = intProf_cells(struct); 
close Figure 1 
 
struct = fitPeaks (struct, num_peaks, snr_threshold); 
 
struct.R2 
struct = goodProfiles(struct, r2_threshold); 
 
struct.dev_to_analyze 
struct.index_dev_to_analyze 
 
lane = 11; % choose the lane for which you want to report stats  
struct.fit_coefficients(:,:,lane) 
struct.int_prof(:,:,lane) 
 
save AllVariables_run001.mat 
scIEF_roiGeneration 
function [struct] = scIEF_roiGeneration(filename,horzspacing,vertspacing, vert_offset) 
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%This function rotates/aligns the raw image and segments the image into ROIs 
%   Outputs:   
%Struct [structure]: A data structure containing objects (3D matrix 
%with each ROI contained in a different z, and coordinates of the ROIs) 
%   Inputs: 
%filename [string]: A string containing the name of the fluorescence image to be processed 
%horzspacing [num]: Well-to-well spacing (horizontal) 
%vertspacing [num]: Well-to-well spacing (vertical) 
%vert_offset [num]: Offset from the well center to the end of the separation  (vertical) 
  
%% versions 
% 0.1-Created April, 2016 
% 0.2 (5.15.16): Updated to apply same transform for ROI generation if user 
% inputs a struct with the fields "angle" and "rotate". 
%0.3 (5.20.16): Added "rows" and "wells per row" fields to structure. 
% 0.4 (2017): adapted for single row of microwells for scIEF 
 
% TODO deleted option for inputting script 
  
% TODO suppress warning on resizing image 
warning('off','images:initSize:adjustingMag')  
  
%ask the user the name of their protein target 
prompt = 'What is the name of your protein target?'; 
str = input(prompt,'s'); 
struct.name=str; 
  
%Load the image file in Matlab 
img=imread(filename); 
%Display more contrasted img in window 
contrasted_img=histeq(img); 
imshow(contrasted_img); 
 
% TODO remove rotation option 
imgrotated=img; 
  contrasted_img_r=histeq(imgrotated); 
  imshow(contrasted_img_r); 
  size(imgrotated) 
test=1; 
  
% TODO modified to accommodate only 1 row of microwells 
while test==1 
    %Prompt user to select the upper right well of the array.  
    title('Please zoom in on the middle of the upper left well and press any key.'); 
    zoom on;   % use mouse button to zoom in or out 
    pause() 
    zoom off; 
    title('Please click on the middle of the upper left well.'); 
    [x_click,y_click]=ginput(1); 
    x_upperleftwell=x_click; 
    y_upperleftwell=y_click; 
    zoom out; 
    %Prompt user to select the upper right well  
    title('Please zoom in on the middle of the upper right well and press any key.') 
    zoom on;   % use mouse button to zoom in or out 
    pause() 
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    zoom off; 
    title('Please click on the middle of the upper right well.'); 
    [x_click,y_click]=ginput(1); 
    x_upperrightwell=x_click; 
    y_upperrightwell=y_click; % TODO modified for no rotation 
    % y_upperrightwell=y_upperleftwell; % TODO modified for no rotation 
    zoom out; 
     
    % Construct a questdlg to ask the user if they are happy with their well selection 
    choice = questdlg('Are you happy with your well selections?', 'Well selections for array boundaries', ... 
   'Yes','No','Yes'); 
        % Handle response 
        switch choice 
            case 'Yes'; 
                disp([choice 'Great, let''s keep going then!']) 
                test = 0; 
            case 'No'; 
                disp([choice 'That''s okay, try again!']) 
                test = 1; 
        end 
    if (x_upperrightwell<x_upperleftwell)         
        test=1; 
        title('Oh no! We detected you selected the wells in the wrong order. Please try again. Press any key 
to continue') 
        pause() 
    else 
        test=0; 
    end 
end 
  
%store the coordinates of the direction vector that extends from the upper left well to the right most point 
of the array 
dir_vector1=[x_upperrightwell,y_upperleftwell]-[x_upperleftwell,y_upperleftwell]; 
%store the coordinates of the direction vector that extends from the upper left well to the upper right well  
dir_vector2=[x_upperrightwell,y_upperrightwell]-[x_upperleftwell,y_upperleftwell]; 
%Find angle between the two direction vectors [angle in degrees] 
cosangle=dot(dir_vector1,dir_vector2)/(norm(dir_vector1)*norm(dir_vector2)); 
angle=acosd(cosangle); 
    if (y_upperrightwell<y_upperleftwell) 
        angle=-angle; 
    end 
     
%Rotate the image so the array is aligned 
b=imrotate(imgrotated,angle,'nearest','crop'); 
b_contrasted=histeq(b); 
imshow(b_contrasted); % TODO CHANGE BACK IF YOU WANT 
% imshow(b); %  
hold on 
sz=size(b)/2; 
rotation_matrix=[cosd(-angle),-sind(-angle);sind(-angle),cosd(-angle)]; 
new_upper_left=rotation_matrix*[(x_upperleftwell-(sz(2)));(y_upperleftwell-sz(1))]; 
new_upper_right=rotation_matrix*[(x_upperrightwell-sz(2));(y_upperrightwell-sz(1))]; 
x_new_upper_left=new_upper_left(1)+sz(2); 
y_new_upper_left=new_upper_left(2)+sz(1) - vert_offset; 
x_new_upper_right=new_upper_right(1)+sz(2); 
y_new_upper_right=new_upper_right(2)+sz(1) - vert_offset; 
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%generate matrix to store ROIs 
%Determine number of wells per row 
wells_per_row=round((x_new_upper_right-x_new_upper_left)/horzspacing) 
 
% TODO only one row of microwells 
%Determine number of rows 
rows=1; 
%Determine total number of wells 
total_wells=wells_per_row*rows; 
%for loop to fill in the 3D matrix with ROIs from the image (proceeds row by row of the microwell array 
from left to right) 
mat=zeros(vertspacing,horzspacing,total_wells); 
for i=1:rows 
    for j=1:wells_per_row 
        z=(wells_per_row)*(i-1)+j; 
        row_start=(round(x_new_upper_left)-horzspacing/2)+((j-1)*horzspacing); 
        row_end=row_start+horzspacing; 
        col_start=(round(y_new_upper_left)+((i-1)*vertspacing)); 
        col_end=col_start+vertspacing; 
        x=row_start:1:(row_end-1); 
        y=repmat(col_start,1,length(x)); 
        y2=col_start:1:(col_end-1); 
        x2=repmat((row_end-1),1,length(y2)); 
        mat(:,:,z)=b(col_start:(col_end-1),row_start:(row_end-1)); 
        plot(x',y','Color','w','LineStyle','-'); 
        plot(x',y','Color','k','LineStyle',':'); 
        plot(x2',y2','Color','w','LineStyle','-'); 
        plot(x2',y2','Color','k','LineStyle',':'); 
         
        % TODO label lane 
        text(row_start,col_start,num2str(j)); 
    end 
     
    % TODO label pixel values (start, 1/3, 1/2, 2/3, end) 
    % for ease of consultation for peak identification in fit_peaks 
    text(row_end,col_start,num2str(col_start)); 
    col_t13 = (col_end - col_start) / 3 * 1 + col_start; 
    text(row_end,col_t13,num2str(col_t13)); 
    col_t12 = (col_end - col_start) / 2 * 1 + col_start; 
    text(row_end,col_t12,num2str(col_t12)); 
    col_t23 = (col_end - col_start) / 3 * 2 + col_start; 
    text(row_end,col_t23,num2str(col_t23)); 
    text(row_end,col_end,num2str(col_end)); 
end 
struct.rois=mat; 
struct.vert_offset = vert_offset; 
  
% TODO save image, using protein target name & filename, assuming .tif 
fn = strsplit(filename,'.tif'); 
struct.filename = strjoin(strcat(fn(1), '_', str)); 
imgname = strjoin(strcat(fn(1), '_', str, '_roiGeneration')); 
print(figure(1),imgname,'-dtiffn'); 
 
figure; imshow(b);  
end 
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intProf_cells 
function [struct] = intProf_cells(struct,backgroundwidth) 
%Generate intensity profiles from the ROI stacks in the output of roiGeneration 
% and perform background subtraction on the profiles 
% Outputs 
%Struct [structure]: A data structure containing objects (Intensity profiles for each ROI, 3D matrix with  
%each ROI contained in a different z, and coordinates of the ROIs) 
% Inputs 
%Struct [structure]: The data structure from roiGeneration containing the ROIs for each lane 
%backgroundWidth [num]: width of the background region for axial background subtraction (in pixels) 
mat=struct.rois; 
[x_dim,y_dim,z_dim]=size(mat); 
int_profiles=zeros(x_dim,2,z_dim); 
  
%pix_conversion is the number of microns per pixel 
pix_conversion=5; % FOR CELLS -- GENEPIX 
 
% for loop to generate the intensity profiles for each ROI in the z-stack of the matrix Mat. The intensity  
% profile is an average of the pixel intensities across the short-axis of the ROI. The background regions  
% are defined by the parameter backgroundWidth, and the average pixel intensity in the left and 
% right background regions are calculated. The background subtracted intensity profile is generated by  
% subtracting the mean background intensity at each point along the long-axis of the ROI from the  
% average pixel intensity. 
figure 
for i=1:z_dim 
    lane=mat(:,:,i); 
    dist=(0:pix_conversion:pix_conversion*(x_dim-1)); 
    int=sum(lane,2); 
    avg_int=int/(y_dim); 
    left_backgroundregion=lane(:,(1:backgroundwidth));  
    right_backgroundregion=lane(:,(((end+1)-backgroundwidth):end)); 
    left_background_int=(sum(left_backgroundregion,2))/backgroundwidth; 
    right_background_int=sum(right_backgroundregion,2)/backgroundwidth; 
    mean_background=(left_background_int+right_background_int)/2; 
 
    bsub_int=avg_int-mean_background; 
    lane_profile=[dist',bsub_int]; 
    int_profiles(:,:,i)=lane_profile; 
     
    plot(dist',bsub_int); 
    hold on 
end 
struct.int_prof=int_profiles; 
end 
fitPeaks and goodProfiles 
See Appendix 11. 
 
  
 175 
Appendix 13: Characterization of background fluorescence in PA gels 
Researchers in the Herr lab have observed high background and noise in fluorescence 
channels in polyacrylamide (PA) gels used in the single-cell Western blotting (scWB) 
and single-cell isoelectric focusing (scIEF) assays, with the subsequent immunoblot. In 
these gels, background is defined as the average fluorescence intensity in areas of the 
gel sufficiently far away from fluorescently-labeled protein bands; noise is defined as the 
standard deviation of the average fluorescence intensity in the background regions. 
During the analysis of scWB and scIEF gels, the background is subtracted from the gel, 
to distinguish the fluorescence signal contribution of the gel from the fluorescence signal 
of the proteins focused and immobilized in the gel. High noise in the fluorescence 
channels from the gel affects the signal-to-noise ratio (SNR) of these assays and 
obscures the fluorescence signal from low-abundance protein isoforms, which increases 
the lower limit of detection (LLOD) of these assay. In order to use these PA gels for 
interrogations of biologically relevant proteins, it is important to characterize the source 
of this high background and noise, especially if this might be due to entropic trapping of 
antibodies within the heterogeneous PA gel network.93 Thus, in a short study, we 
interrogated the source of that high background and noise from PA gels used for protein 
separations with an immunoblot. 
Methods 
We defined three groups of gels: gels in the “A” group contain BPMA and were exposed 
to UV; “B” group contain BPMA but were not exposed to UV; “C” group do not contain 
BPMA and were exposed to UV. The gel formulations used in this study included the 
6%T 3.3%C PA gels polymerized with APS/TEMED, termed “standard gel.” In addition, 
we compared these gels to 6%T 8%C gels polymerized with LAP and with added 
soluble 0%, 0.5%, 1%, 1.5%, or 2% PEG in the precursor, referred to by the % PEG 
content. These gels were also used in Chapter 4, and are listed in Table 10-1 and 
Table 10-2 for clarity. 
 
This study used the same materials listed in Chapter 4. We fabricated a wafer with SU-
8 rails of 40 µm, spaced 22 mm apart, coated with GelSlick® to avoid gel adhesion to 
the wafer. We fabricated gels on the wafer and incubated the gels in 1× TBS-T for 12 
hours for diffusive removal of soluble PEG. These gels were not exposed to protein at 
any point. These gels were imaged on the GenePix 4300A microarray scanner 
(Molecular Devices) for fluorescence in both the 488 and the 647 channels. A subset of 
gels was UV-exposed to activate the BPMA protein immobilization moieties within the 
gels, rinsed for 1 hour in 1× TBS-T, and imaged a second time. Subsequently, all gels 
were exposed to a 1:26.6 dilution (final 500 nM) of secondary polyclonal antibody 
AlexaFluor-647-labeled donkey-anti-mouse (Invitrogen A-31571) for 1 hour, then rinsed 
for 1 hour in TBS-T. The gels were then imaged a last time. Images were analyzed 
using an in-house Fiji script. Briefly, each well was segmented into a region of interest 
(ROI) avoiding edges. For each ROI, we measured average fluorescence intensity, 
defined as “background,” and the standard deviation of the fluorescence intensity, 
defined as “noise.” For the images acquired by the GenePix scanner, 1 pixel is 5 μm × 5 
μm.  
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Table 10-1. Gel nomenclature for the brief study on gel background and noise. 
 
Gel nomenclature Standard gel 0% 
PEG 
0.5% 
PEG 
1.0% 
PEG 
1.5% 
PEG 
2.0% 
PEG 
Acrylamide content 6%T 6%T 6%T 6%T 6%T 6%T 
Bisacrylamide : 
acrylamide ratio 
3.3%C 8%C 8%C 8%C 8%C 8%C 
10 kDa PEG 0.0% 0.0% 0.5% 1.0% 1.5% 2.0% 
Polymerization 
chemistry 
APS/TEMED LAP LAP LAP LAP LAP 
BPMA photo-
immobilization moiety 
5 mM 5 mM 5 mM 5 mM 5 mM 5 mM 
 
Table 10-2. Conditions of gel exposure for the brief study on gel background and noise.  
 
Category BMPA content UV exposure AlexaFluor-647-
labeled antibody 
exposure 
C Yes Yes Yes 
B Yes No Yes 
C No Yes Yes 
Results 
For the standard PA gels, we observed higher background and noise in the 488 channel 
than in the 647 channel (Figure 10-1A, B). This is of interest, considering that these 
gels were not exposed to any fluorescently-labeled protein at any point, and were only 
exposed to an AlexaFluor-647-labeled secondary antibody at the last stage (red bars). 
 
Additionally, we isolated the increased background and noise to gels both containing 
BPMA and exposed to UV (group “A” in Figure 10-1C, D). Minimal contribution to the 
background and noise was observed from the PA gels not containing BPMA, termed 
group “C”. After discussions with multiple Herr lab members, interrogation of the 
literature,90,335 and independent research completed by Alison Su, a PhD candidate in 
the Herr lab, the current hypothesis is that upon UV exposure, the BPMA may form 
benzopinacol moieties with neighboring BPMA molecules, which would have increased 
fluorescence. Further research is needed to elucidate the exact source of this UV-
induced fluorescence increase in these PA gels. 
 
The background and noise decreased in the LAP-polymerized, PEG-containing gels 
compared to the standard gels (Figure 10-2), indicating a potential use of the LAP-
polymerized gels as an improved substrate for immunoblotting. Chapter 4 includes 
further characterization of these gels towards application in the scIEF immunoblot. 
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A 
 
B 
 
 
C 
 
D 
 
Figure 10-1. Increases in background and noise from standard PA gels were observed specifically 
from UV exposure of gels containing BPMA. 
(A) In the standard 6%T 3.3%C APS/TEMED gel, background signal in only the 488 channel increased 4-
fold due to UV exposure alone, and 5-fold due to the combination of UV exposure and exposure to 
AlexaFluor-647-labeled antibody. The background signal in the 647 channel did not increase after UV 
exposure alone, and increased 14-fold after both UV and AlexaFluor-647-labeled antibody exposure. (B) 
The noise in the 488 channel for the standard gels increased 4-fold due to UV exposure alone, and 5-fold 
from the combined exposure. The noise in the 647 channel did not increase after UV exposure alone, and 
increased 18-fold after the combined exposure. These increase in background did not occur in gels 
containing BPMA but not exposed to UV, nor in gels not containing BPMA and exposed to UV, in the (C) 
488 channel and (D) 647 channel. 
 
A 
 
B 
 
C 
 
 
Figure 10-2. High background and noise from the PA gel immunoblots were decreased several 
fold in the LAP-polymerized PA gels. 
Ratio of in-gel fluorescent signal (AFU) post-antibody-incubation / pre-antibody-incubation for 
polyacrylamide gels in a protein-free platform indicates (A) a 2-fold decrease in background signal, (B) a 
4-fold decrease in noise, and (C) more than a 10-fold decrease in noise scaled by the antibody 
concentration in gel from the standard PA gels to the 2% PEG gels. 
 
 178 
Appendix 14: Preliminary efforts towards the delivery of an IEF protein ladder via 
protein microparticles in the ultrathin IEF assay 
This research was conducted in collaboration with Dr. Peggy Chan. 
 
For improved characterization of reproducibility between IEF experiments, we attempted 
to use the protein microparticles developed by Dr. John Kim, Dr. Peggy Chan, and 
others143 to deliver an IEF protein ladder to the ultrathin IEF assay. Briefly, this method 
involves the conjugation of His-tagged proteins to microparticles (10 μm diameter) 
conjugated with a Ni surface chemistry. These microparticles are incorporated in the 
solution of singularized cells and settled into the microwells along with the cells. The 
lysis solution with the cell-relevant detergents is supplemented with a high concentration 
of imidazole, which outcompetes the His tags for the Ni, thus releasing the proteins from 
the microparticle surface.143 
Methods 
The materials used in this study are all included in Chapter 4, as well as imidazole 
(Sigma 792527), PureProteome nickel magnetic microparticles, 10 µm (Sigma), 
recombinant Protein G with His Tag (Abcam, 26 kDa), and Alexa Fluor 647 NHS ester 
labeling kit (Life). His-tagged Protein G was labeled in-house with AlexaFluor-647, and 
conjugated onto the microparticles. 
 
As described in Chapter 4, the same silicon wafer with rails was used to fabricate 6%T 
3.3%C PA gels chemically polymerized with APS/TEMED. The ultrathin IEF was 
conducted as previously described19 with minor modifications to accommodate purified 
protein solutions (further details in Appendix 3) and the protein-G-laden microparticles. 
Briefly, gels of height 40 µm were briefly rinsed in DI water, with the fluid layer wicked 
off the top of the gel, then microparticles were settled on top of the gel for 30 minutes at 
room temperature, protected from light. The 3-component IEF lid was fabricated using a 
1:100 dilution of the stock 40% SinuLyte® ampholytes for a final concentration of 0.4% 
and 250 mM imidazole. Table 10-3 lists the components of the lid gel, which was 
polymerized for 4 minutes per component (in the order of catholyte, anolyte, and 
focusing region) at 20 mW/cm2 light intensity using a 390 nm UV long-pass filter 
(Edmund Optics) on an OAI Model 30 Collimated UV light source. 
 
The PA gel and lid gel were assembled in the IEF device previously described,19 and 
set on an Olympus IX-71 inverted microscope with an Olympus UPlanFi 4× (NA 0.13) 
objective and a EMCCD Camera iXon2 (Andor), with imaging settings loaded into 
MetaMorph software (7.10.1.161, Molecular Devices). After a 30 second delay for the 
soluble reagents in the focusing lid gel to diffuse into the PA gel, IEF was conducted by 
applying 690 V for 12 minutes using the Power-Pac high-voltage power supply device 
(HVPS, Bio-Rad 1645056). During this focusing period, Protein G was imaged using a 
Cy5 filter cube (Chroma 49009). The lab markers used to denote the gel edges along 
the separation axis is visible in brightfield imaging. 
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Micrographs were analyzed using an in-house MATLAB (R2015b, MathWorks) 
script6,48,49 adapted to this microwell-containing variant of the IEF (code in Appendix 
12). Briefly, the micrographs were segmented into regions of interest (ROIs), converted 
into line plots averaged across the width of the ROI (maintaining the separation axis), 
and background-subtracted using the average background intensity across the ROI. 
Gaussian curve fitting to the line plots led to the extraction of the peak height, peak 
location, peak width, area under the curve, SNR, and other assay-specific parameters 
from each ROI. Validation of the Gaussian curve fits is conducted analytically (R2 ≥ 0.7 
and signal-to-noise ratio SNR ≥ 3) and confirmed manually. For the images taken on the 
Olympus microscope setup, 1 pixel corresponds to 4 μm. 
 
Table 10-3. Composition of IEF lid gel for the protein microparticle study. 
Components of the 3-part lid gel used for lysis and electrophoresis in this study. 
 
Lid gel components pH 4 anolyte Focusing region pH 10 catholyte 
Polyacrylamide gel 15% T 
3.3% C 
0.2% VA-086 
15% T 
3.3% C 
0.2% VA-086 
15% T 
3.3% C 
0.2% VA-086 
IEF reagents and 
detergents 
 
0.4% final SinuLyte® 
ampholytes 
 
1% TritonX-100 
 
250 mM imidazole 
 
Boundary conditions 13.5 mM pKa 3.6 
immobiline 
 
6.4 mM pKa 9.3 
immobiline 
 
5.6 mM pKa 3.6 
immobiline 
 
14.4 mM pKa 9.3 
immobiline 
Results 
First, we observed disruption of the formation of the pH gradient required for an IEF 
protein separation, by the inclusion of 250 mM imidazole (Figure 10-3). This region of 
Protein G aligns between the typical locations of the pI 5.5 and 6.6 markers (not shown 
here). Interestingly, imidazole may be a ampholyte of pI ~6.1).16 We hypothesized that 
this high concentration of imidazole overwhelmed the buffering capacity of the 400+ 
ampholytes in the ampholyte solution, resulting in the observed disrupted pH gradient. 
Additional characterization with pI markers confirmed the disruption of the pH gradient 
due to 250 mM or 1 M imidazole (not shown here). In this experiment, the pI markers 
were diffusively introduced throughout the gels. Upon application of the electric field, the 
pI markers swept across the separation axis, from both boundary conditions, but formed 
a leading edge around the pI 5-6 range, instead of resolving into distinct protein bands. 
 
In addition, from the streaky nature of the Protein G bands (Figure 10-3), we may have 
observed continuous loading of Protein G from the microparticles. This indicates a need 
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for modified lysis conditions for bulk release of the His-tagged Protein G mediated by 
imidazole within the 30 s lysis timeframe. 
 
 
Figure 10-3. Inverted fluorescence micrograph of Protein G indicates a disrupted pH gradient. 
Gel is oriented with the pH 4 anolyte boundary condition at the top of the image. After 10 minutes of 
electrophoresis, the Protein G forms a poorly-resolved hazy region across the center of the gel, indicating 
poor focusing in the pH 5-6 region. 
 
We concluded that this particular method of delivering a protein ladder to the scIEF 
assay was incompatible with IEF. Subsequent to this study, further research into the 
development of a protein ladder for the scIEF assay was conducted, documented in 
Chapter 6. 
Appendix 15. Research eddies 
Throughout the development of this dissertation, several research eddies were noted. 
For the amusement and possibly even edification of other researchers, a select few are 
included here.  
 
First, several chapters in this dissertation use the scIEF assay to also characterize 
photocapture efficiency with BPMA (including Chapters 3 and 4). As an attempt to 
develop a robust platform for characterizing in-gel photocapture efficiency independent 
of the IEF assay, we attempted to use a Mylar mask (CAD Art Services) to selectively 
pattern a region of turboGFP purified protein. Extensive exposure of the Mylar mask 
with UV light using a Hamamatsu LC8 device (Hamamatsu Photonics K.K.) at < 1 cm 
distance may induce inadvertent removal of the mask material, rendering a hole in the 
mask itself. Such damage was not duplicated by use of the OAI, nor by use of the 
Hamamatsu at an extended distance. 
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Figure 10-4. Mask inadvertently damaged via exposure to high-intensity UV light. 
 
Next, Chapter 3 describes the development and utilization of highly-porous, laterally-
aggregated PA gels. Directly and visually characterize the porosity of these hydrogels in 
their hydrated form is an ongoing challenge in the biomaterials landscape. As a proof-
of-concept attempt, we interrogated the porosity of the 6%T 8%C APS/TEMED + 2% 
PEG gel composition, compared to the benchmarking 6%T 3.3%C APS/TEMED gel 
composition. 
 
Figure 10-5A-B were collected with the assistance of Dr. Andrew Barazia during a 
demo of the Lattice Lightsheet microscope (Intelligent Imaging Innovations, 3i) through 
the UC Berkeley CRL Molecular Imaging Center in February 2019. The gels were 
polymerized on 5 mm coverslips with rhodamine methacrylamide incorporated into the 
gel matrix for visualization, and maintained in a water bath during imaging. Figure 
10-5A depicts the benchmarking gel, with no clear gaps in the gel microstructure 
(fluorescence imaging via rhodamine, false-colored white). In contrast, Figure 10-5B 
depicts gaps in the gel microstructure of the highly-porous 2% PEG gel. By best 
estimate, these images represent 250 nm resolution within the top 30 microns of the gel 
material. Timelapse imaging of the 2% PEG gels (not reported here) included 
movement within the PA gel during imaging, potentially indicative of Brownian motion of 
the PA gel in a fluid bath. 
 
Figure 10-5C-D are SED images (SEM-like, from dehydrated gels) collected by Dr. 
Heather Robison, among others, on a multiplexed ion beam imaging (MIBI) platform in 
spring 2019. Similar to the lightsheet microscopy images, the 2% PEG gels may 
indicate a porous microarchitecture not seen in the benchmarking gels. The cracks in 
the benchmarking gels may be attributable to salt content pre-gel-dehydration. 
 
It is essential to note that these are proof-of-concept images, for which significant 
imaging optimization is required. Nevertheless, these images are promising indicators 
that the highly-porous 2% PEG gels do contain acrylamide bundles on the order of 200 
nm, and large pores on the order of 500 nm, similar to the laterally-aggregated 
polyacrylamide gels reported by Righetti et al.70 Furthermore, the minimal sample 
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preparation required for these measurements of pore dimensions in hydrated gels is 
particularly intriguing. 
A 
 
B 
 
 
C 
 
 
D 
 
Figure 10-5. Visual characterization of the porosity of highly-porous PA gels. 
(A and B) are 2-dimensional depictions of 3-dimensional images collected on the Lattice lightsheet 
microscope, oriented with the gel surface at the top of the image. (C and D) are 2-dimensional SED 
images of the surface of the gels, collected on the multiplexed ion beam imaging platform. The field of 
view is approximately 400 microns. (A and C) represent the 6%T 3.3%C APS/TEMED gel composition. (B 
and D) represent the 6%T 8%C APS/TEMED + 2% PEG gel composition. Images are attributable to (A-B) 
Dr. Andrew Barazia and (C-D) Dr. Heather Robison. 
Appendix 16: Development of a lab cybersecurity SOP 
After an unfortunate cybersecurity incident in the Herr lab, Dr. Samantha Grist and I 
developed a lab cybersecurity SOP, with assistance from other Herr lab members, the 
UC Berkeley Information Security and Policy office, and others at UC Berkeley. We are 
grateful to John Ives, Craig Carlson, Chris Doane, and many others in the development 
of this document. The June 2018 version, modified for distribution among other 
research groups, is included in this dissertation. 
 
This document reports current practices for cybersecurity for the Herr Lab at UC 
Berkeley, and was designed with UC Berkeley security policies in mind and reviewed by 
the UC Berkeley ISP office.  When adapted for other research groups, please refer to 
the relevant university ISP/IT services offices and university online resources to ensure 
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that the group SOP meets minimum security standards for networked devices at the 
relevant university.   
 
This SOP is separated into sections for all lab members, for superusers of equipment 
connected to lab PCs, and for cybersecurity superusers. 
All lab members  
Our group protection against cybersecurity threats is only as strong as the weakest of 
our individual protections, so it is crucial that we all employ stringent cybersecurity 
practices in both our personal devices and use of shared lab PCs. 
 
Please review the university’s minimum security standards for all networked devices, as 
well as recommendations on steps that you can take for protection against ransomware, 
and best practices for cybersecurity.  By following this Herr Lab security policy, we are 
meeting campus policies for minimum security standards. 
 
Accounts and passwords 
1. Current recommendations (please review the link to ensure you are using secure 
passwords!) suggest that passwords need to be >10 characters in length to 
ensure security.  Use strong and different passwords/passphrases for each of 
your personal computers as well as all online accounts.   
2. Ensure that all personal accounts on lab computers have secure passwords.  
3. Consider enabling two-step verification in your CalNet ID for increased security 
(Dropbox, Gmail, etc. have similar options which add an extra level of security: 
you cannot login from new devices without having a code from your phone).   
4. Consider also using a password manager (e.g. 1password) to make sure you can 
remember and do not repeat your passwords.  Make sure that you are changing 
passwords from computers that are known to be secure (e.g. clean virus scan 
from 2+ software for thoroughness, no signs of infection). 
 
Personal computers 
1. Ensure that you are promptly receiving and installing all security updates.  
Prompt security updates are our best protection against vulnerabilities.  Ensure 
that Windows Defender also receives updates. 
2. Ensure that you have enabled computer screen lock to ensure no unattended 
sessions, and set a lock-out threshold to help protect against brute-force attacks.   
3. Install Microsoft System Center Endpoint Protection, Malwarebytes, Avast (free 
for Windows) and/or Sophos (free for Mac OSX) for additional protection.  
4. Ensure that Windows Defender and Avast (Windows) or Sophos (Mac) are 
automatically scanning the PC and receiving updated threat definitions (set it up 
to scan every day, in the middle of the night). 
5. Make sure that the firewall is enabled. 
6. Back up your data.   It is important to implement automated off-site backups in 
case of fire/flood/theft (and there is a chance that directly connected external 
drives could also be compromised in case of ransomware infection).  Backblaze 
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can be used for off-site backup, with automated backup as well as 30-day 
rollback on backups. There are also other similar services with similar pricing 
(e.g. Crashplan), and UC Backup. 
7. Report any malware issues promptly to the cybersecurity superusers as well as 
security@berkeley.edu. 
 
USB drives 
USB drives are a primary vector for malware.  We need to practice stringent security 
hygiene with all of our USB flash and hard drives. 
1. Where possible, avoid use of USB drives (use cloud share tools to transfer files). 
2. Regularly scan your USB drives with antimalware software (particularly after 
using any computers in shared facilities, and at least once a week during regular 
use).  Please scan your USB before opening or transferring files. This will not 
only protect vulnerable lab PCs but also your personal files, data, and 
information.  
3. If using USB drives with computers that are not connected to the internet and/or 
running unsupported Windows (XP, Vista, or older than these, as of June 2018), 
scan your USB drive both before and after use with the vulnerable machine to 
avoid spreading malware. This includes several shared lab computers and all 
shared facility computers. 
4. Report any malware found on your USB drive to the cybersecurity superusers, 
along with a record if possible of the PCs to which you recently connected. 
 
Use of lab PCs 
1. Be careful about websites you access, emails you open, and files you download. 
2. See something?  Say something!  Read all dialogue boxes and report any virus 
scan or other issues to the cybersecurity superusers. 
3. If using USB drives with computers that are not connected to the internet and/or 
running unsupported Windows (XP, Vista, or older, as of June 2018), scan your 
USB drive both before and after use with the vulnerable machine to avoid 
spreading malware. 
 
Remote access 
Note that on computers with remote access enabled, we have initiated a lockout policy 
for enhanced security. Take care with typing passwords on these PCs to minimize 
disruption. Remote access should only be enabled when necessary and should only 
be enabled by the cybersecurity superusers, so discuss with them if you propose 
remote access should be enabled on any PC. 
Superusers of equipment connected to PCs 
All superusers are responsible for basic cybersecurity hygiene on the PCs connected to 
their equipment. This involves making sure that the PCs are as up-to-date as possible 
and regularly scanned for malware, and verifying that the computer inventory is current 
and complete. 
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First, determine if the PC is running Windows that is currently supported by Microsoft.  
Then follow the instructions below, depending on whether the Windows version still 
receives security updates. 
 
Supported Windows (7, 8, and 10, as of June 2018) 
1. Make sure that the PC has internet access so that it can receive necessary 
security updates and threat definitions.  Prompt security updates are our best 
protection against vulnerabilities.  
2. Install additional antivirus protection. 
3. Ensure that all antivirus software are automatically scanning the PC (set it up to 
scan every day, in the middle of the night).  
4. Make sure that the firewall is enabled. 
5. Ensure automatic updates are enabled.  If automatic updates are absolutely not 
possible (e.g. we regularly need to run things overnight on that PC, and cannot 
handle weekly or biweekly restarts for security updates), disable automatic 
updates and schedule a time weekly when you will manually check for and install 
the updates and restart the PC.  You are responsible for making sure that this PC 
is kept up to date.  Add PC updates as an event to both the equipment calendar 
(so others schedule their work accordingly) and to your calendar (so you 
remember to do this crucial step).  Windows updates are released weekly on 
Tuesday nights.   
6. Check the PC every week, looking at the antivirus scan logs and reporting any 
issues to the cybersecurity superusers. 
7. Ensure that you have enabled computer screen lock to ensure no unattended 
sessions, and set a lock-out threshold to help protect against brute-force attacks.   
 
Unsupported Windows (XP, Vista, older as of June 2018) 
All computers running unsupported Windows are a security risk as they do not have 
access to security updates.  We need to work to minimize the number of these kinds of 
systems that we have as well as mitigate risks associated with their presence. 
 
1. Ensure the PC is not connected to the internet. Deactivate Ethernet connection, 
WiFi adapters, remote access, and any other ports that could enable internet 
connection. Remove all unnecessary wiring. 
2. Verify that the computer inventory is complete (listed hardware/software 
incompatibility is preventing us from updating Windows).  If not, contact the 
previous superusers and the equipment manufacturer for all connected hardware 
to determine whether Windows can be updated. 
3. If Windows can be updated, work with the cybersecurity superusers to bring it up 
to date. 
4. If Windows cannot be updated, ensure that the most recent service pack 
(Windows 7 and later, XP) and patches for that Windows version are installed.  If 
they aren’t, work with the cybersecurity superusers to install them (we may 
temporarily connect the PC to the internet). 
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5. If possible, install antivirus protection software and Sophos virus removal tool (via 
a known clean USB) on the PC. 
6. Set up a daily virus scan and check the results once a week, reporting any issues 
to the cybersecurity superusers. 
7. When training users, stress the importance of scanning USB drives before and 
after use with the at-risk machine. 
Cybersecurity superusers  
This section describes the cybersecurity superuser duties and recommendations for 
setting up remote access. 
 
Superuser duties 
1. Ensure all lab computers are running up-to-date antimalware. 
2. Train all lab members in best practices outlined above. 
3. Train equipment superusers on the use of antimalware and Windows updates as 
outlined above. 
4. Assist group members with cybersecurity questions. 
5. Keep this document and best practices up-to-date. 
6. Set up security settings on all lab PCs. 
7. Work with the data storage superusers to ensure that all computers are backed 
up (automated, off-site backup for maximum reliability). 
8. Work with equipment superusers to ensure that PCs are up-to-date. 
9. Initiate review of cybersecurity best practices provided by the information security 
office to ensure that our best practices are up to date. 
10. When threats are detected: 
a. If necessary, report the threat to the information security office and to 
federal governmental agencies. 
b. Assist in the removal of the threat from the device on which it was found 
(including a complete wipe and reinstall if needed). 
c. Assist in tracking from where the threat originated and removing it from 
there as well (for USB drives being infected from other lab or shared 
facility PCs). 
d. Quickly report the threat to the group, with necessary next steps (email). 
e. Summarize the threat and learning points for reporting to our group. 
f. Make any necessary changes to improve the set of best practices and 
recommendations in our group’s cybersecurity policies. 
 
Setting up remote access 
Remote access should only be enabled when necessary.  Remote access will always 
make computers more vulnerable to attack, but this risk may be worthwhile in cases 
with significant benefit in work efficiency (e.g. check and restart long simulations from 
home, or check on long experiments with monitoring).  Remote access should only be 
enabled by the cybersecurity superusers, so discuss with them if you propose enabling 
remote access on any PC. 
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Cybersecurity/IT superusers should review the university’s security recommendations 
for Windows Remote Desktop.  This article should be periodically read by the 
superusers, and the recommendations below should be updated as needed. 
Appendix 17: Cell line authentication and mycoplasma testing certificates 
2016 cell line authentication and mycoplasma testing 
   
 
 
  
	
	
University	of	California,	Berkeley	
Cell	Culture	Facility	
	
Certificate	of	Analysis	
Cell	Line	Short	Tandem	Repeat	(STR)	Report	
Sample	name:	2-U251	
Date	received:	9/2/16	
Client:	Elaine	Su	
	
LOCUS	 ALLELE	SIZE	
THO1	 9.3	
D5S818	 11,12	
D13S317	 10,11	
D7S820	 10,12	
D16S539	 12	
CSF1PO	 11,12	
AMEL	 X,Y	
vWA	 16,18	
TPOX	 8	
	
Results	 indicate	the	al lele(s) 	detected	at	each	locus	tested.	Each	al lele	represents	the	number	of	short	
tandem	 repeats	 present	 at	 that	 locus. 	 General ly, 	 a	 DNA	 profi le	 uniquely	 identif ies	 an	 individual	 cel l 	
l ine.	 However, 	 some	 cel l 	 l ines	 may	 exhibit 	 genomic	 instabil ity	 over	 t ime	 leading	 to	 sl ight	 changes	 in	
the	DNA	profi le. 	
	
IDENTIFIED	CELL	TYPE(S)	 PERCENT	MATCH	
U-251	MG	 100%	
	
Based	 on	 STR	 analysis, 	 the	 results	 indicate	 a	 high	 probabil ity	 (80%	 or	 higher)	 match	 with	 the	 U-251	
MG	cell 	 l ine. 	Multiple	cel l 	 l ines	with	≥80%	match	are	considered	to	be	derived	from	common	ancestry. 	
Electropherograms	are	available	upon	request. 	
	
Mycoplasma	 test: 	NEGATIVE	9/2/16	 	Cells 	were	 f ixed	with	methanol	and	stained	with	Hoechst	nuclear	
stain	to	visualize	nuclei. 	Small 	nuclei 	present	 in	the	cel lular	membrane	indicate	mycoplasma	infection. 	
	
Disclaimer: 	 While	 every	 reasonable	 effort	 has	 been	 made	 to	 assure	 the	 accuracy	 of	 these	 data,	 no	
warranty,	express	or	 implied,	 is 	made	by	this	faci l ity. 	
	
	
	
	
	
Al ison	N.	Ki l l i lea, 	Ph.D.	|	Bioscience	Faci l ity	Manager	
	
	
University	of	California,	Berkeley	
Cell	Culture	Facility	
	
Certificate	of	Analysis	
Cell	Line	Short	Tandem	Repeat	(STR)	Report	
Sample	name:	1-MCF-7	
Date	received:	9/2/16	
Client:	Elaine	Su	
	
LOCUS	 ALLELE	SIZE	
THO1	 6	
D5S818	 11,12	
D13S317	 11	
D7S820	 8,9	
D16S539	 11,12	
CSF1PO	 10	
AMEL	 X	
vWA	 14,15	
TPOX	 9,12	
	
Results	 indicate	the	al lele(s) 	detected	at	each	locus	tested.	Each	al lele	represents	the	number	of	short	
tandem	 repeats	 present	 at	 that	 locus. 	 General ly, 	 a	 DNA	 profi le	 uniquely	 identif ies	 an	 individual	 cel l 	
l ine.	 However, 	 some	 cel l 	 l ines	 may	 exhibit 	 genomic	 instabil ity	 over	 t ime	 leading	 to	 sl ight	 changes	 in	
the	DNA	profi le. 	
	
IDENTIFIED	CELL	TYPE(S)	 PERCENT	MATCH	
MCF-7	 100%	
	
Based	 on	 STR	 analysis, 	 the	 results	 indicate	 a	 high	 probabil ity	 (80%	 or	 higher)	 match	 with	 the	 MCF-7	
cel l 	 l ine. 	 Multiple	 cel l 	 l ines	 with	 ≥80%	 match	 are	 considered	 to	 be	 derived	 from	 common	 ancestry. 	
Electropherograms	are	available	upon	request. 	
	
Mycoplasma	 test: 	NEGATIVE	9/2/16	 	Cells 	were	 f ixed	with	methanol	and	stained	with	Hoechst	nuclear	
stain	to	visualize	nuclei. 	Small 	nuclei 	present	 in	the	cel lular	membrane	indicate	mycoplasma	infection. 	
	
Disclaimer: 	 While	 every	 reasonable	 effort	 has	 been	 made	 to	 assure	 the	 accuracy	 of	 these	 data,	 no	
warranty,	express	or	 implied,	 is 	made	by	this	faci l ity. 	
	
	
	
	
	
Al ison	N.	Ki l l i lea, 	Ph.D.	|	Bioscience	Faci l ity	Manager	
	
	
University	of	California,	Berkeley	
Cell	Culture	Facility	
	
Certificate	of	Analysis	
Cell	Line	Short	Tandem	Repeat	(STR)	Report	
Sample	name:	11-CHO	parent	
	 	 					12-CHO	p	95	
	 	 					13-CHO	p185	 	 	
Date	received:	9/2/16	
Client:	Elaine	Su	
	
	
Mycoplasma	 test: 	NEGATIVE	9/2/16	 	Cells 	were	 f ixed	with	methanol	and	stained	with	Hoechst	nuclear	
stain	to	visualize	nuclei. 	Small 	nuclei 	present	 in	the	cel lular	membrane	indicate	mycoplasma	infection. 	
	
Disclaimer: 	 While	 every	 reasonable	 effort	 has	 been	 made	 to	 assure	 the	 accuracy	 of	 these	 data,	 no	
warranty,	express	or	 implied,	 is 	made	by	this	faci l ity. 	
	
	
	
	
	
Al ison	N.	Ki l l i lea, 	Ph.D.	|	Bioscience	Faci l ity	Manager	
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University	of	California,	Berkeley	
Cell	Culture	Facility	
	
Certificate	of	Analysis	
Mycoplasma	Testing	
Sample	names:	U-251-GFP,	BJ	fibroblasts,	BT474,	HEK	293,	MCF-7,	MDA-MB-231,	MDA-MB-
231	GFP	Actin,	MDA-MB-231	GFP	Actin	+	sh	HSF1B	
Date	received:	9/22/2017	
Client:	Alisha	Geldert	
	
	
Mycoplasma	 test: 	 NEGATIVE	 9/22/17:	 Cells 	 were	 f ixed	 with	 methanol	 and	 stained	 with	 Hoechst	
nuclear	 stain	 to	 visualize	 nuclei. 	 Small 	 nuclei 	 present	 in	 the	 cel lular	 membrane	 indicate	 mycoplasma	
infection.	
	
Disclaimer: 	 While	 every	 reasonable	 effort	 has	 been	 made	 to	 assure	 the	 accuracy	 of	 these	 data,	 no	
warranty,	express	or	 implied,	 is 	made	by	this	faci l ity. 	
	
	
	
	
	
Al ison	N.	Ki l l i lea, 	Ph.D.	|	Bioscience	Faci l ity	Manager	
	
	
University	of	California,	Berkeley	
Cell	Culture	Facility	
	
Certificate	of	Analysis	
Mycoplasma	Testing	
Sample	names:	U-2OS	+	Halotag	+CTCF	C32,	U-251	+	TurboGFP,	HeLa,	MCF-7,	
MDA-MB-231,	MCF-7	+GFP,	BT474,	CHO-p185HER2,	CHO-p110HER2,	CHO-
p95HER2,	BJ	fibroblasts,	MDA-MB-231	GFP	Actin	
Date	tested:	10/30/18	
Client:	Alisha	Geldert	
	
	
Mycoplasma	 test: 	 NEGATIVE	 10/30/18:	 Cells 	 were	 f ixed	 with	 methanol	 and	 stained	 with	 Hoechst	
nuclear	 stain	 to	 visualize	 nuclei. 	 Small 	 nuclei 	 present	 in	 the	 cel lular	 membrane	 indicate	 mycoplasma	
infection.	
	
Disclaimer: 	 While	 every	 reasonable	 effort	 has	 been	 made	 to	 assure	 the	 accuracy	 of	 these	 data,	 no	
warranty,	express	or	 implied,	 is 	made	by	this	faci l ity. 	
	
	
	
	
	
Al ison	N.	Ki l l i lea, 	Ph.D.	|	Bioscience	Faci l ity	Manager	
 
 
University of California,  Berkeley 
Cell Culture Facility 
 
Certif icate of Analysis 
Cell Line Short Tandem Repeat (STR) Report 
Sample name: U-251 + GFP 
Date received: 10/30/19 
Client: Alisha Geldert-UCB 
 
LOCUS ALLELE SIZE 
THO1 9.3 
D5S818 11,12 
D13S317 10,11 
D7S820 10,12 
D16S539 12 
CSF1PO 11,12 
AMEL X,Y 
vWA 16,18 
TPOX 8 
 
Results indicate the allele(s) detected at each locus tested. Each allele represents the number of short 
tandem repeats present at that locus. Generally,  a DNA profi le uniquely identifies an individual cell  
l ine. However, some cell  lines may exhibit genomic instabil ity over time leading to sl ight changes in the 
DNA profi le.  
 
 
IDENTIFIED CELL TYPE(S) PERCENT MATCH 
U-2 51  100% 
 
 
Based on STR analysis,  the results indicate a high probabil ity (80% or higher) match with the cell  l ine  
#1 l isted. Multiple cell  l ines with ≥80% match are considered to be derived from common ancestry. 
Electropherograms are available upon request. 
 
Disclaimer:  While every reasonable effort has been made to assure the accuracy of these data, no 
warranty, express or implied, is made by this facil ity.  
 
 
 
 
 
Alison N. Kil l i lea, Ph.D. | Bioscience Facil ity Manager 
 
 
University of California,  Berkeley 
Cell Culture Facility 
 
Certif icate of Analysis 
Cell Line Short Tandem Repeat (STR) Report 
Sample name: MCF-7 GFP 
Date received: 10/30/19 
Client: Alisha Geldert-UCB 
 
LOCUS ALLELE SIZE 
THO1 6 
D5S818 12 
D13S317 11 
D7S820 8,9 
D16S539 11,12 
CSF1PO 10 
AMEL X 
vWA 14,15 
TPOX 9,12 
 
Results indicate the allele(s) detected at each locus tested. Each allele represents the number of short 
tandem repeats present at that locus. Generally,  a DNA profi le uniquely identifies an individual cell  
l ine. However, some cell  lines may exhibit genomic instabil ity over time leading to sl ight changes in the 
DNA profi le.  
 
 
IDENTIFIED CELL TYPE(S) PERCENT MATCH 
MC F-7  97% 
 
 
Based on STR analysis,  the results indicate a high probabil ity (80% or higher) match with the cell  l ine  
#1 l isted. Multiple cell  l ines with ≥80% match are considered to be derived from common ancestry. 
Electropherograms are available upon request. 
 
Disclaimer:  While every reasonable effort has been made to assure the accuracy of these data, no 
warranty, express or implied, is made by this facil ity.  
 
 
 
 
 
Alison N. Kil l i lea, Ph.D. | Bioscience Facil ity Manager 
 
 
University of California,  Berkeley 
Cell Culture Facility 
 
Certif icate of Analysis 
Mycoplasma Testing 
Sample names: BT474, SK-BR-3, MCF-7 naive, MDA-MB-231, HEK 293, CHO-p185, 
CHO-p110, CHO-p95, U-251 + TurboGFP, MDA-MB-231 GFP Actin, MDA-MB-231 -
sh scramble GFP Actin, MDA-MB-231 GFP Actin+HSF1 OE, MDA-MB-231 GFP Actin 
+RFP lenti,  MDA-MB-231 GFP Actin+sh HSF1B, MDA-MB-231 GFP control,  BJ 
fibroblasts, U251 naïve, HeLa 
Date tested: 10/31/19 
Client: Alisha Geldert 
 
 
Mycoplasma test:  NEGATIVE 10/31/19: Cells were f ixed with methanol and stained with Hoechst nuclear  
stain to visualize nuclei.  Small  nuclei present in the cellular membrane indicate mycoplasma infection. 
 
Disclaimer:  While every reasonable effort has been made to assure the accuracy of these data, no 
warranty, express or implied, is made by this facil ity.  
 
 
 
 
 
Alison N. Kil l i lea, Ph.D. | Bioscience Facil ity Manager 
